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Riassunto 
 
La proteomica è un potente e sensibile strumento per studiare le proteine nel loro 
“insieme” e permette, in definitiva, di comprendere nella loro complessità i fenomeni 
biochimici che avvengono nei processi cellulari 1-2. Se, parafrasando una definizione 
di biotecnologia della European Federation of Biotechnology, le cellule o parti di esse 
vengono specificamente utilizzate per la “produzione di beni e servizi” 3, appare 
evidente come sempre più la proteomica, insieme con le altre discipline omiche, 
svolga ormai un ruolo centrale nel rispondere alle richieste delle biotecnologie 
industriali in termini di miglioramenti ed ottimizzazione dei processi esistenti, di 
sviluppo di nuovi prodotti per l’industria chimica e farmaceutica, di risposta alle 
sempre più impellenti esigenze di energia da fonti rinnovabili 4. In una recente 
rassegna 3 la proteomica è rappresentata come uno degli ingranaggi centrali che 
consente di estendere gli approcci della “biologia dei sistemi” alle biotecnologie. 
Recentemente, in seguito ai notevoli progressi tecnologici nel campo della 
progettazione e della realizzazione di spettrometri di massa ad elevata risoluzione e 
sensibilità, sono state sviluppate una serie di metodologie per l’analisi di modifiche 
post-traduzionali, basate sull’utilizzo di tecniche di spettrometria di massa. Tuttavia 
esiste la necessità di sviluppare metodologie di analisi quantitativa per sfruttare 
adeguatamente queste innovazioni strumentali e per rispondere in termini quantitativi 
ad esigenze poste, ad esempio, dall'implementazione dei processi biotecnologici. 
Un'esigenza particolarmente sentita si riferisce alla necessità di definire in termini 
quantitativi alcune modifiche post-traduzionali che, a livello sub-stechiometrico, 
comportano l'accensione o lo spegnimento di importanti circuiti metabolici. Un 
approccio che potenzialmente è in grado di rispondere a questo tipo di problematica, 
e che è stato da me utilizzato durante il mio dottorato di ricerca, è rappresentato da 
procedure di derivatizzazione chimica selettiva mediante molecole isotopicamente 
marcate, in combinazione con l’utilizzo di tecniche avanzate di spettrometria di 
massa. Una molecola adatta a questo tipo di applicazione è iTRAQ 5. La scelta di 
iTRAQ è motivata dalla possibilità di utilizzare questa molecola per strategie definite 
RIGhT (Reporter Ion Generating Tag) 6 per l’analisi selettiva di modifiche post-
traduzionali; strategie analitiche di questo tipo sfruttando le caratteristiche di 
frammentazione in fase gassosa degli iTRAQ-derivati e le potenzialità di uno 
spettrometro di massa dotato di analizzatore ibrido a triplo quadrupolo e trappola 
ionica lineare (QqLIT), in grado di effettuare analisi utilizzando una particolare 
modalità di scansione definita Precursor Ion Scan (PIS). Con questa modalità è 
possibile effettuare un’analisi dei soli ioni precursori che durante frammentazione 
producono uno specifico ione frammento che. Un’analisi di questo tipo, rispetto ad 
una classica analisi LC-MS/MS, semplifica notevolmente l’interpretazione dei dati: 
infatti, a meno di falsi positivi, gli unici spettri MS ed MS/MS che si otterranno 
dall’analisi, saranno quelli relativi ai peptidi marcati con iTRAQ. In questo modo si 
può effettuare contemporaneamente l’analisi qualitativa e quantitativa dei campioni in 
esame, evitando ulteriori passaggi di purificazione o arricchimento delle specie di 
interesse, che sono fondamentali nelle strategie finora proposte per l’analisi delle 
suddette modifiche. L’eliminazione del passaggio di arricchimento consente di 
aumentare la sensibilità della strategia analitica, fattore estremamente importante 
dato il carattere sub-stechiometrico delle modifiche post-traduzionali che sono state 
oggetto di studio durante lo svolgimento della tesi di dottorato. In particolare durante 
il mio dottorato mi sono occupato dello sviluppo di metodologie per l’analisi 
 2 
 
qualitativa e quantitativa della nitrazione dei residui di tirosina, della carbonilazione 
dei residui di lisina e della fosforilazione dei residui di serina e treonina.  
 
Analisi quantitativa dei residui di 3-nitrotirosina 
La nitrazione di residui di tirosina (conversione della tirosina in 3-nitrotirosina) è una 
tra le più comuni modifiche post-traduzionali indotte da stress ossidativo 7; si tratta di 
una modifica chimica irreversibile, difficilmente analizzabile mediante approcci di 
proteomica classica dato il suo carattere sub-stechiometrico. Molti degli studi 
pubblicati sullo studio di questa modifica sono basati sull’utilizzo della elettroforesi 
bidimensionale in combinazione con la tecnica del Western blot, sfruttando la 
disponibilità di anticorpi specifici per i residui di tirosina nitrati 8; dati i limiti di queste 
metodologie, risulta però molto difficile ottenere informazioni circa la precisa 
localizzazione del sito di modifica in una proteina, nonché informazioni quantitative 
sulla stechiometria della modifica in oggetto. Per superare tali limitazioni è stato 
quindi necessario progettare una strategia di analisi estremamente specifica e 
sensibile, che consentisse di ottenere sia informazioni qualitative sia quantitative dei 
residui in esame. Come già specificato questa strategia si è basata sull’impiego di 
reattivi iTRAQ. Oltre all’ottimizzazione dei processi chimici di derivatizzazione e 
marcatura, sono stati effettuati studi sulle caratteristiche di frammentazione in fase 
gassosa delle molecole utilizzate, mediante l’utilizzo di uno spettrometro di massa 
dotato di analizzatore ibrido a triplo quadrupolo e trappola ionica lineare. La strategia 
sviluppata durante la mia tesi di dottorato ha previsto: i) l’idrolisi triptica della miscela 
proteica in esame; ii) la protezione dei gruppi amminici primari (N-term, Lys) 
mediante acetilazione; iii) la riduzione dei nitrogruppi ad amminogruppi; iv) la 
marcatura selettiva degli amminogruppi generati. Data l’irreperibilità in commercio di 
proteine modello per l’analisi dei residui di 3-nitrotirosina, è stato inoltre necessario 
mettere a punto una strategia di modifica chimica per l’introduzione di nitro-gruppi sui 
residui di tirosina; tale strategia ha previsto l’utilizzo di tetranitrometano (TNM) 9 per 
la nitrazione di tali residui. Per l’ottimizzazione dell’intera strategia è stata scelta 
come proteina modella l’albumina di siero bovino (BSA), proteina che presenta nella 
sua struttura primaria 20 residui di Tyr; la verifica della avvenuta nitrazione dei 
residui di Tyr è stata effettuata mediante analisi di spettrometria di massa MALDI-
TOF delle miscele peptidiche ottenute dall’idrolisi enzimatica delle proteine 
modificate. Dai dati ottenuti in questa prima fase è stato possibile verificare che non 
tutti i residui di Tyr della proteina sono convertiti a 3-NO2Tyr. Questo dato è in linea 
con altri dati presenti in letteratura circa la selettività della nitrazione dei residui di 
Tyr, selettività che dipende essenzialmente dall’accessibilità al solvente di tali residui 
e dalle caratteristiche chimico-fisiche dell’intorno amminoacidico delle singole Tyr 10. 
Negli esperimenti condotti i residui di Tyr che sono stati identificati come nitrati in 
seguito alla reazione con TNM sono le Tyr in posizione 137, 331, 400 e 451. La 
protezione dei gruppi amminici primari è stata effettuata mediante acetilazione; 
esperimenti preliminari sono stati condotti utilizzando anidride acetica come reattivo 
acetilante, ma analisi di spettrometria di massa hanno evidenziato come la resa della 
reazione non fosse quantitativa. Per tale motivo è stato successivamente scelto 
come reattivo l’acido acetico N-idrossisuccinimmide estere, che ha consentito di 
ottenere l’acetilazione pressoché quantitativa dei gruppi amminici presenti. Solo in 
seguito alla reazione di acetilazione è stato possibile effettuare la riduzione dei 
nitrogruppi delle o-nitrotirosine ad amminogruppi, suscettibili alla reazione con 
iTRAQ. Tale conversione è stata realizzata utilizzando Na2S2O4 11 e anche in questo 
caso la reazione è stata verificata mediante analisi di spettrometria di massa MALDI-
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TOF. Per la reazione di marcatura sono stati utilizzati i reattivi iTRAQ disponibili in 
commercio, nelle varianti isotopiche comunemente denominate iTRAQ 114 e iTRAQ 
117, ottimizzando il protocollo di reazione proposto dalla casa produttrice dei reattivi 
stessi (Applied Biosystems). Successivamente alla reazione di marcatura, le miscele 
risultanti sono state riunite in modo da ottenere campioni che contenessero BSA 
nitrata marcata con iTRAQ 114 e con iTRAQ 117 in rapporto molare 1:1 e 1:4 
rispettivamente. Le due miscele (1:1 e 1:4) sono state quindi analizzate mediante 
LC-MS/MS in modalità Precursor Ion Scan per gli ioni reporter tipici dei reattivi 
iTRAQ (m/z 114 e m/z 117), usando un 4000QTrap accoppiato ad un sistema 
nanoHPLC; in questo modo è stato possibile identificare i siti di nitrazione ed 
effettuare l’analisi quantitativa relativa dei soli peptidi nitrati con una singola analisi. 
Per dimostrare l’applicabilità di tale strategia all’analisi proteomica, è stato costruito 
un opportuno sistema modello di maggiore complessità, aggiungendo ad un intero 
estratto proteico di E. coli, la BSA nitrata. Successivamente è stato utilizzato il 
protocollo di analisi precedentemente descritto per l’analisi di questa miscela. La 
miscela è stata infine analizzate mediante LC-MS/MS come descritto in precedenza; 
l’interpretazione dei dati ottenuti è stata effettuata utilizzando il software MASCOT 
per l’identificazione delle proteine nitrate presenti nel campione; sebbene in questo 
caso la miscela fosse molto più complessa, il risultato ottenuto ha consentito di 
identificare gli stessi siti di nitrazione della BSA già identificati nel caso dell’analisi 
della singola proteina. La strategia proposta è stata infine utilizzata per identificare i 
residui di o-nitritirosina nell’intera frazione proteica del latte bovino. In particolare tale 
frazione proteica è stata nitrata in vitro, come per la BSA, e il grado di nitrazione è 
stato verificato mediante SDS-PAGE e Western blot per verificare che la percentuale 
di proteine nitrate nel campione fosse bassa, in modo da riprodurre il più possibile i 
reali livelli di proteine nitrate presenti nelle cellule. 
Anche in questo caso i campioni proteici sono stati sottoposti al protocollo di 
reazione precedentemente illustrato, e marcati con i reattivi iTRAQ 114 e 117; anche 
in questo caso sono state preparate miscele composte da campione marcato con 
iTRAQ 114 e campione marcato con iTRAQ 117 in rapporto molare 1:1 e 1:4 
rispettivamente. Le successive analisi mediante LC-MS/MS in modalità PIS, hanno 
permesso sia di identificare i siti di nitrazione presenti sia di effettuare l’analisi 
quantitativa relativa dei residui nitrati nelle due miscele in esame. 
 
Marcatura selettiva dei residui carbonilati per l’analisi qualitativa mediante 
spettrometria di massa bidimensionale e per l’analisi quantitativa 
Una strategia di analisi simile a quella ottimizzata per l’analisi della nitrazione, è stata 
utilizzata per l’analisi dei residui di carbonilazione, generati in seguito ad eventi di 
ossidazione. La carbonilazione è una modifica post-traduzionale chimica irreversibile; 
consiste nella aggiunta di un gruppo carbonilico (aldeide o chetone) su particolari 
residui amminoacidici (lisina, arginina, prolina, treonina, istidina) a causa della 
presenza di elevati livelli di ROS (Reactive Oxygen Species) 12. Durante il mio 
dottorato mi sono occupato in particolare dell’analisi di residui di semialdeide α-
amminoadipica, generati dall’ossidazione di residui di lisina 12. La carbonilazione di 
tali residui è una delle maggiori conseguenze dei fenomeni di stress ossidativo; per 
tale motivo riuscire ad avere informazioni qualitative e quantitative su tali fenomeni, 
può risultare di fondamentale importanza nella comprensione dei danni cellulari 
causati dallo stress ossidativo. Per ottenere tale risultato mi sono servito di strategie 
di tipo RIGhT mediante l’utilizzo combinato di particolari reattivi per la marcatura 
selettiva dei residui d’interesse in combinazione con tecniche avanzate di analisi di 
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spettrometria di massa; in particolare in un primo momento ho messo a punto una 
metodologia per l’analisi qualitativa dei residui di semialdeide α-amminoadipica, 
sfruttando la dansil-idrazide, un derivato del dansile presente in commercio specifico 
per i gruppi carbonilici, e in seguito ho sintetizzato un nuovo derivato di iTRAQ, 
l’iTRAQ-idrazide, per l’analisi quantitativa di tali residui. La strategia proposta 
risponde alle necessità di sensibilità e specificità per l’analisi di una modifica sub-
stechiometrica, quale appunto la carbonilazione. Le metodologie esistenti, basate 
essenzialmente su tecniche immunochimiche 13, non hanno la capacità di consentire 
l’identificazione puntuale dei residui modificati, nonché di effettuarne un’analisi 
quantitativa.  
Data l’irreperibilità in commercio di proteine modello con residui carbonilati, è stato 
innanzitutto necessario mettere a punto una strategia di modifica chimica per 
l’introduzione di residui di semialdeide α-amminoadipica in una proteina modello. Per 
ottenere tale sistema modello sono state provate varie condizioni di ossidazione su 
varie proteine disponibili in commercio; in seguito a tali prove la proteina scelta è 
stata la ribonucleasi A bovina, che è stata ossidata mediante trattamento con NaClO 
in condizioni controllate 14. Dai dati ottenuti in questa prima fase è stato possibile 
verificare che non tutti i residui ossidabili della proteina sono convertiti nelle rispettive 
forme ossidate; questo dato è in linea con altri dati presenti in letteratura circa la 
selettività della reazione di carbonilazione 15. Ottenuto il modello proteico carbonilato, 
mi sono dedicato all’ottimizzazione del processo chimico di marcatura dei residui di 
interesse con dansil-idrazide, e all’ottimizzazione del metodo di analisi mediante LC-
MS/MS. La marcatura dei residui di interesse è stata effettuata in seguito all’idrolisi 
triptica della miscela proteica in esame; l’analisi selettiva dei soli peptidi modificati è 
stata effettuata sfruttando le caratteristiche di uno spettrometro di massa ibrido 
QqLIT. In particolare l’analisi è stata condotta mediante LC-MS/MS e i peptidi marcati 
sono stati isolati mediante due criteri di selezione basati su due esperimenti 
successivi di spettrometria di massa tandem: un’analisi precursor ion scan (PIS), 
seguita da un’analisi in MS3, in una sorta di analisi di spettrometria di massa 
bidimensionale. La modalità PIS mi ha consentito di isolare all’interno della miscela 
in esame i soli ioni precursori che in seguito a frammentazione generano lo ione 
frammento a m/z 170, tipico dei dansil derivati 6; i precursori così selezionati vengono 
poi sottoposti ad un’ulteriore analisi di spettrometria di massa in modalità MS3, 
sfruttando la transizione tipica dei dansil derivati m/z 234-170. Mediante l’utilizzo di 
questa analisi di spettrometria di massa multidimensionale è stato possibile isolare 
dalla miscela peptidica in esame il solo peptide 1-10 della RNasi A, recante un 
residuo di lisina carbonilato e marcato con dansil-idrazide (in particolare il residuo di 
lisina in posizione 7). Per verificare la capacità di tale strategia di individuare 
selettivamente residui carbonilati in miscele più complesse, 100 µg di RNasi A 
carbonilata, sono stati aggiunti a 10 mg di un intero estratto proteico di E. coli. La 
miscela proteica ottenuta è stata sottoposta al protocollo di marcatura e analizzata 
mediante la strategia di LC-MS/MS bidimensionale descritta in precedenza. Anche in 
questo caso è stato possibile individuare un unico peptide marcato che, in seguito ad 
interpretazione dei rispettivi spettri MS e MS/MS, è stato attribuito nuovamente al 
peptide 1-10 della RNasi A, carbonilato e marcato con dansil-idrazide sul residuo di 
lisina in posizione 7. La mancanza di una molecola di dansil-idrazide marcata 
isotopicamente, non mi ha permesso di utilizzare questo reattivo per l’analisi 
quantitativa selettiva dei residui carbonilati. Per ovviare a ciò ho modificato 
chimicamente la molecola di iTRAQ con l’aggiunta di un residuo di idrazina, per 
dirigerne la specificità ai gruppi carbonilici. È stato, quindi, necessario ottimizzare le 
 5 
 
condizioni di reazione e di purificazione per l’ottenimento della molecola di iTRAQ-
idrazide. La molecola è stata ottenuta facendo reagire l’iTRAQ con la molecola di 
idrazina disponibile in commercio; il prodotto è stato successivamente purificato 
mediante RP-HPLC e verificato mediante analisi di spettrometria di massa MALDI-
TOF. L’iTRAQ-idrazide è stata utilizzato per la marcatura dei residui carbonilati della 
RNasi A, seguendo il protocollo descritto in precedenza per la dansil-idrazide. La 
marcatura è stata effettuata utilizzando due varianti isotopiche del reattivo iTRAQ, 
l’iTRAQ 114 e l’iTRAQ 117, con lo scopo di avere due miscele differenzialmente 
marcate sui residui carbonilati. I campioni marcati sono stati poi riuniti in modo da 
ottenere due differenti miscele con rapporto molare 1:1 e 1:4, del campione marcato 
con iTRAQ-idrazide 114 e di quello marcato con iTRAQ-idrazide 117, 
rispettivamente. Tali miscele sono state analizzate mediante la strategia LC-MS/MS 
descritta per l’analisi dei residui nitrati. L’interpretazione degli spettri MS e MS/MS 
ottenuti, mi ha permesso di individuare il residuo di lisina in posizione 7 sul peptide 1-
10 della RNasi A carbonilata come unico residuo modificato; in più, la presenza nello 
spettro di frammentazione dei segnali degli ioni reporter di iTRAQ, ha reso possibile 
effettuare l’analisi quantitativa relativa delle due miscele analizzate; i dati relative alle 
aree sottese dei segnali degli ioni reporter di iTRAQ, hanno consentito di calcolare 
un rapporto sperimentale di 1.07 + 0.03 per la miscela 1:1 e di 3.97 + 0.17 per la 
miscela 1:4. Questa metodologia di analisi qualitativa e quantitativa, rappresenta la 
prima strategia analitica in grado di consentire contemporaneamente la 
localizzazione e la quantificazione dei residui carbonilati di una proteina; inoltre ha 
dimostrato di possedere la specificità tale per consentire l’analisi qualitativa e 
quantitativa di tali residui su scala proteomica.  
 
Analisi quantitativa selettiva dei residui di pSer e pThr 
Durante il mio lavoro di tesi mi sono, inoltre, dedicato allo sviluppo di una 
metodologia analitica per l’analisi selettiva e quantitativa dei residui di pSer e pThr. 
La fosforilazione è una modifica post-traduzionale reversibile che agisce come un 
interruttore nella maggior parte dei meccanismi di regolazione dell’attività enzimatica 
e di trasduzione del segnale 16. La fosforilazione riveste, quindi, un ruolo centrale 
nella regolazione dei fenomeni cellulari e riuscire ad avere informazioni sui residui 
modificati in un dato evento cellulare e sulla stechiometria di tale modifica, risulta di 
fondamentale importanza per la comprensione dell’evento stesso. Anche la 
fosforilazione è una modifica sub-stechiometrica e come tale è molto difficile da 
studiare, soprattutto se si considera il suo carattere di modifica transiente, al 
contrario della nitrazione e della carbonilazione. Per tali motivi l’analisi proteomica 
della fosforilazione è ancora oggi di difficile realizzazione. Oltre alle classiche 
strategie di analisi che sfruttano le potenzialità dell’elettroforesi bidimensionale in 
combinazione con tecniche immunochimiche e colorimetriche per l’individuazione di 
proteine fosforilate 17-18, sono state sviluppate una serie di metodologie che fanno 
uso della spettrometria di massa e di tecniche cromatografiche di arricchimento, in 
fosfoproteine e fosfopeptidi, delle miscele in esame 19-20. Durante il mio lavoro di tesi 
ho sviluppato una strategia per l’analisi quantitativa selettiva dei residui di pSer e 
pThr, basata sulla modifica chimica selettiva dei residui di interesse e sull’analisi 
mediante tecniche avanzate di spettrometria di massa tandem. La strategia prevede 
la modifica chimica dei residui di pSer/pThr utilizzando un nuovo reattivo di classe 
RIGhT basato su molecole iTRAQ da me modificate con l’aggiunta di un residuo di 
cisteammina. In accordo con le cosiddette strategie di proteomica “gel free” la 
strategia prevede che la marcatura sia effettuata sulla miscela peptidica dopo idrolisi 
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triptica dei campioni. La procedura consiste in una reazione di β-eliminazione del 
gruppo fosfato dei residui di pSer/pThr, seguita da addizione di Michael del risultante 
residuo α,β-insaturo con la molecola di iTRAQ-cisteammina precedentemente 
sintetizzata. Questa molecola è stata scelta sia perché risponde alla necessità di 
avere un gruppo SH libero da utilizzare come donatore per la reazione di addizione 
di Michael, sia perché possiede un residuo iTRAQ, necessario per l’analisi 
quantitativa selettiva. Per questo motivo il primo obiettivo del mio lavoro è stato 
quello di sintetizzare e purificare tale molecola. La sintesi è stata messa a punto 
utilizzando cistammina e iTRAQ come prodotti di partenza; la molecola di iTRAQ-
cistammina ottenuta è stata ridotta mediante l’utilizzo di TBP ad iTRAQ-cisteammina 
e purificata mediante RP-HPLC. Il prodotto della reazione è stato verificato mediante 
analisi di spettrometria di massa MALDI-TOF. La procedura di marcatura selettiva in 
due passaggi è stata ottimizzata utilizzando come proteina modella la α-caseina 
bovina, una proteina naturalmente fosforilata. La reazione di β-eliminazione è stata 
effettuata incubando un’aliquota di miscela peptidica di α-caseina con una soluzione 
satura di Ba(OH)2 6; è infatti noto che a pH elevati, i residui di pSer/pThr perdono il 
gruppo fosfato in seguito a β-eliminazione catalizzata da basi 21. I residui α,β-insaturi 
generati sono ottimi accettori di Michael e sono stati modificati mediante reazione 
con iTRAQ-cisteammina; in particolare due differenti aliquote di miscela peptidica β-
eliminata sono state sottoposte ad addizione di Michael con due varianti di iTRAQ-
cisteammina, sintetizzate a partire rispettivamente dalle varianti 115 e 116 di iTRAQ. 
I campioni differenzialmente marcati sono stati successivamente riuniti in modo da 
ottenere tre differenti miscele con rapporti molari 1:1, 1:2 e 1:4 tra campione marcato 
con il derivato di iTRAQ 115 e quello marcato con il derivato di iTRAQ 116, 
rispettivamente. Le tre miscele sono state analizzate separatamente mediante LC-
MS/MS in modalità precursor ion scan, sfruttando le potenzialità di uno spettrometro 
ibrido QqLIT accoppiato ad un sistema nanoHPLC. Utilizzando la PIS è stato 
possibile selezionare all’interno della miscela in esame le sole specie in grado di 
generare, in seguito a frammentazione, il gruppo reporter tipico delle molecole 
iTRAQ; di conseguenza le sole specie rivelabili sono quelle in cui il gruppo fosfato è 
stato sostituito con un residuo di iTRAQ-cisteammina. Con questa analisi è stato 
possibile isolare selettivamente il peptide 104-119 con un residuo di pSer in 
posizione 115 modificato con iTRAQ-cisteammina. Inoltre, utilizzando il valore delle 
aree sottese ai segnali dei gruppi reporter di iTRAQ negli spettri MS/MS, è stato 
possibile calcolare i rapporti quantitativi per le tre miscele in esame, ottenendo 
risultati molto vicini ai rapporti teorici: 1,02 + 0,08 per la miscela 1:1, 2,06 + 0,06 per 
la miscela 1:2 e 3,99 + 0,05 per la miscela 1:4. Per dimostrare l’applicabilità di tale 
strategia all’analisi proteomica, è stato costruito un opportuno sistema modello di 
maggiore complessità, aggiungendo ad un intero estratto proteico di E. coli, 
un’aliquota di α-caseina β-eliminata. La miscela è stata quindi sottoposta al 
protocollo di marcatura e analizzata mediante LC-MS/MS come descritto in 
precedenza; l’interpretazione dei dati ottenuti è stata effettuata utilizzando il software 
MASCOT per l’identificazione delle proteine modificate. I risultati ottenuti da tale 
analisi hanno consentito di identificare selettivamente le sole specie marcate con 
iTRAQ-cisteammina, consentendo di individuare i siti di fosforilazione e di effettuarne 
l’analisi quantitativa anche in miscele complesse. 
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Summary 
 
The proteome is defined as the set of all expressed proteins in a cell, tissue or 
organism. Proteome analysis presents specialized analytical problems in two major 
areas: i) dynamic expression range and ii) diversity of protein expression (multiple 
protein forms).  
Post-translational modification of proteins is part of what makes proteomics so much 
challenging. It is an event with dramatic effects on the complexity of the proteome. 
Nowadays the attention towards PTMs is notably increased due to the fact that they 
play a critical role in cellular functioning and they vary in response of environmental 
stimuli. There are many classical techniques designed to analyse PTMs.  
This PhD thesis focuses on the development of new proteomics approaches for 
qualitative and quantitative analysis of protein nitration, protein carbonylation and 
protein phosphorylation, three of the most important known PTMs. The approaches 
are mainly based on selective chemical modification of residues of interest coupled to 
advanced mass spectrometry methods. These approaches aim at a comprehensive 
analysing of such modifications by identification of the modified proteins, exact 
localization of the modified residues and quantification of the modification. 
The first section of this thesis is focused on the development and the optimization of 
a new strategy for the qualitative and quantitative analysis of nitration of tyrosine 
residues. Thus, improved approach, based on chemical labelling and mass 
spectrometric procedures, for the selective analysis of 3-nitrotyrosine residues in 
protein mixtures is described. However the major aim of this work is devoted to the 
use of isotopically labelled molecule to allow a simple and direct quantitative MS 
analysis. 
The second part aims to the optimization of a labelling protocol of carbonylated 
residues coupled to advanced mass spectrometry based scanning techniques to 
improve detection of such residues. Moreover a method for selective quantitative 
analysis is also described, aimed at the direct quantification of oxidation levels of 
proteins in different samples. 
The last part of the work is focused on the development of a strategy for qualitative 
and quantitative analysis of serine and threonine phosphorylation without preliminary 
enrichment but using chemical labelling in combination with the high performance of 
a novel hybrid mass spectrometer Linear Ion Trap.  
To prove their wide enforceability these methodologies were set up first on model 
proteins and then applied to more complex systems. 
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I. INTRODUCTION 
 
 
I.1 Proteomics in modern Biotechnology 
 
The relevance of biotechnology in the production of industrial biochemicals is 
growing steadily owing to the development of new products, new production 
processes and, in the future, the growing need to use renewable resources. Major 
biotechnological products include bioethanol, amino acids, polymers, vitamins and 
enzymes. The development of powerful analytical technologies, usually summarized 
by the term “functional genomics”, has a significant role in this growth. These 
techniques include genomics, transcriptomics, proteomics, and metabolomics 
together with carbon flux determinations. Most of these technologies, developed over 
the past decades, are more or less strongly dependent on the deciphering of 
genomes. Nevertheless, even if the knowledge of an organism’s genome is 
necessary, the “omics” era has shown that it alone is not sufficient to understand the 
life of an organism. On these bases, transcriptomics and proteomics have helped us 
to better understand how these organisms transfer their genetic information into life. 
Even though proteomics technologies were first developed more than twenty years 
ago, this technique has become a powerful tool with the availability of genetic 
information obtained from genome sequencing projects. In fact in the last few years 
proteomics has become a powerful tool for the discovery of new proteins and the 
investigation of complex biochemical processes and protein-protein interactions 1-2. In 
medical sciences, proteomics techniques lead to the discovery of disease 
biomarkers, especially in cancer and neurodegenerative diseases, becoming key 
milestones on the way to better and more targeted medical treatment 3-5. Proteomics 
methods are mostly based on mass spectrometry, a relative expensive tool that at 
the beginning limited the spread of proteomics in food technology and biotechnology. 
During the last years only few works have been presented really dealing with the 
application of proteomics in biotechnology 6-7. However, it has changed rapidly and 
proteomics technologies are becoming more practical, and the terms “industrial 
process proteomics” 8 and “industrial proteomics” 9 have already been used. Recently 
in a review by Gupta and Lee 10 it is described the use of genomic and proteomic 
techniques in the design and optimization of bioprocesses, starting with cell culture 
and fermentation, and continuing with further process development steps such as 
downstream processing, scale up, and process characterization and validation. An 
example of efforts made to improve proteomics technologies, can be found in the 
production of amino acids by using C. glutamicum cells 11. Proteomics studies of C. 
glutamicum have been reviewed 12 and the relatively new field of post-translational 
modifications has been described 13. Similar works describe applications of these 
technologies to other industrially relevant organisms, such as B. subtilis, C. 
acetobutylicum and E. coli 14-19. Nowadays proteomics has finally progressed into 
different branches of biotechnology. It is also shown that proteomics technology can 
be very useful in development of production processes for therapeutic proteins by 
use of genetically engineered animal cells 10,20 or human stem cells 21. In “classical” 
fermentation industry, proteomic methods can also be used for identification of 
targets for bioprocess improvement 22 and for quality control of industrial processes 
of other food products of animal origin 23. Unlike mammalian cells that are used 
almost exclusively for production of protein-based therapeutics 10, microbial cells are 
also widely used for production of small molecules 22. Microbial fermentation in food 
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processing has been a tradition for thousands of years 24. The genomes of most 
economically important microbial cells are already sequenced and proteomic 
technologies can be applied during various process development steps, starting with 
the selection and optimization of the functions of the industrial strains, application of 
the knowledge of cell function in response to the changes of production parameters, 
validation of the downstream processing, and thorough characterization of the final 
product (figure I.1). 
 
 
 
Figure I.1. A possible role of genomics and proteomics tools in process development. Fundamental 
understanding of genomic and proteomic processes can facilitate the selection of productive 
organisms. It can also facilitate product or impurity characterization between different cell lines, 
leading to better integration of upstream and downstream processing operations. These resulting 
systems can then be used at late-stage process development to validate and scale-up the process. 
 
I.2 Proteomics analysis 
 
In 1994, Wilkins defined the Proteome as the “protein complement to a genome” 25. 
Proteomics is the study of the expressed protein complement of a genome at a 
specific time 26. The terms “proteomics” and “proteome” mirror the terms “genomics” 
and “genome”. Proteomics was only introduced as a concept in the mid 1990s but it 
has deep roots in the early 1970s, as a result of important technical advances in 
biochemistry and genetics. The drivers of genomic and proteomic analyses are the 
technological achievements of the past decade that enable the quantitative analysis 
of the DNA sequence, mRNA and protein expression inside cells and include tools 
such as DNA microarrays, two-dimensional gel electrophoresis (2D-GE) and mass 
spectrometry (MS). The application of these methods in drug discovery has heralded 
a new era for target identification 27-30. These genome-wide approaches have been 
adopted by the biotechnology and pharmaceutical industries to complement 
traditional approaches for target identification and validation, for hypotheses 
generation and for experimental analyses in traditional-based methods. 
Proteomics arose directly from protein chemistry, taking advantage of analytical tools 
of the latter, but moving away from the latter. In fact proteomics is based on the idea 
that to really understand the cellular function and its molecular mechanisms, in which 
proteins play a key role, it is necessary to study the complete proteome as a single 
“complex analyte” rather than as a “mixture” of isolated proteins.  
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For this reason proteomics is a core part of functional genomics, which relies on 
high-throughput approaches for determining the relations between a given genome 
and the corresponding phenotypes. 
Proteome analysis presents specialized analytical problems in two major areas:  
 
- expression proteomics;  
- functional proteomics. 
 
Expression proteomics studies the variations in expression levels that occur at some 
proteins in a given tissue following specific stimuli. This approach aims to compare 
patterns of protein expression in a given tissue under certain conditions. The great 
advantage of expression proteomics upon transcriptomics is that it studies and 
measures directly the final protein product rather than the levels of mRNA. In this 
way it is possible to evaluate quantitative and qualitative differences among proteins 
in samples. Moreover expression proteomics aims to define profile patterns of PTMs 
of proteins 31. However it is not enough to map and identify all the proteins that are 
extant in cells, they must also be assigned with respect to their function and 
interactions with other proteins or genes. This means that the proteome must be 
studied under in vivo conditions and that the dynamic properties of the proteome 
must be explicitly exploited to obtain such information. This is the target of functional 
proteomics that can be defined as the use of proteomics methods to monitor and 
analyze the spatial and temporal properties of the molecular networks and fluxes 
involved in living cells 32-33, often using mathematical modelling or other systems 
biology tools. It also provides readouts for chemical biology and chemical genetics 
that are necessary to interpret the action of drugs. 
Proteomics have to deal with several analytical problems. First of all protein samples 
presents a high complexity in terms of number of analytes; moreover these analytes 
could have a very huge range of concentration in a sample that reflect their 
concentration in a cell or in a tissue 34. An additional layer of complexity is possible 
for the presence of different isoforms of proteins that arise not only by differential 
splicing of mRNA but mainly as a result of the plethora of PTMs that are possible, 
such as phosphorylation, nitration, acetylation, glycosylation and so on. Moreover 
PTMs are often of low stoichiometry and transient nature. For example 
phosphorylation stoichiometry was found between < 10% and 90% depending on the 
phosphorylation site and protein, but is rarely being determined on a proteome-wide 
scale 35. Therefore analysis of the proteome requires a huge set of tools that fulfil the 
necessity of scientist for sensitivity, specificity, high dynamic range and that are 
capable of high throughput applications.  
Nowadays proteomics can rely on powerful analytical protein-separation technologies 
(chromatography, electrophoresis), that serve to simplify complex protein mixtures to 
compare apparent differences in protein levels between two samples. However the 
most powerful analytical tools for proteomic analysis is mass spectrometry (MS), 
whose instrumentation has undergone huge changes over the past years, 
culminating in the development of highly sensitive, robust instruments that can 
reliably analyze biomolecules, particularly proteins and peptides. 
 
I.2.1 Mass Spectrometry in Proteomics 
 
Mass spectrometry plays a key role in proteomics studies because of its capability of 
identifying proteins and characterizing post-translational modifications. Most 
 12 
 
important features of mass spectrometry are: reproducibility, sensitivity, resolution 
and accuracy. In particular mass spectrometry is a reproducible methodology based 
on the determination of the molecular mass, which is not dependent on the 
experimental conditions. 
 
Principles and instrumentations 
 
Mass spectrometry is based on the production of gas phase ions 36. These ions can 
interact with an electric field and can be resolved following their electro-dynamic 
attitude, which is dependent on their mass-to-charge ratio. In principle all molecular 
and atomic ions are accessible to mass spectrometric analysis; for this reason mass 
spectrometry is a very powerful tool for chemical and biochemical analysis in general. 
Today a wide variety of mass spectrometers are available, all sharing the capability 
to assign mass-to-charge values to ions, although the principles of operation and the 
types of experiments that can be done on these instruments differ greatly. 
Mass spectrometers have four essential parts: a) a system for sample introduction b) 
a source that produces gas phase ions from the sample  c) one or more mass 
analyser to separate ions d) an ion detector. 
Sample under investigation has to be introduced into the ion source of the 
instrument, where molecules are ionized. Then these ions are extracted into the 
analyser region where they are separated according to their mass-to-charge ratios 
(m/z). The separated ions are detected and the generated signals are collected and 
sent to a data system where the m/z ratios and their relative abundances are 
presented in form of an m/z spectrum 
(figure I.2). 
Generally mass spectrometers can be 
distinguished both on the type of 
ionization systems and on the type of 
analyser; the latest one is an essential 
component to define the accessible 
mass range, sensitivity and resolution of 
an instrument. All mass spectrometers 
are operated at very low pressure (from 
10-5 to 10-9) in order to prevent collisions 
of ions with residual gas molecules in the 
analyser during the flight from the ion 
source to the detector.  
In the 1970s mass spectrometry was 
limited to the analysis of volatile and low-
molecular-weight components, because 
of the absence of ion sources able to 
transfer organic macromolecules (such 
as peptides, proteins, nucleic acids, 
lipids and so on) from liquid or solid state to gaseous phase. These problems were 
solved with the development of new ionization methods and in particular with the 
introduction of Electrospray Ionization (ESI) 37 and Matrix Assisted Laser Desorption 
Ionization (MALDI) 38 techniques, that are the most common ionization techniques 
used for biological applications. These ionization techniques are considered “soft” 
ionisation methods, in the sense that the generated ions undergo poor fragmentation.  
Figure I.2. Process of measuring of a mass 
spectrometer. 
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For MALDI ion source, analytes needs to be embedded in a solid matrix which 
absorbs energy at the wavelength of the laser. A pulsed laser hits clusters of 
analytes and matrix, leading to intense heating and generating a plume of ejected 
material that rapidly expands and undergoes cooling, in a “pulsed beam” fashion. 
Generation of ions is believed to arise through ion/molecule reactions in the gas 
phase. Generally, [M+H]+ ions are preferentially formed in the positive ion mode, and 
[M-H]- ions in the negative ion mode. The presence of singly-charged signals in 
MALDI spectra allows to correlate each peak one-to-one with analytes, thus allowing 
the analysis of complex mixtures. 
ESI starts by samples in aqueous solution. Analytes exist as ions in solution because 
they contain functional groups whose ionization is controlled by the pH of the 
solution. Samples are dissolved in a polar, volatile solvent and pumped through a 
narrow, stainless steel capillary. A high voltage is applied to the tip of the capillary 
and the sample emerging from the tip is dispersed into a spray of highly charged 
droplets; this process is aided by a co-axially introduced gas, called nebulizing gas, 
flowing around the outside of the capillary. The charged droplets diminish in volume 
by solvent evaporation, assisted by a warm flow of nitrogen, known as desolvatation 
gas, which flows perpendicularly to the front of the ionization source. Once the 
droplets have reached the Rayleigh limit, ions are desorbed from the droplet 
generating gas-phase ions in a “continuous beam” fashion. This technique gives rise 
to multiply-charged molecular-related ions such as (M+nH)n+ in positive ionization 
mode and (M-nH)n- in negative ionization mode; the number of charges depends on 
the chemical-physical characteristics of analytes; thus each analytes could assume 
more than one charge complicating the form assumed by the signal. For this reason 
this source is not useful to analyse complex mixtures except using pre-fractionation 
systems. In fact most uses of ESI-MS are made in combination with chromatographic 
separation, the so called LC-MS technique. A great enhancement of ESI ion sources 
has come from the reduction of the flow rate of the liquid used to create the spray to 
a nano-scale level. This device leads to a higher efficiency in creating ions 39 
because the charge density at the Rayleigh limit increases significantly with 
decreasing droplet size (zR α 8R3/2). Others advantages related to the use on µLC 
and nLC are the low consumption of sample and the higher sensitivity of the methods 
because of the increase in the concentration of the analyte as it elutes off the 
column.  
Once generated, gas phase ions must be analysed/separated; usually mass 
analysers act as mass filters, based on the interactions of charged analytes with 
electric and magnetic fields. The revolution in biological mass spectrometry was not 
only due to improvements in ionization techniques but also to improvements in mass 
analysers such as quadrupoles (Q), ion traps (IT), time-of-flight (TOF), Fourier 
transform ion cyclotron resonance (FTICR), Orbitrap or combination of these in 
“hybrid instruments”, that are commonly used in proteomics (figure I.3); they differ for 
their resolution, sensitivity and accuracy and for the types of experiments that are 
able to perform. TOF analysers are typically used in combination with MALDI 
(MALDI-TOF MS instruments); however both MALDI sources and TOF analysers can 
be used in different configurations.  
In a TOF analyser (working under high vacuum (10-8-10-9 atm)) ions can be 
separated during their flight in a field-free drift region basing upon the time they use 
to pass through the tube. Their different velocities depend on their m/z ratios. All ions 
entering the TOF tube have a fixed kinetic energy which is proportional to the applied 
accelerating voltage and the charge. This implicates that the higher is the mass of 
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the ion the lower is its velocity and the longer it takes before the ion reaches the 
detector. A detector, which has been triggered by the laser pulse, records the time-
of-flight of the ions. MALDI ionization process causes a spread of kinetic energy of 
ions resulting in different points, in time and space, of ions formation within the ion 
source. Thereby ions with the same mass obtain different kinetic energies and 
velocities during their extraction out of the ion source. This results in peak 
broadening, causing a loss in resolution. This peak broadening has been reduced by 
the introduction of the “delayed extraction” and of a “reflectron” at the end of the 
linear flight tube 40. The reflectron allows ions to slow down and reverse their flight 
path to a second detector. Ions with lower kinetic energy do not penetrate the 
reflectron as deep and thus turn around faster, catching up with ions of slightly 
greater kinetic energy that penetrate the reflectron deeper. Thereby the flight times of 
ions with identical m/z values, but different kinetic energy values, will be corrected 
when the ions arrive to the detector. TOF based instruments have high resolution 
and accuracy characteristics. 
 
 
 
Figure I.3. Typical mass spectrometers used for proteomics analysis. 
 
Quadrupole (Q) mass analysers have become one of the most widely used types of 
mass analyser mainly because of their ease of use, small size and relative low cost. 
A quadrupole mass filter 41 consists of four parallel rods to which fixed DC and 
alternating RF potentials are applied. Ions drift through the middle of the quadrupole 
to the mass detector. Ions oscillate in the x,y-plane and the frequency of oscillations 
depends on their m/z values and on the applied potentials. If the oscillation of an ion 
is stable, the ion will pass through the rods and reach the detector. All other ions do 
not have a stable trajectory through the quadrupole mass analyzer and will collide 
with the quadrupole rods, never reaching the detector. The m/z values of the ions 
able to move on stable trajectories depend on the amplitude of RF and DC voltages. 
The RF is varied to bring ions of different m/z into focus on the detector and thus 
build up a mass spectrum.  
The quadrupole ion trap (QIT) is based on the same principle as the quadrupole 
mass filter, except that the quadrupole field is generated within a three-dimensional 
trap. The trap consist of three electrodes, a rotationally symmetrical ring electrode of 
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hyperbolic shape and two hemispherical end cap electrodes of the same cross-
section. One end cap electrode usually has a hole in it to allow ions to enter the trap. 
Ions are injected axially and to overcome the exit of the ions, their high kinetic energy 
is dissipated by cooling them collisionally, filling the trap with gas molecules 42. Ions 
are dynamically stored in a three-dimensional quadrupole ion storage device by an 
electric quadrupole field generated by the applied RF voltage. The RF voltage can be 
scanned to eject successive mass-to-charge ratios from the trap to the detector. The 
advantages of the ion-trap mass spectrometer include compact size and the ability to 
trap and accumulate ions (typically the ion trap can hold up about 105–106 ions 
before coulombic repulsions significantly affect their trajectories and reduce the mass 
resolution) to increase the signal-to-noise ratio of a measurement. Mass 
spectrometer equipped with QIT technology has good sensitivity but low resolution 
and mass accuracy. Due to its small trapping volume, QIT has a limited trap capacity; 
when the number of ions in the trap is too high, we assist to deterioration in the mass 
spectrum and loss of dynamic range due to space-charging interactions. To avoid 
these effects, the number of ions introduced into the trap has to be strictly controlled 
43
. Trapping of ions can also be performed in linear ion trap devices (LIT) 44-45. LITs 
have two major advantages over QIT: a larger ion storage capacity and a higher 
trapping efficiency. In LIT devices analysis is performed by ejecting the ions radially, 
through the slits of the quadrupole rods, using the mass instability mode as a QIT. 
Detection is performed by two detectors placed axially along to the rods 46. 
An FTICR mass spectrometer is essentially composed by an ICR cell, which typically 
consists of pairs of plates arranged as a cube or capped cylinder, and a surrounding 
strong magnetic field (4,7-13 Tesla) 47, so that one of the opposing pair of plates is 
orthogonal to the direction of the magnetic field. Ions are trapped in the cell by an 
electric field applied to the trapping electrodes and by the magnetic field. Trapped 
ions move on a circular orbit (cyclotron motion) with orbital frequencies inversely 
proportional to their mass-to-charge ratios. An RF sweep is then applied across the 
excitation plates. Ions with cyclotron frequencies in resonance with the applied RF 
are accelerated and increase their orbit radius bringing them closer to detector 
plates, which then record the image current. The complex image current is 
deconvoluted by fast Fourier transformation from which the mass-to-charge ratio is 
then determined. FTICR mass spectrometers are the most accurate and the highest 
resolving power instruments currently available 48. 
 
Tandem Mass Spectrometry 
 
Mass spectrometric analysis produces ions that are separated by m/z and analysed 
directly. Using a soft ionization method the mass spectrum will yield the molecular 
weight values of single analytes but little or no structural information. Tandem mass 
spectrometry (MS/MS) is used to produce structural information about a compound 
by fragmenting specific analytes inside the mass spectrometer and analysing the 
fragment ions. Tandem mass spectrometry also enables specific compounds to be 
detected in complex mixtures on account of their specific and characteristic 
fragmentation patterns. MS/MS is based on two stages of mass analysis, one to 
select a precursor or parent ion and the second to analyze fragment or daughter 
ions, using two different mass analysers; the first mass analyser is used to selectively 
pass an ion into another reaction region while the second mass analyzer is used to 
record the m/z values of the dissociation products. Generally the reaction region, or 
collision cell, is the region into which an inert gas (e.g. nitrogen, argon, helium) is 
 16 
 
admitted to collide with the selected ions causing the fragmentation. This process is 
known as Collisionally Induced Dissociation (CID) or Collisionally Activated 
Dissociation (CAD) 49. Inelastic collisions between the precursor ion with a high 
translational energy and a neutral target gas, cause the conversion of part of the 
translational energy into internal energy of the ion, leading to subsequent 
decomposition 50. The CID process is highly dependent on the relative masses of the 
two species. The overall CID process is assumed to occur by a two-step mechanism, 
where the excitation of the precursors and their fragmentations are separated in time. 
Generally fragmentation of a precursor ion can occur if the collision energy is high 
enough to allow the ion to be excited beyond its threshold of dissociation. All CID 
processes can be separated into two categories based on the energy of the 
precursor ion. Low-energy collisions are common in triple quadrupoles (QqQ), hybrid 
devices, such as QqLIT and QqTOF, trapping devices, such as ion traps (IT), and 
Fourier-transform ion cyclotron resonance (FTICR) instruments; they occur in the 1–
100 eV range of collision energy and, even though the average energy deposited per 
collision may be lower than in high-energy CID, product ion yields are very high, 
especially because multiple collisions are allowed, for example, by the time chosen 
for CID in ion trap devices or by changing the gas pressure in a QqQ. High-energy 
collisions, seen in sector and TOF/TOF instruments, are in the keV collision energy 
range; the precursor ion beam, having a kinetic energy of a few keV, can enter the 
collision cell, usually causing single collisions before mass analysis of the product 
ions. Moreover high-energy CID spectra usually show increased side-chain 
fragmentation 51. The observed fragmentation pattern depends on various 
parameters including the amino acid composition and size of the peptide, excitation 
method, time scale of the instrument, the charge state of the ion, etc 52. Peptide 
precursor ions, dissociated by the most usual low-energy collision conditions, 
fragment along the backbone at the amide bonds 53-55 forming structurally informative 
sequence ions and less useful non-sequence ions by losing small neutrals like water, 
ammonia, etc. The amino acid backbone has three different types of bonds (NH-CαH, 
CαH-CO and CO-NH) and each of them can be fragmented originating different 
fragment ions. Each bond breakage gives rise to two species, one neutral and the 
other one charged, and only the charged species is monitored by the mass 
spectrometer. Hence there are six possible fragment ions for each amino acid 
residue and these are labelled as in the figure I.4, with the a, b, and c ions having the 
charge retained on the N-terminal fragment, and the x,  y and z ions having the 
charge on the C-terminal fragment. The most common cleavage sites are at the CO-
NH bonds which give rise to the b and/or the y ions 56. The most comprehensive 
model currently available to describe how protonated peptides fragment is the so-
called “mobile proton” model 52. According to this model peptides activated under 
low-energy CID, fragment mainly by charge directed reaction. In fact protonation of 
the amide nitrogen along the amino acid backbone leads to considerable weakening 
of the amide bond and leads to cleavage, generating fragment ions.  Considering, for 
example, a doubly protonated tryptic peptide, one proton will be localized on C-
terminal Arg or Lys side chain and the second may be localized at one of the amide 
bonds or the N-terminal. In this case the “heterogeneous population model” 57 
assumes that, when the second proton is mobilized along the amino acid backbone, 
it will exist different protonated forms of the precursor ion that can easily fragment 
giving complementary series. 
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Figure I.4.  Peptides fragmentation scheme. 
 
Instruments for tandem mass spectrometry can be classified as tandem in space or 
tandem in time (figure I.5). 
 
 
 
Figure I.5. Schematic representation of tandem-in-space and tandem-in-time instruments. 
 
Tandem in space means that ion selection, ion fragmentation and fragments 
analysis, are events that occur in three different regions of the spectrometer; 
instruments of this type are the triple quadrupole (QqQ) and hybrid instruments such 
as QqTOF, QqLIT or TOFTOF. In tandem in time instruments, those three steps of 
analysis occur in the same region of the spectrometer but in different times; QIT and 
LIT are instruments classified as tandem in time. 
For triple quadrupole mass spectrometers several scan modes are available. The 
most common scan is the product ion scan, where a specific precursor is selected in 
Q1, fragmented in q2 and the products are subsequently analysed in Q3. A second 
scan is the precursor ion scan (PIS), in which the Q3 is set to select a specific product 
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ion formed in q2 and the Q1 is scanned for all precursor ions generating the fragment 
of interest. A third experiment is the neutral loss scan (NL) in which both the Q1 and 
Q3 scan and collect data across the whole m/z range, but the two are off-set so that 
the second analyser allows only those ions which differ by a certain number of mass 
units (equivalent to a neutral fragment) from the ions transmitted through the first 
analyser. Multiple stages of CID can be performed in IT instruments, although the 
experiment is restricted to the product ion scan. Several hybrid geometries have 
recently been introduced with specific advantages, including the quadrupole-linear 
ion trap (QqLIT) and the quadrupole-time of flight (QqTOF) instruments. The former 
allows triple quadrupole scan types as well as MS3 capabilities in the linear ion trap 
58
, while the latter yields product ion spectra with greater resolution and higher mass 
accuracies for product ions 59. 
 
QqLIT mass spectrometer  
 
Triple quadrupole (QqQ) is a commonly used instruments for tandem mass 
spectrometry; this instrument is constituted by two resolving quadrupole mass filters 
(Q1 and Q3) separated by a fragmentation cell (q2). Triple-quadrupoles are 
considered to be “beam-type” mass spectrometers since they are usually used with a 
continuous ion beam source; this is both a strengthens and a weakness of these 
instruments; in fact when one of the mass filters is scanning, most of the ions are 
rejected by the instrument, resulting in poor sample use and low sensitivity 60, 
whereas when the mass filters are not scanning, but are transmitting a pre-selected 
ion, sensitivity and sample use are very high. These features, coupled with a high 
dynamic range, are the reasons why triple quadrupole mass spectrometers are 
among the most common instrument for mass spectrometric analysis of complex 
mixtures 61. Moreover triple quadrupole systems are particularly interesting because 
they allow to perform unique and very selective analysis using particular scan modes 
such as Selected Reaction Monitoring (SRM) and Multiple Reaction Monitoring 
(MRM), Product Ion, Neutral Loss (NL) and Precursor Ion (PIS) scans 62. These 
specific scan modes can lead to improve the detection of peptides with PTMs. For 
example in the precursor ion scan mode the Q1 allows the transmission of all sample 
ions, while the Q3 is set to monitor specific fragment ions, which are generated by 
fragmentation of the molecules in the collision cell (q2). By this approach it is possible 
to reduce the analysis to groups of compounds, contained within a complex mixture, 
which fragment to produce characteristic fragment ions; a proteomics application of 
this scan mode is achieved by setting the Q3 to specifically detects the fragment at 
m/z -79 Da specifically generated by loss of PO3− from phosphorylated peptides in 
MS2 analysis 63. Fragmentation spectra obtained with this kind of instruments are of 
high quality since MS and MS2 events are spatially separated. However the switch 
from the MS to MS2 mode cause the reduction of the duty cycle of the instruments 
from 100% to about 0.1–0.01% per m/z, drastically reducing the sensitivity of the 
analysis. Additional limits for this analyzer are the low resolution and the inability to 
perform MSn experiment. 
As for ion-trap analyzers, they can’t be classified as beam-type instruments, since 
they analyze pulse of ions that are introduced into the device, trapped radially by RF 
and then analyzed. In comparison with triple quadrupole mass spectrometers, ion 
trap mass spectrometers are more sensitive because of the capacity to accumulate 
ions. Moreover ion trap analyzers are defined as “tandem in time” devices that means 
that with single mass analyzer experiments of MSn may be performed, providing 
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detailed structural information of the analytes. However ion traps are not capable of 
the selective scans discussed for triple quadrupole devices. As for three-dimensional 
ion traps (3D-IT), they are characterized by having a limited trapping capacity, mainly 
because of the space-charges effects (ion-ion coulombic interactions) caused by the 
three dimensional nature of the RF filed that entraps ions in the center of the ion trap. 
In addition to this limitation 3D-IT is characterized by an inherent low-mass cut-off in 
the resulting spectra at about 1/3 of the precursor ion m/z because the precursor ion 
and the lowest mass fragments must be stable simultaneously in the device during 
MSn analysis.  
Some of these disadvantages have been overcome by the introduction of a new 
class of ion trap, namely linear ion trap (LIT) devices. LIT optic is based on a 
classical quadrupole mass analyzer in which are added two lens at the end of the 
roads (entrance lens and exit lens) at which are applied a stopping potential DC. In 
the LIT ion are stored in a linear oscillatory motion along the z axis of the device, 
rather than in a three dimensional fashion by the RF potentials; this leads to enhance 
ion storage capacity. In addition the axial ion injection avoids the interference with the 
RF field improving the trapping efficiency. Recently radially ejection of trapped ions 
has been introduced by using an auxiliary voltage (e.g. Thermo-Finnigan LTQ). The 
presence of two detectors doubles the sensitivity of the analysis 46 (figure I.6).  
 
 
 
Figure I.6. Comparison between LIT produced by Applied Biosystems and Thermo. Both the devices 
are characterized by the axial injection of the ions. The Applied Biosystems LIT is characterized by 
axial ejection and may be rapidly converted in a classical quadrupole consenting to insert it in a QqQ 
optic. Thermo equips their FT-ICR and Orbitrap mass spectrometers with the more sensitive radial 
ejection LIT. The double detection and the emptying efficiency make the Thermo LTQ a stand-alone 
analyzer. 
 
These devices usually have an ion storage capacity of about 10 folds greater than 
the 3D-IT devices. Recently LIT with radial ejection has been used as stand-alone 
mass analyzer 64. An advantage of LIT is that trapped ions may also be ejected 
axially 65, by applying deformed fringing RF field to the exit lens of the LIT; this 
phenomena converts the motion of the ions along the plan x, y in an axial motion for 
that ions that are at boundary stability conditions of Mathieu diagram. Thus ions can 
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come across the DC barrier of the exit lens and can be selectively axially ejected 
changing RF potential, which brings different m/z species at the boundary conditions. 
However axially ejection has a low efficiency respect of radially ones (20% of ions are 
detected), because of the short-range effect of the fringing field. However, even if the 
axial ejection is less sensitive than the radial ejection, these systems make possible 
to switch rapidly from the LIT configuration into a classical quadrupole device. 
These feature has been used from Applied Biosystems to design an hybrid mass 
spectrometer, commercialized with the name “QTRAP®”, consisting of a triple 
quadrupole optic in which the Q3 can operate as an axially ejection LIT 66 (figure I.7). 
 
 
 
Figure I.7. Schematic representation of a QTRAP® mass spectrometer with QqLIT optic. 
 
This combination combines all the vantages of a triple quadrupole with that of LIT 66; 
in fact this device makes possible to perform all the selective scan modes of the triple 
quadrupole instruments with LIT sensitivity and high scan rate. Moreover there is no 
inherent low-mass cut-off in the MS/MS spectra because the fragmentation and the 
ion trapping steps are spatially separated 67. Using Q3 as a LIT it is also possible to 
perform MSn analysis, taking advantage of the characteristics of higher trapping 
efficiency of LIT upon 3D-IT and reduced space-charge interactions that limit the 
number of ions that can be stored. Moreover Q3 is operated at a very low pressure (3 
x 10-5 Torr) that insure that the ions entering the LIT are collisionally cooled thereby 
enhancing trapping efficiency and sensitivity of MSn. This instrument can be operated 
both as triple quadrupole and QqLIT on a chromatographic timescale because the 
switch from QqQ to QqLIT modes is accomplished by changes in electrical voltages 
that occur in less than 1 ms. Moreover the QTrap mass spectrometer, and in 
particular the 4000QTrap device, allows to perform chromatographic compatible MS3 
experiments too. The space separated fragmentation events and the high scan rate 
features of 4000QTrap lead to very rapid MS3 scans (0.3-0.5 sec) allowing to carry 
out this kind of experiments in a LC-MS/MS method. 
 
QqTOF mass spectrometer 
 
Quadrupole-time of flight (QqTOF) mass spectrometers have rapidly been embraced 
by the scientific community as powerful and robust instruments with unique 
capabilities. QqTOF tandem mass spectrometer can be described as a triple 
quadrupole with the last quadrupole section replaced by a TOF analyser. It combines 
the high performance of TOF devices, in both the MS and MS/MS modes, with the 
widely used techniques of electrospray ionization. QqTOF mass spectrometers are 
characterized by high sensitivity, high mass accuracy and high mass resolution for 
both precursor and product ions, and also by the simplicity of operation 68-69. This 
advantage does not inherently apply to the more specialized scan modes as the 
precursor ion, neutral loss, and multiple reaction monitoring of triple quadrupole 
systems, and until recently these scan methods could not be performed with any 
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reasonable efficiency. The popularity of the QqTOF has been significantly advanced 
by the rapid growth of semi-automated instrument control and data processing and 
by continuing improvements in the core performance characteristics of mass 
resolution and sensitivity. In the usual QqTOF configuration, an additional RF only 
quadrupole Q0 is added to provide collisional cooling and focusing of the ions 
entering the instrument. So the instrument (figure I.8) consists of three quadrupoles, 
Q0, Q1 and q2, followed by a reflecting TOF mass analyzer with orthogonal injection 
of ions 69.  
 
 
 
Figure I.8. Schematic representation of a QTRAP® mass spectrometer with QqLIT optic. 
 
For single MS measurements, the mass filter Q1 is operated in the RF only mode so 
that it serves simply as a transmission element, while the TOF analyser is used to 
record spectra. The resulting spectra benefit from the high resolution and mass 
accuracy of the TOF instruments, and also from their ability to record all ions in 
parallel, without scanning. Both Q0 and q2 are operated in the RF only mode: the RF 
field creates a potential that provides radial confinement of the precursor and/or 
fragment ions. Since the RF quadrupoles are normally operated at a pressure of 
several millitorr, they provide both radial and axial collisional damping of ion motion. 
Ions are thermalised in collisions with neutral gas molecules, reducing both the 
energy spread and the beam diameter and resulting in better transmission into and 
through both the quadrupole 70 and TOF 71 analysers. 
For MS/MS, Q1 is operated in the mass filter mode to transmit only the parent ion of 
interest. The ion is then accelerated to an energy of between 20 and 200 eV before it 
enters the collision cell q2, where it undergoes collision induced dissociation (CID) 
with neutral gas molecules (usually Ar or N2). The resulting fragment ions are 
collisionally cooled and focused by RF fields. This step is even more important in 
QqTOF instruments than it is in triple quadrupoles because the TOF analyzer is 
much more sensitive to the “quality” of the incoming ion beam than is Q3 in a triple 
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quadrupole instrument. Both sensitivity and resolution benefit from the additional 
collisional focusing in the pressurized collision cell. After leaving the collision cell, 
ions are re-accelerated to the required energy (usually several tens of eV per unit 
charge), and focused by ion optics into a parallel beam that continuously enters the 
ion modulator of the TOF analyzer. Initially the modulator region is field-free, so ions 
continue to move in their original direction in the gap. A pulsed electric field is applied 
at a frequency of several kHz across the modulator gap, pushing ions in a direction 
orthogonal to their original trajectory into the accelerating column, where they acquire 
their final energy of several keV per charge. From the accelerating column, ions 
arrive in the field-free drift space, where TOF mass separation occurs. The ratio of 
velocities (or energies) in the two orthogonal directions is selected such that ions 
reach the ion mirror and then the TOF detector naturally, without requiring an 
additional deflection in the drift region, which could affect the mass resolution 72-73.  
  
I.2.2 The 1st generation proteomics 
 
Proteomics was built around the two-dimensional gel electrophoresis (2D-GE). The 
idea that multiple proteins can be analyzed in parallel grew from two-dimensional gel 
maps 25,74-75. Initial efforts to analyse proteomes had to deal with the high complexity 
of samples which exceeded the capacity of analytical systems, normally obtaining 
limited amount of information 76. 2D-GE was the first analytical tool successfully 
applied to proteomics analysis; in fact even if it was developed in the late 70s 77 it has 
the capability to resolve complex protein mixtures and to give protein maps from 
which it is possible to detect differences in protein expression patterns between 
different samples. 
From the point of view of separations technology, 2D-GE is an orthogonal separation 
technique in which proteins are separated by two different physico-chemical 
properties: isoelectric point and molecular mass. Proteins are first separated on the 
basis of their (pH-dependent) net charges by isoelectric focusing (IEF) and further 
separated on the basis of their molecular masses by denaturing electrophoresis 
(SDS-Page). Both procedures are carried out in polyacrylamide gels.  
Despite 2D-GE had the highest resolution power for protein separation, it still 
suffered from the inability to identify protein spots from 2D gels; so the foundation of 
the field of proteomics had to wait three technological advances of great importance: 
i) the introduction of large-scale nucleotide sequencing of both expressed sequence 
tags (ESTs) and genomic DNA; ii) the development of mass spectrometers able to 
ionize and mass-analyse biological molecules; iii) the development of computer 
algorithms able to match MS and MS/MS spectra with translations of the nucleotide 
sequence databases. The ability of MS to identify peptides and proteins on the base 
of their molecular weight 78, joined with the high resolving power of 2D-GE, was the 
basis for the born of proteomics.  
While 2D-GE is an ideal tool for discovery-phase research, not all expressed proteins 
can be displayed in a single gel. Specific classes of proteins have long been known 
to be excluded or under-represented in 2D gels. Low-abundance proteins are not 
detected at all due to the limited sensitivity of commonly used dyes, or they are 
masked by higher abundant co-migrating proteins; excessively large and excessively 
small proteins, basic and acidic proteins, and membrane hydrophobic proteins 
present their own special challenges. Furthermore, difficult automation and 
reproducibility problems still remain. Some experimental improvements and technical 
advances, including more sensitive staining methods 79-80, large-format higher 
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resolving gels 81 and sample fractionation prior to 2D-GE have alleviated, but not 
eliminated, these drawbacks. 2D gels has historically been used to try to solve the 
problems of protein quantification; in fact comparative 2D gel approach has been 
typically used to identify proteins differential expressed (up- or down- regulated) in 
different samples as for example in a disease state. For this purpose a reliable 
analysis of quantitative changes of protein spots is important 82; new programs for 
comparison of 2D-GE maps like algorithms based on characteristics of spot image on 
gel (PDQuest, Phoretix 2D and Melanie) or algorithms based on direct comparison of 
images by distribution of intensity (Z3 and MIR), are rising. 
 
I.2.3 The 2nd generation proteomics 
 
2D-GE method still presents some limitations such as the difficulty to analyse 
membrane proteins because of their poor solubility their low recovery after the 
extraction procedures; less abundant proteins don’t reach the detection limits 
because only low quantity of sample can be analyzed; the PTMs identification results 
very difficult because of the sub-stoichiometric nature of these biological 
modifications. For these reasons several techniques have been developed with the 
aim of enabling more comprehensive, less biased proteome analyses based on liquid 
separations coupled online with mass spectrometry, the so-called “gel-free” 
approaches (shotgun proteomics). For these approaches, protein samples are 
usually hydrolysed (most common using trypsin) to obtain more complex peptide 
mixtures, then subjected to liquid chromatographic separation steps prior to MS 
analysis. A powerful MS approach is the use of tandem mass spectrometry (MS/MS) 
to induce fragmentation of individual tryptic peptides after online liquid phase 
separation. Because of the high complexity of peptide mixtures obtained, a single-
dimension chromatography does not provide sufficient peak capacity to separate all 
analytes; one approach to obtain high-resolution separation of peptides is using 
multidimensional chromatographic approaches; most common approaches use 
micro-capillary format liquid chromatography (µLC), in an orthogonal fashion, 
combining strong cation exchange (SCX) and reverse phase chromatography 33,83-85, 
in order to separate peptides firstly by their electrostatic charge features and then by 
their hydrophobicity, prior to online MS/MS analysis.  
Even if progresses in MS instrumentations, as the introduction of high scan rate 
mass spectrometers and the realization of data depend method of acquisition, have 
made possible to analyse a large number of peptides in a single analysis, it is not 
enough to compensate the large dynamic range of protein concentration in biological 
samples. In order to reduce the complexity of such a mixture, a number of strategies 
able to select only a subpopulation of peptides for further analyses have been 
developed (figure I.9). In particular, if peptides carrying rare amino acids like 
cysteine, methionine or tryptophan are selected, a given protein may only contribute 
a single or a few peptides to the selected fraction; in most cases these remaining 
peptides still allow the unambiguous identification of the proteins they originate from 
86
. These analytical strategies allow the identification of less abundant proteins, as for 
as the enrichment of peptides carrying various PTMs.  
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The first innovative methodologies called ICAT 
(Isotope Coded Affinity Tag) was introduced by 
Aebersold’s group in 1999 87. They based their 
strategy on the enrichment and the analysis of 
the only fractions of peptides containing 
cysteine residues. It was chosen this amino acid 
because of the evidence that it is present in the 
92% of Saccharomyces cerevisiae proteins and 
by their hydrolysis with trypsin only the 10% of 
the resulting peptides contains it 88. The global 
strategy consists in the labelling of cysteine 
residues with a thiol reactive biotin and the 
sequent affinity enrichment for cysteine 
containing peptides by streptavidin affinity 
chromatography prior to 2D-LC-MS/MS 
analysis. On these basis many others labelling 
strategies had been developed aimed to 
enhance both the global protein identification 
and more specific PTMs.  
 
I.2.4 The 3rd generation proteomics 
 
Third generation proteomics represents a 
progress in simplification processes of 
proteomics analysis. In fact it aims not only to 
eliminate the use of 2D-GE as a separation 
step, but also to avoid the enrichment step, 
required to reduce peptide mixture complexity, 
prior to LC-MS/MS analysis. The guidelines of 
this methodology are: i) selective labelling of 
residues of interest; ii) employment of particular 
derivatizing reagents that supply characteristic 
ions of particular stability in fragmentation; iii) 
selective analysis by tandem mass 
spectrometry. This analytical technique has been called RIGhT (Reporter Ion 
Generating Tag) strategy 89. It is included in the class of analytical methodologies that 
require the use of hybrid instruments for MS analysis, by which it is possible to carry 
out analysis in precursor ion scan mode. PIS allows the selective analysis of the only 
precursor ions that generate the specific fragment of interest; this represents a great 
advantage in terms of analysis sensitivity. Interesting examples of RIGhT 
methodology are its use for selective identification of pSer/pThr containing peptides 
89
, for identification of 3-nitrotyrosine residues 90 and for selective identification of 
carbonylated lysine residues 91. 
 
I.2.5 Quantitative proteomics 
 
The field of proteomics has moved beyond simple protein identification and is now 
addressed to accurately and reliably quantitate the differences and the relative 
variation in protein abundance in an organism, cell, or tissue, at a given time or under 
a particular condition 92-94. Traditionally, quantitative analysis has been exploited 
Figure I.9. The use of chemical tagging 
strategies for sample fractionation. A 
protein mixture is either first labeled with 
an affinity tag and then digested (left) or 
first digested and then labeled (right). In 
both cases, labeled peptides are 
subsequently enriched by an affinity 
chromatography step, so that ideally only 
the tagged peptides remain. 
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using a so-called differential display 2D-GE approach, whereby differences in protein 
abundances were determined by comparing stained protein spot volumes, followed 
by identification of proteins by mass spectrometry. This approach suffers from the 
disadvantages noted above for the 2D-GE and, in addition, spot intensities can be 
affected by limited precision because of sample handling and sample processing 
variability. 
More recently quantitative proteomics has moved beyond the 2D-GE approach and 
can be separated into two major approaches: the use of stable isotope labelling and 
label-free techniques.  
As for stable isotope labelling, the most common strategies involves labelling of 
peptides with iTRAQ (isobaric tag for relative and absolute quantification) 95 or TMT 
(tandem mass tag) 96, labelling of proteins with ICAT (isotope-coded affinity tag) 86, 
using the serine protease catalysed attack of 18O water in the digestion step 97-98 or 
using SILAC strategy for metabolically labelling proteins by incorporation of isotope 
labels in cell cultures 99. These strategies are considered to be more accurate in 
quantitation, but they require expensive molecules, specific software and expertise to 
analyse data. Moreover the number of samples that can be contemporary analysed is 
limited by the number of available labels and not all strategies can be applied to all 
types of samples. As for labelling strategies, targeted towards specific amino acid 
residues (cysteine, histidine and methionine) or N- or C-terminal, they permit both the 
enrichment of subfractions via affinity clean-up and the quantitation leading 
contemporary to the identification of an ever increasing number of proteins and to 
their quantitative analysis 100. A typical approach based on the isotope stable affinity 
tagging and mass spectrometric analysis is isotope coded affinity tag (ICAT) 
methodology 87. The reagent consists of: i) a cysteine reactive group (an 
iodoacetamide moiety); ii) a linker that contains either a group of heavy or light 
isotopes; iii) a biotin affinity tag that allows the enrichment of labelled peptides via 
streptavidin affinity chromatography (figure I.10). The light and heavy reagents are 
chemically identical but differ in masses. ICAT reagent is commercialized by Applied 
Biosystems in two different isotopic forms with a different distribution of 12C/13C 
atoms that allows the relative quantitative estimation between two samples. Labelled 
proteins are firstly combined and then digested with proteolytic enzyme, usually 
trypsin. Labelled peptides (namely cysteine-containing peptides) are isolated using 
avidin affinity chromatography and subsequently identified and quantified by MS. The 
ratio of protein between the two samples can then be measured by the peak ratio 
between the “light sample” and the “heavy sample” 101.  
 
 
 
Figure I.10. Structure of a common ICAT reagent. 
 
A more recent methodology for quantitative analysis by means of mass spectrometry, 
concerns the use of iTRAQ reagents. iTRAQ technology has been developed and 
commercialized by Applied Biosystems and allows to quantitate proteins by MS2 
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analysis rather than by MS analysis 95. The structure of iTRAQ reagents is shown in 
figure I.11; the complete molecule consists of: i) a reporter group (N-
methylpiperazine moiety), that retain the charge and provides a stable signal during 
MS/MS analysis; ii) a mass balance group (carbonyl moiety), lost as neutral 
molecule; iii) a peptide-reactive group (NHS ester).  
 
 
 
Figure I.11. Structure and isotopic composition of iTRAQ reagents. 
 
The overall mass of reporter and balance components of the molecule are kept 
constant using differential isotopic enrichment with 13C, 15N, and 18O atoms (figure 
I.11). The reporter group ranges in mass from m/z 114.1 to 117.1, while the balance 
group ranges in mass from 28 to 31 Da, such that the combined mass remains 
constant (145.1 Da) for each of the four reagents. The reagents, reactive toward 
primary amino groups, are differentially isotopically labelled such that all derivatized 
peptides are isobaric and chromatographically indistinguishable, therefore also 
identical in single MS mode. Upon fragmentation, the reporter groups are detached, 
creating signals in the low mass range of the MS/MS spectrum; thus low mass 
reporter ion signals allow quantitation, while peptide fragment ion signals allow 
protein identification 95. 
 
I.3 Post-translational modifications 
 
Post-translational modifications (PTMs) are chemical or enzymatic modifications of a 
protein after its synthesis. Post-translational modification of proteins is part of what 
makes proteomics so much challenging. Amino acids can be modified by literally 
hundreds of modifications that change their molecular weights, the fundamental 
physical property measured by mass spectrometry. Clearly, post-translational 
modification of proteins is an event with dramatic effects on the complexity of the 
proteome. Post-translational modification of amino acids extends the range of 
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functions of proteins by attaching them other chemical functional groups, by changing 
chemical nature of amino acids or by making structural changes 102. 
Nowadays the attention towards PTMs is notably increased due to the fact that they 
play a critical role in cellular functioning and they vary in response of environmental 
stimuli, widespread or development of diseases. Phosphorylation, acetylation, 
nitration, are only some examples of post-translational modification involved in 
important cellular processes 103-105. For these reasons they are object of study in 
proteomics laboratories. New methodologies in qualitative proteomics, such as 
“shotgun proteomics”, and in quantitative proteomics, have the capability to be 
applied in rational strain improvement projects and could be considered the starting 
point for industrial bioprocesses improvement and for the  design of novel 
bioprocesses as for as for the design of new producer strains 106-107. PTMs play an 
important role for rational strain improvement since they are the main way in which 
cells regulate their enzymatic and metabolic activity. Protein phosphorylation is a 
typical example of a PTM involved in the modulation of enzymatic activity as for as in 
signal transduction pathways. PTMs linked with oxidative stress phenomena, are 
also important in modulation and fine optimization of productive processes that 
involve microorganism; this PTMs are mainly due to the accumulation of ROS 
(Reactive Oxygen Species) and RNS (Reactive Nitrogen Species) in the cytosol and 
in the broth, with the progress of fermentative production processes 108-110. In a 
perspective such as that of systems biotechnology, the global study of the 
mechanisms by which the presence of these oxidizing species and the phenomena 
of enzymatic activity regulation bearing on efficiency of producer strains, plays a key 
role in the design of new producer strains through targeted strategies of cellular 
engineering.  
 
Proteomics for studying PTMs 
 
Proteomics is one of the disciplines of choice to study these mechanisms, and a 
number of strategies of analysis for the study of PTMs are already of common use. 
Unfortunately, the efforts made in this direction have produced only lists of modified 
proteins, struggling to demonstrate the correlation to observed phenotypes. There is 
so much to do in this area, particularly to develop methods of quantitative analysis to 
be exploited for the development of new biotechnological processes. 
Most of the common strategies for the analysis of PTMs exploit the potential of 2D-
GE 111-112 coupled to Western blot analysis 113. However, 2D-GE has well known 
drawbacks that limit the analysis of post-translationally modified proteins. A major 
limitation concerns the ability to pinpoint the modification site that is fundamental in 
order to design a strategy of targeted engineering of proteins. Moreover it is not 
always possible to have quantitative information about selected modified residues 
that are fundamental to compare different growth conditions. For these reasons it is 
preferable to use liquid chromatography-electrospray ionization methods (ESI-LC-
MS/MS) 114, although PTMs analysis from gels is sometimes the only option. There 
are some problems related to mass spectrometric analysis of PTMs; first of all the 
modified peptide must be detected. In fact, even if it is almost always possible to 
identify a protein from MS/MS spectra of only a few of its peptides, locating the exact 
site of a modification requires detection, and in most cases MS/MS sequencing, of 
the specific modified peptide. This can be difficult since not all peptides are equally 
detected; moreover not all species are equally abundant in a sample and in particular 
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post-translationally modified ones are usually less abundant than the non modified 
species.  
 
I.3.1 Protein phosphorylation  
 
Phosphorylation is the addition of a phosphate group to specific amino acid residues. 
Proteins and peptides phosphorylation is one of the most important and abundant 
PTMs and a biochemical process of absolute biological relevance; in fact kinases 
and phosphatases, the enzyme responsible for protein phosphorylation and 
dephosphorylation, account for 2-4% of eukaryotic proteomes 115-116; phosphorylation 
cycles are very dynamic and rapid in order to satisfy necessity of the cell for highly 
dynamic regulation processes. Phosphorylation acts as a molecular switch, in a 
reversible manner, to turn “on” or “off” a protein activity or a cellular pathway, 
regulating enzymatic activities or substrate specificities, folding and function of 
proteins, protein localization, complexes formation and degradation. Cellular 
processes ranging from cell cycle progression, differentiation, development, 
hormones response, signal transduction, metabolic maintenance and adaptation, are 
all regulated by protein phosphorylation. Recent estimations of proteins 
phosphorylation, suggest that almost one-third of eukaryotic proteins are 
phosphorylated 117-118.  
One of the major problems concerning the analysis of this PTM is the rate of 
phosphorylation; in fact phosphoproteins abundance is very low and can be 
quantified as 1-2% of the total protein amount in a cell. So protein phosphorylation 
can be classified as a sub-stoichiometric modification and usually, while some 
residues are always phosphorylated, others may only be transiently phosphorylated. 
As for modification sites, we have to distinguish different kinds of protein 
phosphorylation, on the basis of the amino acid residues involved; we can classify 
four different types of phosphorylation: i) O-phosphorylation is the most common 
class and in this case phosphate groups are mostly attached to serine, threonine and 
tyrosine residues, but also to unusual amino acids such as hydroxyl-proline; ii) N-
phosphorylation occurs mostly on histidine and lysine (N-phosphates); iii) S-
phosphorylation occurs on cysteine (S-phosphates); iv) acyl-phosphorylation occurs 
on aspartic and glutamic acid residues (acyl-phosphates). Except for O-phosphates 
others classes of phosphorylation are less common. In many cases, the effects of 
phosphorylation are combinatorial and multiple sites could be phosphorylated 
contemporary.  
For all of these reasons the definition of sites, abundances, and roles of each of 
these modifications in a biological sample is a challenging task for proteomics, mainly 
because they are not accessible to a single analytic method altogether at the same 
time. 
 
Phosphoproteome analysis 
 
To analyse protein phosphorylation the first step is the correct sample preparation, in 
order to avoid that protein phosphatases will become active and phosphate groups 
will be lost 119. Several methods have been developed for detecting phosphoproteins. 
2D-GE has been used for this purpose 120-121. After electrophoretic separation 
proteins can be classically visualized using standard protein stains, as Coomassie or 
silver staining; with this strategy the modified proteins could not be univocally 
identified because they could appear at different pI according to the nature of the 
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phosphorylation (addition or subtraction of negative charges along the molecule). 
This is especially evident for multiply phosphorylated proteins.  
Phosphoproteins separated by 2D-GE can also be visualized using phosphospecific 
stains such as Pro-Q Diamond 122-123, a fluorescent dye that allows to detect 1-20 ng 
of phosphoprotein, depending on the phosphorylation state of the protein. For 
individual phosphoproteins, the strength of the signal correlates with the number of 
phosphate groups. Using a specific staining procedure, this method can be used to 
specifically detect Ser/Thr- phosphorylations. 
Phosphoproteins on 2D gels can also be visualized by Western blotting using special 
antibodies against phosphoserine, phosphothreonine or phosphotyrosine residues 
124
. To measure changes in protein phosphorylation state, two distinct proteome 
samples can be run and immunoblotted and the intensity of spots can be compared. 
All these methods have a great drawback in the inability to provide information on 
modification sites. Protein spots of interest must be excised from gels and the 
proteins analysed by MS, but in a high number of cases this analysis can be difficult 
and less useful due to co-migrating proteins. Another classical approach to study 
phosphoproteins is the radioactively labelling using 32P or 33P 123,125 and their 
detection by autoradiography; this method is the most sensitive available, but relies 
with handling radioactive compounds and therefore is not the right choice for a high 
throughput strategy. Moreover radioactive labelling is not compatible with classical 
proteomics procedures first of all MS analysis. 
Radioactive labelling is possible both in vivo and in vitro. In in vivo studies, cells are 
incubated with 32P; in some cases, the presence of endogenous ATP can interfere 
with the incorporation of the label resulting in inefficient radioactive labelling 126. In in 
vitro studies, proteins are incubated with specific kinases in the presence of [γ-32P]-
ATP, and under appropriate conditions 32P is incorporated at the phosphorylated 
amino acid residue. The major drawback of this method is the possibility that kinases 
may phosphorylate proteins aspecifically, due to their unnatural high concentration 
127
. The quantitative analysis in this case is performed by comparing differences in 
relative abundance of 32P-labeled phosphoproteins, visualized by autoradiography, 
by measuring relative intensities of the spots on the gel. 
In order to increase sensitivity, selectivity, speed and to eliminate the need for 
radioactive labelling and antibodies, several strategies have been developed, the 
majority of which are mass spectrometry based, for the analysis of phosphorylation. 
MS based methods are mostly based on the analysis of phosphopeptides obtained 
by proteolytic processing, rather than on the analysis of phosphoproteins. However, 
phosphopeptides are difficult to analyze by MS, especially in the presence of non 
modified peptides, mainly because of their low ionization efficiency. Thus, efficient 
enrichment of the phosphorylated species prior to MS analysis is a critical step to 
increase sensitivity of the method and to achieve a more efficient characterization. 
Different enrichment strategies have been developed, and still continue to evolve. 
The most frequently used enrichment strategies are affinity-based, such as 
immobilized metal affinity chromatography (IMAC) and metal oxide affinity 
chromatography (MOAC), or strong cation exchange (SCX) chromatography. 
IMAC 128 is the classical phosphopeptide enrichment technique and is based on the 
principle that positively charged metal ions, such as Fe(III) 129-130 or Ga(III) 131, 
chelated onto a solid phase resin, interact with negatively charged phosphate groups 
at acidic pH; subsequently phosphopeptides are eluted at basic pH. Some protocols 
make use of a derivatization step to convert carboxylic acids to their corresponding 
methyl esters prior to IMAC to prevent non specific binding 132.  
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Recently MOAC protocols have been developed taking advantage of titania or 
zirconia as metal oxide chromatography modifiers 133. Actually titanium dioxide (TiO2) 
remains the most commonly used modifier. In contrast to IMAC, which can have 
greater affinity for multiply phosphorylated peptides, TiO2–MOAC seems to be more 
specific towards singly phosphorylated peptides 134.  
By SCX chromatography, phosphopeptides are enriched in the earlier-eluted 
fractions since they have lower affinity for the negatively charged resin than  
corresponding non-phosphorylated peptides of the same sequence. 
Recent efforts have aimed to completely automate the multistep, tedious task of 
phosphopeptides enrichment by conducting IMAC 135, TiO2 136-137, or SCX 138 online 
with MS. 
A number of alternative enrichment strategies for phosphopeptides have recently 
been proposed. An example is the BEMA (β-elimination/Michael addition) strategy, 
that takes advantage of the ease of β-elimination of pSer and pThr residues at basic 
pH, and the ability to subject the resulting products to Michael type addiction with a 
desired tag 139; the major disadvantages of this techniques are that pTyr residues 
cannot be addressed and the possibility to have contamination from peptides with 
other modifications that also undergo β-elimination, such as O-glycosylated peptides. 
In 2001, Zhou and co-workers introduced a strategy called phosphoramidate 
chemistry (PAC), which can be applied to all phosphorylated residues 140. 
Phosphopeptides are derivatized by a sulfhydryl group and linked to iodoacetyl 
groups immobilized on a resin through phosphoramidate chemistry. The phosphate 
groups are reconstituted by acid hydrolysis (using TFA) of the phosphoramidate 
bonds in order to allow the identification of the phosphorylation sites by MS. 
However, this strategy is time consuming and sample may be lost at each step. 
 
Mass spectrometry for the analysis of phosphorylation 
 
In phosphorylation studies it is very important to be able to specifically identify the 
amino acid residue or the amino acid residues that are phosphorylated upon a 
certain stimulus. Using mass spectrometric analysis it would be possible to address 
the average number of phosphorylation sites just by looking at the increment of the 
protein mass compared with the unmodified one, as a phosphate group gives a mass 
increment of 80 Da. However, the exact location and nature of the modifying group 
cannot be achieved just by mass spectrometric measurement of the intact protein. 
Nowadays most phosphorylation sites are identified by analysing the list of observed 
masses of peptides obtained from tryptic digestion of protein of interest and 
comparing them with the list of expected peptide masses, in order to find mass 
increases of 80 Da. Although this method is relatively straightforward, it could miss 
some phosphorylated species, especially because of their low ionization efficiency 
(caused by the increased acidity of phosphorylated peptides) and because of the 
competition for ionisation of peptides in complex mixtures, which results in 
suppression of signals for some peptides. A useful solution could be removing 
phosphate group in order to enhance the relative intensity of phosphorylated species 
142
. Any ambiguities can be resolved by sequencing the peptide using tandem MS 140-
141; ideally, an MS/MS spectrum of a phosphorylated peptide generates a numbers of 
fragment ions that differ in mass by a single amino acid, that can be used to 
determine the peptide sequence and position of the phosphoryl residue(s).  
In order to solve the problem of competition for ionization, a powerful approach 
makes use of LC-ESI-MS/MS strategies 143-144. In fact this tool has established the 
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basis for several novel methodologies for the identification of phosphopeptides. Whit 
this trick the ion suppression phenomena are reduced by separation of peptides prior 
to MS analysis. Moreover this method has the advantages to concentrate samples 
and to remove salts that could interfere with ionization. As for MS/MS analysis of 
phosphopeptides, the latest have characteristic fragmentation patterns that can be 
exploited for the selective analysis of these species. In fact, in the case of serine and 
threonine phosphorylated peptides, it is possible to find specific fragment ions, with a 
∆M of -98 Da from parent ions, due to the loss of H3PO4 as a neutral molecule 145-147. 
This characteristic fragmentation behaviour can be used in MS/MS experiments, by 
using QqQ mass spectrometers, to selectively analyse phosphorylated peptides, 
using the neutral loss scan mode typical of these instruments.  
 
I.3.2 PTMs induced by oxidative stress 
 
In living cells, following oxidative metabolism, oxygen molecules are normally 
reduced to produce water molecules, a reaction catalyzed by cytochrome oxidase as 
the terminal part of the electron transport chain; a minimal part of oxygen (1-2%) 148-
149
 can be reduced partially with the formation of partially reduced by-products, such 
as superoxide anion (O2-•) and hydroxyl radical (•OH), collectively named ROS, 
reactive oxygen species. These molecules are characterized by an unpaired electron 
(in fact they are also called free radicals) and are extremely reactive toward the 
surrounding molecules in an indiscriminate fashion; for this reason these molecules 
are short-lived and can be harmful if they are not controlled. The major source of 
ROS is the electron transport chain in mitochondria 150-151. In physiological conditions 
ROS have an essential role in cell signaling 152-154 and their activity is normally tightly 
regulated by a thick network of antioxidants, both enzymes and small organic 
molecules. A significant increase in the levels of intracellular oxidizing species 
causes an imbalance between antioxidant systems and ROS that leads to the onset 
of oxidative stress conditions; this state is frequently connected to pathological 
conditions 155-158. However, in most disorders, oxidative/nitrosative stress is a 
consequence and not a cause of the primary disease process. When superoxide 
anion increases its cellular concentration, it is rapidly converted to hydrogen peroxide 
(H2O2) and oxygen (O2) by superoxide dismutase (SOD), that is the main regulator of 
cellular concentration of O2-• 159. H2O2 is then removed by catalase and peroxidase 
that convert it in water. If H2O2 accumulates in the cell, it can react rapidly with 
transition metals giving rise to the hydroxyl radical (•OH), a very reactive and toxic 
specie 160. In addition to producing ROS, the mitochondrial respiratory chain can 
produce nitric oxide (NO•), which has itself an unpaired electron, and other nitric 
oxide by-products called RNS, reactive nitrogen species. RNS play many 
physiological roles, mainly as signal molecules 161, but if they are present in high 
concentration may induce strong modifications in many biological macro-molecules 
162
. Nitric oxide is a ubiquitous intercellular messenger that modulates blood flux and 
neural activity and it is also important for nonspecific host defense, helping to kill 
tumours and intracellular pathogens. Nitric oxide by itself is not a toxic compound; 
the toxicity of nitric oxide results from its reaction with ROS to produce a class of 
derivatives extremely reactive towards proteins, lipids, and DNA 163; for instance 
when nitric oxide reacts with superoxide anion it is produced peroxynitrite (ONOO-) a 
powerful and toxic oxidant 164.  
Obviously both enzymatic and non-enzymatic systems protect cells and tissues 
against the toxic effects of ROS/RNS produced by metabolism. However, in particular 
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cases, such as inflammatory states or during fermentative processes 165, the 
concentration of such species may exceed the cell antioxidant skills making relevant 
the toxic effects of these molecules. 
Post-translational modifications of proteins by ROS and RNS are associated to a 
large number of pathologies and to cellular aging 156,157. Some of these PTMs affect 
the structural and functional integrity of specific proteins. Most of such oxidants will 
react in a non specific fashion with several amino acid residues, yielding to multiple 
products. However, only a few of these reactions will lead to stable and specific 
products, characteristic for a selected oxidant, which can be used as a signature for 
the reaction of one specific oxidant with a protein in vivo. 
 
I.3.2.1 Protein nitration 
 
The presence of peroxynitrite in cells can cause nitration of amino acid residues. 
Targets of nitration include nucleic acids, sugars, lipids, alcohols, small organic 
molecules and aromatic amino acids 166. Nitration of proteins modulates catalytic 
activity, cell signalling and cytoskeletal organization. Sites of nitration in proteins are 
phenylalanine, tryptophan and, in particular, tyrosine residues; in fact the phenolic 
ring of tyrosine is particularly active towards this kind of reaction. Nitration of 
tyrosines is a stable PTM that reflects the extent of the production of oxidants during 
both physiological and non-physiological conditions. For this reason nitrated tyrosines 
have been recognized as the prevalent and functionally significant PTM that serves 
as an indicator of RNS mediated oxidative reactions 167. 
There are two different catalytic mechanisms proposed for in vivo nitration (figure 
I.12), both involving the formation of tyrosyl radical 168, generated by the presence of 
some ROS, such as CO3-• and OH•, mainly formed by peroxynitrite 168. Tyrosyl 
radical reacts with nitrogen dioxide to generate NO2Tyr. Tyrosyl radical can also 
reacts with another tyrosyl radical to yield the 3-3’-dityrosine specie, which can 
generate intramolecular cross-links or protein multimerization. These pathways might 
be less important in vivo compared with in vitro observation because of the presence 
of tyrosyl radical reductants, steric hindrance and tyrosyl radical low accessibility in 
vivo. 
Another possible way for nitration of tyrosines in vivo is the reaction of tyrosyl radical 
with nitric oxide (NO•), resulting in the formation of 3-nitrosotyrosine. Nitrosotyrosine 
is apparently not stable and it is oxidized by two electrons to form 3-nitrotyrosine 
(figure I.12) 169.  
Addition of an NO2 group to the orto position of tyrosine residues decreases the pKa 
of the tyrosine hydroxyl group of about three units 170; this introduces a net negative 
charge to approximately half of nitrated tyrosine residues at physiological pH. This 
new anionic amino acid residue can induce changes in protein conformation and 
biological activity and it can generate antigen epitopes; moreover the altered pKa of 
hydroxyl groups can cause inhibition of tyrosine phosphorylation by protein kinases. 
Nitration of tyrosine seems to have certain selectivity; in fact not all tyrosine residues 
are nitrated; tyrosine nitration usually occurs near acidic residues, in loop regions 171-
172
 or in areas free from steric hindrances. Tyrosine nitration sites are localised within 
specific functional domains of nitrated proteins 171.  
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Figure I.12. Main pathways of in vivo generation of 3-nitrotyrosine residues. 
 
Nitration of tyrosine is one of the sub-stoichiometric PTMs related to ROS/RNS that is 
stable in vivo and it is directly linked to the instauration of oxidative stress conditions 
caused by the iper-production of nitric oxide 173. For these reasons NO2Tyr is 
currently considered the best biomarker for the identification and quantification of 
oxidative stress events related to RNS 174. 
 
Nitroproteome analysis 
 
Most of the studies on protein nitration published so far are focused on the detection 
and quantification of nitrotyrosine by using 2D-GE and Western blot 175-176, immune-
histochemical or ELISA techniques 177-178, or chromatographic methods using either 
high performance liquid chromatography (HPLC) separation 179-181 combined with 
electrochemical detection or GC-MS techniques. MS can also be used to analyse 
overall levels of 3-nitrotyrosine in proteins; in fact the formation of NO2Tyr residues 
cause an increment of 45 Da in the molecular mass of the modified peptide respect 
to the unmodified one. MALDI mass spectrometry has been extensively used for the 
analysis of nitrotyrosines; however, nitrotyrosine containing peptides are sensitive to 
laser light and undergo a decomposition process yielding, besides the expected 
mass increase of 45 Da, other major peaks corresponding to nitrosotyrosine ((Tyr-
NO) [M + H+ + 29]), aminotyrosine ((Tyr-NH2) [M + H+ + 15]), and nitrenetyrosine 
((Tyr-N) [M + H+ +13]) 182-183. While on the one hand this phenomenon constitutes a 
unique fingerprint, it also impairs the sensitivity of the analysis, since it spreads the 
signal of nitrated peptide over at least three major species, hence reducing the signal 
intensity of nitrated specie by as much as 60-70%, which may result in the failure to 
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observe nitrated peptides in complex peptide mixtures 184-186. This drawback is 
aggravated by the fact that tyrosine nitration is a low-abundance PTM with an 
occurrence of 1 in 10000 tyrosines in vivo 168. It has been showed by Petersson and 
co-workers 183 that using ESI mass spectrometry this phenomenon is absent. 
Moreover it is possible to use  ESI-MS/MS in precursor ion scan mode to detect 
nitrated peptides in complex mixtures using a characteristic fragment ion of nitrated 
peptides such as the immonium ion of nitrotyrosine 183. 
 
I.3.2.2 Protein carbonylation 
 
ROS generally reacts with proteins via metal-catalysed reactions (MCO) 187-188 
causing cleavage of polypeptide backbone 189, intermolecular cross-linking and 
modification of the amino acid side chains, leading to the loss of protein function and 
to structural alteration 190. MCO generally involves generation of H2O2 and reduction 
of Fe(III) or Cu(II) by a suitable electron donor, like NADH, NADPH, ascorbate, and 
so on; Fe(II) and Cu(I) ions bind to specific metal binding sites on proteins and react 
with H2O2 to generate OH•, an highly reactive free radical specie 191-192. 
Among the various oxidative lesions caused by this radical, protein carbonylation is 
an irreversible and irreparable chemical post-translational modification that cannot be 
reversed by the enzymatic repair machinery of cells. Carbonyl derivatives are 
essentially formed by direct MCO attacks on the amino acid side chains of arginine 
(R), lysine (K), threonine (T) and proline (P) residues 193-194. Carbonyl groups can 
also be introduced into proteins via secondary oxidation reactions; in fact lipid 
peroxidation products 195 and glycation end products 196 can react with amino acid 
residues via Schiff-base formation and further oxidation.  
Lysine, arginine and proline residues are readily and directly oxidized by metal ion-
catalyzed oxidation (MCO) systems 197-198; oxidation of the side chains of lysine, 
arginine, proline, and threonine residues has been shown to yield carbonyl 
derivatives; oxidation products of arginine and proline residues (glutamic 
semialdehyde) and lysine residues (α-aminoadipic semialdehyde) (figure I.14), are 
very reactive groups; as for histidine residues, they are converted to 2-oxo-histidine 
194
. It has been demonstrated that oxidation of proline residues can lead to peptide 
bond cleavage 199. In addition it was demonstrated that the oxidation of glutamic acid 
and aspartic acid residues can also lead to peptide bond cleavage in which the N-
terminal amino acid of the C-terminal fragment will exist as the N-pyruvyl derivative 
200
. Carbonyls containing proteins can also be generated by reaction of ε-amino 
groups of lysine residues with reducing sugars or their oxidation products (glycation-
glycoxidation reactions) 201-203 and also by Michael type addition reactions of lysine, 
cysteine, or histidine residues with α,β-unsaturated aldehydes formed during the 
peroxidation of poly-unsaturated fatty acids 204. 
Approximately 10% of the proteome is more prone to carbonylation during ageing, 
starvation or disease 205-208. There are several possible explanations for this 
specificity, as for examples the presence of a transition metal in the protein or the 
localisation of these proteins close to ROS generating sites; however the exact 
molecular basis for this apparent specificity still remain unclear 209. 
Recent studies have demonstrated that only few sites are selectively carbonylated 
among all possible carbonylatable sites and carbonylation sites are mainly located at 
the protein surface 210-214. The formation of carbonylated species in proteins seems to 
be a common phenomenon during oxidation due to aging or inflammatory processes, 
and the quantification of carbonylated species can be used to measure the extent of 
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oxidative damage. In fact usually carbonyls are more difficult to induce than 
methionine or cysteine oxidation, and might therefore indicate a more severe 
oxidative stress 215. This has prompted the development of a number of analytical 
strategies to determine the protein carbonyl content in biological samples; a common 
method exploits the derivatization of carbonyl groups with 2,4-dinitrophenylhydrazine 
or tritiated borohydride followed by quantification with UV spectroscopy or 
radiography, respectively 216-218; another method to quantify carbonyl content is by 
derivatizing with a fluorophore such as fluorescamine; the resulting product is 
fluorescent and can be revealed by spectroscopy 219. 
 
 
 
Figure I.14. Common amino acid side chains involved in oxidation and their oxidation products. 
 
A number of methods are based on immunological detection of derivatized carbonyl 
groups; an example is the use of 2,4-dinitrophenol antibodies to detect and quantify 
2,4-dinitrophenylhydrazyne derivatized proteins 220. For identification of carbonylated 
proteins all these methods use mass spectrometry as final tool; although these 
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methods are able to quantify and identify carbonylated proteins they are not able to 
pinpoint sites of carbonylation; however identification of oxidation sites provides a 
tool for deeper understanding what oxidative stress causes in living cells. 
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II. QUANTITATIVE IDENTIFICATION OF PROTEIN NITRATION SITES 
 
 
II.1 Introduction 
 
In this chapter I report a novel proteomics strategy, based on the use of iTRAQ 
reagents coupled to mass spectrometry analysis, for the selective analysis of o-
nitrotyrosine residues. This method was proved to lead the simultaneous localisation 
and quantification of nitration sites both in model proteins and in biological systems. 
The strategy proposed may be classified as belonging to a class of general 
derivatization methods defined with the acronym RIGhT (Reporter Ion Generating 
Tag) (see chapter I.3.1). This approach is based on the selective labelling of the 
target residues with reagents capable to generate reporter ions in MS2 experiments. 
The detection of the reporter is a very stringent criterion that is used to reduce the 
analytical complexity to a few numbers of species, resulting in an improved duty 
cycle and enhanced dynamic range achievable by the MS analysis. In operative 
terms, the use of a high selective MS replaces the off-line chromatographic steps 
(affinity and/or bidimensional chromatography) aimed to enrich the mixture in labelled 
peptides. So the strategy proposed in this chapter can be considered as a third 
generation proteomics methodology. 
 
II.1.1 Proteomics analysis of nitrated proteins 
 
A number of so-called tagging (or labelling) strategies have been developed to target 
specific amino acid residues and/or post-translational modifications (PTMs). These 
methods enable the enrichment of subfractions via affinity clean-up. A practical 
approach consists in targeting the specific structural traits followed by an affinity 
chromatography step 1-3. This approach simplifies the proteome while preserving 
most of the vital information necessary for the analysis. With a similar strategy, it is 
also possible to isolate post-translationally modified peptides 4-6. The presence of 
phosphorylation, glycosylation, glycation, nitration, and specific types of oxidation are 
examples of PTMs that can be targeted. Analysis of PTMs provides one of the 
strongest cases for targeted selection. Although many proteins are post-
translationally modified during their biological lifetime, perhaps only one out of 20-50 
of their tryptic peptides will be modified, depending on the PTM. Thus after a trypsin 
digestion only one or few peptides carrying the modifying group will be generated. As 
a consequence, PTM specific selection will lead to a number of peptides to be 
examined reduced at least of an order of magnitude 7. 
Several modifications have been described and they differ substantially in the extent 
of the modification of proteins. For this reason, some PTMs can be targeted more 
specifically than others, and the tagging concepts currently described in the literature 
are most often directed towards phosphorylated proteins, although recently methods 
for the study of glycosylation and tyrosine nitration have been proposed 8-9. 
Among PTMs, protein nitration can occur in cells during oxidative stress and over-
production of nitric oxide (section I.3.2.1) 10-11. Nitration sites in proteins are 
phenylalanine, tryptophan and, in particular, tyrosine residues. Tyrosine nitration is 
becoming increasingly recognized as a prevalent, functionally significant protein post-
translational modification. Nitration of proteins modulates catalytic activity, cell 
signalling and cytoskeletal organisation 12. Addition of NO2 group to the orto position 
of tyrosine decreases the pKa of the tyrosine hydroxyl group of about three units; this 
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introduces a net negative charge to approximately half of nitrated tyrosine residues at 
physiological pH. This bulky substituent can induce changes in protein conformation, 
resulting in the generation of antigen epitopes, altered enzyme catalytic activity, 
modulation of metabolic pathways and inhibition of tyrosine phosphorylation by 
protein kinases 13-15. For these reasons and for its chemical stability NO2Tyr is 
considered the most important biomarker for identification and quantitation of cellular 
processes, associated to RNS over-production, that lead post-translational 
modification of proteins.  
Many research groups have focused their attention towards 3-nitrotyrosine residues, 
developing various methodologies for revelation and quantification of these residues. 
Most of the studies published so far focused on the detection and quantification of o-
nitrotyrosine by the use of 2D-GE and Western blot, followed by the MS analysis of 
the in situ digested proteins, positive to the immuno-assay. For 2D-GE fractionated 
proteins, the identification based on the fragmentation spectra were presented in only 
a limited number of works 16-17. This lacking of data may be caused by the classical 
limitations of the 2D-GE technique (section 1.2.2). In particular the low quantity of 
proteins analysable by IEF is very limiting considering the sub-stoichiometric nature 
of most PTMs. Immune-histochemical or ELISA techniques have been used as 
alternative to 2D-GE and Western blot but are unable to specifically identify the site 
of modification. Moreover these procedures generally led to the identification of 
nitrated proteins but the exact localization of the nitration sites in complex protein 
mixtures still remain a challenging task. More recently chromatographic methods 
have been developed using either high performance liquid chromatography (HPLC) 
separation combined with electrochemical detection or GC-MS techniques 18-20. In 
addition at the common 2D-GE limits, also the MS and MS2 analysis of nitrated 
peptides has some technical aspects that have to be considered. The development 
of gel free methods has represented an advance in nitroproteins analysis, allowing to 
work with a much larger amount of nitrated proteins or peptides. By using 
multidimensional chromatography-tandem mass spectrometry (SCX-RP-MS2) 
approaches, the rat neuroproteome was explored identifying 31 sites of nitration in 29 
different proteins 21. However, although this approach allows to overcome many limits 
of gel-based methods, the detection of lower abundant nitrated proteins remains 
problematic. To analyse these PTMs at a proteomics level, a specific enrichment 
step is highly advised prior to MS analysis. The unique method to directly enrich 
nitro-proteins uses anti-nitrotyrosine based affinity chromatography. However this 
strategy is not so spread 22-23. This is probably due to the low specificity of anti-
nitrotyrosine antibodies. There are no effective enrichment methods for nitrated 
peptides, probably because of the poor chemical reactivity of nitro group. However, 
different strategies were introduced based on the conversion of NO2Tyr nitro group in 
amino group, which is much more reactive. Nikov et al. reported a novel method for 
the identification of peptides containing nitrotyrosine residues in complex mixture 24. 
This strategy involved first free thiols blocking by iodoacetamide, then nitrotyrosine 
reduction to aminotyrosine. Then aminotyrosines residues were labelled with a 
cleavable biotin tag and the protein sample was digested. The biotinylated peptides 
were purified on a streptavidin derivatized solid support. Further nitrated peptides 
were eluted and they were directly analysed by MALDI-TOF mass spectrometry. 
Zhang et al. introduced an improved enrichment strategy 25. In fact they derivatized 
reduced aminotyrosines with N-succinimidyl S-acetylthioacetate (SATA). Then the 
thio-esther group was converted to thiol allowing purification by using thiopropyl 
sepharose beads. The enriched peptides, analyzed by LC-MS/MS, showed 6-10 
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times more nitrotyrosine-containing peptides than the global analysis of not enriched 
samples. 
MALDI mass spectrometry has been extensively used for the analysis of 
nitrotyrosines; although NO2Tyr residues formation causes an increment of 45 Da of 
the molecular mass of the modified peptide respect to the unmodified one, 
nitrotyrosine containing peptides are sensitive to laser light and undergo a 
decomposition process yielding, besides the expected mass increase of 45 Da, other 
major peaks corresponding to nitrosotyrosine ((Tyr-NO) [M + H+ + 29]), aminotyrosine 
((Tyr-NH2) [M + H+ + 15]), and nitrenetyrosine ((Tyr-N) [M + H+ +13]) 26-27. While on 
the one hand this phenomenon constitutes a unique fingerprint, it also impairs the 
sensitivity of the analysis, since it spreads the nitrated peptide signal over at least 
three major species, hence reducing the signal intensity by as much as 60-70%, 
which may result in the failure to observe nitrated peptides in complex peptide 
mixtures 28-30. This is worsened by the fact that tyrosine nitration is a low-abundance 
PTM with an occurrence of 1 in 10000 tyrosines in vivo 31. 
It has been showed by Petersson and co-workers 27 that using ESI mass 
spectrometry, this phenomenon is absent. Moreover it is possible to use ESI-MS/MS 
in precursor ion scan mode to detect nitrated peptides in complex mixtures using a 
characteristic fragment ion of nitrated peptides, such as the immonium ion of 
nitrotyrosine 27. 
My tutor’s research group has recently suggested a strategy leading to the selective 
detection of nitrated tyrosine residues by using dansyl chloride labelling coupled to 
advanced mass spectrometry experiments 32. The tryptic digest from the entire 
protein mixture is directly analyzed by MS on a linear ion trap mass spectrometer. 
Discrimination between nitro- and unmodified peptide is based on two selectivity 
criteria obtained by combining a precursor ion scan and an MS3 analysis. The 
proposed strategy is certainly rapid and easy to use but the major limit resulted in the 
absence of heavy form of dansyl chloride. Thus quantitative analysis of complex 
protein mixtures cannot be addressed. Taking advantage of the above mentioned 
strategy, i used selective labelling of 3-nitrotyrosine residues exploiting the potential 
of iTRAQ reagents to perform quantitative analysis of this post-translational 
modification in proteins. The strategy proposed is outlined in the figure II.1. 
 
 
 
Figure II.1. Strategy for selective labelling of 3-nitrotyrosine residues 
 
II.1.2 Quantitative analysis for nitrated proteins 
 
So far the iTRAQ chemistry has been limited to primary amines. With my work I am 
planning to widen the chemistry of this reagent to address quantification of functions 
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other than primary amines, by taking advantage of the experience made with dansyl 
chemistry. In fact, the research group in which I worked for my PhD thesis has 
already reported a totally new approach involving dansyl chloride labelling of the 
nitration sites that rely on the enormous potential of MSn analysis 32. 
Stable isotope methods have been introduced into MS-based proteomics to allow to 
determine relative changes in protein expression  33. The principle of these methods 
is the incorporation of a stable isotope derivative in one of the states to be compared. 
Stable isotope incorporation shifts the mass of the peptides by a predictable amount. 
The ratio of analyte between the two or more states can then be determined 
accurately by the measured peak ratio between the heavy and light derivatized 
samples. One of the first approaches based on the isotope stable affinity tagging and 
MS is the isotope coded affinity tag strategy (ICAT) 34 specifically addressed towards 
Cys residues. Other elegant approach uses cell culture enrichment with a stable 
isotope-labelled amino acid, for in vivo incorporation of a mass difference to perform 
relative quantitation 34.  
A novel methodology for quantitative analysis by mass spectrometry makes use of 
iTRAQ (acronym for Isobaric Tag for Relative and Absolute Quantification) 
technology, a newly developed method by Applied Biosystems for relative and 
absolute quantification of proteins 35. The iTRAQ reagents are specifically reactive 
towards primary amino groups (namely N-terminal of proteins and peptides and ε-
amino group of lysine residues) and marketed in four different forms called iTRAQ 
114, 115, 116 and 117, depending of m/z value of reporter group. The reagents are 
differentially isotopically labelled such that all derivatized peptides are isobaric 
(isobaric tag with a mass of 145.1 Da). In fact, the overall mass of reporter and 
balance components of the molecule are kept constant using differential isotopic 
enrichment with 13C, 15N, and 18O atoms. The iTRAQ reagents allow the 
simultaneously multiplexed analysis of four or eight samples. Each of these samples 
is labelled with one of the iTRAQ reagents; all peptides with the same sequence, but 
carrying different versions of the tag will be chromatographically indistinguishable 
and identical in mass, therefore, also identical in single MS mode. Upon 
fragmentation, the reporter group is detached, creating signals in the “quite” low 
mass range region (114-117 Da) of the MS/MS spectrum. The balance group is lost 
as a neutral, so that the remaining peptide backbone remains unmodified and can 
generate backbone fragments that are identical in m/z for all samples, resulting in 
improved S/N ratios because all differentially coded samples contribute to MS/MS 
spectrum. Thus low mass reporter ion signals allow quantitation, while peptide 
fragment ion signals allow protein identification. Very recently, an octu-plex iTRAQ kit 
has been proposed thus allowing the simultaneous analysis of eight different 
samples 36. 
 
II.1.2 iTRAQ as a RIGhT reagent 
 
RIGhT approach is based on the selective MS analysis of species of interest by using 
the molecular structure features of labelled peptides and the MS2 characteristic 
fragmentation pathway introduced by the chosen reagent. RIGhT reagents have a 
peculiar structure consisting in a reactive group toward the interesting residues, a 
linker group that is loss as neutral moiety in MS2 experiment and a reporter group 
that leads to generate stable fragment ions, selectively detectable in MS2 experiment.  
For the development of a RIGhT strategy that allows the identification and 
quantitation of nitrated proteins, iTRAQ was chosen as RIGhT reagent. iTRAQ is a 
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primary amines reactive molecule, with all the structural features of a RIGhT reagent 
(figure II.2). 
 
 
Figure II.2. iTRAQ as RIGhT reagent. 
 
After MS2 fragmentation, iTRAQ peptides give rise to peculiar ions with m/z 114-117 
according to the iTRAQ molecule used for labelling. These characteristics fragments 
were exploited by using an Applied Biosystems 4000QTrap mass spectrometer. By 
the coupling of this instrumentation and of the iTRAQ derivatives characteristics, it 
was set up a high throughput LC-MS/MS method based on Precursor Ion Scan (PIS) 
analysis. PIS was chosen as survey scan for its selectivity and its high scan rate. In 
this scan mode the Q1 performs a scan across the full mass range; the ions 
separated are fragmented in the collision cell (q2); finally the Q3 is set to transmit only 
ions with the specific mass of the diagnostic fragment (m/z 114-117). Selected 
precursor ions are then submitted to a classical MS2 experiment exploiting the LIT 
features of the QTrap. This MS based selection of labelled peptides substitutes 
others chromatographic steps so that the mass spectrometer can be considered as 
the second dimension of the RP-LC separation. 
 
II.2 Materials and methods 
 
Chemicals  
Bovine serum albumin (BSA), tetranitromethane (TNM), ammonium bicarbonate 
(AMBIC), guanidine, dithiothreitol (DTT), trypsin, iodoacetamide (IAM) and triethyl 
ammonium carbonate (TEAB) were purchased from Fluka. 
Tris(hydroxymethyl)aminomethane, sodium dithionite as well as the MALDI matrix α-
ciano-4-idrossicinnamic acid were purchased from Sigma. iTRAQ reagents were 
furnished by Applied Biosystems. Methanol, trifluoroacetic acid (TFA) and acetonitrile 
(ACN) are HPLC grade type from Carlo Erba, whereas the other solvents are from 
Baker. Gel filtration columns PD-10 are from Pharmacia, the HPLC ones from 
Phenomenex, whereas the pre-packed columns Sep-pak C-18 are from Waters. 
 
BSA nitration 
An aliquot of BSA was dissolved in Tris 200 mM pH 8.0 buffer and was added an 830 
nmol/ml solution of TNM in ACN in molar ratio 1:10 BSA : TNM. Reaction was carried 
out under agitation for 30 min at room temperature. Product was then purified by size 
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exclusion chromatography on a SEPHADEX G-25M column; the elution was carried 
out with Tris 300 mM and the fractions analyzed through UV spectrometry at 220 and 
280 nm wavelength. Positive fractions were collected and dried. 
 
Reduction and carboamidomethylation of BSA 
Dried nitrated BSA (N-BSA) was dissolved in denaturation buffer (guanidine 6 M, Tris 
0.3 M, EDTA 10 mM, pH 8.0). Reduction was carried out by using a 10:1 
DTT:cysteine molar ratio. After incubation at 37°C for 2 h, iodoacetamide was added 
to perform carboamidomethylation using an excess of alkylating agent of 5:1 respect 
to the moles of thiolic groups. The mixture was then incubated in the dark at room 
temperature for 30 min. The alkylation reaction was stopped by addition of formic 
acid, in order to achieve an acidic pH. The product was purified by size exclusion 
chromatography. The elution was performed with TEAB 50 mM pH 8.0. 
 
BSA digestion 
Digestion of N-BSA was carried out in TEAB 50mM pH 8.0 buffer using trypsin at a 
50:1 protein : trypsin mass ratio. The sample was incubated at 37°C for 16 h. Then 
sample was dried.  
 
Acetylation of peptide mixture 
Peptide mixture was dissolved in 30% TEAB 500mM pH 8.0, 70% ACN. Acetylation 
was performed by using acetic acid N-hydroxy-succinimide esther in molar ratio 
500:1 reagent : peptides. The reaction was carried out for 1 h at room temperature.  
 
Nitro groups reduction 
Reduction of nitro groups to amino groups was performed by adding. Na2S2O4 at 
100:1 Na2S2O4: NO2Tyr molar ratio. Reaction was carried out at room temperature 
for 10 min under stable stir. Product was purified by SEP-PAK RP-LC with C18 
column. Peptides were eluted using 80% ACN, 20% formic acid 0.1%. Fractions 
were collected and lyophilized. 
 
iTRAQ selective labelling 
Sample was dissolved in TEAB 500mM pH 8.0 and then was divided in two shares 
and each of these was differentially labelled with alternatively iTRAQ reagent 114 
and iTRAQ reagent 117, following a modified version of iTRAQ labelling protocol 
furnished by Applied Biosystems; the reaction was carried out in 60% ACN, 40% 
TEAB 500mM pH 8.0, for 2 h at 37 °C. 
 
Labelling of Bovine Milk Protein Extract 
A sample of commercially available bovine milk was reacted with a 10 mM solution of 
TNM for 30 min at room temperature. Modified milk proteins were purified by 
precipitation with the Amersham Clean Up kit and dissolved in denaturant buffer. 
Reduction of both the SH and nitro groups of the protein mixture was carried out in 
“one pot” using 20 mM DTT, 40 mM iodoacetamide, and a 200 mM solution of 
Na2S2O4 in the dark for 30 min. The protein mixture was purified by size exclusion 
chromatography on a Sephadex G-25 M column equilibrated and eluted with 50 mM 
TEAB. Protein fractions were concentrated and then digested with trypsin as already 
described. The resulting peptide mixture was acetylated and reacted with ITRAQ as 
described above. 
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nanoLC Mass Spectrometry 
Peptide mixture, obtained as previously described, was analysed by LC-MS/MS 
analysis using a 4000QTrap (Applied Biosystems) coupled to an 1100 nanoHPLC 
system (Agilent Technologies). The mixture was loaded on an Agilent reverse-phase 
pre-column cartridge (Zorbax 300 SB-C18, 5x0.3 mm, 5 µm) at 10 µL/min (A solvent 
0.1% formic acid, loading time 7 min). Peptides were separated on a Agilent reverse-
phase column (Zorbax 300 SB-C18, 150 mm X 75µm, 3.5 µm), at a flow rate of 0.2 
µL/min with a 5 to 65% linear gradient in 60 min (A solvent 0.1% formic acid, 2% 
ACN in water; B solvent 0.1% formic acid, 2% water in ACN). Nanospray source was 
used at 2.3 kV with liquid coupling, with a declustering potential of 20 eV, using an 
uncoated silica tip from NewObjectives (O.D. 150 µm, I.D. 20 µm, T.D. 10 µm). 
Spectra acquisition was based on a survey precursor ion scanning for the ion m/z 
114 and 117. It was performed over a mass range of m/z 400-1400 with Q1 set to low 
resolution and Q3 set to unit resolution. Precursors were collided in q2 with a collision 
energy ramp from 25 to 65 eV across the mass range. Spectra acquisition was based 
on a survey precursor ion scan. A positive ion enhanced resolution scan was 
performed at 250amu/s to determine the charge state of the ion. Enhanced product 
ion (EPI) scans (MS/MS) were performed at 4000 amu/s and collision voltages were 
calculated automatically by rolling collision energy and it performed a maximum of 
one repeat before adding ion to the exclusion list for 60 s. Once this duty cycle was 
completed, the polarity was switched back and the cycle repeated. The entire cycle 
duration, including fill times and processing times was less than 4.3 s. Data were 
acquired using Analyst software (Applied Biosystems) and processed by using in 
house Mascot software. 
 
II.3 Results and discussions 
 
According to the so-called “gel-free procedures”, the analysis is carried out at level of 
peptides following tryptic digest of the whole protein mixture. The approach 
presented in this chapter was first applied to bovine serum albumin (BSA) as model 
protein to prove its effectiveness. The BSA was nitrated using TNM as described in 
materials and methods section. After nitration, aliquots of BSA and N-BSA mixtures 
were reduced, alkylated and hydrolyzed using trypsin. The peptide mixtures were 
then analysed via MALDI-MS to verify the extent of nitration.  
 
II.3.1 Analysis of 3-nitrotyrosine residues of a model protein 
 
BSA is a protein of about 66 kDa and it has 20 tyrosine residues along its sequence. 
However nitration was limited to only few tyrosine residues, namely tyrosine residues 
exposed in the structure of protein and thus more sensible to nitration.  
Nitrated peptides were identified by MALDI mapping procedure, by comparing the 
experimental peptides masses with the theoretical values on the basis of amino acid 
sequence. As already reported a ∆M of +45 was attributed to the modified peptide, 
due to introduction of a nitro group 37. The MALDI-MS spectrum showed the 
occurrence of four signals at m/z 972.5, 1524.8, 1612.9, 1770.8, respectively whose 
molecular masses were 45 Da higher than the theoretical ones. These signals were 
attributed to the peptides 143-149, 403-415, 329-341, 451-464 having the Tyr 
residues modified by a nitro group. As further proof, these signals exhibited the 
characteristic pattern of nitrated peptides, due to photodecomposition of nitrated 
tyrosine residues by MALDI source 37 (figure II.3).  
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Figure II.3. Detail of a MALDI spectrum obtained from the analysis of nitrated BSA. The spectrum 
shows the presence of a signal at m/z 972.57 attributable to the nitrated peptide 143-149 and the 
peaks at m/z 956.58, 941.59 because of the photodecomposition on nitrated tyrosine residue. 
 
In our previous work 32, a new methodology for the selective labelling of o-
nitrotyrosine residues was essentially based on a reduction step and conversion to o-
aminotyrosine residues followed by specific dansylation at pH 4.7. Similar strategy 
was attempted here. However, iTRAQ labelling does not permit to exploit the 
characteristic pKa 4.7 38 of such aromatic amine to obtain a selective labelling, as 
proposed for the dansyl chloride labelling. In fact, although in solution at pH 5.0 the 
free amino groups able to give nucleophilic attack, are not abundant, a small 
percentage of primary amine modification was observed, as also already 
demonstrated 39-40. This behaviour may be due to an “ankymeric effect”, namely an 
increased reactivity of iTRAQ molecule due to both slower rate of hydrolysis of the N-
hydroxysuccynimide esther in mild acidic condition and the acid activation of acylic 
nucleophilic substitution 41. Thus, a double step strategy was set up. First of all, lysine 
residues and N-terminus primary amines were protected to facilitate specific labelling 
of the 3-nitrotyrosine residues. Blocking can be easily performed under mild 
conditions by a variety of reagents that are commercially available. In fact, several 
strategies to introduce NH2- labels have been described 42-43. Generally, it is not 
possible to reliably control the selectivity of the reaction, because the ε-amino group 
of lysine is readily and stably modified by reagents that target the N-terminus 44-45. 
Blocking the N-terminus and the lysine side chain can be done either prior to or after 
enzymatic digestion of the sample. By blocking the lysines after digestion, we 
retained the ability to use trypsin as enzyme for proteolytic cleavage. Thus, nitrated 
peptides were subjected to acetylation using acetic acid N-hydroxy-succinimide 
esther as described in material and methods section. All successive analyses 
revealed that every peptide detected had the N-terminal amine and eventually ε-
amino group of lysine protected. 
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Only after acetylation step it was possible to reduce the nitro group of 3-nitrotyrosine 
residues to an amino group, susceptible to iTRAQ addition. Conversion of 
nitropeptides into their amino derivatives was accomplished by Na2S2O4 treatment 46. 
The peptide mixture was desalted by sep-pak C18 cartridge and the extent of 
reduction was monitored by MALDI-MS (figure II.4).  
 
 
 
Figure II.4. Detail of a MALDI spectrum obtained from the analysis of acetylated and reduced nitrated 
BSA. The spectrum shows the presence of a signal at m/z 984.59 attributable to the acetylated 
NH2Tyr peptide 143-149; as a consequence of nitro group reduction, signals attributable to 
photodecomposition phenomena disappeared.  
 
In order to perform quantitative analysis, iTRAQ 114 and 117 molecules were used. 
Labelling reaction was carried out on the newly generated amino groups by following 
the protocol proposed in methods section. iTRAQ technology allows quantitative 
analysis of protein expression through the use of isobaric tags, enabling the 
quantitation of four 35 up to eight samples 47 in a single multiplexed analysis. Isobaric 
tagging methods are emerging as an important tool to study protein expression 
dynamics. 
To further illustrate the ability of this labelling strategy in quantifying the relative 
nitration of a peptide from two different samples, iTRAQ 114 and iTRAQ 117 
molecules were used to label samples containing stoichiometric concentrations of N-
BSA in ratios of 1:1 and 1:4. The two samples were pooled and then submitted to 
LC-MS/MS analysis. We set up an experiment by using a precursor ion scan (PIS) 
for the iTRAQ reporter ions at m/z 114.1 and 117.1. In order to demonstrate that the 
choice of the fragment to monitor in PIS mode is un-relevant, due to the isobaric 
characteristic of the iTRAQ, we analysed the same sample in two separate 
chromatographic runs. Thus, we performed two PIS by selecting either for m/z 114.1 
and m/z 117.1 fragment ions. It should be noted that PIS ion current is recorded from 
the fragment generated in MS2 and no memory is retained about the intensity of the 
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parent ion. The chromatographic profiles are quite identical and super imposable but 
differing in the intensity depending on the amount of the precursor ion chosen (either 
114 or 117 reporter ions), as shown in the figure II.5.  
 
 
 
Figure II.5. Overlapped chromatograms of nitrated BSA recorded respectively by PIS analysis of ions 
114 (grey line) and 117 (bold line). The chromatogram of PIS 114 is shift back of 1 minute to lead a 
better comparison of signals. Symbols +, Ο, X , *, ∆, ∂, are referred respectively at BSA peptides 143-
149, 403-415, 451-464, 329-341, unspecific detected in PIS114, unspecific peptide detected in PIS 
117.  
 
To gain information about the sequence of the peptide and the site of nitration, a 
second stage of mass analysis is performed in which the precursor ion is selected by 
the first mass analyzer and fragmented. Differentially labelled peptides were 
indistinguishable during a single step of MS analysis because they were isobaric 
species due to typical characteristics of iTRAQ reagents. During MS/MS, labelled 
peptides produce fragmentation spectra that allow to identify the protein. Moreover, 
MS/MS produces fragmentation at sites modified by the iTRAQ reagent yielding 
reporter ions (m/z 114 and 117) that are visible as separated peaks in the low mass 
region of the MS/MS spectrum. The ratios of related areas of these peaks were then 
used to perform a relative quantitative analysis 48-49.  
Figure II.6 shows the reconstructed ion chromatogram for the precursor ion scan (A). 
The precursor ion scan mode showed the occurrence of a number of signals, not all 
related to 3-nitrotyrosine-containing peptides. However, the PIS analysis led to a 
reduced number of signals with respect to a classical full scan MS (B) improving also 
the duty cycle of the method and the sensitivity toward nitro-peptides enhancing 
signal/noise ratio.  
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Figure II.6. Panel B Chromatogram of nitrated BSA recorded in PIS 117. Panel A Chromatogram of 
nitrated BSA recorded in a full scan MS. 
 
However, others signals appeared in the chromatogram not related to nitrated 
peptides. This effect might be generated by the presence of different fragment ions in 
the region 113-114 or 116-117, many of which generated after acetylation step (table 
II.1). Thus I used 114 and 117 iTRAQ reagents, in order to have the worst condition 
of selectivity and to demonstrate the feasibility of this methodology.  
 
 
 
 
 
 
 
 
 
 
 56 
 
Interfering ions Mass Peptides Scan 
(Ac)b1 Ala 114.1 (Ac)ADE(Ac)K(Ac)KFWGK(Ac) PIS 114 
(Ac)b1 Ala 114.1 (Ac)AEFVEVTK(Ac) PIS 114 
(Ac)Immonium Val 114.1 (Ac)VLASSARQR PIS 114 
(Ac)Immonium Val 114.1 (Ac)VH(Ac)KECCHGDLLECADDR PIS 114 
(Ac)Immonium Thr 116.1 (Ac)TCVADESHACCEK(Ac) PIS 117 
(Ac)Immonium Thr 116.1 (Ac)TVMENFVAFVDK(Ac) PIS 117 
 
Table II.1. Un-labelled BSA peptides and their precursor detected in PIS 114 and PIS 117 modes. 
 
An accurate manual analysis of MS2 spectra revealed that many false positive were 
selected for the presence of m/z 114 fragment whose intensity would not have effect 
on quantitative estimation (figure II.7). 
 
 
 
Figure II.7. MS2 spectra enlargement of characteristic iTRAQ m/z region relative at un-specific 
detected BSA peptides. Panel A peptide AEFVEVTK was detected in PIS114 mode because of the 
presence of an acetylated b1 ion of Alanine at m/z 114.2. Panel B peptide VLASSARQR was detected 
in PIS114 mode because of the presence of an acetylated immonium ion of Valine at m/z 114.0. C 
peptide TVMENFVAFVDK was detected in PIS117 mode because of the presence of an acetylated 
immonium ion of Threonine at m/z 116.3 or its isotope. 
 
To enhance the selectivity of the strategy I also tried to introduce an MS3 event as 
done in previous work 32. In particular I tried to fragment in MS2 the ion at m/z 145 
and monitor the loss of CO giving rise to the peculiar reporter ions of iTRAQ in MS3 
mode. 
Preliminary experiment revealed that MS3 spectra exhibited a very poor intensity 
caused by the low yield of ion fragment at m/z 145 in MS2 mode. Thus, it was found 
that to enhance the selectivity of LC-MS/MS analysis good results were obtained 
increasing the signal threshold of PIS using the great difference in signal intensity 
between the iTRAQ reporter ions and others mentioned previously. However, I 
inferred that these LC-MS/MS conditions resulted to be a good compromise between 
selectivity and sensibility, fundamental parameter because of the sub-stoichiometric 
characteristic of protein nitration. Furthermore, the unspecific precursor selection 
problem is solved making a separate double PIS analysis; indeed unspecific ions 
detected in PIS of 114 were not detected in PIS of 117 and vice versa (figure II.5). 
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Identification of nitrated tyrosine residues was carried out by taking advantage of the 
flexibility of the in house Mascot software. The software was properly modified by 
adding in the “modification file” the value of ∆M 159 Da for iTRAQ labelled 
aminotyrosine residue. For Mascot analysis it was necessary to set the software 
supplying key information, e.g. proteolytic enzyme, fixed modifications, variable 
modifications, sample taxonomy, eventually missed cleavage, etc. The data obtained 
from MS/MS analysis in PIS mode where exploited both to identify nitration sites by 
using SwissProt database and to perform quantitative analysis.  
Nitration sites Y137, Y406, Y457, Y337 was identified by the detection and by MS/MS 
spectra interpretation respectively from MH22+ ions at m/z 564.8, 841.0, 963.5, 885.3. 
As an example the MS/MS spectrum of modified peptide 137-143 is presented in 
figure II.8 A. The derivatized product ions were identified from either the 
corresponding b or y product ion series.  
By using the Analyst software tool for calculation of peaks area it was possible to 
compare the areas of signals relative to reporter ions at m/z 114 and 117. For the 
MS/MS spectrum mentioned above was calculated a ratio of 1.1 + 0.2.  
Figure II.8 B showed the MS/MS spectrum relative to the peptide 469-482 for the 
mixture 1:4 molar ratios between N-BSA labelled with iTRAQ 114 and N-BSA 
labelled with iTRAQ 117. In this case nitration site was detectable from y ions and the 
area ratio for the reporter ions at m/z 117 and 114 was 4.1 + 0.4, thus providing an 
accurate measurement of the relative abundance of each nitrated peptide.  
It is also interesting to note in both spectra (figure II.8) the presence of an intense 
iTRAQ-labelled amino tyrosine immonium ion at 295.2 m/z that may be also used as 
indication of a nitration site presence in the peptide.  
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Figure II.8. Panel A MS2 spectrum of nitrated BSA peptide 143-149 labelled by iTRAQ reagent in 1:1 
ratio. Panel B MS2 spectrum of nitrated BSA peptide 451-464 labelled by iTRAQ reagent in 1:4 ratio. 
Spectra enlargement shows iTRAQ signals allowing quantitative estimation. 
 
II.3.2 Analysis of complex mixtures  
 
In order to investigate the feasibility of applying the method to proteomics analysis, 
1.5 nmol of N-BSA was added to 30 mg of an E. coli entire protein extract. Aliquots of 
mixtures of BSA and N-BSA, as control, and E. coli extract spiked with BSA mix were 
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fractionated by SDS-PAGE and submitted to Western blot analysis using anti-
nitrotyrosine antibody as indicated in figure II 9.  
The figure II.9 shows that the amount of N-BSA is quite impossible to differentiate 
from the other bacterial proteins. Moreover, in lane D is possible to appreciate that 
the sample used could be considered similar to a ‘dirty’ N-BSA E. coli protein extract, 
thus being a good candidate for nitro-proteome study.  
The total protein extract was then submitted to the procedure described above. The 
mixture was hydrolyzed with trypsin and lysine residues were protected by 
acetylation. Nitrotyrosines were then reduced with dithionite, and the newly 
generated aminotyrosine-containing peptides were submitted to the iTRAQ labelling 
protocol, using 114 iTRAQ molecule.  
 
  
 
Figure II.9. SDS-PAGE and western blot analyses of E. coli protein digest spiked with nitrated BSA 
(lane B) where N-BSA band was indistinguishable by the others. Lane A: Standard mix of BSA and N-
BSA as control. Lanes C and D: Western blot analysis by using anti-nitrotyrosine antibody of control 
and E. coli samples, respectively. 
 
After labelling reaction, LC-MS/MS analysis of the mixture was performed as already 
described. In figure II.10 it was shown a three-dimensional graphic, called Counter 
Plot, representing LC-MS/MS parameters, time of elution, m/z and ion intensity 
expressed in greyscale intensity. This graphical view, obtained by an Analyst 
software tool, shows the duty cycle and sensitivity improvement of the strategy 
proposed. Figure II.10 A is referred to a full scan MS analysis of N-BSA spiked with 
an entire digest of E. coli proteins extract. As clearly shown in figure this kind of MS 
analysis it is not competitive for a so complex peptide mixture. Indeed, because of 
the large time spent by the spectrometer to analyse the more abundant peptides, 
lead to identify just 3 of 4 nitrated peptides present in the mixture. The high selectivity 
of PIS analysis proposed (figure II.10 B) reduces greatly the number of species 
analysed, leading the spectrometer to spend more time detecting labelled peptide, 
with a real gain in sensitivity.  
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Identification of nitrated proteins was carried out using the modified Mascot software 
as described above. In particular, these peptides corresponded to the same peptides 
previously detected in the analysis of homogeneous N-BSA. Thus, these results 
underscored the ability of the proposed selective labelling strategy to discriminate 
nitropeptides from their unmodified counterparts in a complex mixture. 
 
 
 
Figure II.10. Counter plot representation of a whole E. coli protein digest spiked with nitrated BSA 
analyzed, by a classical full scan MS (Panel A) and PIS (Panel B) after iTRAQ selective labelling. 
 
The proposed strategy was finally employed to identify unknown 3-nitrotyrosine 
residues in a complex sample as the entire bovine milk. Bovine milk was nitrated in 
vitro with TNM 32 and the extent of nitration was monitored by SDS-PAGE and 
Western blot analysis as described above. 
Figure II.11 (lane A) showed that the high difference of milk protein abundance in the 
sample reflected the high dynamic range features of the proteomic analysis. In 
addition the immuno-detection (lane B) showed the low extent of protein nitration 
thus indicating that this model system could be suitable for proteomic analysis. 
The entire milk protein extract was then dissolved in denaturant buffer, and cysteine 
alkylation and nitro groups reduction were performed in “one pot” as described in the 
materials and methods section. The protein sample was then desalted and digested 
with trypsin. The resulting peptide mixture was acetylated, divided in ratio 1:1 and 1:4 
then selectively labelled with iTRAQ reagents and analysed by nanoLC-MS/MS in 
PIS mode either for the ion 114 or for the ion 117.  
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Figure II.11. SDS-PAGE (lane A) and Western blot analysis by using anti-nitrotyrosine antibody (lane 
B) of in vitro nitrated milk proteins. 
 
Identification of nitrated milk proteins was carried out using the modified Mascot 
software as described. The common results obtained from a triplicate analysis of the 
two PIS mode are summarised in the table II.2.  
 
Observed 
m/z Score Sequence 
Ratio 
114:117 Protein, accession no. 
740.2 59 (Ac)VLVDTY*K(Ac)K(Ac) 4.1 + 0.1 
1.2 + 0.2 
β-Lactoglobulin, P02754 
796.5 49 (Ac)DMPIQAFLLY*QEPVLGPVR 3.8 + 0.4 
0.9 + 0.2 
β-Casein, P02666 
573.5 44 (Ac)TVY*QHQK(Ac) 4.3 + 0.2 
1.2 + 0.3 
α-S1-Casein, P02663 
568.8 42 (Ac)Y*LYEIAR 3.9 + 0.1 
0.8 + 0.3 
Albumin bovine, P02769 
426.8 36 (Ac)ADLIAY*LK(Ac)K(Ac) 4.1 + 0.4 
1.3 + 0.2 
Cytochrome c, P62849 
716.3 34 (Ac)STRTVSSSSY*R 4.1 + 0.4 
1.2 + 0.4 
Vimentin, P48616 
617.4 30 (Ac)AY*PTPARSK(Ac) 4.2 + 0.7 
1.4 + 0.3 
Glycoprotein hormones a 
chain, P01217 
565.9 29 (Ac)HFHLY*GR 5.2 + 1.6 
1.8 + 0.9 
Integrin α-L, P61625 
559.8 29 (Ac)LELY*LPK(Ac) 7.1 + 3.4 
1.8 + 1.2 
Plasma serine protease 
inhibitor, Q9N212 
 
Table II.2. Nitrated milk Proteins detected by the selective iTRAQ labelling strategy coupled with a 
selective PIS-MS analysis. 
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As indicated in the table, besides the high-abundant milk proteins (α-casein and β-
lactoglobulin), this procedure was also able to assess the nitration sites occurring in 
low-abundant proteins, like Vimentin and Integrin, thus demonstrating the feasibility 
of this strategy for the identification of protein nitration in proteomics. Concerning the 
quantifications we realized the quantitative estimation of 7/9 nitrated peptides. 
Indeed, if from a side the less abundant proteins spectra lead to unequivocally 
identify the sequence, the quality of signals for the ions 114 and 117 were too low to 
make an accurate quantitative measure.  
In figure II.12 it is shown the MS/MS spectrum relative to the nitrated α-casein, it is 
interesting noting that the presence of an acetylated threonine in N-terminal position 
has not effect on the quantitative estimation. 
 
 
 
Figure II.12. MS2 spectrum relative at  α-Casein nitrated peptide TVYQHQK detected in an in vitro 
nitrated milk proteins extract. In the spectrum enlargement of iTRAQ mass region it is visible the 
characteristic signals of the reporter and also a signal at 116.1 m/z relative at Acetylated Threonine 
immonium ion. The presence of this fragment has not effect on the quantitative estimation. 
 
II.4 Conclusions 
 
The iTRAQ approach has been successfully applied to a variety of prokaryotic and 
eukaryotic samples including Escherichia coli, yeast, human saliva, human fibroblasts 
and mammary epithelial cells to identify and quantify the proteins in these samples 50-
51
. Zhang et al. 52 combined the iTRAQ labelling approach with immunoprecipitation 
to quantify tyrosine phosphorylated peptides in epithelial cells. However, iTRAQ has 
been applied to identify and quantify protein level in shotgun proteomics approach 53-
54
. The work presented in this chapter represents the first innovative application of 
iTRAQ labelling strategy to the analysis of post-translational modifications. In 
particular it was addressed the analysis of protein nitration, thus providing a powerful 
analytical methods to identify nitrated protein, localise tyrosine nitration sites and  
quantitate the extent of protein nitration in a single experiment.  
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Here the strategy proposed, taking in account the availability of QqLIT instruments to 
select specific labelled peptides giving rise to diagnostic MS2 product ions, resulted to 
be of interest in the selective detection of protein nitration. Moreover, because of its 
operational simplicity, avoiding long-lasting and time-consuming fractionation 
procedures, this new strategy seems to be well suited for large-scale proteomic 
profiling of nitration sites.  
The strategy reported here was set up with a 4000QTrap mass spectrometer; 
however, this approach may be realised also using others mass spectrometer optics, 
with opportune modifications. For example, Niggeweg et al. 55 showed the possibility 
to perform PIS compatible with chromatographic separations by a QTOF. Moreover, 
it would be very interesting to evaluate possible improvements, in terms of selectivity 
and quantitative estimation, by measuring with high resolution and accuracy (< 10 
ppm) iTRAQ reporter ions. This may be accomplished by a Thermo LIT/Orbitrap 
performing MS/MS experiments in higher energy CID (HCD) 56. The optic and the 
electronics of this instrument lead to perform analysis in an operation mode called 
"Parent Ion Mapping" that may be considered as reconstructed PIS. However, our 
feeling is that, because of the higher duty cycle of a triple quadrupole-based PIS, 
eventual improvement would have real effectiveness in an offline LC-MALDI-MS/MS 
analysis more than a classical LC-ESI-MS/MS. 
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III. DANSYL LABELLING AND BIDIMENSIONAL MASS 
SPECTROMETRY TO INVESTIGATE PROTEIN CARBONYLATION  
 
 
III.1 Introduction 
 
In this chapter it is reported a new methodology for selective analysis of carbonylated 
residues, and in particular of carbonylated lysine residues. As for protein nitration 
analysis, the strategy proposed may be classified as belonging to the class of RIGhT 
methodologies (section I.2.4). The approach proposed is based on the labelling of 
target residues with reagents capable to generate reporter ions in MS2/MS3 
experiments. The advantages of this analytical strategy are reported in the previous 
chapter (section II.1). The results discussed in the previous chapter showed that by 
using a very selective MS analysis it is possible to improve both the dynamic range of 
the mass spectrometer and the signal/noise ratio. In operative terms, the use of a 
high selective MS replaces the off-line chromatographic steps (affinity and/or 
bidimensional chromatography) aimed at isolating the labelled peptides, in order to 
avoid the time consuming analysis and the tremendous decrease in sensitivity. The 
strategy proposed here can be considered as a third generation proteomics 
approach. The method proposed was proven to lead the precise localisation of 
carbonylated residues in proteins.  
 
III.1.1 Proteomics analysis of carbonylated proteins 
 
Carbonylation of proteins may be the most widely type of damage used to infer 
oxidative stress 1-3, mainly because carbonyl modifications can be induced by a wide 
variety of ROS as well as by by-products of lipid oxidation (section I.3.2.2). 
The increase in carbonylated proteins during cellular ageing or in response to 
oxidative stress is not a casual event; in fact some proteins are more susceptible to 
ROS than others; moreover most of these proteins are specie specific 4-9. Thus the 
definition of the entire set of target proteins of oxidative stress is a hard challenge. 
For these reasons analysis of protein carbonylation is not easy and several methods 
have been developed to determine the content of carbonyl groups in proteins 10-15. 
Protein carbonyl groups have no distinguishing spectrophotometric 
absorbance/fluorescence properties, so they cannot be directly determined. For this 
reason, detection and quantification of carbonyl groups of proteins require the use of 
specific chemical probes. A simple and accurate method to quantify protein oxidation 
uses 2,4-dinitrophenylhydrazine, which specifically reacts with carbonyls to form 2,4-
dinitrophenylhydrazone 16-17; the amount of hydrazone is quantified by using 
spectrophotometric technique. An important caveat to be considered when using this 
method is that proteins containing chromophores (i.e. heme-containing proteins) 
have absorbance wavelengths similar to DNPH and may interfere with its 
measurement 18, leading to inaccurate estimation of protein carbonyls. The DNPH 
assay has also been used in combination with SDS-PAGE and Western blot analysis 
using commercially available anti-DNPH antibodies, thus enhancing the sensitivity of 
the method 19-22. Initial studies adopting SDS-PAGE approach led to the observation 
that not all proteins in a given proteome were subject to equivalent oxidative 
chemical modification, supporting the current view that protein oxidation is a selective 
process 23-24. More recent studies have successfully analyzed DNPH-modified 
samples using 2D-GE in a variety of experimental systems 25-29. Using fluorescent 
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secondary antibodies, protein carbonyl groups derivatized with DNPH can also be 
visualized through in situ immunofluorescent imaging 30-34. Using this strategy it is 
possible to go further insights into the mechanisms of cellular oxidative stress during 
physiological and pathological conditions 35-36. An excellent example of in situ 
immunofluorescent imaging of carbonylated proteins is represented by the work of 
Desnues et al. 32, in which the level of protein carbonylation in whole Escherichia coli 
cells was shown to be greatly elevated by H2O2 treatment. 
As an alternative to DNPH treatment, fluorescent methods have been developed; in 
particular two visible-wavelength fluorescence probes have been developed based 
on the use of fluorescein-5-thiosemicarbazide (FTC) 37-39 and Alexa 488 fluorescence 
hydroxylamine (FHA, Invitrogen) 40. Both probes are commercially available and have 
been successfully used in 2D-GE based proteomics. Application of these probes to 
quantify carbonyl content in protein mixtures has been limited, presumably because 
of the fact that it is difficult to completely remove the excess probes. Moreover the 
use of 2D-GE based analytical strategies is limited by the drawbacks of this analytical 
tool. A unique probe for this kind of analysis is APTB that is not fluorescent by itself 
but becomes fluorescent upon reaction with carbonyl groups 41. Using these probe 
protein carbonyl content could be read directly from protein mixtures with a 
fluorometer, because the unconjugated excess APTB is non-fluorescent. The use of 
fluorescence probes offers at least two advantages when used in combination with 
gel-based proteomics. First of all, there are no Western blot experiments to be 
carried out, so the whole process can be completed in a shorter time. Secondly, the 
same gel can be used for both protein staining and protein carbonyl imaging 37-38; this 
reduces errors associated with gel spot identification and excision for subsequent 
mass spectrometric analysis, while using DNPH gels are used for total protein 
staining and Western blot membranes are used for imaging of the carbonylated 
proteins 25-26.  
A radioactive method has been developed that uses tritiated sodium borohydride 
(NaBH4) to reduce carbonyl groups and their Schiff bases; in this case tritium is 
incorporated selectively into the carbonylated proteins 42 and the radioactivity can be 
measured to quantitate the carbonyl content of proteins. This strategy is also 
compatible with SDS-PAGE separation of labelled proteins; in this case bands of 
interest can be excised and identified 43. This methodology can be used when target 
proteins have absorbance near 360 nm that would otherwise interfere with DNPH 
measurement, but has some drawbacks such as the use of radioactive reagents, with 
risks for safety, and non specific incorporation of tritium into proteins 42. 
Recently proposed methods for detection of carbonyl groups use biotin for carbonyls 
labelling; biotin probes take advantage of the affinity binding between biotin and 
avidin, among the strongest known non-covalent interactions 44. The most used biotin 
probe for the analysis of protein carbonyls is biotin-hydrazide 4. Proteins labelled with 
this probe can be either affinity captured using avidin beads 13 or analysed using 2D-
GE approaches. In this case the advantage is that no secondary antibodies are 
required when biotin-containing probes are used for Western blot detection of 
carbonyls. Using this probe the initial reaction between a carbonyl group and the 
hydrazide forms a hydrazone moiety that is unstable and must be reduced to a more 
stable hydrazine group 4. This strategy has been used in combination with affinity 
chromatography step and mass spectrometric analysis to identify specific sites of 
carbonylation in proteins 45-49. An excellent application of this probe is the profiling of 
carbonylated proteins in human plasma 13. In this study, the use of biotin-hydrazide 
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allowed accurate estimation of total carbonylated proteins in plasma of healthy 
humans (0.2%). 
All the strategies described could be used in combination with mass spectrometric 
identification of carbonylated proteins. As for gel-based approach, bands (1D-GE) or 
spots (2D-GE), whether detected by chemiluminescence, radioactivity, or 
fluorescence, can be analysed by LC–MS/MS techniques following in situ trypsin 
digestion. The major drawbacks of this method are linked to the limits of gel-based 
proteomics (see section I.2.2); moreover this approach will only identify proteins that 
are putatively carbonylated 26,50 and it suffers from the difficulty to pinpoint the 
modified residues unless peptides laying carbonylated residues are sequenced. 
Unfortunately this is usually the case for complex samples that do not receive prior 
selective enrichment of modified species, since PTMs are sub-stoichiometric 
modifications. Therefore to selectively identify the proteins that undergo 
carbonylation, a shotgun proteomic approach may be used 51-52. This means that 
protein carbonyl groups have to be derivatized with biotin-containing probes, then 
digested by trypsin and enriched by affinity capture of the carbonylated/tryptic 
peptides, using avidin beads, prior to mass spectrometric analysis 13,51,53-54. The use 
of biotin probes facilitates isolation and enrichment of the carbonylated peptides and, 
at the same time, tags the carbonylated sites that can be distinguished by mass 
spectrometry. However biotin tags can diminish the ionization efficiency and can alter 
the fragmentation pattern of modified peptide causing a loss in signal intensities and 
in the quality of MS/MS spectra.  
The research group in which i worked for this PhD thesis have recently reported 
innovative RIGhT (Reporter Ion Generating Tag) approaches, which involve dansyl 
labelling of nitration and phosphorylation sites and rely on the enormous potential of 
MSn analysis 55-56. Taking advantage of the experience already made, this chapter 
reports a novel RIGhT methodology for selective labelling of carbonyl groups in 
proteins using dansylhydrazide coupled with selective analysis by precursor ion scan 
mode and MS3. This strategy is certainly rapid and easy to use but suffers from the 
impossibility to perform quantitative analysis of samples of interest because of the 
absence of heavy form of dansyl-hydrazide molecule. For this reason in the last part 
of this chapter it is reported a preliminary approach that exploits the potential of 
iTRAQ reagents to perform selective and quantitative analysis of carbonyl groups of 
proteins. 
 
III.1.2 Dansyl derivatives as RIGhT reagent 
 
By using reagents as iTRAQ or Dansyl (DNS) it is possible to design analytical 
strategies defined as RIGhT approaches 56; these approaches are based on the 
separation of analytes by using the molecular structure features of selectively labeled 
peptides and the fragmentation characteristics introduced by the reagent chosen, 
rather than using chromatographic or electrophoretic fractionation. RIGhT reagents 
(as described in section II.1.2) are characterized by having a reactive group toward 
the residues of interest, a linker group that is loss as neutral moiety in MS2 
experiment and a reporter group that generates stable fragment ions selectively 
detectable in MS2 experiment.  
For the development of a RIGhT strategy to selectively identify carbonylated residues 
of proteins, dansyl-hydrazide (DNSH) has been chosen as molecular probe. DNSH is 
a specific carbonyl reactive molecule with all the structural features of a RIGhT 
reagent (figure III.1). 
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The choice of this reagent was due to the well known fragmentation features of 
dansyl-derivatives in gas phase 56. My tutor’s research group has a relevant 
experience in the usage of dansyl-derivatives in the years before the commercial 
availability of mass spectrometers. Since the introduction of these instruments, at the 
end of the 60th, MS characteristics of dansyl derivatives have been extensively 
studied; in the 1968 Marino et al. showed fragmentation features of dansyl-
derivatives during electronic impact fragmentation events 57. 
 
 
 
Figure III.1.  Dansyl-hydrazide has the peculiar structure of RIGhT reagents. 
 
During MS2 fragmentation, dansyl peptides give rise to two specific fragment ions at 
170 m/z and 234 m/z; in addition the last one may be further fragmented in a 
diagnostic MS3 transition 234-170 m/z (figure III.2).  
These features were exploited by using characteristic scan modes of an Applied 
Biosystems 4000QTrap mass spectrometer. By coupling this instrumentation and 
dansyl-derivatives it was possible to set up a high throughput LC-MS/MS method 
based on Precursor Ion Scan (PIS) and MS3 experiments. PIS consists in: i) a Q1 
scan across the full 
mass range; ii) ions 
separated are 
fragmented in the 
collision cell (q2); iii) Q3 
is set to transmit only 
ions with the specific 
mass of the diagnostic 
fragment m/z 170. 
Selected precursor 
ions are then 
submitted to combined 
MS2/MS3 experiments, 
to specifically detect 
only those ions giving 
rise to the transition 
234-170 in MS3 mode, 
Figure III.2. Peculiar dansyl-peptides CID fragmentations. 
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thus leading to the selective detection of dansyl-peptides. This MS based selection of 
labelled peptides substitutes other chromatographic steps so that the mass 
spectrometer can be considered as the second dimension of the RP-LC separation. 
 
III.2 Materials and methods 
 
Chemicals 
Dithiothreitol (DTT), ethylendiaminetetraacetic acid (EDTA), trypsin, urea, α-cyano-4-
hydroxycinnamic acid, sodium hypochlorite solution, bovine ribonuclease A (RNase 
A), lysozime and hydrazine solution were from Sigma (St. Louis, MO).  5-N,N-
(dimethylamino)naphthalene-1-sulfono-hydrazide (DNSH), ammonium hydrogen 
carbonate (AMBIC) and iodoacetamide (IAM) were purchased from Fluka. 
Acetonitrile (ACN) was from Romil. Trifluoroacetic acid HPLC grade was purchased 
from Carlo Erba. All solvents were of the highest purity available from Baker. All other 
reagents and proteins were of the highest purity available from Sigma. 
 
In vitro carbonylation of RNase A  
RNase A was dissolved in a 5 mM NaClO solution to a final concentration of 0.5 
mg/ml. The reaction was carried out at 37 °C for 15  min. Carbonylated RNase A was 
immediately desalted by size exclusion chromatography on a Sephadex G-25M 
column (GE Healthcare). Protein elution was monitored at 220 and 280 nm. Fraction 
containing protein was collected, lyophilized and stored at -20 °C. 
 
Disulfide bridges reduction, Cys alkylation and tryptic digestion  
Carbonylated RNase A was dissolved in denaturant buffer (urea 6M, Tris 300 mM pH 
8.0, EDTA 10mM) and disulfide bridges were reduced with DTT (10-fold molar 
excess on the Cys residues) at 37 °C for 2 h and th en alkylated by adding IAM (5-fold 
molar excess on thiol residues) at room temperature for 30 min in the dark. Protein 
samples were desalted by size exclusion chromatography on a Sephadex G-25M 
column (GE Healthcare). Fraction containing protein was lyophilized and the 
dissolved in 50 mM AMBIC buffer pH 8.0. Trypsin digestion was performed using an 
enzyme/substrate ratio of 1/50 w/w at 37 °C for 16 h. 
 
Labelling of carbonyl groups with DNSH 
Sample was lyophilized and then dissolved in 10 µl of H2O. To this solution it was 
added 100 µl of a 6.5 % of TFA solution in ACN and an equal volume of a 5 mM 
DNSH solution in ACN. Solutions were allowed to react at 37 °C for 8 h. 
 
Bacterial strains, growth conditions and proteins extract preparation 
Escherichia coli K12 strain was grown in aerobic conditions at 37 °C in LB medium. 
After 16 h, bacteria were harvested by centrifugation and resuspended in Buffer Z 
(25 mM HEPES pH 7.6, 50 mM KCl, 12.5 mM MgCl2, 1 mM DTT, 20% glycerol, 0.1% 
triton) containing 1 mM PMSF. Cells were disrupted by sonication. The suspension 
was centrifuged at 9000 x g for 30 min at 47 °C. Af ter centrifugation the protein 
concentration of the extract was determined by Bradford assay. 
 
iTRAQ-hydrazide synthesis 
iTRAQ-hydrazide was obtained by reaction of iTRAQ (Applied Biosystems, 
Framingham, MA) (1 nmol/µl dissolved in ethanol) with hydrazine (50 nmol/µl in 
ethanol) (molar ratio 2:1). Reaction was carried out at room temperature for 6 h at 
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room. Product was purified by RP-HPLC using an Agilent Zorbax C18 column 
(4,6mm X 150mm) (Palo Alto, California) using a 10% to 65% linear gradient in 20 
min from water to acetonitrile (ACN) and verified by MALDI-MS analysis.  
 
Labelling of carbonyl groups with iTRAQ-hydrazide 
Lyophilized peptide sample was dissolved in 10 µl of H2O. To this solution it was 
added 100 µl of a 6.5 % of TFA solution in ACN and an equal volume of a 5 mM 
iTRAQ-hydrazide solution in ACN. Solutions were allowed to react at 37 °C for 18 h. 
After reaction sample was concentrated and diluted in HCOOH 0.1% for mass 
spectrometric analysis. 
  
Mass Spectrometry 
MALDI-MS experiments were performed on a Voyager-DE STR MALDITOF mass 
spectrometer (Applied Biosystems, Framingham, MA) equipped with a nitrogen laser 
(337nm). 1 µl of the total mixture was mixed (1/1, v/v) with a 10 mg/ml solution of α-
cyano-4-hydroxycinnamic acid in ACN/50 mM citrate buffer, 70/30 v/v. 
MALDI-MS/MS analysis of protein mixtures labelled with iTRAQ-hydrazide, was 
performed on a MALDI TOFTOF 4800 Plus mass spectrometer (Applied Biosystems, 
Framingham, MA). 0.5 µl of the total mixture was mixed (1/1, v/v) with a 10 mg/ml 
solution of α-cyano-4-hydroxycinnamic acid in ACN/50 mM citrate buffer, 70/30 v/v. 
Standard mixtures furnished by Applied Biosystems was used for calibrations of both 
MALDI mass spectrometers.  
NanoLC-MS/MS experiments were performed on a 4000QTrap mass spectrometer 
(Applied Biosystems) coupled to a 1100 nanoHPLC system (Agilent Technologies). 
Peptide mixtures were loaded onto an Agilent reversed-phase pre-column cartridge 
(Zorbax 300 SB-C18, 5 x 75 µm, 3.5 µm) at 20 µl/min with solvent A (0.1 % formic 
acid, 2% ACN in water, loading time 5 min). Peptides were then separated on an 
Agilent reversed-phase column (Zorbax 300 SB-C18, 150 mm x 75 µm, 3.5 µm), at a 
flow rate of 300 nl/min using 0.1 % formic acid, 2% ACN in water as solvent A and 
0.1% formic acid, 2% water in ACN as solvent B. The elution was accomplished by a 
7-50% linear gradient of solvent B in 50 min. A nano-ionspray source was used at 2 
kV with liquid coupling, with a declustering potential of 50 eV, using an uncoated 
silica tip (o.d. 150 µm, i.d. 20 µm, tip diameter 10 µm) from New Objectives (Ringoes, 
NJ).  Spectra acquisition was based on a survey precursor ion scan for m/z 170. The 
Q1 was scanned from 400 to 1400 in 2 s with resolution “low”, and the precursor ions 
were fragmented in q2 using a linear gradient of collision energy from 30 to 80 eV. 
Finally, Q3 was set to transmit only ions at m/z 170 with resolution “unit”. This scan 
mode was followed by an enhanced resolution experiment for the ions of interest and 
then by MS2 and MS3 experiments of the two most abundant species. MS2 spectra 
were acquired using the best collision energy calculated on the basis of m/z values 
and charge state (rolling collision energy). MS3 spectra were performed on the 
fragment ion at m/z 234, with a fixed LIT fill time of 350 ms and an activation time of 
100 ms, scanning the mass range from 160 to 180 m/z. 
 
III.3 Results and discussions 
 
The analytical strategy described in this chapter fulfils the proteomics needs of 
sensitivity and specificity for the analysis of sub-stoichiometric post-translational 
modifications associated to protein oxidation 58, such as protein carbonylation. 
Compared to existing methodologies, essentially based on immunochemical 
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techniques 21-22,25, the strategy proposed here maintains sensitiveness but adds the 
capability to localise the modified residues; this information is often required to 
completely understand the biological significance of modification. The dansyl 
derivatization introduces: (a) a basic secondary nitrogen into the molecule that 
enhances the efficiency of ionization and (b) a dansyl moiety whose fragmentation is 
highly reproducible and can be used for RIGhT strategies 55-56. 
 
III.3.1 Carbonylation of a model protein 
 
The first part of this work concerns the optimization of an oxidation protocol able both 
to selectively oxidize lysine residues to α-aminoadipic semialdehyde residues, 
without undesired side reactions, and to introduce only a few numbers of 
modifications, in a controlled fashion, to reproduce in vivo conditions. This was 
necessary because of the commercial unavailability of carbonylated model proteins. 
The oxidation protocol was firstly optimized using a model peptide: the fragment 163-
171 of the human interleukin-1β; this peptide has a molecular mass of 1004.40 Da 
(MH+ = 1005.40 Da) and its primary structure is VQGEESNDK, with a single lysine 
residue at the C-terminus; for this reason this peptide was chosen as a model. Two 
different oxidation protocols were tested using NaClO 12 and Fe(III)Cl3 59. Reaction 
conditions were optimized in terms of reagent concentrations, time and temperature. 
Using Fe(III)Cl3 as oxidizing agent, the reaction produced a lot of undesired by-
products not easy to characterize, while using NaClO the reaction was more 
selective and was easy to control, as demonstrated by the MALDI spectrum reported 
in figure III.3, where can be noted the presence of a most intense signal at m/z 
1004.34, showing a ∆M = - 1 Da from the theoretical mass of the peptide, assigned to 
the oxidized form of the peptide. The ∆M of - 1 Da corresponds to the mass 
difference existing between lysine and α-aminoadipic semialdehyde after protein 
carbonylation event.  
 
 
 
Figure III.3. Particular of the MALDI spectrum of the oxidized interleukin-1β fragment; in the spectrum 
it can be noted the presence of a most intense signal at m/z 1004.34 that can be assigned to the 
oxidized form of the model peptide showing a ∆M = - 1 Da, corresponding to the mass difference 
existing between lysine and α-aminoadipic semialdehyde after protein carbonylation event. 
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In fact, protein carbonyls generated by oxidation of lysine, arginine, or proline 
residues and frequently used as markers for oxidative protein modification, determine 
a difference in the molecular mass of amino acid side chains 60.While lysine residue 
side chain oxidation leads to the formation of α-aminoadipic semialdehyde, oxidation 
of proline and arginine residues side chain leads to the formation of glutamic 
semialdehyde. The hydroxyl group of threonine side chain can also be oxidized to 
form 2-amino-3-oxo-butanoic acid. 
Reaction conditions for oxidation with NaClO were optimized as reported in material 
and methods section and the strategy was used for the oxidation of a model protein; 
the chosen proteins were bovine ribonuclease A and lysozyme, because of the fact 
that both proteins present a lysine residue at the N-terminus that should be easily 
accessible to oxidation mixture. 
RNase A (0.5 mg) was oxidized by using NaClO under controlled conditions (see 
materials and methods) and, after reaction, rapidly purified by size exclusion 
chromatography to remove oxidising solution. Aliquots of the sample containing 
RNase A and carbonylated RNase A, were reduced with DTT, alkylated with IAM and 
digested with trypsin. The obtained peptide mixture was then analysed by MALDI 
mass spectrometry, in order to identify the modification(s) induced by NaClO 
treatment. MS analyses led to the verification of about 95% of protein sequence and 
let me to locate the carbonylated residue in the peptide 1-10. In fact, MALDI-MS 
spectra showed the occurrence of a signal at m/z 1149.63 (figure III.4) exhibiting a 
molecular mass not corresponding to a theoretical one within the RNase A sequence. 
This signal was assigned to the peptide 1-10 showing a ∆M = - 1 Da that, as 
described above, correspond to the conversion of a lysine residue to α-aminoadipic 
semialdehyde residue. The presence in the MALDI spectrum of the signal at m/z 
1150.6 attributed to the theoretical peptide 1-10 of RNase A, indicates that the 
oxidation reaction was not quantitative; this represents a good result because it 
reproduces the sub-stoichiometric nature of this PTM. No evident signal occurring at 
m/z 1148.6, corresponding to the peptide 1-10 doubly modified by carbonylation at 
the second lysine residue, was detected.  
 
 
 
Figure III.4. Particular of the MALDI spectrum of the oxidized RNase A; the spectrum shows a signal 
at m/z 1150.6 that can be attributed at the peptide 1-10 of the RNase A, while the signal at m/z 1149.6 
can be assigned to the oxidized form of the same peptide (∆M = - 1 Da). No evident signal occurring at 
m/z 1148.6, corresponding to the peptide 1-10 doubly modified by carbonylation at the second residue 
of lysine, can be detected.  
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The same procedure was used for the oxidation of lysozyme. The tryptic mixture of 
oxidised lysozyme was then submitted to MALDI-MS analyses. The interpretation of 
MALDI-MS spectra revealed the occurrence of a signal whose molecular mass could 
not be explained on the basis of the theoretical masses. It should be noted that, as 
RNase A, lysozyme showed the presence of a lysine residue at the N-terminal 
position. In this case the expected signal at m/z 605.4 corresponding to carbonylated 
peptide 1-5 was not detected. However, a signal at m/z 587.4 (18 Da lower than 
carbonylated specie), was detected (figure III.5 A).  
 
 
 
Figure III.5. Particular of MALDI spectra of carbonylated lysozyme (panel A) and acetylated 
carbonylated lysozyme (panel B). In panel A spectrum is evident the presence of a signal at m/z 
606.47, attributed to peptide 1-5 of lysozyme, and of a signal at m/z 587.42 tentatively assigned to a 
cyclic intermediate formed after carbonylation of protein. In panel B spectrum is evident the presence 
of two related signals at m/z 647.34 and 690.38. These signals were attributed to the peptide 1-5 
carbonylated and acetylated (∆M = + 42 Da) and the same peptide doubly acetylated, respectively. 
The absence of the signal at m/z 587.32 could be appreciated, thus confirming the formation of the 
cyclic intermediate at the N-terminal residue. 
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This peak was absent in the spectrum of untreated lysozyme, and was tentatively 
assigned to a cyclic intermediate originated from the reaction of N-terminal amino 
group with the aldehyde of the oxidized lysine residue in position 1. 
To support this hypothesis, the strategy was modified introducing an acetylation step 
to block amino groups (N-terminus and Lys ε-amino groups) 61.Following the 
reaction, the acetylated N-terminal amino group can not react with aldehyde moiety 
generated by oxidation. The acetylation reaction was carried out by using acetic acid 
N-hydroxysuccinimide esther (1000-fold molar excess on proteins). The mixtures 
were then analysed by MALDI mass spectrometry and the spectra revealed the 
disappearance of signals attributed to the cyclic intermediate formation. In fact the 
MALDI spectra showed the presence of two related signals at m/z 647.4 and 690.4, 
that were attributed to the peptide 1-5 carbonylated and acetylated (∆M = + 42 Da) 
and to the same peptide doubly acetylated (∆M = + 84 Da), respectively. The 
absence of the signal at m/z 587.4 (figure III.5 B) could be appreciated, thus 
confirming that acetylation of N-terminus amino group blocks the formation of the 
cyclic intermediate when α-aminoadipic semialdehyde is at the N-terminal residue.  
 
III.3.2 Labelling with DNSH 
 
The formation of the cyclic intermediate was an undesired side reaction since it 
blocks the reactivity of carbonylated lysine, which was not suitable for reaction with 
hydrazide moiety of DNS derivate. Moreover the acetylation of carbonylated 
lysozyme caused the introduction of a further step that complicated the analytical 
strategy and was not useful for my proposal. For these reasons RNase A was 
chosen as oxidised model protein. According to “gel-free procedures”, the analysis 
was carried out at level of peptides following tryptic digest of the whole protein 
mixture. Labelling of carbonylated residues of RNase A was carried out using dansyl-
hydrazide (figure III.6). 
 
 
 
Figure III.6. Dansyl-hydrazide molecule. 
 
The yield of the reaction was monitored by MALDI-MS analysis. Mass spectral 
analysis showed the disappearance of the signal at m/z 1149.6 (figure III.7 C), 
indicating the successful labelling of this specie. A new signal at m/z 1396.7 was 
detected showing a mass increment of + 247 Da (figure III.7 B). This signal was 
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attributed to the peptide 1-10 modified by α-aminoadipic semialdehyde hydrazone 
formation following dansyl-hydrazide reaction (figure III.7 A) on the RNase A.  
 
 
 
Figure III.7. Panel A shows the formation of the α-aminoadipic semialdehyde hydrazone following 
dansyl-hydrazide reaction. Panel B shows the MALDI spectrum of the carbonylated RNase A peptide 
mixture after dansyl-hydrazide reaction. Mass spectral analysis showed the loss of the signal at m/z 
1149.60, indicating the labelling of this specie. A new signal at m/z 1396.70 was detected showing a 
mass increment of + 247 Da. This signal was attributed to the peptide 1-10 modified by hydrazone 
formation (∆M = + 247 Da). Panel C shows a particular of MALDI spectrum. 
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Moreover the absence of further species with a ∆M = + 247 Da, indicated that the 
reagent was specific for carbonyl groups. MALDI-MS spectrum also showed the 
presence of a signal at m/z 1131.6 assigned to the cyclic intermediate originated 
from the reaction of N-terminal amino group with the aldehyde of the oxidized lysine 
residue in position 1; the formation of this intermediate caused the disappearance of 
carbonyl groups of lysine in position 1, thus this residue was not yet reactive towards 
hydrazide moiety. 
 
III.3.3 LC-MS/MS analysis of dansylated peptides 
 
Discrimination between modified and unmodified peptides was achieved by taking 
advantage of the instrumental features of a QqLIT mass spectrometer (section I.2.1). 
Analysis of peptide mixtures were carried out by using LC-MS/MS method; ions of 
interest were discriminated by a combination of two selection criteria, based on the 
combination of a precursor ion scan analysis as survey scan and an MS3 scan, in a 
bidimensional tandem mass spectrometry selection 57. By using precursor ion scan 
mode it was possible to selectively detect the only precursor ions producing the 
fragment at 170 m/z, generated by typical fragmentation of dansyl and its derivatives 
56
. The selected precursor ions were then analyzed by combined MS2 and MS3 scan 
mode, to specifically select the dansylated species by exploiting the precursor ion 
scan selection for the fragment at 170 m/z and taking advantage of the dansyl-
specific MS3 transition m/z 234→170 (figure III.2). LC-MS/MS chromatograms 
obtained from the analysis of dansylated oxidised-RNase A peptide mixture are 
shown in figure III.8 A-B-C. 
 
 
 
Figure III.8 A. This panel shows the TIC of the Full Scan MS/MS analysis, in which are present a 
large number of signals most of which not related to dansyl modified peptides. 
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Figure III.8 B - C. The combination of PIS and MS3 (panels B and C) analysis let me to obtain a 
significant increase in signal/noise ratio and a significant increase in sensitivity of mass spectrometric 
analysis. The unique signal at 19.8 min in PIS TIC was correlated to 1-10 peptide of RNase A 
carbonylated and labelled by dansyl-hydrazide. 
 
By comparing the TIC profiles from PIS and MS3 (panels B and C) with the TIC 
chromatogram of LC-MS/MS full scan analysis (panel A), the precursor ion scan 
mode still showed the occurrence of a large number of signals, most of which not 
related to dansyl modified peptides. In fact, the corresponding MS2 spectra did not 
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show the occurrence of fragment ion at m/z 234. The further selection based on the 
MS3 scan removed a large number of false positives leading to a simple ion 
chromatogram essentially dominated by a unique signal, indicating the presence of a 
single dansyl-modified peptides. 
The combination of PIS and MS3 analysis let me to obtain a significant increase in 
signal/noise ratio and a significant increase in sensitivity of mass spectrometric 
analysis, due to the reduction of duty cycle of the mass spectrometer. The unique 
peak with a retention time of 19.8 min in PIS chromatogram was correlated by its MS 
and MS/MS spectra to peptide 1-10 of carbonylated RNase A, labeled by dansyl-
hydrazide. Manual interpretation of fragmentation spectrum obtained from this 
species, allowed to identify the modified peptide and to locate the modified residue. 
Figure III.9 shows the MS2 spectrum of triply charged ion at m/z 466.2 attributed to 
peptide 1-10 of RNase A carrying a dansyl-hydrazone moiety. Modified lysine residue 
was easily detected by interpretation of fragmentation spectrum, thus confirming 
previous hypothesis of carbonylation at level of lysine residue in position 7 of this 
peptide. This MS2 spectrum showed the presence of fragment ions belonging to both 
the y and the b series. However, some features made difficult MS/MS spectrum 
interpretation. In particular the modified peptide was not very stable during collision 
induced dissociation; moreover the peptide bond between alanine in position 6 and 
modified α-aminoadipic semialdehyde in position 7 was not completely fragmented 
under condition used in the experiment. Thus the occurrence of a signal 
corresponding to y4 ion could be detected even if at very low intensity. This fragment 
ion corresponded to the peptide sequence KFER still containing lysine residue 
modified by dansyl moiety. Moreover the neutral loss of DNS moiety (m/z 234 Da) 
from modified α-aminoadipic semialdehyde residue could be appreciated. In fact it 
could be observed y ions exhibiting a ∆M of 233 Da, corresponding to y fragments 
that have lost DNS moiety but that still retained the hydrazone moiety (figure III.9). 
 
 
 
Figure III.9. MS2 spectrum of triply charged ion at m/z 466.2 of the peptide 1-10 carrying a dansyl-
hydrazone moiety. 
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III.3.4 Analysis of a complex protein mixture 
 
The proposed strategy was finally applied to the analysis of a more complex sample, 
in order to demonstrate the ability of this analytical method to specifically locate 
carbonylated residues on a proteomics scale. For this purpose 100 µg of the 
carbonylated RNase A were spiked with 10 mg of an entire protein extract of E. coli 
cells. This complex mixture was analysed using the procedure described above. 
Disulfide bridges were reduced by DTT and free cysteines were alkylated by IAM; 
then protein mixture was digested with trypsin and the resulting peptide mixture was 
submitted to labelling with dansyl-hydrazide as described. An aliquot of the resulting 
dansylated peptide mixture was submitted to bidimensional LC-MS/MS analysis in 
PIS and MS3 modes as described above. Results of LC-MS/MS analysis are 
summarized in figure III.10, showing the chromatographic profiles of TIC (panel A) 
and PIS (panel B) experiments. In the TIC profile a large number of signals are 
present, that could be due both to false positives or real dansylated peptides.  
However the selectivity of the bidimensional analysis allowed to eliminate all false 
positives since by MS3 analysis a unique signal was detected, attributable to 
carbonylated and dansylated peptide 1-10 of RNase A. Manual interpretation of MS2 
spectrum related to this signal allowed me to reconstruct the sequence of the above 
mentioned peptide and to locate the modification site on the lysine in position 7.To 
the best of my knowledge this strategy represents the first method leading to the 
direct identification of carbonylation sites in proteins, thus indicating the feasibility of 
this strategy to investigate protein carbonylation in proteomics approaches. However 
by using dansyl-hydrazide it is not possible to perform quantitative analysis of 
carbonylation sites. For this reason it was necessary to design a new strategy that 
makes use of an iTRAQ derivative for specific labelling and quantitative analysis of 
carbonyl groups of proteins. 
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Figure III.10. Chromatographic profiles of PIS (panel A) and MS3 (panel B) experiments obtained by 
bidimensional LC-MS/MS analysis of 100 µg of the carbonylated RNase A was spiked to 10 mg of 
entire cellular extract of E. coli. The precursor ion scan profile still shows a large number of signals 
that could be due both to false positives or real dansylated peptides. However the selectivity of the 
MS3 analysis allowed us to eliminate all false positives since in the MS3 profile a unique signal 
referable to carbonylated and dansylated peptide 1-10 of RNase A was detected.  
 
III.3.5 iTRAQ-hydrazide labelling of standard mixtures 
 
iTRAQ molecules are specific toward amino groups, so in order to use iTRAQ for the 
specific labelling of carbonylated lysine residues, it was necessary to modify iTRAQ 
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molecule. For this purpose it was designed a strategy to obtain a new iTRAQ 
derivative, namely iTRAQ-hydrazide (iTRAQH), by reacting iTRAQ and hydrazine 
molecules (figure III.11).  
 
 
 
Figure III.11. Reaction scheme of the synthesis of iTRAQ-hydrazide molecule. 
 
The synthesis of the iTRAQ-hydrazide molecule was achieved by reacting iTRAQ 
and hydrazine following the procedure described in materials and methods section. 
Reaction product was purified by RP-HPLC and analysed by MALDI mass 
spectrometry in order to verify the success of reaction. As shown in the MALDI 
spectrum reported in figure III.12, a signal at m/z 177.2 is present, which corresponds 
to the expected m/z of the iTRAQ-hydrazide product (molecular mass = 176.2 Da). 
As for DNSH labelling, the strategy was optimised using oxidised RNase A model 
protein. According to “gel-free procedures”, the labelling was carried out at level of 
peptides following tryptic digestion of the whole protein mixture. An aliquot of 
carbonylated RNase A was reduced by DTT and free thiols were alkylated by IAM 
prior to tryptic digestion.  
A solution of iTRAQ-hydrazide freshly synthesized was added to the oxidised peptide 
mixture and the reaction was carried out as reported in the materials and methods 
section, following a slightly different strategy optimized for DNSH labelling. 
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Figure III.12. Particular of the MALDI spectrum obtained from the analysis of iTRAQ-hydrazide newly 
synthesised. The spectrum shows a signal at m/z 177.2 that corresponds to the expected m/z value of 
the iTRAQ-hydrazide molecule.  
 
After reaction the modified peptide mixture was analysed by MALDI mass 
spectrometry in order to verify the success of the labelling. Figure III.13 shows the 
MALDI spectrum obtained from the analysis of modified peptide mixture; in the 
spectrum is still present the signal at m/z 1149.6 attributable to the carbonylated 
peptide 1-10 of RNase A, but is also present a signal at m/z 1307.7 (∆M = + 158 Da) 
assigned to the carbonylated peptide 1-10 of RNase A modified with iTRAQ-
hydrazide, resulting in the formation of an hydrazone moiety of the iTRAQ derivative. 
 
 
 
Figure III.13. Particular of the MALDI spectrum obtained from the analysis of iTRAQ-hydrazide 
labelled peptide mixture of oxidized RNase A. In this spectrum is present a signal at m/z 1307.7 (∆M = 
+ 158 Da) attributed to the carbonylated peptide 1-10 of RNase A modified with iTRAQ-hydrazide with 
the formation of a hydrazone moiety of the iTRAQ derivative.  
 
The use of iTRAQ-hydrazide to label oxidised lysine residues makes possible to 
quantitate differentially oxidised proteins; for this purpose two different iTRAQ 
molecules were chosen to synthesize the hydrazide derivatives. In particular iTRAQ 
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114 and iTRAQ 117 were used and it was possible to obtain iTRAQ-hydrazide 114 
(iTRAQH 114) and iTRAQ-hydrazide 117 (iTRAQH 117).  
Aliquots of peptide mixtures of oxidised RNase A, labelled with the two different 
isobaric variants of iTRAQ-hydrazide, were mixed in order to obtain two different 
mixtures in which molar ratios between RNase A labelled with iTRAQH 114 and 
RNase A labelled with iTRAQH 117 were 1:1 and 1:4, respectively. However 
because of the isobaric nature of iTRAQ molecules (section II.1.2), differentially 
labelled peptides are indistinguishable by a simple MS analysis, whereas the iTRAQ 
reporter ions are generated after fragmentation events, thus allowing the quantitative 
analysis by using MS/MS analysis. The two peptide mixtures were analyzed by using 
a MALDI-TOFTOF mass spectrometer in order to verify the feasibility of the 
quantitative approach. Among the MS/MS spectra obtained from the analysis of the 
peptide mixture, it was possible to find iTRAQ reporter signals only in one spectrum 
as expected; this spectrum was originated by the precursor ion at m/z 1307.7 
attributed to the oxidised peptide 1-10 of RNase A labelled by iTRAQ-hydrazide 
(figure III.14).  
By manual interpretation of MS/MS spectrum it was possible to reconstruct the 
sequence of the peptide 1-10 of RNase A both with y ions and b ions retaining the 
modified residue, thus indicating a stable modification of the residue of interest; 
moreover it was possible to identify the modification site on the lysine residue in 
position 7 as for the case of DNSH modified protein. In the low mass region of the 
spectrum it was also possible to find the signals of iTRAQ reporter ions that could be 
used for quantitative analysis. 
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Figure III.14. MS/MS spectrum of the precursor ion 1307.7 attributed to iTRAQ modified oxidized 
peptide 1-10 of RNase A. articular of the MALDI spectrum obtained from the analysis of iTRAQ-
hydrazide labelled peptide mixture of oxidized RNase A. In the spectrum are present all the expected 
fragments of y and b series and by manual interpretation it was possible to reconstruct the entire 
sequence of the peptide 1-10 of RNase A retaining the modified residue; moreover it was possible to 
specifically identify the modification site on the lysine residue in position 7. The low mass region of the 
spectrum shows the signals of iTRAQ reporter ions that could be used for quantitative analysis. 
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The two mixtures (1:1 and 1:4) were analysed separately and it was possible to 
determine the molar ratios of the two differentially labelled peptide mixtures by 
measuring the area above the signals of iTRAQ reporter ions. Figure III.15 shows a 
magnified section of an MS/MS spectrum for both mixtures, in which are shown the 
signals of iTRAQ. reporter ions By replicating these experiments it was possible to 
calculate an experimental ratio of 1.07 + 0.03 for the 1:1 mixture and 3.97 + 0.17 for 
the 1:4 mixture. These preliminary data demonstrate the feasibility of this method for 
quantitative analysis of protein carbonylation. 
 
 
 
Figure III.15. Magnified sections of MS/MS spectra of modified peptide 1-10 of RNase A for 1:1 and 
1:4 mixtures. The signals of reporter ions of iTRAQ can be used for quantitative analysis. 
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III.4 Conclusions 
 
In this chapter the use of dansyl-hydrazide in combination with advanced mass 
spectrometric experiments, allowed the selective identification of carbonylation sites 
of RNase A also in a complex mixture as the entire protein extract of E. coli. The 
generation of carbonyl groups in RNase A was obtained by the oxidation with NaClO, 
with a slight modification of the protocol proposed by Headlam and co-workers 12; it 
was possible to specifically convert just one lysine residue (namely Lys 7) of RNase 
A to α-aminoadipic semialdehyde, thus miming the in vivo conditions. Dansyl-
hydrazide was then used to specifically label α-aminoadipic semialdehyde residues 
and the peculiar fragmentation pathway of dansyl derivatives was then exploited for 
mass spectrometric analysis with a hybrid instrument, such as QqLIT, in Precursor 
Ion Scan analysis, combined with MS3 analysis, in a bidimensional LC-MS/MS 
method. The combination of PIS and MS3 let me to obtain a significant increase in 
signal/noise ratio and a significant increase in sensitivity of mass spectrometric 
analysis, due to the reduction of duty cycle of the mass spectrometer. By this way it 
was possible to specifically identify the only modified peptide of RNase A and, at the 
same time, to locate the modification sites (the oxidised residue). This work 
represents the first method leading to the direct identification of carbonylation sites in 
proteins; moreover the capability of bidimensional mass spectrometric analysis to 
selectively identify the modified peptide in a complex peptide mixture indicates the 
feasibility of this strategy to investigate protein carbonylation on a proteomics scale. 
However by using dansyl-hydrazide it was not possible to specifically quantify the 
extent of protein carbonylation; for this reason a new iTRAQ derivative was 
synthesized exploiting the specificity of hydrazide derivatives toward carbonyl groups 
in combination with the unique features of iTRAQ reagents for quantitative analysis; 
this new iTRAQ-hydrazide reagent was used to label a tryptic peptide mixture of 
oxidised RNase A. This strategy has to be optimized for complex mixtures analysis, 
but initial results led to both selective qualitative and quantitative analysis of 
carbonylated residues. 
 
III.5 References 
 
1. Shacter, E. Methods Enzymol. 2000, 319, 428-436.  
2. Stadtman, E.R. Ann NY Acad Sci. 2001, 928, 22-38.  
3. Sorolla, M.A.; Reverter-Branchat, G.; Tamarit, J.; Ferrer, I.; Ros, J.; Cabiscol, 
E. Free Radic Biol Med. 2008, 45, 667-678. 
4. Yoo, B.S.; Regnier, F.E. Electrophoresis. 2004, 25, 1334-1341.  
5. Magi, B.; Ettorre, A.; Liberatori, S.; Bini, L.; Andreassi, M.; Frosali, S.; Neri, P.; 
Pallini, V.; Di Stefano, A. Cell Death Differ. 2004, 11, 842-852.  
6. Johansson, E.; Olsson, O.; Nyström, T. J Biol Chem. 2004, 279, 22204-22208.  
7. England, K.; O'Driscoll, C.; Cotter, T.G. Cell Death Differ. 2004, 11, 252-260. 
8. England, K.; Cotter, T.G. Biochem Biophys Res Commun. 2004, 320, 123-
130.  
9. Soreghan, B.A.; Yang, F.; Thomas, S.N.; Hsu, J.; Yang, A.J. Pharm Res. 
2003, 20, 1713-1720. 
10. Levine, R.L.; Wehr, N.; Williams, J.A.; Stadtman, E.R.; Shacter, E. Methods 
Mol Biol. 2000, 99, 15-24.  
 88 
 
11. Ghezzi, P.; Bonetto, V. Proteomics. 2003, 3, 1145-1153.   
12. Headlam, H.A.; Davies, M.J. Free Radic Biol Med. 2004, 36, 1175-1184.  
13. Madian, A.G.; Regnier, F.E. J Proteome Res. 2010, 9, 1330-1343.  
14. Mirzaei, H.; Regnier, F. Anal Chem. 2005, 77, 2386–2392. 
15. Mirzaei, H.; Regnier, F. Anal Chem. 2006, 78, 770–778. 
16. Levine, R.L.; Garland, D.; Oliver, C.N.; Amici, A.; Climent, I.; Lenz, A.G.; Ahn, 
B.W.; Shaltiel, S.; Stadtman, E.R. Methods Enzymol. 1990, 186, 464-478.  
17. Levine, R.L.; Williams, J.A.; Stadtman, E.R.; Shacter, E. Methods Enzymol. 
1994, 233, 346-357. 
18. Yan, L.J. Curr Protoc Protein Sci. 2009, Chapter 14, Unit 14.4. 
19. Keller, R.J.; Halmes, N.C.; Hinson, J.A.; Pumford, N.R. Chem Res Toxicol. 
1993, 6, 430-433.  
20. Shacter, E.; Williams, J.A.; Lim, M.; Levine, R.L. Free Radic Biol Med. 1994, 
17, 429-437. 
21. Sharma, R.; Nakamura, A.; Takahashi, R.; Nakamoto, H.;  Goto, S. Free Radic 
Biol Med. 2006, 40, 1179-1184. 
22. Blackburn, A.C.; Doe, W.F.; Buffinton, G.D.  Free Radic Biol Med. 1999, 27, 
262-270. 
23. Yan, L.J.; Levine, R.L.; Sohal, R.S. Proc Natl Acad Sci USA. 1997, 94, 11168-
11172.  
24. Yan, L.J.; Sohal, R.S. Proc Natl Acad Sci USA. 1998, 95, 12896-12901. 
25. Nakamura, A.; Goto, S. J Biochem. 1996, 119, 768-774.  
26. Choi, J.; Forster, M.J.; McDonald, S.R.; Weintraub, S.T.; Carroll, C.A.; Gracy, 
R.W. Free Radic Biol Med. 2004, 36, 1155-1162.  
27. Boyd-Kimball, D.; Castegna,  A.; Sultana, R.; Poon, H.F.; Petroze, R.; Lynn, 
B.C.; Klein, J.B.; Butterfield, D.A. Brain Res. 2005, 1044, 206-215.  
28. Mello, C.F.; Sultana, R.; Piroddi, M.; Cai, J.; Pierce, W.M.; Klein, J.B.; 
Butterfield, D.A. Neuroscience. 2007, 147, 674-679.  
29. Reverter-Branchat, G.; Cabiscol, E.; Tamarit, J.; Ros, J. J Biol Chem. 2004, 
279, 31983-31989. 
30. Barreiro, E.; Gea, J.; Di Falco, M.; Kriazhev, L.; James, S.; Hussain, S.N. Am J 
Respir Cell Mol Biol. 2005, 32, 9-17. 
31. Aguilaniu, H.; Gustafsson, L.; Rigoulet, M.; Nystrom, T. Science. 2003, 299, 
1751-1753.  
32. Desnues, B.; Cuny, C.; Gregori, G.; Dukan, S.; Aguilaniu, H.; Nystrom, T. 
EMBO Rep. 2003, 4, 400-404.  
33. Hernebring, M.; Brolen, G.; Aguilaniu, H.; Semb, H.; Nystrom, T. Proc Natl 
Acad Sci USA. 2006, 103, 7700-7705.  
34. Erjavec, N.; Larsson, L.; Grantham, J.; Nystrom, T. Genes Dev. 2007, 21, 
2410-2421. 
35. Frank, J.; Pompella, A.; Biesalski, H.K. Free Radic Biol Med. 2000, 29, 1096-
1105.  
36. Frank, J.; Pompella, A.; Biesalski, H.K. Methods Mol Biol. 2002, 196, 35-40. 
 89 
 
37. Chaudhuri, A.R.; deWaal, E.M.; Pierce, A.; Van Remmen, H.; Ward, W.F.; 
Richardson, A. Mech Ageing Dev. 2006, 127, 849. 
38. Jung, Y.; Chay, K.; Song, D.; Yang, S.; Lee, M.; Ahn, B.; Arch Biochem 
Biophys. 1997, 345, 311-317.  
39. Ahn, B.; Rhee, S.G.; Stadtman, E.R. Anal Biochem. 1987, 161, 245-257. 
40. Poon, H.F.; Abdullah, L.; Reed, J.; Doore, S.M.; Laird, C.; Mathura, V.; Mullan, 
M.; Crawford, F. Biol Proced Online. 2007, 9, 65-72. 
41. Langhals, H.; Jona, W.; Chem Eur J. 1998, 4, 2110. 
42. Lenz, A.G.; Costabel, U.; Shaltiel, S.; Levine, R.L. Anal Biochem. 1989, 177, 
419-425. 
43. Yan, L.J.; Sohal, R.S. Anal Biochem. 1998, 265, 176-182. 
44. Gitlin, G.; Bayer, E.A.; Wilchek, M. Biochem J. 1987, 242, 923-926. 
45. Temple, A.; Yen, T.Y.; Gronert, S. J Am Soc Mass Spectrom. 2006, 17, 1172-
1180. 
46. Mirzaei, H.; Regnier, F. J Chromatogr A. 2007, 1141, 22-31.  
47. Meany, D.L.; Xie, H.; Thompson, L.V.; Arriaga, E.A.; Griffin, T.J. Proteomics. 
2007, 7, 1150-1163.  
48. Mirzaei, H.; Baena, B.; Barbas, C., Regnier, F.  Proteomics. 2008, 8, 1516-
1527.  
49. Hensley, K. Methods Mol Biol. 2009, 536, 457-462.  
50. Caperna, T.J.; Shannon, A.E.; Blomberg Le, A.; Garrett, W.M.; Ramsay, T.G. 
Comp Biochem Physiol B Biochem Mol Biol. 2010, 156, 189-196. 
51. Soreghan, B.A.; Lu, B.W.; Thomas, S.N.; Duff, K.; Rakhmatulin, E.A.; 
Nikolskaya, T.; Chen, T.; Yang, A.J. J Alzheimers Dis. 2005, 8, 227-241.  
52. McDonagh, B.; Ogueta, S.; Lasarte, G.; Padilla, C.A.; Barcena, J.A. J 
Proteomics. 2009, 72, 677-689. 
53. Roe, M.R.; Xie, H.; Bandhakavi, S.; Griffin, T.J. Anal Chem. 2007, 79, 3747-
3756.  
54. Chavez, J.; Chung, W.G.; Miranda, C.L.; Singhal, M.; Stevens, J.F.; Maier, 
C.S. Chem Res Toxicol. 2010, 23, 37-47. 
55. Amoresano, A.; Monti, G.; Cirulli, C.; Marino, G. Rapid Commun Mass 
Spectrom. 2006, 20 (9), 1400-1404.  
56. Amoresano, A.; Chiappetta, G.; Pucci, P.; D'Ischia, M.; Marino, G. Anal Chem. 
2007, 79 (5), 2109-2117. 
57. Marino, G.; Buonocore, V. Biochem J. 1968, 110, 603-604. 
58. Nakamura, A.; Kawakami, K.; Kametani, F.; Nakamoto, H.; Goto, S.  Ann NY 
Acad Sci. 2010, 1197, 33-39. 
59. Linert, W.; Jameson, G.N. J Inorg Biochem. 2000, 79 (1-4), 319-326.  
60. Requena, J.R.; Chao, C.C.; Levine, R.L.; Stadtman, E.R. Proc Natl Acad Sci 
USA. 2001, 98, 69-74. 
61. Brancia, F.L.; Oliver, S.G.; Gaskell, SJ. Rapid Commun Mass Spectrom. 2000, 
14, 2070-2073. 
 
 90 
 
IIII. QUANTITATIVE IDENTIFICATION OF PROTEIN 
PHOSPHORYLATION SITES   
 
 
IIII.1 Introduction 
 
This chapter focuses on the development of a new proteomics approach aimed to 
study and quantify the extent of protein phosphorylation. In order to develop an 
analytical methodology that could be classified as RIGhT (Reporter Ion Generating 
Tag) (section I.3.1), iTRAQ reagents were chosen as the starting molecules for 
labelling of phosphorylation sites. At the best of my knowledge the iTRAQ chemistry 
has been limited so far to primary amines 1-5. This work lies within a research line of 
our laboratory intended to expand the chemistry of this class of reagents with the aim 
to quantify PTMs carrying chemical moieties different from primary amines.  
 
IIII.1.1 Proteomics analysis of phosphorylated proteins 
 
Analysis of protein phosphorylation at a proteomics level still represents a 
challenging and highly relevant task both for the impact of enzyme-catalyzed 
phosphorylation and dephosphorylation on the function of many proteins 6 and for the 
sub-stoichiometric nature of this post-translational modification 7; usually while some 
residues are always phosphorylated, others may only be transiently phosphorylated; 
moreover phosphoproteins abundance is very low and it can be quantified as 1-2% of 
the total protein amount in a cell. For these reasons it is necessary to develop 
analytical strategies able to isolate or enrich phosphorylated species before 
identification in order to increase the sensitivity and the selectivity of the analysis.  
Protein phosphorylation has been traditionally studied and quantified by using 
radioactive labelling with 32P followed by 2D-GE 8-9 or Edman degradation chemistry 
to sequence phosphopeptides in order to locate phosphorylation site(s) 6. Both 
techniques have the advantage to allow the contemporary detection of N-, S- and O-
phosphorylation. Quantitative analysis can be performed by comparing differences in 
relative abundance of 32P-labeled phosphoproteins, visualized by autoradiography, 
measuring relative intensities of the spot on the gel 10. However these methods have 
the disadvantage to be time consuming and laborious and in the most cases they 
require large amounts of purified protein; moreover 32P labelling could not be the 
method of choice for high-throughput proteome-wide analysis because of risks 
associated with handling radioactive compounds and because of the contamination 
of analytical instrumentation with radioactive materials. To avoid the use of 
radioactive probes, alternative approaches have been developed, based on the use 
of specific phospho-stains. Obviously they are less sensitive than radioactive probes, 
but they can be easily handled and used in high-throughput strategies. An example 
of these stains is the Pro-Q Diamond, a phospho-stain developed by Molecular 
Probes, specific for serine and threonine phosphorylation; Pro-Q Diamond is a 
fluorescent dye that can be used to stain phosphoproteins with sensitivity in the order 
of 1-20 ng of phosphoproteins as the lower limit. For a single protein the strength of 
the fluorescent signal can be correlated to the amount of phosphate groups. One of 
the most sensitive methodologies to analyse protein phosphorylation and to 
discriminate between serine, threonine and tyrosine phosphorylation, is based on the 
use of specific antibodies. Most commonly antibodies are used for phosphotyrosine 
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detection rather than phosphoserine/phosphothreonine because of their higher 
specificity and low cross-reactivity 11. 
Recent efforts to eliminate the necessity to use radioactive probes or antibodies for 
the analysis of phosphorylation, have lead to the development of mass spectrometry 
based methods; these MS methods have emerged as the preferred tools for the 
analysis of proteins phosphorylation due to higher sensitivity, selectivity and rapidity 
than most biochemical techniques 12-13. Phosphorylated proteins can be identified 
simply by the precise measurement by mass spectrometry of the molecular weight of 
the intact protein, just by looking at the increment of the protein mass compared with 
the unmodified one. However with this methodology the precise localization and 
nature of the modifying group. To better characterize the phosphorylated residues of 
a protein it is necessary to analyze the peptide mixture generated by enzymatic 
(usually trypsin) or chemical hydrolysis of the entire protein. With this approach 
phosphopeptides may be identified simply by compare experimental m/z values with 
theoretical ones, searching for mass increases of 80 Da. Also in this case it is 
possible to have ambiguities, which can be resolved by sequencing the peptide using 
tandem mass spectrometry 12,14. A powerful mass spectrometric approach for 
phosphopeptides analysis 15-16 is based on the combined used of electrospray 
ionization and on-line liquid chromatography (LC-MS) 17. 
However, the sub-stoichiometric nature of phosphorylation at a given site could be a 
problem also for MS analysis, thus resulting in sensitivity problems; moreover 
challenging fragmentation behaviour of many phosphopeptides under MS/MS 
conditions generally interfere with the elucidation of peptide sequences and with 
direct assignment of phosphorylation sites 18. For these reasons separation 
technologies such as affinity, reverse phase, ion exchange chromatographies and 
capillary electrophoresis have been introduced prior to MS analysis to enrich the 
mixture in phosphopeptides or phosphoproteins that may otherwise be lost during 
mass spectrometric analysis. The enrichment step combined with the high sensitivity 
of MS technologies provides great potential for phosphoproteome characterization 19-
23
. Recently, the use of miniaturized immobilized metal affinity chromatography 
(IMAC), in which phosphopeptides are bound non-covalently to solid supports that 
chelate Fe(III) or other trivalent metals has proved to be a potentially valuable 
method in phosphopeptides enrichment. With further refinement, this technique may 
offer the best performance for large-scale phosphorylation analysis 24-26. Newly 
developed enrichment strategies are based on the use of MOAC protocols that take 
advantage of titania or zirconia as metal oxide chromatography modifiers 27. Actually 
titanium dioxide (TiO2) remains the most commonly used modifier.  
 
IIII.1.2 Chemical tagging for the analysis of phosphorylation 
 
Further several methods for selective enrichment of phosphopeptides use chemical 
modification of phosphorylated residues. In fact a series of chemical tagging 
procedures for phosphoproteomics, involving chemical reactions to facilitate the 
analysis of phosphorylated species, have been introduced 28, based mainly on β-
elimination of phosphoserine (pSer) and phosphothreonine (pThr) residues under 
alkaline conditions, to form dehydroalanine (∆Ser) or β-methyldehydroalanine (∆Thr) 
respectively, and their ability to be targets for Michael type addiction with desired 
tags 29 (figure IIII.1). Treatment with an appropriate derivatizing agent has the 
potential to improve the detectability of phosphopeptides by mass spectrometric 
analysis. For example by adding a chemical compound containing a free sulfhydryl 
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group to β-eliminated residues, a new thiol group is created in the peptide that can be 
used as a linker for a molecular probe (for example a biotin probe) 19 or for direct 
affinity purification 30-31. A smart approach was proposed by Knight and co-workers 
that  used the combination of reaction and proteolysis to aid the assignment of 
phosphorylation sites using tandem MS analysis 32. They converted pSer and pThr to 
aminoethylcysteine and β-methylaminoethylcysteine, respectively, both targets for 
lysine specific proteases. In this way peptides cleaved at the specific site of pSer or 
pThr were generated.  
Via β-elimination Michael addition approach stable-isotope labelled tags can also be 
introduced. One limitation of β-elimination-based concepts is that pTyr residues 
cannot be addressed using this strategy. Furthermore is possible to have the 
contamination from peptides with other modifications that also undergo β-elimination, 
such as O-glycosylation. 
 
 
 
Figure IIII.1. Tagging chemistry to address pSer and pThr residues. 
 
In this chapter, a chemical modification strategy of phosphorylation sites, based on  
β-elimination and Michael addition, is proposed aimed at the direct identification 
quantitative analysis of phosphorylated residues. 
 
IIII.1.2 4000QTrap (QqLIT) for RIGhT strategy 
 
RIGhT approaches are based on the selective MS analysis of species of interest by 
exploiting the fragmentation features of reagents chosen for selective labelling of 
residues of interest. As described in section II.1.2, iTRAQ reagents have the 
characteristics features of RIGhT reagents, since they have a reactive group toward 
the interesting residues, a linker group that is loss as neutral moiety during MS2 
experiment and a reporter group that leads to generate stable fragment ions 
selectively detectable in MS2 experiment.  
For the development of a RIGhT strategy that allows the identification and 
quantitation of phosphorylated proteins, iTRAQ was modified in order to obtain a 
donor for Michael type addiction. Although iTRAQ molecule was modified by 
cystamine addiction, its characteristic fragmentation pathway was not modified, thus 
it could still be used as RIGhT reagent. These characteristics fragmentation features 
were exploited by using an Applied Biosystems 4000Q-Trap mass spectrometer. By 
coupling the potential of this device and of the iTRAQ derivatives characteristics, it 
was possible to set up a high throughput LC-MS/MS method, based on Precursor Ion 
Scan (PIS) analysis, that allowed me to reduce the complexity of peptide mixtures by 
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mass spectrometric enrichment of phosphopeptides, rather than enriching and 
separating phosphopeptides prior to mass spectrometric analysis. Furthermore, the 
nanospray ESI source combined with nanoflow chromatographic system showed 
performances characterized by higher sensitivity and resolution, leading to the 
detection of samples even present at sub-stoichiometric amounts as 
phosphopeptides.  
PIS was chosen as survey scan for its selectivity and its high scan rate. In this scan 
mode the Q1 performs a scan across the full mass range; the ions separated are 
fragmented in the collision cell (q2); finally the Q3 is set to transmit only ions with the 
specific mass of the diagnostic fragment (m/z 114-117). Selected precursor ions are 
then submitted to a classical MS2 experiment exploiting the LIT features of the 
QTrap. This MS based selection of labelled peptides substitutes others 
chromatographic steps so that the mass spectrometer can be considered as the 
second dimension of the RP-LC separation. 
 
IIII.2 Materials and methods 
 
Materials  
Ammonium bicarbonate (AMBIC), guanidine, dithiothreitol (DTT), trypsin, 
iodoacetamide (IAM) and triethyl ammonium carbonate (TEAB) were purchased from 
Fluka. Bovine α-casein, tris(hydroxymethyl)aminomethane, tributylphosphine, 
cystamine, sodium dithionite as well as the MALDI matrix α-ciano-4-idrossicinnamic 
acid were purchased from Sigma. iTRAQ reagents were furnished by Applied 
Biosystems. Acetonitrile (ACN) was from Romil. Methanol and trifluoroacetic acid 
HPLC grade were purchased from Carlo Erba. All solvents were of the highest purity 
available from Baker. All other reagents and proteins were of the highest purity 
available from Sigma. Gel filtration columns PD-10 were from Pharmacia, whereas 
the pre-packed columns Sep-pak C-18 were from Waters. 
 
iTRAQ-cysteamine synthesis 
iTRAQ-cysteamine was obtained by reacting iTRAQ reagents (0.2 mmol/ml dissolved 
in acetonitrile) with cystamine (molar ratio 3:1). Reaction was carried out at room 
temperature for 1 hr, in 40% TEAB 500mM pH 8.0 and 60% ACN. The product was 
verified by MALDI-MS analysis. Then ACN was pushed away and the product was 
reduced in presence of 20 mM tributylphosphine. Reaction was carried out for 30 min 
at room temperature under nitrogen. Product was purified by RP-HPLC using an 
Agilent Zorbax C18 column (4,6mm X 150mm) (Palo Alto, California) using a 10% to 
65% linear gradient in 20 min from water to ACN and verified by MALDI-MS analysis.  
 
Disulfide bridges reduction, Cys alkylation and proteolysis  
Bovine α-casein was dissolved in denaturant buffer (urea 6M, Tris 300 mM pH 8.0, 
EDTA 10mM) and disulfide bridges were reduced with DTT (10-fold molar excess on 
the Cys residues) at 37 °C for 2 h and then alkylat ed by adding IAM (5-fold molar 
excess on thiol residues) at room temperature for 30 min in the dark. Protein samples 
were desalted by size exclusion chromatography on a Sephadex G-25M column (GE 
Healthcare). Fraction containing protein was lyophilized and the dissolved in 50 mM 
TEAB pH 8.0 buffer; trypsin digestion was performed using an enzyme/substrate 
ratio of 1/50 w/w at 37 °C for 16 h. 
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β-elimination reaction  
β-elimination reactions were carried out by incubating the peptide mixture in 0.1 M 
Ba(OH)2, at 37°C, for 90 min under nitrogen. Carbonic diox ide was then added. The 
precipitated barium carbonate was then removed by centrifugation at 13000 g/min for 
10 min.  
 
Michael addiction reaction 
iTRAQ-cysteamine in Tris buffer 500mM pH 11.0 was added to the β-eliminated 
peptide mixture of α-casein. The mixture was allowed to react for 1 h in microwave 
oven 33 and then for 16h at 57°C. 
 
Bacterial strains, growth conditions and protein extract preparation 
Escherichia coli K12 strain was grown in aerobic conditions at 37°C in LB medium. 
After 16 h, bacteria were harvested by  centrifugation and resuspended in Buffer Z 
(25 mM HEPES pH 7.6, 50 mM KCl, 12.5 mM MgCl2, 1 mM DTT, 20% glycerol, 0.1% 
triton) containing 1 mM PMSF. Cells were disrupted by sonication. The suspension 
was centrifuged at 90000 x g for 30 min at 47°C. After centrifugation the protei n 
concentration of the extract was determined with Bradford assay. 
 
MALDI-TOF mass spectrometry 
MALDI-TOF mass spectra were recorded using a Voyager DE-PRO mass 
spectrometer (Applied Biosystems, Framingham, USA). Prior to mass spectrometric 
analysis, peptide mixtures were purified using ZipTip pipette from Millipore (Billerica, 
MA, USA) using the recommended purification procedure. Peptides were eluted 
using 20 µL of 70% ACN, 0.1% HCOOH in water. A mixture of the eluted peptide 
solution and α-cyano-4-hydroxycinnamic acid (10 mg/ml in 70% ACN, 30% citric acid 
50 mM in water) was loaded in 1/1 v/v ratio onto the metallic sample plate and dried 
at room temperature. Mass calibration was performed using a mixture of peptides 
from Applied Biosystems, containing des-Arg1-Bradykinin, Angiotensin I, Glu1-
Fibrinopeptide B, ACTH (1-17), ACTH (18-39) as external standards. Raw data were 
analysed using Data Explorer software provided by Applied Biosystems and reported 
as monoisotopic masses. 
 
nanoLC Mass Spectrometry 
Peptide mixtures, obtained as previously described, were analysed by LC-MS using 
a 4000QTrap (Applied Biosystems) coupled to an 1100 nano HPLC system (Agilent 
Technologies). The mixture was loaded on an Agilent reverse-phase pre-column 
cartridge (Zorbax 300 SB-C18, 5x0.3 mm, 5 µm) at 10 µL/min (A solvent 0.1% formic 
acid, loading time 7 min). Peptides were separated on a Agilent reverse-phase 
column (Zorbax 300 SB-C18, 150 mm X 75µm, 3.5 µm), at a flow rate of 0.2 µL/min 
with a 5% to 65% linear gradient in 60 min (A solvent 0.1% formic acid, 2% ACN in 
water; B solvent 0.1% formic acid, 2% water in ACN). Spectra acquisition was based 
on a survey precursor ion scan. Data were acquired and processed using Analyst 
software (Applied Biosystems).  
 
Precursor Ion Scan analysis 
Precursor ion scan analysis was performed over a mass range of m/z 400-1400 with 
a scan time of 2 s ( with Q1 set to low resolution and Q3 set to unit resolution), with a 
nanospray voltage of 2 kV applied to an uncoated Silica Picotip (O.D. 150 µm, I.D. 10 
µm, T.D. 15 µm) (New Objective, Woburn, MA). Precursors were fragmented in q2 
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with a collision energy ramp of 30 to 80 V across the mass range. If a precursor of 
114-117 m/z was detected above a pre-set threshold value (1500 cps), enhanced 
resolution scan was performed at 250amu/s to determine the charge state of the ion. 
The Information dependent acquisition (IDA) software automatically assigns a more 
accurate monoisotopic mass. Enhanced product ion (EPI) scans (MS/MS) were 
performed at 4000 amu/s and collision energies were calculated automatically by 
rolling collision energy and it performed a maximum of one repeat before adding ion 
to the exclusion list for 60 s. The analysis was performed on the three most abundant 
ions and he entire cycle duration, including fill times and processing times, was less 
than 4 s. 
 
IIII.3 Results and discussions 
 
Selective detection of phosphopeptides from proteolytic digests is a challenging and 
highly relevant task in many proteomics applications. Because of the impact of 
enzyme-catalyzed phosphorylation and dephosphorylation on the function of many 
proteins, there is a demand to improve the methods for a reliable analysis of 
phosphopeptides. Phosphoproteins are usually present in low abundance in cells 
compared to their non-phosphorylated forms, and they need selective isolation or 
enrichment before identification. Moreover, phosphopeptides are easily suppressed 
in mass spectrometry in both MALDI and ESI ionization modes. Furthermore, the low 
stoichiometry of phosphorylation in proteins makes important to increase the 
selectivity of the analysis. Treatment with an appropriate derivatizing agent has the 
potential to improve the detectability of these analytes by MS.  
Here it is suggested that derivatization may include chemical moiety capable to give 
rise to characteristic fragment ions, thus allowing the exploitation of the enormous 
potential of MS2 34-35 analysis. A newly “in house” synthesized iTRAQ derivative is 
presented to selectively label and quantify phosphorylation sites. The procedure 
consists in the β-elimination of pSer/pThr residues and in the Michael addiction of the 
resulting α,β-unsatured residues with iTRAQ-cysteamine (figure IIII.3).  
 
 
 
Figure IIII.3. Reaction scheme for the synthesis of iTRAQ-cysteamine molecule. 
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This reagent was chosen because of the need to have an SH moiety to perform 
Michael type addiction and to have an iTRAQ moiety to perform quantitative analysis. 
So the first objective was the optimization of the conditions for the synthesis of the 
iTRAQ-cystamine molecule and then for the Michael type addiction on β-eliminated 
phospho-residues. This derivatization introduces an iTRAQ moiety that fragments 
according to iTRAQ features (section I.2.5). Using the great capabilities of a QqLIT 
mass spectrometer, it was possible to take advantage of the distinctive m/z 114-117 
fragments in MS2. The methodology was first optimized by using a model 
phosphoprotein, bovine α-casein, and then to prove its wide enforceability this 
methodology applied to more complex samples. 
 
IIII.3.1 Bovine α-casein 
 
Bovine α-casein is a protein of bovine milk and it has eight phosphorylation sites, 
corresponding to serine residues 46, 48, 64, 66, 67, 68, 75 and 115; five of these 
residues are located on the same tryptic peptide, as shown by following sequence, 
where sites of phosphorylation are highlighted.  
 
RPKHPIKHQGLPQEVLNENLLRFFVAPFPEVFGKEKVNELSKDIGSESTEDQAMEDIKQMEA
ESISSSEEIVPNSVEQKHIQKEDVPSERYLGYLEQLLRLKKYKVPQLEIVPNSAEERLHSMKE
GIHAQQKEPMIGVNQELAYFYPELFRQFYQLDAYPSGAWYYVPLGTQYTDAPSFSDIPNPIG
SENSEKTTMPLW 
 
Commercial α-casein consists of α-casein S1 and α-casein S2 in traces and the 
preparations are usually contaminated with traces of β-casein.  
A list of the theoretical tryptic phosphorylated peptides derived from α-caseins S1-S2 
and their molecular masses, is shown in table IIII.1. 
 
Protein Sequence Monoisotopic 
mass 
Modifications Peptide 
 
α-casein S1 DIGSESTEDQAMEDIK 1926.68 2P 43-58 
α-casein S1 QMEAESISSSEEIVPNSVEQK 2719.90 5P 59-79 
α-casein S1 KYKVVPQLEIVPNSAEER 2079.90 1P 103-119 
α-casein S1 YKVPQLEIVPNSAEER 1950.94 1P 104-119 
α-casein S1 VPQLEIVPNSAEER 1659.78 1P 106-119 
α-casein S2 KNTMEHVSSSEESIISQETYK 2617.89 4P 1-21 
α-casein S2 NANEEEYSIGSSSEESAEVATEEVK 3007.72 4P 46-70 
α-casein S2 EQLSTSEENSK 1410.49 2P 126-136 
α-casein S2 TVDMESTEVFTK 1465.60 1P 138-149 
 
Table IIII.1. Theoretical phosphorylated peptides originated by tryptic digestion of a mixture of α-
caseins S1 and S2. 
 
IIII.3.2 Synthesis of iTRAQ-cysteamine  
 
iTRAQ is known to react with ε-amino group of lysine as well as with N-terminal 
amino group. In this chapter, using chemical manipulations coupled with iTRAQ 
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labelling, a methodology capable of large-scale proteomic profiling and quantitative 
analysis of phosphorylation sites is shown. This method is based: i) on the selective 
modification of pSer/Thr residues with a novel iTRAQ derivative of cysteamine (figure 
IIII.3); ii) on the selective detection and identification of labelled peptides by exploiting 
the characteristic fragmentation pathway of iTRAQ-derivatives. 
For synthesis of iTRAQ derivative of cystamine, it was used a slightly modified 
version of the protocol proposed by Applied Biosystems for iTRAQ labelling of 
peptides and proteins (see materials and methods section). iTRAQ-cystamine 
molecules obtained by reaction were analysed by MALDI-MS; as an example in 
figure IIII.4 it is reported a MALDI spectrum obtained from the analysis of an iTRAQ-
cystamine sample; in this case it was chosen iTRAQ 115 as starting reagent. In the 
spectrum a signal at m/z 441.2 is evident that was attributed to the iTRAQ-cystamine 
molecule (theoretical molecular mass = 440.1 Da). Moreover it is present the signal 
at m/z 115.1 typical of the iTRAQ reagent chosen for the reaction. 
 
 
 
Figure IIII.4. MALDI-MS spectrum of iTRAQ-cystamine molecule.  
 
For reduction of iTRAQ-cystamine to iTRAQ-cysteamine several reducing agents 
were used, in order to find the best reagent for my purposes; in particular the 
reduction was achieved by using DTT, tris(2-carboxyethyl)phosphine (TCEP) and 
tributylphosphine (TBP). 
With regard to reducing power toward the cystamine disulfide bond, the best 
reducing agent was proven to be DTT while the worst one was TCEP; however DTT 
was difficult to remove from reaction mixture by RP-HPLC because it has physical-
chemical characteristics similar to the iTRAQ-cysteamine molecule; moreover if some 
DTT was still present during Michael addiction, it could react as Michael donor, thus 
generating undesired by-products. For these reasons it was chosen to use TBP to 
perform iTRAQ-cystamine reduction; although it was not the best reagent in terms of 
reducing power, its hydrophobicity allowed me to easily separate it from iTRAQ-
cysteamine molecules by RP-HPLC. After reduction, the product was purified by RP-
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HPLC and the fractions collected were analysed by MALDI-MS. As expected, the 
reduction reaction generated a specie at m/z 222.1, as shown in figure IIII.5, 
corresponding to the reduction of disulfide bond of iTRAQ-cystamine  
 
 
 
Figure IIII.5. MALDI-MS spectrum of iTRAQ-cysteamine molecule. 
 
IIII.3.3 β-elimination reaction 
 
Under strong alkaline conditions the phosphate moiety on pSer/pThr undergoes to β-
elimination to form dehydroalanine (∆Ser) or β-methyldehydroalanine (∆Thr), 
respectively. The α,β-unsatured residues are strong Michael acceptors, which can 
readily react with a nucleophile 29,36-37. 
The conditions for Michael type addition were optimized using bovine α-casein as 
model phosphoprotein. An aliquot of bovine α-casein was reduced with DTT and 
alkylated by IAM prior to tryptic digestion. The obtained peptide mixture was 
subjected to β-elimination reaction of phosphate moieties from pSer and pThr by 
using barium hydroxide as already reported 38. The barium hydroxide was used 
replacing the previously reported NaOH 39-40 for its higher purity and its higher 
reactivity towards the pThr residues. To remove excess of reagent it was simply 
added solid carbon dioxide. The use of carbon dioxide permitted to remove the 
barium carbonate as a pellet on the bottom of a vial after centrifugation. Moreover 
when the pellet of barium carbonate was dissolved and analysed by MALDI-MS, no 
peptides were detected in the mass spectrum thus indicating the absence of a non-
specific precipitation. The supernatant was equally analysed by MALDI mass 
spectrometry, using a Voyager-DE STR mass spectrometer. Prior to MS analysis, 
peptide mixtures were purified using ZipTip pipette, using the recommended 
purification procedure. As expected the MALDI spectrum (figure IIII.6) showed the 
occurrence of signals not attributable to tryptic peptides of phosphorylated bovine α-
casein; these signals showed a ∆M of -98 Da respect to phosphorylated peptides, 
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and were attributed to corresponding β-eliminated peptides. As an example, the ions 
at m/z 1854.6 and m/z 1563.5 were assigned, respectively, to peptide 104-119 and 
106-119 of α-casein, occurring 98 Da lower than that expected, indicating that the 
pSer115 was converted in dehydroalanyl residue after β-elimination reaction. The 
yield of reaction was almost 100%. 
 
 
 
Figure IIII.6. MALDI-MS spectrum of peptide mixture from α-casein following β-elimination reaction. 
As evident two signals are present at m/z 1563.48 and 1854.63 attributable to newly β-eliminated 
peptides occurring at minus 98 Da respect to phosphorylated forms. 
 
The α,β-unsatured residues are Michael acceptor, which can readily react with a 
nucleophile.  
 
IIII.3.4 iTRAQ-cysteamine addiction 
 
The β-eliminated peptide mixture was modified with iTRAQ-cysteamine via Michael 
type addition by following the procedure described in materials and methods section. 
The rationale behind the choice of this reagent was due to the possibility to use the 
iTRAQ moiety for selective mass spectrometric analysis through precursor ion scan 
mode and at the same time to use it for quantitative analysis of phosphopeptides. 
The addition reaction resulted in the replacement of what was formerly a phosphate 
moiety with an iTRAQ moiety. The interpretation of MALDI spectrum obtained from 
the analysis of a labelled peptide mixture (figure IIII.7) revealed the presence of two 
signals at m/z 1784.8 and m/z 2075.4, attributed to β-eliminated peptides 106-119 
and 104-119, respectively, modified by iTRAQ-SH (∆M = + 221 Da).  
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Figure IIII.7. MALDI-MS spectrum of peptide mixture from α-casein following Michael type addiction 
with iTRAQ-cysteamine molecule. As evident two signals are present at m/z 1784.81 and 2075.43 
attributable to the β-eliminated peptides 106-119 and 104-119, respectively, modified by iTRAQ-
cysteamine (∆M = + 221 Da). 
 
The relative amounts of iTRAQ-modified peptide peaks and β-eliminated peptide 
peaks in MALDI spectra indicates that the yield of the addition reaction was quite 
good but not quantitative (about 70%), as expected for a typical Michael addition 
reaction 31. However, the direct MALDI-MS analysis of the entire peptide mixture 
suffered from suppression phenomena leading to the disappearance of other 
species; in fact it was not possible to directly identify other β-eliminated and iTRAQ-
cysteamine modified peptides both from α-casein S1 and S2, despite of the fact that 
it should be other phosphorylated residues in both proteins. To solve this problem, 
peptide mixtures were analysed by LC-MS/MS exploiting the characteristic features 
of a 4000QTrap system.  
 
IIII.3.5 Analysis by LC-MS/MS 
 
An aliquot of the modified peptide mixture was submitted to LC-MS/MS analysis by 
using 4000QTrap coupled to an 1100 nano HPLC system. We settled an experiment 
using as survey scan a precursor ion scan (PIS) for the iTRAQ reporter ions at m/z 
117/114. The PIS is a typical triple quadrupole scan mode which can be used when 
an ion loses a diagnostic charged fragment during MS2 experiments. The use of PIS 
as survey scan allowed to enrich the mixture in modified peptides during MS 
analysis; the reconstructed ion chromatogram for the precursor ion scan mode of α-
casein peptide mixture after Michael type addiction is reported in figure IIII.8. 
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Figure IIII.8. Total Ion Current of Precursor Ion Scan analysis. 
 
This chromatogram showed a simple profile not attributable to the analysis of a 
complex peptide mixture; this is due to the fact that only peptides generating iTRAQ 
reporter ions during MS2 analysis could be revealed by the mass spectrometer. MS2 
spectra of the species eluted from 28.5 to 30.9 min were attributed to the β-
eliminated phosphopeptides 104-119 and 106-119 of α-casein carrying an iTRAQ-
cysteamine moiety. As an example, the MS/MS spectrum of the modified peptide 
106-119 is reported in figure IIII.9. This ion was stable during collision induced 
dissociation and provided easily interpretable product ion spectra. In fact, the y and b 
fragment ions still retained the modifying group on the β-eliminated Ser residue, thus 
allowing the exact localisation of the phosphorylation site. 
It is worth considering that α-casein contains also a di-phosphorylated and a penta-
phosphorylated tryptic peptides which escaped to be detected using this approach 
probably due to the chemical-physical characteristics of the modified fragments. In 
fact the introduction of a high number of iTRAQ moieties increases the 
hydrophobicity of peptides; moreover the low efficiency of Michael addition results 
dramatically increased when more than one sites are present in the same peptide.  
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Figure IIII.9. MS/MS spectrum of peptide 104-119 modified with iTRAQ-cysteamine on Ser 115; the y 
and the b series are reported, highlighting the presence of the modified residue. 
 
IIII.3.6 Analysis of a complex mixture  
 
In a proof of principle experiment, in order to demonstrate the ability of this analytical 
method to specifically locate phosphorylated residues in a proteomics analysis, 10 
mg of an entire cellular extract of Escherichia coli cells, was spiked with 5 µg of β-
eliminated α-casein tryptic mixture. This complex peptide mixture was then modified 
by reaction with iTRAQ-cysteamine via Michael-type addition by following the 
procedure described above. 1 pmol of the peptide mixture was then submitted to LC-
MS/MS analysis using precursor ion scan mode, as described above. Figure IIII.10 
shows the reconstructed ion chromatogram for the selective iTRAQ fragmentation in 
MS2 mode.  
Data obtained by MS/MS analysis in precursor ion scan mode were exploited both to 
confirm the presence of modified α-casein in the mixture and to identify modified 
peptides By taking advantage of the flexibility of the in house Mascot software. The 
software was properly modified by adding in the “modification file” the value of ∆M + 
221 Da for iTRAQ labelled β-eliminated pSer and pThr residues. For Mascot analysis 
it was necessary to set the software supplying key information, e.g. proteolytic 
enzyme, fixed modifications, variable modifications, sample taxonomy, eventually 
missed cleavages, etc. Mascot search results are reported in figure IIII.11. 
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Figure IIII.10. Total Ion Current of Precursor Ion Scan analysis obtained from the analysis of a 
complex peptide mixture after iTRAQ-cysteamine modification of β-eliminated phosphopeptides of α-
casein. Despite the complexity of the mixture the chromatogram appeared to be very simple, due to 
the PIS simplification of the sample in analysis; in fact the only peaks presents in the chromatograms 
are attributable to iTRAQ modified phosphopeptides. 
 
 
 
Figure IIII.11. Mascot search result of the data form LC-MS/MS analysis of the complex protein 
mixture. 
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As shown by Mascot data, this analytical strategy led to identification of only α-casein 
S1 and α-casein S2, even if a more complex mixture was analysed by LC-MS/MS. 
Moreover exploiting the fragmentation features of iTRAQ molecules in combination 
with PIS analysis, it was possible to selectively isolate from the entire mixture only 
modified peptides. A summary of peptides identified during this analysis is reported in 
table IIII.3. However, other peptides appear in the table not related to modified 
phosphopeptides. This effect could be due to the presence of different fragment ions 
in the region 113-114 or 116-117 in combination with the ion resolution of 
quadrupoles during PIS analysis; in fact in order to increase the sensitivity of mass 
spectrometric analysis, Q1 and Q3 peak widths were set to 0.7 amu. 
It is interesting to note the presence of two modified peptides that were not present in 
previous analysis. In fact it was possible to identify the di-phosphorylated peptide of 
α-casein S1, with both phosphorylated residues (serine 46 and serine 48) labelled 
with an iTRAQ-cysteamine moiety, and a modified phosphopeptide of α-casein S2. 
These data prove the selectivity and the sensitivity of the strategy proposed; indeed, 
despite the increase in sample complexity, it was possible to detect modified 
peptides. 
 
Protein Sequence Monoisotopic mass Modifications 
α-casein S1 YLGYLEQLLR 1267.80  
α-casein S1 FFVAPFPEVFGK 1384.93  
α-casein S1 HQGLPQEVLNENLLR 1760.19  
α-casein S1 YKVPQLEIVPNSAEER 2075.36 iTRAQ-cysteamine 
α-casein S1 VPQLEIVPNSAEER 1784.72 iTRAQ-cysteamine 
α-casein S1 DIGSESTEDQAMEDIK 2174.74 2 iTRAQ-cysteamine 
α-casein S2 FALPQYLK 979.59  
α-casein S2 ALNEINQFYQK 1366.99  
α-casein S2 TVDMESTEVFTK 1589.94 iTRAQ-cysteamine 
α-casein S2 TVDMESTEVFTKK 1718.37 iTRAQ-cysteamine 
α-casein S2 KTVDMESTEVFTKK 1846.35 iTRAQ-cysteamine 
 
Table IIII.3. Summary of peptides identified during LC-MS/MS analysis of the complex protein mixture. 
Despite the complexity of the sample it was possible to identify phosphorylated peptides of both α-
casein S1 and S2. 
 
IIII.3.7 Quantitative analysis of protein phosphorylation  
 
To address the problem of quantitation, having added an iTRAQ moiety to pSer/pThr 
residues, it is possible to follow basically the strategy outlined by Gygi et al. 41. The 
peptides were quantified by measuring, in the mixture, the relative signal intensities 
for pairs of peptide ions of identical sequence, differentially labelled with two different 
forms of iTRAQ. The mass difference within the iTRAQ reporter ions reliably allows a 
separation between such ions; the ratio between the peak areas of reporter ions 
 105 
 
provide an accurate measurement of the relative abundance of labeled peptides and 
hence of the related proteins in the original samples. In fact the relative intensity of a 
given peptide is independent of the isotopic composition of the defined isotopically 
tagged reagent. To further illustrate the ability of this labelling strategy in quantifying 
the phosphorylation of a peptide from two different samples, iTRAQ-cysteamine 115 
and 116 were used to label samples containing stoichiometric concentrations of α-
casein in ratios of 1:1, 1:2 and 1:4. The peptide mixture were analysed by LC-MS/MS 
analysis by using a precursor ion scan (PIS) for the reporter ions at m/z 115/116. It 
was already demonstrated by a previous work 42 that the choice of the fragment for 
PIS analysis is un-relevant, due to the isobaric characteristic of the iTRAQ 
derivatives. A MS/MS spectrum obtained by PIS analysis of a modified peptide 
mixture is reported in figure IIII.12. The signals present in the spectrum led to the 
reconstruction of almost the entire sequence of the β-eliminated phosphopeptide 
104-119 of α-casein S1 carrying an iTRAQ-cysteamine moiety. Moreover in the 
spectrum it is evident the presence of iTRAQ reporter ions in the low mass region 
that were used to perform relative quantitative analysis of the mixtures; by using the 
Analyst software tool for calculation of peak areas (Applied Biosystems) it was 
possible to compare the areas of signals relative to reporter ions at m/z 115 and 116.  
 
 
 
Figure IIII.12. MS/MS spectrum of the of the β-eliminated phosphopeptide 104-119 carrying an 
iTRAQ-cysteamine moiety. In the spectrum it is evident the presence of iTRAQ reporter ions that can 
be used to perform relative quantitative analysis. 
 
Magnified sections of MS/MS spectra obtained from the analysis of the three different 
mixtures, showing the region of iTRAQ reporter ions, are reported in figure IIII.13 in 
three different panels. 
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Figure IIII.13. Magnified sections of MS/MS spectra, obtained from the analysis of differentially 
labeled α-casein peptide mixtures, showing the region of iTRAQ reporter ions and the peak areas 
used for relative quantification. 
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Peak areas of the iTRAQ reporter ions are reported in table IIII.4; analyses were 
performed in triplicate. Experimental ratios resulted in excellent agreement with the 
theoretical ratios (table IIII.4 and figure IIII.13). 
 
116/115 
Theoretical ratio 
116/115 
Experimental ratios 
1 1,02 + 0,08 
2 2,06 + 0,06 
4 3,99 + 0,05 
 
Table IIII.4. Summary of the results obtained by quantitative analysis of the tree differentially labelled 
aliquots of α-casein peptide mixtures. 
 
 
 
Figure IIII.14. Graphical representation of the results obtained by quantitative analysis of the tree 
differentially labelled aliquots of α-casein peptide mixture. Experimental ratios are in good agreement 
with theoretical ratios.   
 
IIII.4 Conclusions 
 
This chapter reports an integrated simple methodology for the qualitative and 
quantitative analysis of protein phosphorylation, which involves chemical 
replacement of the phosphate moieties by iTRAQ moieties. This methodology can be 
classified as RIGhT procedure, since it makes use of a class of specific reagents  
and takes advantage of novel mass spectrometer such as a liner ion trap. Moreover it 
was proven to lead to the simultaneous localisation and quantification of 
phosphorylation sites both in model proteins and in more complex samples. 
The method to locate and quantitate phosphorylated residues may result of interest 
in signalling pathways and control mechanisms studies involving phosphorylation or 
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dephosphorylation of serine/threonine residues. The quantitative analysis can be 
performed by using the different isotopically labelled forms of iTRAQ reagents to 
selective label the modified sites, thus leading to a quantitative description of 
phosphorylation states.  
It is well known that ion trap tandem mass spectrometry experiments offer high 
sensitivity because of the ability to accumulate precursor ions. Furthermore, the 
novel introduction of a linear ion trap with greatly increased capture efficiency and 
storage capacity resulted in new inputs in the proteomic field. Here the strategy 
proposed, taking in account the availability of linear trap to select specific labelled 
peptides giving rise to diagnostic MS2 product ions, resulted to be of useful in the 
phosphoproteins analysis for proteomics purpose. 
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Several labelling strategies have been developed targeting specific amino acid residues and/or
PTMs. Methods specifically tailored for the qualitative and sometimes quantitative determina-
tion of PTMs have emerged. Many research groups have focused their attention towards o-
nitrotyrosine residues, developing various methodologies for their identification, while direct
quantification has remained elusive. So far the iTRAQ chemistry has been limited to primary
amines. Here, we report a new strategy based on the use of iTRAQ reagents coupled to MS
analysis for the selective labelling of o-nitrotyrosine residues. This method was proved to lead to
the simultaneous localisation and quantification of nitration sites both in model proteins and in
biological systems.
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1 Introduction
A number of tagging (or labelling) strategies have been
developed to target specific amino acid residues and/or
PTMs. These methods enable the enrichment of subfrac-
tions via affinity cleanup [1–3]. A proposed approach consists
in targeting the specific amino acid by an affinity chroma-
tography step (e.g. biotin–avidin chromatography). This pro-
cedure was used for the isolation of post-translationally
modified peptides [4–7]. The presence of phosphorylation,
glycosylation, glycation, nitration and specific types of oxida-
tion are examples of PTMs that can be targeted [8, 9].
Stable isotope methods have been introduced into MS-
based proteomics to allow relative changes in protein
expression to be determined [10]. The principle of these
methods is the incorporation of a stable isotope derivative in
one of the states to be compared. Stable isotope incorpora-
tion shifts the mass of the peptides by a predictable amount.
The ratio of analyte between two or more states can then be
determined accurately by the measured peak ratio between
the heavy and light derivatised samples One of the first
approaches based on the isotope stable affinity tagging and
MS is the ICAT strategy [11] specifically addressed towards
Cys residues. Another elegant approach use cell-culture
enrichment with a stable isotope-labelled amino acid, for in
vivo incorporation of a mass difference to support relative
quantitation [12].
A novel methodology for quantitative analysis by MS
makes use of iTRAQ (acronym for isobaric tag for relative
and absolute quantification) technology, a newly developed
method by Applied Biosystems for relative and absolute
quantification of proteins. This novel reagent has been
applied for the first time by Pappin and coworkers for the
multiplexed protein quantitation in yeast [13]. iTRAQ
reagents are specifically reactive towards primary amino
groups (namely N-terminal of proteins and peptides and
epsilon-amino groups of lysine) and marketed in four differ-
ent forms called iTRAQ 114.1, 115.1, 116.1 and 117.1,
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depending on the m/z value of the reporter group. The
reagents are differentially isotopically labelled such that all
derivatised peptides are isobaric (isobaric tag with a mass of
145.1 Da). In fact, the overall mass of reporter and balance
components of the molecule are kept constant using differ-
ential isotopic enrichment with 13C, 15N and 18O atoms. The
iTRAQ reagents allow the simultaneously multiplexed anal-
ysis of four samples. Each of these samples is labelled with
one of the iTRAQ reagents; all peptides with the same
sequence, but carrying different versions of the tag will be
chromatographically indistinguishable and identical in
mass, therefore, also identical in single MS mode. Upon
fragmentation, the reporter group is detached, creating sig-
nals in the ‘quite’ low mass range region (114–117 Da) of the
MS/MS spectrum. The balance group is lost as a neutral, so
that the remaining peptide backbone remains unmodified
and can generate backbone fragments that are identical in
m/z for all samples, resulting in improved S/N ratios be-
cause all differentially coded samples contribute to MS/MS
spectrum. Thus, low mass reporter ion signals allow quanti-
tation, while peptide fragment ion signals allow protein
identification. Very recently, an octu-plex iTRAQ kit has been
proposed thus allowing the simultaneous analysis of eight
different samples [14]. Moreover, iTRAQ labelling coupled
with pulsed Q dissociation technique has been recently pro-
posed for protein quantitation [15].
Among PTMs, protein nitration can occur in cells during
oxidative stress and over-production of nitric oxide [16, 17].
Tyrosine nitration is becoming increasingly recognised as a
prevalent, functionally significant post-translational protein
modification [18]. This modification is, in fact, implicated in
the control of fundamental cellular processes including cell
cycle, cell adhesion and cell survival, as well as cell prolifera-
tion and differentiation.
Addition of NO2 group to the ortho-position of tyrosine
decreases the pKa of its hydroxyl group of about three units.
This bulky substituent can induce changes in protein con-
formation, resulting in the generation of antigen epitopes,
altered enzyme catalytic activity, modulation of metabolic
pathways and inhibition of tyrosine phosphorylation by pro-
tein kinases [19–21]. For these reasons and for its chemical
stability NO2Tyr is considered the most important biomarker
for identification and quantitation of cellular processes,
associated to reactive nitrogen species (RNS) occurrence,
that lead to PTM of proteins.
Many research groups have focused their attention to-
wards 3-nitrotyrosine residues, developing various meth-
odologies for revelation and quantification of NO2Tyr resi-
dues [22–25].
So far the iTRAQ chemistry has been limited to primary
amines even instrumental for the identification of PTMs. As
an example Pflieger and coworkers showed a protocol for
phosphorylation quantification [26] based on the combina-
tion of iTRAQ isobaric labelling of peptide and phosphatase
treatment for the identification of phosphorylated protein in
complex mixtures.
We are planning to extend the chemistry of the reagent to
address quantification of function of other than primary
amines by taking advantage of the experience recently made
with dansyl chemistry. In fact, our group has already report-
ed a new approach involving dansyl chloride labelling of
nitration sites that rely on the enormous potential of MSn
analysis [27]. A similar approach has been reported by
Smith’s laboratory for the selective enrichment and identifi-
cation of nitrotyrosine-containing peptides based on deriva-
tisation with N-succynimidyl S-acetylthioacetate and LC-MS/
MS analysis of newly generated amino-tyrosines deriving
from sodium dithionite-assisted reduction of nitro groups [8]
Here, we report a new strategy based on the use of
iTRAQ reagents coupled to MS analysis for the selective
labelling of o-nitrotyrosine residues. This method was proved
to lead to the simultaneous localisation and quantification of
nitration sites both in model proteins and in biological sys-
tems.
2 Materials and methods
2.1 Chemicals
BSA, tetranitromethane (TNM), ammonium bicarbonate
(AMBIC), guanidine, DTT, trypsin, iodoacetamide (IAM)
and triethyl ammonium carbonate (TEAB) were purchased
from Fluka. Tris, sodium dithionite as well as the MALDI
matrix CHCA were purchased from Sigma. iTRAQ reagents
were furnished by Applied Biosystems. Methanol, TFA and
ACN are HPLC grade type from Carlo Erba, whereas the
other solvents are from Baker. Gel filtration columns PD-10
are from Pharmacia, the HPLC ones from Phenomenex,
whereas the prepacked columns Sep-pak C-18 are from
Waters.
2.2 BSA nitration
An aliquot of 200 mg BSA was dissolved in Tris 200 mM
pH 8.0 buffer and was added to a 830 nmol/mL solution of
TNM in ACN in a molar ratio 1:10 BSA/TNM. The reaction
was carried out under agitation for 30 min at room tempera-
ture. The mix of BSA and nitrated BSA (N-BSA) was then
desalted by SEC on a SEPHADEX G-25M column; the elu-
tion was carried out with Tris 300 mM and the fractions an-
alysed through UV spectrometry at 220 and 280 nm wave-
length. Positive fractions were collected and dried.
2.3 Reduction and carbamidomethylation of BSA
BSA and N-BSA mixture were dissolved in denaturation
buffer (guanidine 6 M, Tris 0.3 M, EDTA 10 mM, pH 8.0).
Reduction was carried out by using a 10:1 DTT/cysteine
molar ratio. After incubation at 377C for 2 h, iodoacetamide
was added to perform carbamidomethylation using an excess
of alkylating agent of 5:1 respect to the moles of thiolic
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groups. The mixture was then incubated in the dark at room
temperature for 30 min. The alkylation reaction was stopped
by addition of formic acid, in order to achieve an acidic pH.
The product was purified by SEC. The elution was performed
with TEAB 50 mM pH 8.0.
2.4 BSA digestion
Protein digestion was carried out in TEAB 50 mM pH 8.0
buffer using trypsin at a 50:1 protein/trypsin mass ratio. The
sample was incubated at 377C for 16 h. Then the sample was
dried.
2.5 Acetylation of peptide mixture
Peptide mixture was dissolved in 30% TEAB 500 mM
pH 8.0, 70% ACN. Acetylation was performed by using
acetic acid N-hydroxy succinimide esther in molar ratio 500:1
reagent/peptides. The reaction was carried out for 1 h at
room temperature.
2.6 Nitro groups reduction
Reduction of nitro groups to amino groups was performed
by adding. Na2S2O4 at 100:1 Na2S2O4/NO2Tyr molar ratio.
The reaction was carried out at room temperature for 10 min
under stable stir. The product was purified by SEP-PAK RP-
LC with C18 column. Peptides were eluted using 80% ACN,
20% formic acid 0.1%. Fractions were collected and lyophi-
lised.
2.7 Bacterial strains, growth conditions and protein
extract preparation
Escherichia coli K12 strain was grown in aerobic conditions at
377C in LB medium. After 16 h, bacteria were harvested by
centrifugation and resuspended in Buffer Z (25 mM HEPES
pH 7.6, 50 mM KCl, 12.5 mM MgCl2, 1 mM DTT, 20%
glycerol, 0.1% triton) containing 1 mM PMSF. Cells were
disrupted by sonication. The suspension was centrifuged at
90 0006g for 30 min at 47C. After centrifugation the protein
concentration of the extract was determined with Bradford
assay.
2.8 iTRAQ selective labelling
Sample was dissolved in TEAB 500 mM pH 8.0 and then was
divided in two shares and each of these was differentially
labelled with alternatively iTRAQ reagent 114 and iTRAQ
reagent 117, following iTRAQ protocol furnished by Applied
Biosystem.
2.9 Labelling of bovine milk protein extract
A sample of commercially available bovine milk was reacted
with a 10 mM solution of TNM for 30 min under agitation at
room temperature. Modified milk proteins were purified by
precipitation with the Amersham Clean Up kit and dissolved
in denaturant buffer. Reduction was carried out by using a
10:1 DTT/cysteine molar ratio. After incubation at 377C for
2 h, iodoacetamide was added to perform carbamidomethy-
lation using an excess of alkylating agent of 5:1 respect to the
moles of thiol groups. The mixture was then incubated in the
dark at room temperature for 30 min. The alkylation reaction
was stopped by addition of formic acid, in order to achieve an
acidic pH. The protein mixture was purified by SEC on a
Sephadex G-25 M column equilibrated and eluted with
50 mM TEAB. Protein fractions were concentrated and then
digested with trypsin as already described. The resulting
peptide mixture was acetylated and the nitro groups were
reduced using a 200 mM solution of Na2S2O4 for 30 min.
The protein mixture was then reacted with ITRAQ as
described above.
2.10 NanoLC-MS
Peptide mixture, obtained as previously described, was ana-
lysed by LC-MS/MS analysis using a 4000Q-Trap (Applied
Biosystems) equipped with a linear ion trap coupled to an
1100 nano HPLC system (Agilent Technologies). The mix-
ture was loaded on an Agilent reverse-phase pre-column
cartridge (Zorbax 300 SB-C18, 560.3 mm2, 5 mm) at 10 mL/
min (solvent A 0.1% formic acid, loading time 7 min). Pep-
tides were separated on an Agilent reverse-phase column
(Zorbax 300 SB-C18, 150 mm675 mm, 3.5 mm), at a flow
rate of 0.2 mL/min with a 5–65% linear gradient in 60 min
(solvent A 0.1% formic acid, 2% ACN in water; solvent B
0.1% formic acid, 2% water in ACN). Nanospray source was
used at 2.3 kV with liquid coupling, with a declustering
potential of 20 V, using an uncoated silica tip from New-
Objectives (od 150 mm, id 20 mm, TD 10 mm). Spectra acqui-
sition was based on a survey Precursor Ion Scanning for the
ion m/z 114 and 117. It was performed over a mass range of
m/z 400–1400 with Q1 set to low resolution and Q3 set to
unit resolution. Precursors were collided in Q2 with a colli-
sion energy ramp of 25–65 V across the mass range. Spectra
acquisition was based on a survey precursor ion scan (PIS). A
positive ion Enhanced Resolution Scan was performed at
250 amu/s to determine the charge state of the ion.
Enhanced product ion (EPI) scans (MS/MS) were performed
at 4000 amu/s and collision voltages were calculated auto-
matically by rolling collision energy and it performed a max-
imum of one repeat before adding ion to the exclusion list for
60 s. Once this duty cycle was completed, the polarity was
switched back and the cycle repeated. The entire cycle dura-
tion, including fill times and processing times was less than
5.3 s. Data were acquired and processed using Analyst soft-
ware (Applied Biosystems) and processed by using MASCOT
in-house software.
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3 Results and discussion
It is well known that some PTMs due to oxidative stress
events are linked with the pathogenesis of different diseases,
therefore, it is very important to find biological markers able
to furnish us information about localisation and physiologi-
cal effects of oxidative stress. Molecules modified by oxida-
tion, nitration and nitrosilation can act as cellular bio-
markers. Identification of the specific targets of protein oxi-
dation was generally accomplished by the detection and
quantification on o-nitrotyrosine using of 2-DE and Western
blot techniques followed by mass spectral identification of
protein candidates [28]. However, these procedures generally
led to the identification of nitrated proteins but the fine
localisation of the nitration sites in complex protein mixture
still remain a challenging task. In this respect, our group has
suggested a strategy leading to the selective detection of
nitrated tyrosine residues by using dansyl chloride labelling
coupled to advanced MS experiments [27]. The tryptic digest
from the entire protein mixture is directly analysed by MS on
a hybrid triple quadrupole/linear ion trap mass spectrome-
ter. Discrimination between nitro- and unmodified peptide is
based on two selectivity criteria obtained by combining a PIS
and an MS3 analysis. The proposed strategy has resulted to
be specific, sensitive, simple and fast. However, because no
heavy form of dansyl chloride is commercially available,
quantitative analysis of complex protein mixture cannot be
addressed. Now taking advantage of the experience made
with the above strategy, we used selective labelling of o-
nitrotyrosine residues exploiting the potential of iTRAQ
reagents to perform quantitative analysis of this PTM in
proteins. The idea proposed is outlined in the Scheme 1.
According to the so-called ‘gel-free procedures’, the anal-
ysis is carried out at level of peptides following tryptic digest
of the whole protein mixture. This approach was first applied
to BSA as model protein. 200 mg of BSA were nitrated using
TNM as described in Section 2. Then, the resulting BSA and
N-BSA mixture was reduced, alkylated and hydrolysed using
trypsin. The peptide mixture was then analysed via MALDI-
MS to verify the extent of nitration.
BSA is a protein of about 66 kDa, showing 20 tyrosine
residues along its sequence. However, mass spectral analyses
demonstrated that in vitro nitration was limited to only few
tyrosine residues, namely the ones exposed in the structure
of the protein and thus more sensible to nitration. Nitrated
peptides were identified by MALDI mapping procedure, by
comparing the experimental peptides masses with the theo-
retical values on the basis of amino acid sequence. As already
reported, a DM of 145 was attributed to the modified pep-
tide, due to introduction of a nitro-group [29]. Figure 1
(panels A and B) showed partial MALDI-MS spectrum of the
tryptic BSA and N-BSA mixture. As an example, the signals
occurring at m/z 972.5, 1524.8 showed molecular masses
45 Da higher than the theoretical ones. These signals were
attributed to the peptides 137–143, 396–408, having the Tyr
residue been modified by a nitro group. As a whole, the
MALDI-MS analysis showed the occurrence of four signals
exhibiting a mass increment of 45 Da. These signals were
attributed to the nitropeptides 137–143, 396–408, 322–334,
444–457 (at m/z 972.5, 1524.8, 1612.9, 1770.8, respectively)
As further proof, these signals exhibited the characteristic
pattern of nitrated peptides, due to photodecomposition of
nitrated tyrosine residues by MALDI source [29]. Moreover,
mass spectral analysis led to a semiquantitative measure of
the degree of the in vitro protein nitration. In fact, by com-
paring the intensity of signals attributed to nitrated peptides
with respect to the unmodified one it was possible to esti-
mate that almost 30% of BSA resulted to be nitrated.
In our previous work [27], the selective labelling of o-
nitrotyrosine residues was essentially based on a reduction
step and conversion to o-aminotyrosine residues followed by
specific dansylation at pH 4.7. A similar approach was
attempted here. However, iTRAQ labelling does not permit
to exploit the low pKa value [30] of such amine to obtain a
selective labelling, as observed for the dansyl-chloride label-
ling. Only a small percentage of primary aromatic amine
modification by iTRAQ was observed. This behaviour may be
explained by the faster rate of hydrolysis of both the ITRAQ
n-hydroxysuccinimide ester group and the formed amino-
tyrosine-iTRAQ derivative in mild acidic conditions [31].
Thus, it was necessary to set up a double step procedure.
First of all, lysine residues and N-terminus primary amine
were protected to facilitate specific labelling of the o-nitroty-
rosine residues. Blocking can be easily performed under
mild conditions by a variety of reagents that are commer-
cially available. In fact, several strategies to introduce NH2-
labels have been described [32, 33]. Generally, it is not possi-
ble to reliably control the selectivity of the reaction, because
the e-amino group of lysine is readily and stably modified by
reagents that target the N-terminus [34, 35]. Blocking the
Scheme 1. Strategy for selective
labelling of o-nitrotyrosine resi-
dues.
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Figure 1. MALDI-MS spectra enlargement of
nitrated BSA. (A) Detail of MALDI-MS spectrum
relative to nitrated peptide 137–143. (B) Detail of
MALDI-MS spectrum relative to nitrated peptide
396–408. MALDI-MS spectrum shows that the
degree of protein nitration is almost 30%.
N-terminus and the lysine side chain can be done either
prior to or after enzymatic digestion of the sample. By block-
ing the lysines after digestion, we retained the ability to use
trypsin as enzyme for proteolytic cleavage.
Preliminary acetylation experiments were performed by
using acetic anhydride as reagent and peptide mixture
obtained from trypsin digestion of myoglobin, as model.
MALDI-MS analysis performed on the resulting peptide mix-
ture showed that the acetylation reactionwas not quantitative.
Thus, we decided to use acetic acid N-hydroxy succinimide
esther as reagent since it has been shown to lead to an efficient
lysine acetylation [36]. The yield of the reactionwasmonitored
by MALDI-MS. As an example, Fig. 2 reports the partial
MALDI-MS spectrum of the acetylated myoglobin tryptic
mixture. The signal at m/z 1649.2 was attributed to the pep-
tide fragment 18–23 carrying an acetyl group, fully modified.
No signal related to the unmodifiedpeptidewas observed thus
indicating that the acetylation was quantitative.
Thus, nitrated peptides were subjected to acetylation
using acetic acid N-hydroxy succinimide esther as described
in Section 2. All successive analysis revealed that every pep-
tide detected had the N-term amine and eventually the e-
amino group of lysine protected. Only after the acetylation
step it was possible to reduce the nitro-group of o-nitroty-
rosine residues to an amino group, susceptible to iTRAQ
addition. Conversion of nitropeptides into their amino deri-
vatives was accomplished by Na2S2O4 treatment [30]. The
peptide mixture was desalted by sep-pak C18 cartridge and
the extent of reduction was monitored by MALDI-MS.
As for quantitative analysis, labelling reaction was car-
ried out on the newly generated amino groups by following
the default protocol. iTRAQ technology (trademarked by
Applied Biosystems), allows quantitative analysis of protein
expression through the use of isobaric tags, enabling the
quantitation of four [13] to eight complex protein samples
[37] in a single multiplexed analysis. Isobaric tagging meth-
ods are emerging as an important tool to study protein
expression dynamics.
As an example to illustrate the possibility to use iTRAQ
labelling strategy for selective quantitative analysis of o-
nitrotyrosine residues and at the same time to reduce the
costs, we decided to carry out our methodology just on a
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Figure 2. Detail of MALDI-MS spectrum
of acetylated myoglobine showing pep-
tide 18–23 with acetylated N-terminal;
there are no evidence in the spectrum
for non acetylated form of the same
peptide.
duplex. Thus, we analysed only two samples and we choose
iTRAQ 114 and iTRAQ 117 as labelling reagents. After the
labelling, the resulting samples (containing about 30% of N-
BSA), N-BSA(114) and N-BSA(117), were pooled in molar
ratio 1:1 and 1:4, respectively. The two mix (1:1 and 1:4) were
then submitted to LC-MS/MS analysis in PIS mode, by using
4000Q-Trap coupled to a 1100 nano HPLC system, thus
allowing the simultaneous quantification of differentially
labelled peptides in a single chromatographic run. Thus, we
setup an experiment by using a PIS for the iTRAQ reporter
ions at m/z 117.1.
Moreover, in order to demonstrate that the choice of the
fragment to monitor nitrated peptides in PIS mode is irrele-
vant, because of the isobaric characteristic of the iTRAQ, we
decided to analyse the same sample in two separate chro-
matographic runs, the first in PIS of ion 114.1 and the sec-
ond in PIS of ion 117.1. As shown in the Fig. 3, the two
chromatographic profiles are quite identical and super
imposable, differing just in the TIC intensity that reflects the
original ratio 1:4 between the two samples. In fact, it should
be noted that PIS ion current is recorded from the fragment
generated in MS/MS and no memory is retained about the
intensity of the parent ion.
To gain information about the sequence of the peptide
and the site of nitration, a second stage of mass analysis is
performed in which the precursor ion is selected by the first
mass analyser and fragmented. Differentially labelled pep-
tides were indistinguishable during a single step of MS
analysis due to typical characteristics of iTRAQ reagents.
During MS/MS, labelled peptides produce fragmentation
spectra that allow the identification of the protein. Moreover,
MS/MS produces fragmentation at the sites modified by the
iTRAQ reagent yielding reporter ions (m/z 114 and 117) that
are visible as separated peaks in the low mass region of the
MS/MS spectrum. The ratios of related areas of these peaks
were then used to perform a relative quantitative analysis [38-
39].
Figure 4 showed the reconstructed ion chromatogram of
the 1:1 N-BSA sample analysed by PIS of 117 (A) and a clas-
sical full scan MS (B). As clearly shown, the PIS analysis led
to reduce the number of undesired signals, improving also
the duty cycle of the method and the sensitivity towards
nitro-peptides enhancing S/N ratio. However, others signals
appear in the chromatogram not related to nitrated peptides.
This effect might be generated by the presence of different
fragment ions in the region 113-114 or 116-117, many of
which generated after acetylation step (Table 1). Thus we
used 114 and 117 iTRAQ reagents, in order to have the worst
condition of selectivity and demonstrate the feasibility of our
methodology.
An accurate manual analysis of MS/MS spectra, revealed
that many positive false were selected for the presence of
m/z 114 fragment whose intensity would be negligible on
quantitative estimation (Fig. 5). To enhance the selectivity of
the analysis made by 4000QTrap, we also tried to introduce
an MS3 event as done in a previous work [27]. In particular,
Table 1. Unlabelled BSA peptides and their precursor detected in
PIS 114 and PIS 117 mode
Interfering ions Mass Peptides Scan
(Ac)b1 Ala 114.1 (Ac)ADE(Ac)K(Ac)KFWGK(Ac) PIS 114
(Ac)b1 Ala 114.1 (Ac)AEFVEVTK(Ac) PIS 114
(Ac)Immonium Val 114.1 (Ac)VLASSARQR PIS 114
(Ac)Immonium Val 114.1 (Ac)VH(Ac)KECCHGDLLECADDR PIS 114
(Ac)Immonium Thr 116.1 (Ac)TCVADESHACCEK(Ac) PIS 117
(Ac)Immonium Thr 116.1 (Ac)TVMENFVAFVDK(Ac) PIS 117
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Figure 3. Overlapped chroma-
tograms of nitrated BSA recor-
ded by PIS analysis of ions 114
(grey line) and 117 (bold line),
respectively. The chromatogram
of PIS 114 is shifted back of
1 min to have a better compar-
ison of signals. The symbols 1,
s, X, *, are referred to BSA-
nitrated peptides 137–143, 396–
408, 444–457, 322–334, respec-
tively. The symbols D, q are
referred to BSA unspecific pep-
tides detected in PIS of 114 and
PIS of 117, respectively.
Figure 4. (A) Chromatogram of nitrated BSA recorded in PIS 117.
(B) Chromatogram of nitrated BSA recorded in a full scan MS
mode.
we tried to fragment in MS/MS the ion at m/z 145 and
monitor the loss of CO giving rise to the peculiar reporter
ions of iTRAQ in MS3 mode. A Preliminary experiment
revealed that MS3 spectra exhibited a very poor intensity
caused by the low yield of ion fragment at m/z 145 in MS2
mode. Thus, we found that to enhance the selectivity of LC-
MS/MS analysis good results were obtained increasing the
signal threshold of PIS using the great difference in signal
intensity between the iTRAQ reporter ions and others men-
tioned previously (Table 1).
However, we inferred that our LC-MS/MS method for
4000QTrap analysis resulted to be a good compromise be-
tween selectivity and sensibility that are fundamental pa-
rameters in nitro-proteome analysis because of the sub-stoi-
chiometric characteristic of protein nitration. In fact, we
want to underline that, without any chromatographic nitro-
peptide enrichment, just using the mass spectrometer gas
phase fractionation features, we had eliminated about 96%
of BSA undesired peptides detected with a classical LC-MS/
MS approach. Furthermore if eventually, in a borderline case,
the detection of a false positive may complicate the analysis,
the sample may be re-analysed inverting the diagnostic
iTRAQ reporter ion monitored by PIS analysis. Indeed
unspecific ions detected in PIS of 114 were not detected in
PIS of 117 and vice versa.
Identification of nitrated tyrosine residues was carried
out by taking advantage of the flexibility of the in house
MASCOT software. The software was properly modified by
adding in the ‘modification file’ the value of DM 159 for
iTRAQ labelled ammino-tyrosine residue. For MASCOT
analysis it was necessary to set the software supplying key
information, e.g. proteolytic enzyme, fixed modifications,
variable modifications, sample taxonomy, eventually
missed cleavage, etc. The data obtained from MS/MS anal-
ysis in PIS mode where exploited both to identify nitration
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Figure 5. MS/MS spectra enlargement of characteristic iTRAQ m/z region of nonspecifically detected BSA peptides. (A) Peptide AEFVEVTK
was detected in PIS 114 due the presence of an acetylated b1 ion of alanine residue at m/z 114.2. (B) Peptide VLASSARQR was detected in
PIS114 mode because of the presence of an acetylated immonium ion of valine at m/z 114.0. (C) Peptide TVMENFVAFVDK was detected in
PIS 117 mode because of the presence of an acetylated immonium ion of threonine at m/z 116.3 or its isotope.
sites by using SwissProt database and to perform quanti-
tative analysis.
Nitration sites Y137, Y406, Y457 and Y337 were identified by
the detection and by MS/MS spectra interpretation from
MH2
21 ions at m/z 564.8, 841.0, 963.5, 885.3, respectively. As
an example, the MS/MS spectrum of modified peptide 137–
143 is shown in Fig. 6A. The derivatised product ions were
identified from either the corresponding b or y product ion
series. By using the Analyst software tool for calculation of
peaks area (Applied Biosystems) it was possible to compare
the areas signals relative to reporter ions at m/z 114 and 117.
As an example, for the MS/MS spectrum mentioned above a
ratio of 1.1 6 0.2 was calculated.
Figure 6B showed the MS/MS spectrum relative to the
peptide 444–457 for the mixture 1:4 molar ratios between N-
BSA labelled with iTRAQ 114 and N-BSA labelled with
iTRAQ 117. In this case nitration site was detectable from y
ions and the area ratios for the reporter ions at m/z 117 and
114 resulted to be 4.1 6 0.4, thus providing an accurate
measurement of the relative abundance of each nitrated
peptide.
Moreover, the presence of an intense iTRAQ-labelled
amino tyrosine immonium ion at 292.1 m/z could be
detected in both spectra (Fig. 6). This ion might be used as an
indication for the occurrence of a nitration site in the pep-
tide.
3.1 Analysis of complex mixtures
In a proof of principle, to investigate the feasibility of apply-
ing the method to proteomic analysis, a model system was
constituted by adding 5 ng of protein mix containing BSA
and N-BSA to 30 mg of an E. coli entire soluble protein
extract. Aliquots of mix of BSA and N-BSA, as control, and E.
coli extract spiked with BSA mix were fractionated by SDS-
PAGE and submitted to a western blot analysis using anti-
nitrotyrosine antibody as indicated in Fig. 7. The analysis
showed that the amount of N-BSA was quite impossible to
differentiate from the other bacterial proteins. Moreover, in
lane D is possible to appreciate that the sample used could be
considered similar to a ‘dirty’ N-BSA E. coli protein extract,
thus being a good candidate for nitro-proteome study. The
total protein extract was then submitted to the procedure
described above. The mixture was hydrolysed with trypsin
and lysine residues were protected by acetylation. Nitroty-
rosines were then reduced with dithionite, and the newly
generated amino Tyr-containing peptides were submitted to
the iTRAQ labelling protocol, using 114 iTRAQ molecule.
After labelling reaction, LC-MS/MS analysis of the mix-
ture was performed by using 4000Q-Trap, as already de-
scribed. Figure 8 showed a 3-D graphic, defined as Counter
Plot, representing LC-MS/MS parameters, namely elution
time, m/z and ion intensity expressed in greyscale intensity.
This graphical view, obtained by the Analyst software tool,
showed the duty cycle and sensitivity improvement of the
strategy proposed. A full scan MS analysis of N-BSA spiked
with an entire digest of E. coli proteins extract is reported
Fig. 8A. As clearly shown in figure, this MS analysis is not
competitive for such complex peptide mixture. Indeed, due
to the large time spent by the spectrometer analysing the
most abundant peptides, only three out of four nitrated pep-
tides present in the mixture were detected. The high selec-
tivity of the optimised PIS analysis (Fig. 8B) greatly reduced
the number of analysed species, leading to a real increase in
sensitivity. Protein Identification of nitrated proteins was
carried out using the modified MASCOT software as descri-
bed above. These peptides corresponded to the same pep-
tides previously detected in the analysis of homogeneous
nitrated BSA. Thus, our results underscored the ability of the
proposed selective labelling strategy to discriminate nitro-
peptides from their unmodified counterparts in a complex
matrix.
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Figure 6. (A) MS/MS spectrum of nitrated BSA peptide 137–143 labelled by iTRAQ reagent in 1:1 ratio. (B) MS/MS spectrum of nitrated BSA
peptide 444–457 labelled by iTRAQ reagent in the ratio 1:4. Spectra enlargement showed iTRAQ signals allowing quantitative estimation.
The proposed strategy was finally employed to identify
unknown o-nitrotyrosine residues in a complex sample as
the entire bovine milk. Bovine milk was in vitro nitrated with
TNM [27] and the extent of nitration was monitored by SDS-
PAGE and western blot analysis as described above. Figure
9A (lane A) showed that the high difference of milk protein
abundance in the sample reflected the high dynamic range
features of the proteomic analysis. In addition the immuno-
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Figure 7. SDS-PAGE and Western blot analyses of E. coli protein
digest spiked with nitrated BSA (lane B) where N-BSA band was
indistinguishable by the others. Lane A: Standard mix of BSA and
N-BSA as control. Lanes C and D: Western blot analysis by using
antinitrotyrosine antibody of control and E. coli samples,
respectively.
detection (lane B) showed the low extent of protein nitration
thus indicating that this model system could be suitable for
proteomic analysis. The entire milk protein extract was then
dissolved in denaturant buffer, and cysteine alkylation and
nitro-groups reduction were performed ‘one pot’ as described
in Section 2. Two protein samples were then desalted and
digested with trypsin. The resulting peptide mixtures were
acetylated, differentially labelled with iTRAQ reagents (114
and 117) and mixed in molar ratios of 1:1 and 1:4. The sam-
ples were then selectively analysed by nanoLC-MS/MS in PIS
mode for the reporter ion at m/z 117.
Identification of nitrated milk proteins was carried out
using the modified MASCOT software as described. The
results obtained were mediated on triplicate analyses and are
summarised in the Table 2. As indicated in the table, besides
the high-abundant milk proteins (a-casein and b-lactoglobu-
lin), this procedure was also able to assess the nitration sites
occurring in low-abundant proteins, like Vimentin and
Integrin, thus, demonstrating the feasibility of this strategy
for the identification of protein nitration in proteomics. As for
the quantifications, we realised the quantitative estimation of
7/9 nitrated peptides. In fact, the spectra of low abundant
proteins let us to unequivocally identify the sequence; how-
ever, the quality of signals for the ions 114 and 117 were too
low to make an accurate quantitative measure all over the sig-
nals. In Fig. 9B the MS/MS spectrum of a nitrated peptide
within a-casein is shown. It is interesting to note that the
occurrence of an acetylated threonine residue at N-terminal
position does not effect the quantitative estimation.
Finally, the proposed strategy was successfully applied to
the study of complex mixture of proteins in low abundance,
by using plasma samples where real protein nitration
changes are observed, thus representing a critical evaluation
of this methodology.
Table 2. Nitrated milk proteins detected by the selective iTRAQ labelling strategy coupled with a selective PIS-MS
analysis
Observed
m/z
Score Sequence Ratio
114:117
Protein, accession no.
740.2 59 (Ac)VLVDTY*K(Ac)K(Ac) 4.1 6 0.1
1.2 6 0.2
b-Lactoglobulin, P02754
796.5 49 (Ac)DMPIQAFLLY*QEPVLGPVR 3.8 6 0.4
0.9 6 0.2
b-Casein, P02666
573.5 44 (Ac)TVY*QHQK(Ac) 4.3 6 0.2
1.2 6 0.3
a-s1-Casein, P02663
568.8 42 (Ac)Y*LYEIAR 3.9 6 0.1
0.8 6 0.3
Albumin bovine, P02769
426.8 36 (Ac)ADLIAY*LK(Ac)K(Ac) 4.1 6 0.4
1.3 6 0.2
Cytochrome,c P62849
716.3 34 (Ac)STRTVSSSSY*R 4.1 6 0.4
1.2 6 0.4
Vimentin, P48616
617.4 30 (Ac)AY*PTPARSK(Ac) 4.2 6 0.7
1.4 6 0.3
Glycoprotein hormones a chain, P01217
565.9 29 (Ac)HFHLY*GR 5.2 6 1.6
1.8 6 0.9
Integrin a-L, P61625
559.8 29 (Ac)LELY*LPK(Ac) 7.1 6 3.4
1.8 6 1.2
Plasma serine protease inhibitor, Q9N212
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Figure 8. Counter plot representation of
a whole E. coli protein digest spiked with
nitrated BSA analysed, by a classical full
scan MS (A) and PIS (B) after iTRAQ
selective labelling.
Figure 9. (A) SDS-PAGE (lane A) and Western blot analysis using
anti-nitrotyrosine antibody (lane B) of in vitro nitrated milk pro-
teins. (B) MS/MS spectrum of a-Casein nitrated peptide
TVYQHQK detected in an in vitro nitrated milk proteins extract. In
the spectrum enlargement of iTRAQ mass region, the character-
istic signals of the reporter ions and a signal at m/z 116.1 of
acetylated threonine immonium ion are visible.
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Oxidative and nitrosative stress may cause post-translational
changes in plasma proteins that have been described to
accumulate in inflammatory and degenerative conditions.
Inflammation and oxidative/nitrosative stress (O/NS) are
exacerbated in uremia and hemodialysis (HD) patients [40].
Proteomics techniques, also described with the name of
‘redoxomics’ [41], have been tentatively used in these patients
to identify specific PTMs related with O/NS in plasma pro-
teins, and 3-nitro tyrosine is between the most investigated
ones.
Thus, the iTRAQ labelling procedure was successfully
applied to the qualitative and quantitative analysis of 3NT-
containing proteins with different relative abundance and
molecular mass, in 100 mL of plasma and dialysis fluids of
HD patients (Fig. 10). Our strategy let us to identify the
number and position of Tyr residues affected by this post-
translational change in individual proteins. Moreover,
iTRAQ selective labelling of nitration sites showed that
healthy control plasma contained much less nitrated pep-
tides and therefore nitrated proteins, with respect to the ure-
mic ones, and these findings were in agreement with lower
levels of biochemical indices of oxidative stress and inflam-
mation (manuscript in preparation).
Figure 10. Western blotting analysis of SDS-PAGE fractionation
of 3NT-containing proteins in 100 mL of pooled samples of uremic
and healthy control plasma (15 ug of proteins/lane). MW, molec-
ular weight markers stained by ponceau; 1, control plasma; 2,
uremic plasma, 3, uremic ultrafiltrate.
4 Concluding remarks
The iTRAQ approach has been successfully applied to a
variety of prokaryotic and eukaryotic samples including E.
coli, yeast, human saliva, human fibroblasts and mammary
epithelial cells to identify and quantify the proteins in these
samples [42–43]. Zhang et al. [44] combined the iTRAQ
labelling approach with immunoprecipitation to quantify ty-
rosine-phosphorylated peptides epithelial cells.
However, iTRAQ has been also applied to identify and
quantify protein level in shotgun proteomics approach
[45–46]. This work represents the first innovative applica-
tion of iTRAQ labelling strategy to the analysis of PTM.
In particular, we addressed the analysis of protein nitra-
tion, thus providing a powerful analytical method to
identify nitrated protein, localise tyrosine nitration sites
and to quantitate the extent of protein nitration in a sin-
gle experiment.
The newly developed procedure was successfully tested
on complex biological systems (manuscript in preparation),
to assess its feasibility for proteomic investigation of nitro-
proteins.
Here, the strategy proposed, taking in account the
availability of linear trap to select specific labelled peptides
giving rise to diagnostic MS/MS product ions, resulted to
be of interest in the selective detection of protein nitration.
Moreover, because of its operational simplicity, avoiding
long-lasting and time-consuming fractionation procedures,
this new strategy seems to be well suited for large-scale
quantitative profiling of nitration sites. Because of the cost
of iTRAQ kits, we would suggest to integrate our pre-
viously proposed method to selectively identify nitration
sites on a screening scale and further select the samples to
be of interest for quantitative analysis. The strategy report-
ed here was set up with a 4000QTrap mass spectrometer;
however, we believe that this approach may be realised also
using others mass spectrometer optics, with opportune
modifications. For example, Niggeweg et al. [47] showed
the possibility to perform PIS compatible with chromato-
graphic separations by a QTOF. Moreover, it would be very
interesting to evaluate possible improvements, in terms of
selectivity and quantitative estimation, by measuring with
high resolution and accuracy (,10 ppm) iTRAQ reporter
ions. This may be accomplished by a Thermo LIT/Orbitrap
performing MS/MS experiments in higher energy CID
(HCD) [15]. The optic and the electronics of this instru-
ment leads to perform analysis in an operation mode
called ‘Parent Ion Mapping’ that may be considered as
reconstructed PIS. However, our feeling is that, because of
the higher duty cycle of a triple quadrupole-based PIS,
eventual improvement would have real effectiveness in an
offline LC-MALDI-MS/MS analysis more than a classical
LC-ESI-MS/MS.
The authors have declared no conflict of interest.
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Abstract
The importance of post-translational modifications
(PTMs) of proteins has become evident in the proteo-
mic era as it plays a critical role in modulating cellular
function, and can vary in response to different stimuli
thereby tuning cellular mechanisms. Assessment of
PTMs on a proteomic scale is a challenging task since
they are substoichiometric, transient and reversible.
Moreover, the amount of post-translationally modi-
fied proteins is generally very small when compared
to their unmodified counterparts. Existing methodol-
ogies for identification of PTMs essentially relies on
enrichment procedure to selectively increase the
amount of modified peptides. These procedures need
to be integrated with sophisticated mass spectromet-
ric methods to enable the identifications of PTMs.
Although the strategies developed so far are not opti-
mal, a number of examples will be given where the
combination of innovative separation methods along
with advanced mass spectrometric analyses provide
positive results. These experiences are leading the
way for the next generation of proteomic approaches
for identification of a wide range of PTMs.
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Keywords: glycosylation; nitration; phosphorylation;
post-translational modifications (PTMs); proteomics;
tandem mass spectrometry (MS/MS).
Introduction
Over the past few years following the conclusion of
the Human Genome Project, the challenge has again
shifted from the gene to protein, giving rise to what
has been termed the ‘‘proteomic era’’. The aim of this
new era is to identify and characterize proteins locat-
ed within a given organelle, cell or organism, as well
as to unravel the in vivo protein pathways (1–3).
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These new goals are not easily achieved because
the challenge increases by several orders of magni-
tude when moving from genome to proteome
research. The static nature of the genome cannot be
compared to the dynamic properties of the proteome.
Expression profiles of proteins change several times
during the cell cycle and are significantly influenced
by a number of intra- and extra-cellular stimuli includ-
ing temperature, stress, apoptotic signals, and others
(4). In addition, alternative splicing and post-transla-
tional modifications (PTMs) has resulted in re-thinking
of the paradigm ‘‘one gene-one protein’’ that no long-
er reflects the true nature of the cellular proteome.
Modern proteomics research is focused on two
major areas, expression proteomics and functional
proteomics. Expression, or differential, proteomics
aims to investigate changes that occur in the expres-
sion of protein profiles following specific stimuli and/
or pathophysiological conditions. The goal here is to
assess up regulation and down regulation of protein
concentrations in abnormal cells compared with nor-
mal cells. Thus, expression proteomic studies are
strictly concerned with transcriptomics experiments.
However, mRNA concentrations do not necessarily
correlate with the amount of corresponding protein
due to translation regulation mechanisms. Thus,
expression proteomics complements microarray
investigations. This comparative approach is usually
employed in the identification of proteins that are up
regulated or down regulated in specific disease proces-
ses and therefore, may be used as diagnostic markers
or therapeutic targets (5). It is not enough to map and
identify all the proteins in cells; they must also be
categorized with respect to their function and inter-
actions with other proteins or genes. Therefore, the
proteome must be studied in vivo, and the dynamic
properties of the proteome used to obtain this infor-
mation. This is the target of functional proteomics, an
emerging area of proteomic study to investigate pro-
tein function in vivo through the isolation of function-
al complexes within the cell and the identification of
their protein components. It is well understood that
many cellular processes are governed by the rapid
and transient association of protein complexes that
fulfill specific biologic functions. The association of an
unknown protein with others belonging to a specific
complex would be strongly suggestive of its biologi-
cal function.
In this scenario, the importance of PTMs is notably
increased. Protein modification can affect biological
function, thereby playing a critical role in cellular
function. Also, they can vary in response to environ-
2 Amoresano et al.: Post-translational modifications in proteomics
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mental stimuli allowing cellular mechanisms to be
finely tuned. Deregulation might be involved in the
development of disease.
Several mass spectrometry (MS)-based strategies
have previously been developed to identify and char-
acterize PTMs. With these techniques, a single, largely
homogeneous protein was digested, with the result-
ing peptide mixture analyzed using MS procedures.
The site and nature of the PTM could be easily
inferred from the anomalous mass value detected for
the modified peptide(s). The analytical problems
faced today by proteomic laboratories are far more
complicated. First, the sample very often consists of
a complex mixture of proteins, some of which are
modified. Second, the PTMs involved in the regula-
tion of important cellular processes, such as phos-
phorylation, methylation, acetylation, nitration, etc.,
are substoichiometric, affect only a minor portion of
the protein, are transient and are reversible. There-
fore, the amount of modified peptides within a pro-
teomic digest will generally be very small. Also, they
will always occur in the presence of a much larger
concentration of the corresponding unmodified frag-
ments. Thus, an understanding of cellular mecha-
nisms and processes requires a comprehensive
assessment of PTMs and the changes that occur fol-
lowing signaling events (6). New strategies will have
to be employed based on the integration of specific
enrichment procedures with sophisticated mass spec-
trometric experiments.
This paper will review current existing methodolo-
gies to identify PTMs in proteomic experiments, with
a focus on some specific examples.
Mass spectrometry
MS had been the method of choice to elucidate PTMs
in protein chemistry. Today, MS plays a key role in
proteomics studies since it is the only method with
the sensitivity, accuracy, reproducibility and speed
required for identifying unknown proteins and char-
acterizing transient PTMs (7–9).
MS is based on the production of ions in a gaseous
phase that allow for the determination of the molec-
ular mass of analytes. A wide variety of mass spec-
trometers are now available; all sharing the ability to
assign mass-to-charge values to ions, even though,
the principles of operation and the types of experi-
ments that can be done on these instruments differ
greatly. The sample has to be introduced into the ion
source of the instrument where molecules are ion-
ized. The ions are extracted into the analyzer region
where they are separated according to their mass-to-
charge ratio (m/z) and then detected.
Mass spectrometers can be classified according to
its ionization system; an essential component that
defines the measurable mass range, sensitivity and
resolution. Many ionization methods are available.
However, the most widespread ion sources in bio-
chemical analyses are electrospray ionization (ESI)
and matrix assisted laser desorption ionization (MAL-
DI) (10, 11). Over the last few years, ESI (12, 13) has
had a tremendous impact on the use of MS in biolog-
ical research because it is well suited to the analysis
of polar molecules. During standard ESI, the sample
is dissolved in a polar, volatile solvent and pumped
through a narrow, stainless steel capillary (12–14).
High voltage, 3–5 kV, is applied to the tip of the cap-
illary within the ion source. Sample emerging from
the capillary tip is dispersed into a spray of highly
charged droplets. This process is aided by a nebuliz-
ing gas flowing around the outside of the capillary.
The charged droplets decrease in size by solvent
evaporation which is assisted by a flow of warm nitro-
gen gas. This is also known as the drying gas and it
passes across the front of the ionization source. Even-
tually, charged sample ions that are free of solvent
are released from the droplets and pass into the ana-
lyzer of the mass spectrometer. One peculiar aspect
of this technique is that it gives rise to
multiple, charged molecular-related ions such as
(MqnH)nq in positive ionization mode and (M-nH)n–
in negative ionization mode.
MALDI-MS is based on bombardment of sample
molecules with a laser to induce sample ionization.
The sample is pre-mixed on a stainless steel plate
with a highly absorbing matrix such as a weak aro-
matic acid. Once excited, the matrix is able to transfer
energy and protons to the sample. After drying, the
matrix molecules crystallize and solid crystals con-
sisting of sample and matrix are formed. A laser,
usually a pulsed nitrogen laser at 337 nm, is fired into
the sample. The absorbance of the laser energy by the
matrix molecules results in a desorption event. This
energy is used to transfer a proton from the matrix to
the analyte resulting in the formation of MHq ions.
Mass analyzers may incorporate quadrupoles (Q),
ion traps (IT), time-of-flight (TOF), or some combina-
tion of these in ‘‘hybrid instruments’’ in order to
obtain good resolution and sensitivity. The ESI source
is usually employed with quadrupole and ion trap
analyzers (15, 16). The advantages of the ion-trap
mass spectrometer includes compact size, and the
ability to trap and accumulate ions in order to
increase the signal-to-noise ratio. It is also possible to
use this type of mass spectrometer in fragmentation
experiments (see below). Conventional ion trap mass
spectrometers operate with a three-dimensional (3D)
quadrupole field. This confers very high efficiency
with respect to the time required to fill the ion trap
and generate a complete mass spectrum. However,
there are some problems with respect to trapping effi-
ciency, primarily due to the small volume. These pro-
blems have been overcome by the introduction of
linear ion traps (LIT) (17–19), characterized by a larger
ion storage capacity and greater trapping efficiency
(see below).
TOF analyzers are typically used in combination
with MALDI sources. Following MALDI ionization,
ions pass into a TOF tube for mass analysis. The TOF
tube is under high vacuum (10–6–10–8 mbar) and con-
sists of a field-free drift region. All ions entering the
TOF tube have a fixed kinetic energy that is propor-
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Figure 1 MS/MS peptide fragmentation pattern.
Fragment ions are labeled with a, b, and c ions carrying the
charge on the N-terminal fragment. The x, y and z ions hav-
ing the charge retained on the C-terminal fragment.
tional to the applied voltage and the charge. The high-
er the mass of the ion, the lower its velocity and the
longer it takes before the ion reaches the detector.
Ions of different mass can be separated based on their
different velocities in the TOF-tube. Their m/z values
are determined by measuring the time each ion takes
to travel through the field free region.
MALDI and electrospray sources are known as soft
ionization methods because the sample is ionized by
the addition or removal of a proton, with very little
energy remaining to cause fragmentation of the sam-
ple ions. Tandem mass spectrometry (MS/MS) must
then be used to produce structural information about
the compound by fragmenting specific sample ions
inside the mass spectrometer, and then identifying
the fragment ions. MS/MS uses two stages of mass
analysis; the first to pre-select an ion and the second
to analyze fragments. These are separated using a
collision cell into which an inert gas, such as argon
or xenon, is introduced to produce fragmentation.
MS/MS also enables specific compounds to be detect-
ed in complex mixtures based on their characteristic
fragmentation patterns.
Peptides fragment in a well-described manner (20).
There are three different types of bonds that can frag-
ment along the amino acid backbone: NH-CH, CH-CO,
and CO-NH bonds. Each bond break gives rise to two
species, one neutral and the other one charged, with
only the charged species monitored by the mass
spectrometer. Thus, there are six possible fragment
ions for each amino acid residue as shown in Figure
1. The a, b, and c ions carry the charge on the N-
terminal fragment, and the x, y and z ions retain the
charge on the C-terminal fragment. The most com-
mon cleavage sites are the CO-NH bonds which give
rise to the b and/or the y series of ions.
Protein identification by mass spectrometry
The key step in any proteomic study consists in the
identification of proteins that have been separated
either by gel electrophoresis and digested, or cleaved
directly using enzymatic procedures in the so-called
‘‘bottom-up’’ approach (21). Protein identification
from 2D gel electrophoresis is usually obtained by
MALDI-MS analyses (22, 23). Following colloidal
Coomassie staining, protein components are excised
from the gel, reduced and alkylated with iodoacet-
amide to irreversibly block the cysteine residues and
digested with trypsin. The resulting peptide mixture
is extracted from the gel and analyzed directly using
MALDI-MS (24, 25).
Identification of the different proteins is performed
using the peptide mass fingerprinting procedure (26).
This procedure uses the mass values, together with
other information such as the protease used for the
hydrolysis. This information is input into the Mascot
mass search software or analogous programs avail-
able on the internet (27). The experimental mass val-
ues are compared to those obtained from a
theoretical digestion of all proteins present in the
database, allowing for identification of the protein(s).
Alternatively, if the fingerprinting procedure is un-
able to identify the proteins, combined liquid chro-
matography-tandem mass spectrometry (LC-MS/MS)
methods can be used. Peptide mixtures are fraction-
ated by capillary HPLC. The fractions that elute from
the column are applied directly into the electrospray
MS and mass values determined. Peptide ions will be
simultaneously isolated and fragmented within the
mass spectrometer, producing daughter ion spectra
from which information on sequence of individual
peptides can be obtained. This information, together
with the peptide mass values, is then used to search
protein databases enabling identification of the pro-
tein components. It has been shown that sequence
information from just two peptides is sufficient to
identify a protein by searching protein and expressed
sequence tag databases.
Recently, ‘‘top-down’’ proteomics has become pop-
ular in the assessment of PTMs. In this approach, the
multicharged ions of intact proteins are used as pre-
cursor ions and fragmented to provide sequence
information and protein identification. Technically
demanding, sophisticated instrument setup consti-
tutes the main challenge of top-down proteomics (28).
However, recent developments in instrumentation
have been introduced, such as specifically designed
Fourier transform ion cyclotrone resonance (FTICR)
mass spectrometers, making the top-down approach
suitable even for PTM studies (29).
Post-translational modifications (PTMs)
Protein PTMs are thought to be one of the major
determinants for the complexity of life. These modi-
fications increase the molecular heterogeneity of
gene products, adding a further dimension to the pro-
teome as compared to the genome. Greater than 5%
of the genes in the human genome encode for
enzymes that perform such modifications. These
include hundreds of protein kinases and phospha-
tases, ubiquitinyl ligases, acetylases and deacety-
lases, methyl transferases and glycosyl transferases
(30). The repertoire of PTMs is very complex consid-
ering that no -15 out of the 20 common amino acids
may be modified. These modifications range from
addition of a single group to the linkage of a complex
oligosaccharide moiety or glycosyl phospohatidyl
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inositol (GPI) anchor. More than 250 PTMs have been
described to date (31). Genomic studies have not
been able to elucidate complex mechanisms such as
development of disease, aging, differentiation, devel-
opment, and others that are finely regulated by
dynamic changes in protein function mediated
through PTMs.
The pattern of protein PTMs constitute a molecular
code that dictates protein conformation and folding,
cellular localization, cellular interactions and cell
activities, tissue and environmental conditions.
Understanding this code constitutes a major chal-
lenge of proteomics. It should be emphasized that
detection of PTMs, while important, does not distin-
guish the number and type of PTMs that may be pres-
ent on any one intact protein. This disconnection from
the parent protein modifications may lead to the loss
of information on the synergies between PTMs. New
methods and strategies have been developed, and
many more are needed to fully characterize PTMs in
a specific proteome and to describe their changes.
Glycosylation
Glycosylation is a co- and post-translational modifi-
cation where oligosaccharide chains are covalently
linked to proteins. Glycoproteins are ubiquitous,
being found in all living organisms from eubacteria to
eukaryotes (32). They fulfill their biological roles as a
complex mixture of glycosylated variants called gly-
coforms. This microheterogeneity is primarily due to
the fact that oligosaccharide biosynthesis is not tem-
plate driven. Assembly of the glycan moieties is gov-
erned by the relative amount of different glycosidic
enzymes (33), the cell type, and physiological status.
In addition, the reactions involved in glycosylation
and deglycosylation are frequently incomplete, result-
ing in an increase in the heterogeneity of glyco-
proteins.
A new discipline, glycobiology, emerged in the
1980s, with a focus on the structural and functional
characterization of glycoproteins and glycoconjugates
(34). Recently, glycobiology has evolved into glyco-
mics, the investigation of the complete set of glyco-
conjugates and carbohydrates that occur in an
organism. Glycomics show a higher level of complex-
ity than genomics, or even proteomics, primarily due
to the microheterogeneity of glycoforms described
above. Furthermore, glycans have a larger number of
building blocks compared with nucleic acids and pro-
teins. These can be assembled in complex branched
structures in which monomeric units can adopt vari-
ous conformations and binding positions.
Biosynthesis of glycopeptide linkages
The enzymes responsible for glycosylation are
membrane-bound glycosyltransferases and glycosi-
dases that are active in the endoplasmic reticulum
(ER) and Golgi compartments. Their activity can gen-
erate two large classes of glycoforms; N-linked and
O-linked glycans. O-linked oligosaccharides have the
glycosidic component linked to the hydroxyl group of
serine or threonine residues. N-glycosylation is char-
acterized by the formation of an N-glycosidic linkage
on the amide of asparagine residues. This glycosyla-
tion requires a strict consensus sequence Asn-X-Ser/
Thr (35). Although this sequence frequently occurs, it
is not always a site that is gylcosylated. This is most
probably due to conformational factors. N-glycosyla-
tion begins in the ER (36) where a biosynthetic
precursor, a dolichol-P-P-linked oligosaccharide
(Glu3Man9GlcNAc2), is transferred to Asn residues in
nascent polypeptide chains. This glycan is a well-con-
served structure in evolution; the same compound is
seen in plant, fungal and mammalian cells.
Further processing of the oligosaccharide may
occur in the Golgi complex. The structural diversity
found in Asn-linked oligosaccharides from different
organisms, cell types or tissues, originates from pro-
cessing reactions occurring in the Golgi apparatus
(37, 38).
O-glycosylation also occurs in the Golgi and con-
sists of the step-wise addition of sugar residues
directly onto the polypeptide chain. This process
starts from an N-acetylgalactosamine residue linked
to the hydroxyl group of Ser or Thr residues (39). A
specific glycosyltransferase then adds the galactose
residue to the GalNAc. The last steps in biosynthesis
of typical O-glycans are the additions of two N-ace-
tylneuramic acid (sialic acid) residues in the trans-
Golgi reticulum. O-oligosaccharides can vary in size
from a single GalNAc residue, referred to as the Tn
antigen, to oligosaccharides comparable in size to
complex N-oligosaccharides.
The role of glycosylation
The oligosaccharide moiety confers specific physico-
chemical properties to glycoproteins, and fulfills sev-
eral biological functions. Several studies dealing with
the importance of N-glycosylation in the folding pro-
cess have been reported. Glycans constitute bulky
hydrophilic moieties that reduce aggregation and pro-
mote solubility. This feature helps the protein follow
a specific folding pathway. However, the principal
role in the folding process is played by deglycosyla-
tion and reglycosylation in the ER, which occurs
repeatedly during the biosynthesis of glycoproteins.
This system is recognized as a central component of
a quality control and chaperone pathway in the ER
lumen (37, 40–42).
Some oligosaccharides play an important role in
the coating of many glycoproteins, protecting them
from proteases and antibodies and affecting their
turnover and half-life (43, 44). Oligosaccharides can
act as specific receptors for pathogens, being respon-
sible for interactions with vertebrate cells through
lectins. Lectins are specialized glycoproteins that can
recognize vertebrate glycan structures with high spec-
ificity (45). The variable nature of surface glycans may
be a way to escape pathogens’ recognition systems.
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Figure 2 Carbohydrate fragmentation pattern.
Ions retaining the charge at the reducing terminus are
named X, Y and Z. Complementary ions are labeled A, B and
C.
Recognition by ligands or receptors is a constant
characteristic of glycoproteins. Most are cell-surface
receptors, whose glycosylation affects binding and
activity. Cells are covered with a high-density coating
of oligosaccharides, indicating that oligosaccharides
are responsible for cell-cell and cell-matrix interac-
tions and adhesion (43).
Glycoproteome characterization
Understanding the structure, enzymology and cellular
biology of glycosylation is the main goal of glycomics
with the ultimate goal being the comparison of organ-
isms in normal and pathological conditions (44). How-
ever, difficulties exist in the analysis of complex
mixture of glycoconjugates, primarily due to their
microheterogeneity as stated above. These difficulties
largely prevent the simple and direct approach of ana-
lyzing the entire set of glycans following their release
from glycoproteins or glycoconjugates. Several pro-
tocols (46–49) have been developed to release the oli-
gosaccharides from both O-linked and N-linked
glycoproteins. However, the ensemble of all these
glycans constitute a far too complex mixture to be
analyzed directly by any mass spectrometric method.
These analyses can provide information only on the
most abundant glycoforms, leaving the vast majority
of minor glycans undetected.
Various methods have been developed to enrich
glycoproteins in a complex mixture. One approach
relys on capturing N-linked glycoproteins using
hydrazine chemistry. The oligosaccharides of the
glycoproteins are oxidized to form the corresponding
di-aldehydes that can be covalently linked to hydra-
zide beads. The captured glycoproteins are then
digested and the unmodified peptides washed out.
Captured glycopeptides can be deglycosylated with
PNGase F and quantified by isotopic labeling (50).
Chemical derivatization presents several side
reactions. Thus, lectin affinity chromatography has
recently been developed as an analytical tool in gly-
coproteomics. Several lectin-derivatized media are
commercially available for enrichment of glycopro-
teins and glycopeptides. A single lectin recognizes
specific glycoforms, whereas the use of a set of lec-
tins allows the complete set of glycoproteins to be
captured in a single step. Multilectin affinity columns
have been developed combining different lectins:
Hancock and co-workers combined concanavalin A
(ConA), wheat germ agglutinin (WGA) and Jacalin for
the analysis of the serum glycoproteins (51). Com-
parative serum glycoproteomics has been applied to
the study of pathological samples using a multilectin
affinity approach to identify oligosaccharide markers
in such diseases (33, 52–54).
Alternative methods rely on the chemical and/or
enzymatic hydrolysis of glycoproteins, followed by
affinity capture of the entire ensemble of glycopep-
tides with multiple lectins. Selective isolation of gly-
copeptides allows larger recovery of glycoforms since
the steric hindrance of glycoproteins severely affect
the interaction with lectins.
The structural characterization of glycans is still a
difficult task due to the presence, in most cases, of
several different structures at the same glycosylation
site (46). Unfortunately, although MS cannot differ-
entiate between the different hexoses and hexose-
amines, it has become a valuable tool in their
characterization (55).
The determination of the entire structure of oligo-
saccharide chains requires that the intact sugar
moieties be released from the glycoproteins/glyco-
peptides pool using either PNGase F or chemical
methods (56–61). Glycan profiling is then achieved by
MALDI-MS analysis of the intact glycan mixture. The
MALDI-MS spectra show the presence of intense
quasi-molecular ions originating from the whole oli-
gosaccharide moieties; assignment of the different
glycoforms is then performed on the basis of the
molecular weight of the oligosaccharides and their
known biosynthetic pattern (46).
This analysis is not sufficient to provide structural
information about the sequence and linkages of gly-
cans. Combination of MALDI-profiling with post-
source decay (PSD) or collision-induced dissociation
(CID) analyses is generally required (62). Glycan frag-
mentation spectra present some main cleavage sites.
A systematic nomenclature for oligosaccharide frag-
ment ions was established by Domon and Costello
(63), following that already in use for peptides. How-
ever, the structure of carbohydrates necessitates the
use of a more complex annotation due to possible
breakages occurring within the sugar ring. The pri-
mary cleavage sites, termed glycosidic cleavages,
involves the breaking of a single bond between adja-
cent sugars (Figure 2). They provide information on
sequence and branching, but little information on link-
age. Other cleavage sites, termed cross-ring cleav-
ages involving cleavage of two bonds are useful in
determination of the linkage. It is worth noting that
ions retaining the charge on the reducing terminus
are labeled X (cross-ring), Y (C1™O-glycosidic) and Z
(O™Cx glycosidic), while if the charge is retained at
the non-reducing end, the produced ions are called A,
B and C. The B and Y ions are usually the most abun-
dant species.
Cross-ring cleavage necessitates additional super-
script prefixes, denoting the atoms of the two cleaved
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Figure 3 Flow chart showing the strategy to characterize N-linked glycoproteomes in sera from healthy and diseased
individuals.
bonds. The situation becomes more complicated in
cases involving branched oligosaccharides. The
nomenclature is based on the carbohydrate compo-
nent of glycopeptides and glycoproteins, which con-
sist of a ‘‘core’’ unit and the branches, usually called
‘‘antenna’’. Each antenna is identified by a Greek let-
ter with the largest being given the symbol ‘‘a’’ and
the other symbols assigned based on decreasing
molecular weight.
CID provides focused ions and nanospray technol-
ogy provides good sensitivity. It is possible to per-
form MS/MS or MS3 experiments in order to obtain
extensive fragmentation of oligosaccharides or gly-
copeptides. This analysis helps elucidate the different
glycosidic structures present in glycoproteins includ-
ing the branching pattern, the sequence of antenna
and the possible occurrence of modifying groups,
such as sulfate, phosphate, acetyl groups, and others
(64).
Glycoproteome in tumor and inflammation: a case
study
Recently, our group introduced a simple strategy that
provides preliminary insight on the comparison of
glycoproteomes in sera from healthy and diseased
individuals. This technique uses a single affinity chro-
matography step coupled with MS (Figure 3). The N-
linked glycopeptides resulting from digestion of sera
samples with trypsin were selectively enriched in
order to enhance identification of N-glycosylation
sites using LC-MS/MS, and to obtain glycoform pro-
files using MALDI-MS analysis. Human sera from
patients with either myocardial damage or hepatic
carcinoma were evaluated since they represent exam-
ples of inflammatory and malignant disease.
Myocarditis is a group of diseases caused by infec-
tion, toxins, or autoimmune mechanisms character-
ized by inflammation of the heart, leading to necrosis
of myocytes (65, 66). Glycan moieties might be
responsible for the increase in leukocytes in damaged
tissue. Hepatic carcinoma is a primary malignancy of
the liver. There are several hypotheses about the role
that glycans play in the development of cancer. C gly-
can structures are known to contribute to oncogenic
signaling, transformation and metastasis (67).
Aliquots of serum from the two different patient
groups, and healthy donors, were pooled and digest-
ed with trypsin. The three peptide mixtures were sub-
jected to ConA affinity purification. The glycopeptides
were then deglycosylated using PNGase F treatment
and analyzed by MS. Similar analysis was performed
on the unbound ConA fractions which contained
primarily non-glycosylated peptides and highly
branched glycopeptides. The ConA affinity step spe-
cifically retained the high mannose, hybrid and bian-
tenna structures, separating them from the rest of the
glycans.
The oligosaccharides retained by ConA were eluted
and the glycans analyzed with MALDI-MS. Each signal
in the MALDI spectra was tentatively attributed to a
glycan arrangement on the basis of the mass value
and the known N-glycan biosynthetic pathway. Since
desialylation might have occurred in both positive
and negative ion mode, MALDI analyses were also
performed using 2,4,6 trihydroxyacetophenone as
matrix. This has been reported to minimize loss of
sialic acids (68).
More than 50 arrangements were detected, belong-
ing primarily to high mannose and biantenna classes,
indicating a high degree of glycan heterogeneity.
While some qualitative and quantitative differences
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could be recognized in the three glycan profiles, the
amounts did not significantly. However, differences in
the relative intensities of the most abundant peaks
were detected in the samples from patients with dis-
ease compared with those from healthy individuals.
Non-glycosylated peptides and peptides containing
O-glycans and large complex glycans were not
retained on the lectin. These constituted the unbound
fraction from the affinity purification. PNGase F was
added to this fraction, glycans were separated from
peptides by HPLC and analyzed by MALDI-MS. Figure
4A–C shows the negative MALDI spectra of the oli-
gosaccharide unbound fraction of the samples from
the diseased and healthy individuals.
The structure of the various glycoforms was
inferred on the basis of their mass value and the
known biosynthetic pathway. The most common gly-
cans were also selected for PSD fragmentation anal-
ysis to confirm oligosaccharide assignments. As an
example, Figure 5 shows the PSD spectrum of the gly-
coform at m/z 2391.10. This glycoform displays the
classic fragmentation pattern leading to the recon-
struction of the sialylated fucosylated biantenna
glycan.
In contrast to the fraction retained with ConA,
MALDI-MS analysis of the unbound glycan fraction
led to the detection of a plethora of glycoforms, and
highlighted differences in the profiling of the three
sample types. Glycans from patients with disease
were characterized by abnormal glycosylation pat-
terns, with differences in branching, sialylation and
fucosylation. These patients showed an excessive
expression of peculiar structures, the persistence of
incomplete and truncated structures, the accumula-
tion of precursors and the appearance of novel struc-
tures. This resulted in a higher degree of
heterogeneity compared with healthy patients. The
presence of more than 60 different glycoforms was
observed in patients with hepatic carcinoma (K-hepat-
ic). The increased size and branching of N-linked gly-
cans created additional sites for terminal sialic acid
residues; whose role in promoting metastasis is gen-
erally recognized. Myocardial lesions revealed the
presence of hyper-fucosylated signals, whereas K-
hepatic sera were characterized by hyper-fucosylation
and hyper-sialylation.
This study provided an overview of the abnormal
glycosylation that occurs in disease. The ConA affinity
step was instrumental in depleting commonly occur-
ring glycoforms. Without this step, highly branched,
less common glycoforms might have escaped mass
spectral analyses. Our data for K-hepatic serum were
in perfect agreement with results obtained by Zhao
et al. (52) who conducted a similar study on patients
with pancreatic cancer.
Selective labeling procedures in PTMs
Identification of post-translationally modified proteins
requires direct observation of both the modified pep-
tides and the specific residues involved. Due to the
complexity of proteomic samples, identification of
modified proteins often relies on the use of ‘‘specific’’
antibodies able to recognize individual PTMs (70–75).
Once the modified proteins have been labeled with
the specific antibody, they can be identified by MS
procedures such as peptide mass fingerprinting and/
or LC-MS/MS. Frequently, however, the actual modi-
fied peptides cannot be identified. Moreover, the
occurrence of more than one protein in a specific
location of the gel makes identification of PTMs
problematic.
Several new methods based on selective labeling
of modified peptides have recently been proposed
(76–79). The strategy behind these methods consist
of the direct selective analysis of labeled peptides
with the mass spectrometer without the use of 2D
gels and enrichment steps needed to reduce the com-
plexity of the peptide mixture prior to MS analysis.
Methods specifically tailored for the qualitative and
quantitative determination of PTMs have recently
emerged (80–83). The use of stable isotope labeled
tags (light and heavy tags) (78, 79) can also address
the problem of quantitative determination of PTMs.
While the tagging method currently described can tar-
get some PTMs more specifically than others, the
development of suitable selective chemical labeling
strategies that can identify a larger number of PTMs
should provide increased confidence in the identifi-
cation of PTMs.
Reporter ion generating tag strategy (RIGhT)
Several groups have reported on the potential of
chemical derivatization in conjunction with ESI-MS for
the analysis of synthetic and naturally occurring com-
pounds. Treatment with an appropriate derivatizing
agent can improve the ionization of a compound and
thus the detection of the analyte by ESI-MS.
Recently, our group proposed a novel strategy for
identification of PTMs (79, 84). Our strategy has gen-
eral applicability and is based on selective labeling of
phospho-Ser/Thr residues. We proposed that the deri-
vatizating agent may include a chemical moiety capa-
ble of fragmenting in a particular, thus allowing for
selective mass spectral analysis of modified peptides
through use of MSn techniques.
This strategy was given the acronym reporter ion
generating tag (RIGhT) to indicate a common deriva-
tization method based on the labeling of target resi-
dues with reagents capable of generating reporter
ions in MS2/MS3 experiments. Dansyl chloride (DNS-
Cl), a very well-known fluorescent derivatizing re-
agent commonly used in protein chemistry, was
chosen as the reporter tag. Approximately 40 years
ago we discovered that fragmentation of dansyl deriv-
atives gave rise to the typical m/z 170 and m/z 234
daughter ions fragments in electron impact experi-
ments (85).
The RIGhT method is based on: 1) selective modi-
fication of target residues with DNS-Cl or other avail-
able dansyl reagents and, 2) selective detection and
identification of labeled peptides by their character-
istic fragmentation pathway in MS/MS experiments
and the diagnostic m/z 234–170 transition in MS3
mode. Precursor ions scans (PIS) of the m/z 170 frag-
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Figure 4 MALDI-MS profiling in negative ion mode of the oligosaccharide extracted from the unbound fraction of ConA
affinity chromatography.
(A) Healthy serum, (B) myocardial lesions serum, (C) K-hepatic serum. The most important oligosaccharides are depicted;
structures present only in sera from individuals with disease are indicated by a star.
ment can then be combined with MS2 and MS3 anal-
ysis to specifically detect only the parent ions
producing the m/z 234–170 fragmentation (Figure 6).
Application of the RIGhT approach is dependent on
the availability of high-performance MS instruments
able to perform analysis with high-sensitivity and
accuracy. LIT mass spectrometers developed by the
combination of triple quadrupole MS with LIT tech-
nology is one such device capable of this type of anal-
ysis (86). LIT mass spectrometers combine the
advantages of very selective scanning of precursor
ion with a triple quadrupole along with sensitive MS/
MS capabilities of the ion trap (87). This hybrid instru-
ment is suitable for highly sophisticated MSn analysis.
Phosphorylation
Phosphorylation is a reversible modification that acts
as a switch to turn ‘‘on’’ or turn ‘‘off’’ protein activities
or cellular pathways. Phosphorylation acts in a revers-
ible manner by promoting the folding and function of
proteins, enzyme activities or substrate specificities,
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Figure 5 The MNaq ion at m/z 2391.10 was selected and submitted to PSD fragmentation.
Y and B ions as well as fragments originated by double cleavages are indicated.
Figure 6 Fragmentation of dansyl derivatives.
The typical m/z 170 and m/z 234 daughter ions fragments in MS/MS experiments as well as the diagnostic m/z 234-170
fragmentation in MS3 mode are indicated.
regulating protein localization, and complex forma-
tion and degradation. A wide range of cellular pro-
cesses including cell cycle progression, differentiation,
development, peptide hormone response, signal
transduction, metabolic maintenance and adaptation
are all regulated by protein phosphorylation (88). The
variety of functions in which phosphoproteins are
involved necessitates a wide diversity of phosphory-
lation. Several amino acids can be phosphorylated by
four types of phosphorylation. O-phosphates are the
most common class and attach most often to serine-,
threonine- and tyrosine-residues. However, O-phos-
phates can also attach to unusual amino acids such
as hydroxyl-proline. N-, S- and acyl-phosphorylation
are far less common and occur on histidine and lysine
(N-phosphates), cysteine (S-phosphates) and aspartic
and glutamic acid residues (acyl-phosphates).
Another characteristic of phosphorylation is the
ratio of phosphorylated and non-phosphorylated pro-
teins present in the cell. Protein phosphorylation usu-
ally occurs at substoichiometric level in the cell; some
residues are always phosphorylated, while others are
modified only transiently. Phosphorylation rates and
phosphoproteins abundance are very low in signal-
ing pathways, accounting for only 1%–2% of the
entire protein content present in the phosphorylated
form.
Protein phosphorylation is tightly regulated by a
complex set of kinases and phosphatases which are
responsible for protein phosphorylation and dephos-
phorylation, respectively. Kinases and phosphatases
are highly regulated, and phosphorylation cycles may
take place on a very short timescale. In addition to
problems concerning regulation, analysis is compli-
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cated by the complexity of phosphorylation patterns
and the sheer number of phosphorylation sites. In
many cases, phosphorylation effects are combinato-
rial and multiple sites are phosphorylated (89).
It has been estimated that as many as one-third of
the proteins within a given eukaryotic proteome
undergoes reversible phosphorylation, and there are
more than 100,000 estimated phosphorylation sites in
the human proteome. Deciphering the phosphopro-
teome will be a huge and challenging task due to the
different types of phosphorylation generating a vari-
ety of phosphoproteins that are not easily analyzed.
Phosphoproteome analysis
An important part of phosphorylation analysis is sam-
ple preparation that preserves protein phosphory-
lation. Detection of phosphorylated proteins within
complex mixtures is usually not possible without
prior separation of the proteins. Although 2D-gel elec-
trophoresis has been used primarily for separation
and quantification of proteins from different systems,
methods are also being developed to characterize the
phosphoproteome. Phosphoproteins can be visual-
ized directly in 2D gels using phospho-specific stains
or Western blotting.
Commercially available phospho-specific stains are
less sensitive than methods that use radioisotopes,
but the handling of these non-isotopic reagents is
more convenient (90). As an example, Pro-Q Diamond,
(Molecular Probes) a fluorescent dye, allows detection
of 1–20 ng of phosphoproteins in polyacrylamide gel,
depending on the phosphorylation state of the pro-
tein. For individual phosphoproteins, the strength of
the signal correlates with the number of phosphate
groups. Depending on the principle used for staining,
this method is more specific for Ser/Thr phos-
phorylations.
Antibodies can be used to discriminate between
phosphorylation of serine, threonine and tyrosine
(91). The specificity and sensitivity of immunostaining
is highly dependent on the antibody used. Various
antibodies of good specificity toward phospho-tyro-
sine are available with very little cross-reactivity.
Once phosphorylated, protein can be detected on a
gel using either specific staining or immunotech-
niques. A 2D gel can be prepared and developed
using colloidal Coomassie Blue or Silver staining. Fol-
lowing image analysis, phosphorylated protein spots
are matched to protein spots on the preparative gel.
Proteins of interest can then be excised from the gel,
digested and identified by MS. Major advantages
of this approach are in the detection of N-,
S- and O-phosphorylation and in the possibility of
quantitating the modified proteins (92, 93). To meas-
ure changes in the state of protein phosphorylation,
two distinct proteome samples can be analyzed and
immunoblotted, and the intensity of corresponding
spots compared.
The main drawback of the method is that indirect
identification of phosphorylated proteins by staining
methods for direct detection of modified peptides is
very unlikely using MS (94, 95). Moreover, when
many proteins are present in the same location on the
gel, identification of the actual modified protein is not
trivial.
Over the years, several strategies have been devel-
oped to increase the sensitivity of phosphoproteome
analysis that eliminate the need for specific staining
and antibody labeling (96, 97).
Recently, MS based methods have emerged as
powerful and preferred tools for the analysis of PTMs,
including phosphorylation, due to higher sensitivity,
selectively, and speed compared with other biochem-
ical techniques. However, despite advances in MS for
analysis of phosphorylation, many difficulties remain.
First, the generally low phosphorylation stoichiome-
try of proteins, including phosphopeptides, results in
low amounts of protein in the peptide mixtures. Sec-
ond, the increased hydrophilicity results in reduced
retention of phosphopeptides on reversed-phase col-
umns. Finally, there is selective suppression of the
ionization/detection efficiency in the presence of large
amounts of unphosphorylated peptides when using
MS analysis in positive mode. For these reasons,
several technologies such as affinity, liquid reverse
phase, ion exchange chromatography and capillary
electrophoresis, or some combination of these prior
to MS analysis, have been used in proteomics to
enrich phosphoproteins that might otherwise not be
detected. The enrichment step combined with the
high-sensitivity of MS technologies provides great
potential for characterization of the phosphoproteome
(98).
The use of miniaturized immobilized metal affinity
chromatography (IMAC), in which phosphopeptides
are non-covalently bound to resins that chelate Fe(III)
or other trivalent metals, followed by base elution,
has proved to be a potentially valuable method for
enrichment of phosphopeptides (99–102). With fur-
ther refinements, this technique may offer the best
potential for large-scale phosphorylation analysis.
Another approach to enrich phosphoproteins is
based on the use of specific antibodies to immuno-
precipate proteins from complex lysates. With this
approach, the extraction of phosphoproteins leads to
substantial simplification of the protein pattern, and
enrichment phosphoproteins present in low concen-
trations (103).
Several methods for selective enrichment of phos-
phoproteins and phosphopeptides utilize chemical
modification of the phosphate group. This approach
does not distinguish between O-glycosylated and
phosphorylated analytes, thus requiring additional
analysis to confirm phosphorylation. Zhou et al.
established a multi-step derivatization method capa-
ble of enriching not only Ser/Thr-phosphorylated pep-
tides, but all types of phosphorylated peptides as well
(6, 104). Phosphopeptides are bound to sulfidryl-con-
taining compounds via phosphoamidate-bonds and
can, therefore, be linked covalently to a solid support
with immobilized iodoacetyl-groups. The phosphate-
groups are not cleaved off the respective residues, so
native phosphopeptides are obtained after elution
with trifluoroacetic acid (TFA). A drawback of this
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Figure 7 Identification of phosphoSer/Thr by b-elimination
of the phosphate group from Ser/Thr residues, selective
addition of a dansyl derivative on the newly generated dou-
ble bond, and detection by precursor ion/MS2/MS3 mass
spectral analysis.
Figure 8 Synthesis of dansyl-cysteamine.
method is the extensive work is required to quanti-
tatively block all amino- and carboxy-groups within
the peptides to prevent intramolecular and intermo-
lecular condensation.
Another chemical tagging reaction is based on the
b-elimination of phosphate groups in phospho-Ser-
ine/phospho-Threonine (pSer/pThr) residues under
alkaline conditions, followed by a Michael-type addi-
tion of a thiol compound on the resultant double bond
(105).
Dansyl labeling of pSer/pThr
In an attempt to improve and simplify the plethora of
methods described, we employed the RIGhT strategy
(84) to the selective identification of phosphoSer/Thr
peptides. The method consists of (a) b-elimination of
the phosphate group from Ser/Thr residues; (b) selec-
tive addition of a dansyl derivative on the newly
formed double bond, and (c) the selective detection
and identification of labeled peptides by precursor
ion/MS2/MS3 mass spectral analyses (Figure 7).
This approach was first developed using bovine a-
casein as a model phosphoprotein. The phosphate
moieties from a tryptic a-casein digest were removed
from pSer and pThr using barium hydroxide ion-
mediated b-elimination (79). The peptide mixture was
then analyzed using MALDI-MS which showed ions
corresponding to the b-eliminated peptides that were
98 Da lower than expected. However, although DNS-
Cl is known to react with primary NH2 groups, it is
unable to give a Michael addition to double bonds. A
novel dansyl derivative of cysteamine was, therefore,
synthesized following the synthetic route depicted in
Figure 8. The free SH group of dansyl-cystamine was
then reacted with the b-eliminated peptide mixture
via Michael-type addition. The yield of this addition
reaction was monitored with MALDI-MS, showing
that the extent of the reaction was not quantitative as
expected for a typical Michael reaction addition (84).
In a proof-of-principle experiment, a tryptic digest
from ten standard proteins was spiked with a mini-
mum amount of an a-casein tryptic mixture modified
with dansyl-cysteamine. An aliquot of 1 pmol of the
peptide mixture was analyzed by LC-MS/MS with a
LIT instrument, combining a PIS (m/z 170) with MS3
analysis (see above) (Figure 9).
Figure 10 shows a typical reconstructed ion chro-
matogram for the transition m/z 234/170 in MS3 mode
that is dominated essentially by two signals. The cor-
responding MS2 spectra led to reconstruction of the
entire sequence of the b-eliminated phosphopeptides
104–119 and 106–119 that carried a dansyl-cyste-
amine moiety. The modified ion is stable during CID,
providing easily interpretable product ion spectra. In
fact, the y and b product ions still retain the modifying
group linked to the b-eliminated Ser residue, allowing
exact localization of the site of phosphorylation.
However, this approach seems amenable only for
monophosphorylated peptides since the diphospho-
rylated and pentaphosphorylated a-casein tryptic
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Figure 9 Flow chart showing bidimensional mass spectral
analysis.
In PIS mode the Q1 was scanned across the full mass range,
and ions are fragmented in the collision cell. The Q3 was
set to transmit only the mass of the diagnostic product ion
(m/z 170). Therefore, only those precursor ions that origi-
nated the ion at m/z 170 by fragmentation were detected (A);
these selected precursor ions were then submitted to a com-
bined MS2/MS3 experiment to specifically detect only those
ions that produce the transition m/z 234/170 in the MS3 scan
mode leading to the detection of the dansyl peptides (B).
Figure 10 Ion chromatogram for PIS mode analysis (A) and reconstructed ion chromatogram for the transition m/z 234/170
in MS3 mode (B).
The MS3 TIC showed the presence of only two peaks with a large increase in the signal-to-noise ratio.
peptides could not be detected. This is probably due
to steric hindrance and high hydrophobicity of highly
modified dansyl peptides. The detection of multi-
phosphorylated peptides is a difficult challenge.
Among the proposed derivatization procedures, only
the modification strategy that we have proposed
based on the use of dithiothreitol (79) has resulted in
mass spectrometric analysis of multiphosphorylated
peptides that we have confidence in.
Nitration
Nitration can occur in cells during oxidative stress
and inflammation, likely through generation of
peroxynitrite (ONOO–) which is a potent oxidizing and
nitrating agent. Peroxynitrite is produced by the reac-
tion of superoxide anion in the presence of excess
nitric oxide (106, 107). Targets of nitration include
nucleic acids, sugars, lipids, alcohols, small organic
molecules and aromatic amino acids (108). Sites of
nitration in proteins are phenylalanine, tryptophan
and tyrosine residues, with the phenolic ring being
particularly active toward this modification.
Tyrosine nitration is increasingly recognized as the
prevalent, functionally significant post-translational
protein modification that serves as an indicator of
nitric oxide (NO–) mediated oxidative inflammatory
reactions (109). Tyrosine nitration, in fact, reflects the
extent of oxidant production that occurs in both phys-
iological and pathological conditions. Two catalytic
mechanisms have been proposed for in vivo nitration.
Both mechanisms involve the formation of tyrosyl
radicals that can react with nitric dioxide to generate
NO2Tyr. In addition to this principal pathway, tyrosyl
radicals can also react with another tyrosyl radical to
produce the 3-39-dityrosine specie which can generate
intramolecular cross-links or protein multimerization.
Another possible mechanism of protein nitration in
vivo is the reaction of tyrosyl radicals with nitric oxide
(NO), resulting in the formation of 3-nitrosotyrosine
(108). Apparently, nitrotyrosine is not stable and is
oxidized by two electrons to form 3-nitrotyrosine.
Addition of a NO2 group to the orto position of tyro-
sine decreases the pKa of the phenolic group approx-
imately three pH units. This gives a net negative
charge that is approximately half of that of nitrated
tyrosine residues at physiological pH.
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Nitration of proteins modulates catalytic activity,
cell signaling and cytoskeleton organization. This
bulky anionic constituent can induce changes in
protein conformation, resulting in the generation of
antigen epitopes, altered enzyme catalytic activity,
modulation of metabolic pathways and inhibition of
tyrosine phosphorylation by protein kinases. NO2Tyr
is considered the most important biomarker for iden-
tification of cellular processes associated with RNS
formation leading to PTMs of proteins. RNS is the
acronym for Reactive Nitrogen Species used to indi-
cate all chemicals derived by nitrogen metabolism.
These chemicals have a crucial role in regulation of
many biological functions, but if their concentration
increases too much, these species might initiate var-
ious types of cellular damage. It is well-known that
some PTMs due to oxidative stress are linked to the
pathogenesis of different diseases (109). In this
respect, it is important to find biological markers that
can provide information on the localization and phy-
siological effects of oxidative stress. Molecules mod-
ified by oxidation, nitration and nitrosilation can act
as such cellular biomarkers.
For these reasons many research groups have
focused their attention on 3-nitrotyrosine residues,
developing various methodologies for identification
of NO2Tyr residues. Protein nitration has been
observed in connection with more than 60 human dis-
orders including Alzheimer’s disease, atherosclerosis,
acute lung disease, amyotrophic lateral sclerosis
(ALS) and others. Nitration is detected primarily by
immunodetection using antibodies raised against
nitrotyrosine (110).
From the limited number of experiments simulating
in vivo conditions, it is apparent that tyrosine nitration
is a selective process. Not all proteins or all tyrosine
residues are targets for nitration (108). However, nei-
ther the abundance of a protein nor the abundance of
tyrosine residues in a protein can predict nitration.
Several factors such as the nitrating agent, protein
folding, and the presence of glutamate in the local
environment of the tyrosine residue are expected to
contribute to nitration of specific tyrosine residues.
Nitroproteome analysis
Detection and quantification of nitroproteins has been
accomplished essentially using 2D gel electrophoresis
and Western blotting. In particular, a 2D gel contain-
ing an aliquot of the protein sample is stained with
anti-3-nitrotyrosine antibody. The spots containing
modified protein are selectively detected. The remain-
ing portion of the sample can be loaded onto a
preparative 2D gel stained either with colloidal Coo-
massie or Silver stain. Detection of nitrated protein
spots is performed using image analysis by compar-
ing the antibody stained and the preparative gels. The
corresponding protein can then be identified using
conventional mass spectral techniques. Although
widely employed, this procedure has a number of
drawbacks. Recognition of nitroproteins is done with
an antibody which might show some non-specific
detection. Moreover, when two or more proteins are
present in the same spot, definitative identification of
the nitrated component cannot be accomplished.
Finally, oftentimes localization of the site of modifi-
cation within the nitrated protein sequence is impos-
sible unless the modified peptides are detected
during the identification procedure.
Other authors have employed methods using liquid
chromatography separation combined with electro-
chemical detection or GC-MS techniques (111, 112).
An alternative method to examining the overall
amount of 3-nitrotyrosine in proteins is based on the
use of electrospray MS. It has been shown by Peters-
son and co-workers that use of ESI-MS in PIS mode
for detection of nitrated peptides in complex mixtures
can be accomplished by taking advantage of charac-
teristic fragment ions of modified peptides (113). The
immonium ion of nitrotyrosine, in fact, provided un-
equivocal evidence for the presence of this modifica-
tion, suggesting that mass spectral analyses of intact
peptides might be a suitable analytical alternative.
The spectrum of nitrated peptides identified by use
of MALDI shows a specific and unique pattern of
molecular ions that can be used to identify this modi-
fication (113). The mass signal of the modified peptide
occurs 45 Da higher than the unmodified specie due
to substitution of an aromatic hydrogen with NO2.
This signal is usually accompanied by satellite ions
that are 16, 30 and 32 Da lower in mass. This unique
molecular ion pattern generated by photodecompo-
sition during MALDI analysis provides a unique sig-
nature for peptides containing 3-nitrotyrosine. This
fragmentation of nitrated peptides observed with
MALDI-MS reduces the abundance of signals for
nitrated peptides. This results in failure to detect mod-
ified peptides in very complex mixtures. It has been
shown by Petersson and co-workers (113) that ESI-MS
analysis of nitrated peptides prevents photodecom-
position and allows the nitrated peptides to be spe-
cifically detected in PIS mode using the immonium
ion of nitrotyrosine.
Dansyl labeling for the detection of 3-nitrotyrosine
residues
We extended the RIGhT strategy to the selective iso-
lation and identification of o-nitrotyrosine-containing
proteins (114). The philosophy of the method consist-
ed of the specific reduction of 3-nitroTyr to the cor-
responding aminotyrosine (NH2-Tyr). The amino
group of this residue is endowed with a particular low
pKa value, thus allowing selective labeling with
DNS-Cl at variance with aliphatic (10.4–11.1) and
N-terminal amino groups (6.8–8.0), which are largely
protonated.
The methodology was first tested on bovine serum
albumin (BSA) nitrated in vitro as a model protein and
then applied to more complex matrices. BSA was
nitrated in vitro with tetranitromethane (TNM) and the
TNM-induced modifications were determined with
MALDI MS. Spectral analyses led to 85% of BSA
sequence coverage. More importantly, however, 95%
of tyrosine residues could be verified. Two mass sig-
nals recorded at m/z 972.5 and m/z 1524.8 occurred
45 Da higher than the signals corresponding to the
peptides 137–143 and 396–409, respectively. This
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Figure 11 MS/MS spectra of nitrated BSA peptides 137–143 (A), 396–409 (B) and 448–458 (C).
Fragment ions are labeled as ‘‘y’’ or ‘‘b’’ according to the common peptide MS/MS fragmentation rules. Interpretation of the
spectra led to the localization of the original nitration sites and to the determination of the peptide sequence. Unlabeled
signals originated from secondary fragmentation pathways. Dansylated Tyr residues located at the level of Tyr137, Tyr399,
and Tyr451, are highlighted as Y* in the sequence.
suggests that they originated from the nitrated deriv-
atives of these fragments. However, signals corre-
sponding to the unmodified fragments were also
detected, indicating that the nitration reaction was not
quantitative.
Conversion of nitropeptides into their o-dansyl-
amino derivatives was accomplished by treatment
with Na2S2O4. Aminotyrosine residues were then
selectively labeled with DNS-Cl following the proce-
dure reported by Cirulli et al. (115). The reaction was
carried out at pH 5.0, exploiting the different pKa-
value of the o-aminotyrosine (4.7). MALDI-MS analy-
sis showed the presence of two new signals occurring
233 Da higher than the o-aminotyrosine-containing
peptides, corresponding to the expected dansyl deriv-
atives. Signals corresponding to the unmodified
o-aminotyrosine peptides indicated that the extent of
dansyl modification was about 60%. No modification
of the N-terminus or Lys residues was detected.
The exact location of the original nitro groups was
assessed by LC-MS/MS analysis of the peptide mix-
ture using the experimental procedure described
above (101, 103). LC-MS/MS full scan analysis
showed a highly complex mixture of peaks that pre-
vented identification of the modified peptides. The
total ion current (TIC) trace for the m/z 170 PIS dis-
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Figure 12 Flow chart of the analytical strategy for detecting labeled nitroproteins in bovine milk protein extract.
played a simplierd chromatogram with significantly
fewer number of signals. However, too many peaks
were still present and it was very unlikely they could
be related to dansyl derivatized peptides only. Finally,
once the m/z 170 precursor ion and the m/z 234/170
transition scan selectivity criteria were applied, the
MS3 TIC showed the presence of only three peaks
with a large increase in the signal-to-noise ratio. The
corresponding MS2 fragmentation spectra enabled
the determination of the entire sequence of these
species and allowed definitive identification of the
peptides. Of greater interest was the fact that the dan-
sylated Tyr residues were located at the level of
Tyr137, Tyr399 and Tyr451. The allowed for exact
identification of the original nitration sites (Figure 11).
It should be noted that LC-MS/MS analysis revealed
the occurrence of a further nitration site at level of
Tyr451 within the peptide 448–458, which had
escaped previous MALDI analysis.
The MS/MS spectra of o-dansylamino-Tyr-contain-
ing peptides showed additional peculiar features. A
stable fragment signal was always observed at m/z
384 corresponding to the immonium ion of o-dansyl-
amino-Tyr. This could then be used either as an alter-
native diagnostic fragment in the PIS, or to confirm
the presence of an o-dansylamino-Tyr residue in the
peptide sequence.
The feasibility of the MS procedure to identify o-
nitrotyrosine peptides in proteomics was evaluated
by mixing 100 mg of a mixture of BSA and nitrated
BSA with 10 mg of the entire cellular extract from
Escherichia coli. The total protein extract was then
submitted to the procedure described above. The
selection based on the MS3 scan removed a large
number of false positives leading to a simple ion
chromatogram that was dominated essentially by
three intense signals. The MS2 fragmentation spectra
of these signals confirmed the occurrence of the same
three BSA nitrated peptides detected previously.
The proposed strategy was finally employed to
identify o-nitrotyrosine residues in a more complex
sample, bovine milk (114). Bovine milk was nitrated
in vitro with TNM and an aliquot of milk proteins were
fractionated using SDS-PAGE and submitted to West-
ern blot analysis using antibody against o-nitrotyro-
sine to confirm the extent of nitration. The presence
of nitrated proteins was detected essentially in the
regions between 20–35 and 45–60 kDa. The entire
milk protein extract was dissolved in denaturizing buf-
fer and cysteine alkylation and reduction of nitro
groups were performed LC-MS/MS analysis using the
double selectivity criteria led to the identification of
nitropeptides from the high-abundant milk proteins,
a-casein and a-lactoglobulin. In addition, it was able
to assess the nitration sites occurring in proteins pres-
ent in low concentration, such as vimentin and clau-
din 2 (Figure 12).
Conclusions
At the turn of the last century, the international sci-
entific community witnessed a tremendous burst of
interest in the area of expression proteomics. There
was an enormous increase in numbers of papers
being published, new journals being launched and
large amounts of money invested by the pharmaceu-
tical industry in search of new biomarkers of disease
and therapeutic targets. In the last few years, interest
has subsided slightly due to the lack of any new effec-
tive biomarkers being discovered. Also, new applica-
tions in proteomics have begun to emerge. It is easy
to foresee that in the near future, most of proteomic
research will be addressed toward two main goals;
the investigation of cellular mechanisms through iso-
lation of functional complexes, and qualitative and
quantitative analysis of PTMs.
As discussed in this review, assessment of substoi-
chiometric and transient PTMs on a proteomic scale
is still a challenge. Existing procedures are not
endowed with general applicability. The successful
identification of PTMs is still dependent on a number
of factors including the nature and the extent of the
modifications, the amount of sample available, and
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other variables. Despite advances in technology, the
proteomic approach to PTMs still seem far from being
satisfactory and productive.
The recent trend shown by research in this field
suggests that scientists are moving along two main
paths that might also be combined. One path involves
particular attention to areas related to sample prepa-
ration and separation technologies, with particular
emphasis on enrichment procedures. The goal is to
develop selective methodologies able to increase the
amount of modified samples when compared to
unmodified ones.
The other path involves efforts made toward
addressing the utilization of advanced analytical
chemistry strategies focused on the development of
new instrumentation and technologies in the field of
MS. The introduction of sophisticated instrumenta-
tion, like the Orbitrap, or totally new concepts of ion
separation such as the ion mobility MS might open
up ways to utilize ‘‘bidimensional’’ or ‘‘multidimen-
sional’’ mass spectral analysis able to identify modi-
fied peptide ions in very complex mixtures.
The integration of innovative enrichment proce-
dures with these new mass spectrometric techniques
should enable a new generation of proteomic exper-
iments to be performed, thus providing a more gen-
eral approach to analysis of PTMs. In this respect,
specific chemical labeling of modified residues allow-
ing for both selective enrichment with affinity tags,
and sophisticated mass spectral experiments using
reporter tag fragmentation and quantitative analysis
by labeling with isotopes, will play a pivotal role in
the next generation of proteomics.
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Abstract 30-nitrotyrosine (3NT) is a post-translational
modification (PTM) of body fluids and tissues that is sus-
tained by chronic inflammation and oxidative stress, two
main clinical traits of chronic kidney disease (CKD).
Despite this background, protein targets and their differ-
ential susceptibility to in vivo nitration remain almost
completely unexplored in CKD. This study reports a first
investigation of plasma nitroproteome in these patients,
carried out by both immunorecognition and LC-MS/MS
techniques. Plasma proteins of chronic and end-stage KD
patients showed a higher burden of nitration than in healthy
controls, but main nitration targets appeared to be the same
in these populations. Immunoblotting data showed that
uremic albumin is largely represented in the uremic
nitroproteome together with fibrinogen chains (A, B and
C), transferrin, a1-antitrypsin, complement factor D, hap-
toglobin, and IgG light and heavy chains. However,
immunopurification and affinity chromatography experi-
ments demonstrated that the relative content of 3NT on the
albumin molecule was very low when compared with that
of the remaining plasma proteins. The uremic nitroprote-
ome was investigated using also plasma proteins obtained
by in vivo ultrafiltration from patients treated with protein
leaking or standard high-flux hemodialyzers. The study of
these samples revealed the possibility to selectively remove
protein nitration products during hemodialysis. Identifica-
tion of intramolecular sites of nitration was preliminarily
obtained in IgG chains isolated by 2D PAGE and assessed
by bidimensional tandem mass spectrometry after chemo-
selective tagging. Further studies are needed to confirm at
the molecular level the presence of nitrated Tyr residues in
other proteins tentatively identified as nitration targets in
this study and to explore the biological meaning of such a
selective modification of plasma proteins by reactive
nitrogen species in uremia and dialysis patients.
Keywords 30-nitrotyrosine  Protein nitration  Plasma
proteins  Uremia  Hemodialysis  Chronic kidney disease 
Uremic toxins  Proteomics  Nitroproteome  Mass
spectrometry
Introduction
The covalent product of tyrosine nitration, 30-Nitro-Tyro-
sine (3NT), has been measured in the free and protein-
bound form in human plasma as biomarker of inflammation
and cardiovascular risk (Ptolemy et al. 2007; Parastatidis
et al. 2008; Shishehbor et al. 2003; Abello et al. 2009).
Available evidence suggests that protein nitration is a
pathway and target specific event with consequences on the
structure–function relationship of tissue and body fluid
proteins (reviewed in Abello et al. 2009; Souza et al. 2008;
Ischiropoulos 2009; Peluffo and Radi 2007). Despite this,
protein targets and biological consequences of nitration in
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plasma, i.e. the most investigated biological sample in
clinical studies, remain poorly characterized in many
conditions. Fibrinogen (Parastatidis et al. 2008; Heffron
et al. 2009), ceruloplasmin, transferrin, a1-protease inhib-
itor, a1-antichymotrypsin, plasminogen (Gole et al. 2000;
Pignatelli et al. 2001), and the apolipoproteins Apo B and
Apo A1 (Zheng et al. 2004) are in vivo targets, and
nitration has been proposed to produce immunogenic
effects (Ohmori and Kanayama 2005; Thomson et al. 2007;
Parastatidis et al. 2007). These pieces of evidence may
suggest a role in coagulation, lipid metabolism, immune
and vascular functions, but so far only early evidence of
prothrombotic effects by fibrinogen nitration has been
provided in literature (Parastatidis et al. 2008). Moreover,
only few authors have been able to identify Tyr residues
that are modified in vivo by reactive nitrogen species
(RNS), which is in turn the conclusive proof of in vivo
nitration in a given protein (Abello et al. 2009). In support
of a specific and possibly regulated process, albumin as the
most abundant serum protein (approx. 60% of total pro-
teins) was not detected as target of nitration in vivo in
normal subjects or smokers and lung cancer patients
(Pignatelli et al. 2001), as well as in acute respiratory
distress syndrome (ARDS) patients (Gole et al. 2000)
investigated by immunoblotting methods. Recently, Way-
enberg et al. (2009) reported of immunodetectable nitro-
albumin in plasma of perinatal asphyxia patients and
thanks to a newly developed ELISA they were able to
confirm that the relative abundance (mol/mol) of modified
and unmodified Tyr residues of albumin is in the order of
10-5. This study pointed out also on the role that kidney
damage may have to worsen protein damage by RNS.
This evidence was reported in several other studies that
essentially investigated the free form of 3NT as well as
other epitopes of protein damage by oxidative and carbonyl
stress in uremic plasma (Agalou et al. 2005), while much
less attention was paid to characterize protein bound forms.
However, signs of protein damage by oxidative/nitrosative
damage appear in plasma starting from earliest stages of
chronic kidney disease (CKD) (Mitrogianni et al. 2009;
Matsuyama et al. 2009) and return to normal after kidney
transplantation (Galli 2007; Simmons et al. 2005), thus
underlying the key role that the metabolic and depurative
function of kidney play on protein metabolism. At the same
time, oxidative damage to serum proteins has pathogenic
relevance in kidney damage and may thus contribute to the
progression of CKD (see Shi et al. 2008 and references
therein).
Oxidative stress and protein damage reach their maximal
expression in end-stage renal disease (ESRD) and particu-
larly in patients on regular hemodialysis therapy (HD) in
which inflammatory and vascular symptoms are also par-
ticularly exacerbated (reviewed in Galli 2007; Himmelfarb
2009). In recent years, these aspects have stimulated wide
interest on large (or high MW) solutes produced by the
abnormal chemistry of ROS/RNS in uremia and dialysis
patients, which were increasingly considered for a role as
uremic toxins (Vanholder et al. 2006) and for more effective
treatment by dialysis therapy (Ward 2005).
Notwithstanding the available information on protein
damage by nitration reactions in uremic plasma remains
scarce. The extent and targets of nitration during disease
progression from pre-dialysis (i.e. in CKD) to dialysis
therapy (i.e. in HD patients) as well as the effect of dialysis
methods and dialyzer membranes on protein nitration
remains unexplored.
As in other clinical studies (recently reviewed by Peluffo
and Radi 2007 and by Abello et al. 2009), identification of
nitration targets was largely disregarded in uremic plasma.
This actually remains an analytical challenge and early
studies performed by Mitrogianni et al. (2004) by immu-
noblotting and immunoprecipitation methods and more
recent studies by our group (Galli 2007; Piroddi et al. 2007)
carried out by immunoblotting and LC-MS/MS analysis1
tentatively identified only some of the most abundant targets
already described in other inflammatory conditions. How-
ever, many other candidate nitration targets are expected to
be present in plasma samples of these inflamed patients.
To explore these targets, in this work, we set up a pro-
teomic platform that was applied to the systematic inves-
tigation of plasma nitroproteins (the plasma nitroproteome)
(1) to preliminarily identifying a broad number of protein
targets by 3NT immunodetection, (2) to isolate or enrich
these targets for more accurate evaluation and identity
assessment by LC-MS/MS, and finally (3) to confirm with
selective analysis methods the presence of nitration epi-
topes within the structure of isolated proteins.
As a first explorative technique in this multi-step proto-
col, qualitative analysis of nitration targets in uremic and
healthy control plasma was carried out by 2D PAGE and
WB analyses, which were used also to fractionate immuno-
identified nitrated forms to proceed with their identification
by LC-MS/MS analysis. The uremic plasma nitroproteome
was also investigated on protein samples obtained by in vivo
ultrafiltration carried out during HD therapy of patients
treated with different dialyzers membranes. Albumin
depletion and immunopurification experiments followed by
1D WB analyses were used to selectively enrich 3NT-con-
taining proteins in the uremic plasma. Immunoprecipitation
and immunoblotting methods so far validated in previous
studies (Gole et al. 2000; Pignatelli et al. 2001; Galli 2007;
Mitrogianni et al. 2004) were also applied to further char-
acterize the extent and targets of nitration in uremic plasma.
1 Piroddi et al. unpublished data, manuscript in preparation.
Preliminary data presented at the 11th ICAAP, Vienna 2009.
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Unbiased identification of intramolecular targets of nitration
was obtained for the first time for a series of selected protein
spots corresponding to IgG chain regions on 2D PAGE. This
identification was performed by bidimensional tandem MS
after chemoselective tagging of nitration epitopes (Amore-
sano et al. 2007; Chiappetta et al. 2009).
Materials and methods
Patients and blood samples
This observational study has been performed with a cross-
sectional design in order to compare levels and targets of
protein nitration in pre-dialysis CKD, ESRD patients on
hemodialysis therapy (HD), and healthy controls (Ctr).
Essential characteristics of these groups are reported in
Table 1. Plasma samples of HD patients (5 M/5 F) were
obtained from the bank of plasma samples established in
our laboratories (samples collected during the years 2007
and 2008 and maintained at -80C).
Essential criteria to identify CKD patients eligible for
the inclusion in the study were a value of creatinine
clearance B15 ml/min, that is grade IV ? V of the
KDOQI classification (National Kidney Foundation, Inc
2002; Eckardt et al. 2009). Exclusion criteria were age
below to 30 years and higher than 70 years, the absence of
clinical and laboratory signs of severe inflammation and
protein-energy malnutrition (main laboratory indices con-
sidered were plasma levels of IL-6 [5 pg/ml and albumin
levels of \3.5 g/dl; these were measured during the first
visit for the inclusion in the study), the absence of diag-
nosis for diabetes, polycystic kidney disease, Lupus and
other auto-immune diseases, malignancy and recurrent
infections. A final group of 10 CKD patients (6 M/4 F) was
identified to meet these criteria and, after providing
informed consent, these were included in the study. After
inclusion, during one of the morning visits at the ambula-
tory of Nephrology, 10 ml of heparinized blood were col-
lected from the antecubital vein and plasma was obtained
by centrifugation. This was divided in aliquots and stored
at -20C. Blood sampling was performed under overnight
fasting conditions.
HD samples were obtained in the middle-week dialysis
session from patients on regular three times/week HD.
Exclusion criteria were the same than in CKD group plus a
dialysis age of lower than 72 months and higher than
9 months. Moreover, only patients with good metabolic
control and stabilized on HD therapy with high-flux
membranes were considered. Two subgroups of HD
patients were thus identified to investigate uremic proteins
obtained by in vivo ultrafiltration according with the study
design described before in (Galli 2007; Galli et al. 2005).
These HD patients were on treatment with protein leaking
dialyzers (PLD, n = 5) or standard non-protein leaking
high-flux polysulfone dialyzers (NPLD, n = 5). These two
types of high-flux dialyzers differ as regards hollow fiber
composition (polymethylmethacrylate vs. polysulfone,
respectively) and permeability characteristics (percentage
of porosity and pore size result in nominal cut-off values of
C70 KDa and B30 KDa, respectively), which in turn
produce different protein patterns in ultrafiltrate samples
(Galli 2007). Ultrafiltrate samples were obtained in the first
and in the last 5 min of the dialysis treatment by applying a
positive pressure on the blood side of the dialyzer to obtain
by convection a plasmatic water rich of plasma proteins
that was collected from the dialysate chamber by the outlet
port in the dialyzer cartridge. Protein concentration in ul-
trafiltrate samples was checked using the Bradford method
and the protein pattern was preliminarily verified by SDS-
PAGE and densitometric analysis performed using the
software Quantity One (Bio-Rad, CA, USA). Ultrafiltrates
used in this study obtained from PLD- and NPLD-treated
patients showed total protein levels of 2.4 ± 0.9 and
1.5 ± 0.5 mg/ml, respectively. Further details on the rel-
ative abundance and general characteristics of plasma
proteins obtained during in vivo ultrafiltration, and dialyzer
membrane permeability parameters (percent of porosity
and pore size) can be found in (Galli 2007; Piroddi et al.
2007; Galli et al. 2003; Buoncristiani et al. 1999).
Table 1 Clinical characteristics
of the CKD and HD subjects
included in this study
Ctr CKD HD (PLD) HD (NPLD)
Age (years) 66 ± 13 72 ± 13 62 ± 12 70 ± 12
Sex (M/F) 5/5 6/4 5/0 3/2
Total proteins (g/dL) 7.0 ± 0.5 6.3 ± 0.5 6.9 ± 0.6 7.0 ± 0.2
Albumin (g/dL) 4.7 ± 0.2 4.6 ± 0.2 4.2 ± 0.3 4.0 ± 0.4
Transferrin (mg/dL) 272.4 ± 48.2 254.6 ± 99.0 291.6 ± 55.9 228.6 ± 157.2
Fibrinogen (mg/dL) 212 ± 26 236 ± 50 248 ± 25 245 ± 42
Creatinineclearance (mg/mL) 89 ± 22 14.9 ± 4.8 – –
IL-6 (pg/mL) 2.03 ± 0.44 2.47 ± 0.24 5.0 ± 1.9 5.3 ± 2.15
hsCRP (mg/dL) 0.79 ± 3.6 0.77 ± 0.52 2.58 ± 28.6 2.27 ± 33.6
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Laboratory determinations
Immunopurification of 3NT-containing proteins
and albumin removal by affinity chromatography
Immunoprecipitation (IP) experiments were carried out in
whole plasma and ultrafiltrate samples using protein
G-Agarose immunoprecipitation magnetic beads (Invitrogen,
Milan). The anti-3NT antiserum used was the mouse
monoclonal IgG clone 39B6 from Abcam, Cambridge, UK.
Immunoaffinity (IA) of nitroproteins was performed
using a Sepharose 4 fast-flow column conjugated with a
rabbit polyclonal anti-nitrotyrosine IgG (Affiland, Lie`ge,
Belgium) that was used according with the specifications
provided by the manufacturer. Nitrotyrosine-containing
proteins obtained with this procedure were extensively
dialyzed against water and dried down using a speed vac-
uum concentrator before analysis.
The nitroproteins obtained with IP or IA were resus-
pended alternatively in SB to run SDS-PAGE and WB
experiments or in water to perform LC analyses.
In some experiments, albumin was removed from
plasma samples using a blue-agarose gel (Affiland, Lie`ge
Belgium) according with the procedure suggested by the
manufacturer.
Qualitative analysis of nitroproteins by 1D and 2D
PAGE/WB and LC-MS/MS analysis
These analysis methods were used to screen and eventually
to isolate potential nitration targets in plasma. Although
3NT immunorecognition has relatively low specificity, it
remains an essential step of nitroprotein analysis since it
allows to restrict the number of candidate targets in com-
plex protein samples to be further investigated by higher
levels of accuracy and precision for protein identity and
nitration epitope confirmation (see chemoselective labeling
and LC-MS/MS analysis protocols described below). For
1D WB analysis, whole plasma or ultrafiltrate proteins
suspended in SB were incubated for 5 min at 100C, and
15 lg of proteins were loaded in each lane of a mono-
dimensional polyacrylamide gel (1D-PAGE; 10% of T)
that was run using a mini Protean Cell System (Bio-Rad).
After 1D-PAGE, proteins were transferred onto a nitro-
cellulose membrane using a trans-blot SD semi-dry transfer
cell (Bio-Rad), and were incubated with the same mouse
monoclonal IgG used for IP (clone 39B6 from Abcam,
Cambridge, UK). Thus, a further incubation step was per-
formed using a secondary goat anti-mouse peroxidase-
conjugated antibody (Millipore, CA, USA). In some
experiments nitroproteins were also immunodetected using
a rabbit polyclonal anti-3NTprimary antibody (Sigma-
Aldrich, Milan, Italy) and a goat anti-rabbit peroxidase-
conjugated antibody (Millipore, CA, USA). The membrane
was washed three times (5 min each) in TBS containing
0.1% vol/vol Tween 20 and the signal was developed on
BioMax light films (KodaK, NY, USA) using an ECL
solution containing 1 M Tris–HCl pH 8.5, 1.25 mM
luminol in DMSO, 0.25 mM cumaric acid in DMSO,
0.015% vol/vol H2O2. Image analysis and densitometry
were performed using Gel-Pro Analyzer 3.1 (MediaCy-
bernetics, Inc., MD, USA).
Specificity of anti-3NT monoclonal antisera used in this
study was tested by protein reduction with Na2S2O4
according with the procedure previously reported in (Chi-
appetta et al. 2009). Other tests included the saturation of
the incubation medium containing the first antibody with
free 3NT and the omission of the primary antibody. These
tests were performed with either low or high loads of
plasma proteins during SDS-PAGE (7.5 or 15 lg/lane,
respectively) and with different times of exposure of light
films to ECL (from 10 to 60 s.).
For 2 PAGE and WB experiments, proteins were pre-
cipitated overnight in ice-cold acetone and the precipitate
was centrifuged for 2 min at 14,0009g, 4C. The final
pellet (300 lg of proteins) was dissolved in rehydration
buffer and then was diluted to the appropriate final protein
concentration in 350 ll of DTT 60 mM, Tris 40 mM, urea
7 M, thiourea 2 mM, CHAPS 4%, Bio-Lyte ampholite
(Bio-Rad) 0.7 ll, and bromophenol blue. The samples were
loaded onto immobilized pH gradient gel strips (17 cm, pH
3–10 NL), and isoelectric focusing was performed using a
Protean IEF cell system (Bio-Rad Labs). The second
dimension was performed on 9 to 16% polyacrylamide
linear gradient electrophoresis gels using a Protean II xi
Cell (Bio-Rad). 2D WB was performed using the same
procedure described above for 1D WB using a Trans-blot
cell (Bio-Rad). 2D WB and PAGE image matching was
performed by PD Quest software (Bio-Rad), selected spots
were picked and in-gel trypsinization was carried out as
described in (Sultana et al. 2006). Tryptic digest was
evaluated by nanospray LC/MSMS using a an HCT nano-
HPLC-Chip/MS system Agilent 1200 Series equipped with
a tridimensional ion trap system (Agilent Technologies,
Milan, Italy). A customized chip program for shotgun
proteomics was applied according with the manufacturer.
2D map matching for protein identification was performed
using the resources available in the SWISS-PROT data-
base (http://www.expasy.org/cgi-bin/map2/def?PLASMA_
HUMAN).
Semiquantitative analysis of protein 3NT by immuno-
dot blot analysis (DB)
Plasma samples were prepared for the analysis by appro-
priate dilution in Laemli buffer (Tris–HCl 0.12 M pH 6.8,
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glycerol 21.7%, SDS 4.28%), and different amounts of
total proteins were spotted onto a nitrocellulose sheet that
was soaked in Tris–HCl 20 mM pH 7.5, NaCl 500 mM,
and then mounted for the analysis onto a Bio-Dot micro-
filtration apparatus (Bio-rad Laboratories s.r.l., Milan).
Immunoblot and image developing were obtained with the
same procedure described above for 1D WB experiments.
The assay was calibrated using NO-BSA that was pre-
pared according with (Amoresano et al. 2007). Briefly,
BSA (10 mg/mL) in 200 mM Tris buffer (pH 8.0) was
exposed to tetra-nitro-methane (Sigma-Aldrich) at the final
concentration of 350 mM. The reaction mixture was stirred
at room temperature for 30 min, and NO-BSA was rapidly
desalted by size exclusion chromatography on a Sephadex
G-25 M column (Sigma-Aldrich). Protein elution was
monitored at 280 and 360 nm, and the protein-containing
fraction was collected and stored at -20C. The content of
3NT of this nitrated protein was checked by MALDI and
nano-LC-MS/MS analysis according with the method
reported in (Chiappetta et al. 2009). Assuming from
MALDI data that approximately 30% of albumin exposed
to TNM is nitrated, and that 4 Tyr residues per molecule
can be converted to 3NT (Chiappetta et al. 2009), a value
of 20 pmol of 3NT/lg of NO-BSA was considered to make
calibration curves. Incremental concentrations of this ref-
erence protein were loaded in each DB experiment (in the
range 0.4–160 pmol/spot that correspond to 0.02–8 lg/
spot) and the assay response with these protein loads was
verified by linear regression analysis within each analysis
session. Linearity was also tested assessing three different
times of exposure to ECL. With NO-BSA linearity
(R = 0.988, p \ 0.01) was achieved in the range
0.4–16 pmol of protein/spot with time of exposure to ECL
of 15 s. Under these conditions, the observed detection
limit was 0.2 pmol NO-BSA/spot. To further increase
analysis precision, in the same session each DB experiment
was run in duplicate. A first DB run was performed to
calibrate protein load and ECL exposure (usually 0.5 min)
and a second DB run was performed to confirm optimal
conditions and to obtain final semi-quantitative data. In
each of these two DB experiments, three incremental
concentrations of plasma proteins were spotted in series.
The amount of 3NT in plasma proteins was expressed in
pmol/lg of proteins. An intra-assay CV % of B10% was
observed for NO-BSA and of B19% for plasma proteins.
Reduction of nitrated plasma proteins to secondary
amines by Na2S2O4 (dithionite or sodium hydrosulfite)
(Sigma-Aldrich) was used to confirm specificity of anti-
3NT IgG used in these DB experiments by a stripping–
reprobing procedure. Briefly, proteins transferred onto
blotting membranes were stripped using the RestoreTM
stripping buffer (Thermo Scientific, IL, USA) and reduced
incubating the membrane at room temperature in 20 mM
dithionite dissolved in 50 mM borate pH 9.5 for 5 min.
Reprobing was thus performed as described above using
the same primary anti-3NT antibody.
Gel-free bidimensional tandem mass spectrometry
analysis of nitroproteins after chemoselective tagging
Unbiased semiquantitative analysis of nitroproteins in
human plasma was performed by chemoselective tagging
and bidimensional nano-LC-MS/MS according with the
procedure previously described in (Amoresano et al. 2007).
Briefly, after 2D PAGE of plasma proteins, selected spots
in the region corresponding to IgG lambda and heavy
chains were isolated and processed for trypsinization.
Reduction of nitro groups to amino groups in the trypsin
digest was performed by Na2S2O4 at a molar ratio of 100:1
with expected 3NT content as calculated in NO-BSA (A-
moresano et al. 2007; Chiappetta et al. 2009). Then, 3-
aminotyrosines were labeled with a solution of dansyl-
chloride (DNS-Cl) 18.5 ng/lL in ACN (1,000-fold molar
excess) and the peptide mixture was analyzed by LC-MS/
MS analysis using a 4000Q-Trap machine (Applied Bio-
systems) coupled to an 1100 nano-HPLC system (Agilent
Technologies). Total ion counts (TIC), precursor ion scan
(PIS) and MS3 analyses were performed and resulting data
were acquired using Analyst software (Applied Biosys-
tems) and further processed by MASCOT in house soft-
ware as described in (Amoresano et al. 2007).
Statistics
Results were expressed as the mean ± SD. Statistical
analysis and data plotting were carried out using Micro-
calTM Origin 7.5 (Microcal Software Inc., Northampton,
MA, USA) and Sigma Plot 9.0 (Systat Software Inc., San
Jose, CA, USA). Probability values of \0.05 were con-
sidered as significant.
Results
Semi-quantitative analysis of nitroproteins by dot blot
Figure 1 shows a typical semiquantitative DB analysis
carried out to measure nitroproteins in plasma of CKD, HD
and Ctr groups. All the DB experiments were optimized as
regards optimum of protein load, antibody performance and
ECL exposure. The resulting photographic images (Panel
A, left) were digitalized and analyzed by densitometry
against a calibration curve of nitro-BSA (Panel B). Each DB
experiment was tested also for specificity by reduction with
dithionite (Panel A, right). Panel C shows semi-quantitative
data obtained with this test. After correction of unspecific
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recognition revealed by dithionite reduction (this was par-
ticularly marked in CKD group), the levels of immunode-
tectable 3NT in CKD and HD plasma proteins were
determined as 0.212 ± 0.104 and 0.274 ± 0.132 pmol
3NT/lg total proteins, respectively (p = NS). A high inter-
individual variability was observed in these two groups of
patients (Panel C). In Ctr, a four-time higher protein load
per spot than in uremic patients was needed to measure ECL
signals that linearly corresponded to the amount of proteins
assessed in the DB test (not shown), and a value of
0.030 ± 0.017 pmol 3NT/lg total proteins was calculated
(p \ 0.05 vs. both CKD and HD groups).
Qualitative analysis of nitrated proteins
Plasma samples from uremic patient and healthy controls
were first analyzed by 1D PAGE and WB experiments
carried out under saturating conditions (obtained with a
load of 10 lg of total proteins per lane) to explore potential
3NT-containing proteins (shown in the supplemental
material as Fig. 1a) that will be further investigated to
confirm protein identity and nitration sites by LC-MS/MS
(see below). The specificity of the monoclonal antisera
used in this study was confirmed by applying different
analytical conditions as shown in Fig. 1b (see the supple-
mental files).
Although this analysis provides very limited resolution,
abundant immunodetectable material was recognized in
both the uremic (only HD patients were assessed) and
healthy control plasma. Main nitrated species could be
identified in the region between 50 and 80 KDa, while
another series of bands with lower intensity were present in
the 100–260 KDa region. Finally, an intense band was
observed just below 30 KDa. The conditions used to obtain
this qualitative image (protein load and exposure time to
ECL were maximized) interfered with the possibility to
obtain semiquantitative information at least for most
abundant nitrated species.
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Fig. 1 Immuno-dot blot analysis (DB) of 30-nitro-Tyr (3NT)-contain-
ing proteins in chronic kidney disease (CKD), hemodialysis (HD) and
healthy control (Ctr) plasma. This test was carried out using an
improved version of the procedure described by Pignatelli et al. (2001).
3NT immunodetection was performed with the method described in
detail in the section ‘‘Materials and methods’’. DB tests (a) were
performed by loading for each plasma sample three incremental
amounts of total proteins (from 5 to 20 lg) that were selected in order to
achieve a linear response during film exposure to ECL. Specificity in
the immunorecognition of 3NT was checked by reduction with sodium
dithionite (a, right). After densitometry, 3NT concentrations were
calculated using a calibration curve of nitro-bovine serum albumin
(NO-BSA; b). The linear portion of the calibration curve shown by the
straight fitting line was used to calibrate the assay. Mean levels of 3NT
in CKD, HD and Ctr groups are shown in c (as pmol 3NT/lg of total
proteins). *p \ 0.01 versus CKD and HD
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Figure 2a shows the 1D WB analysis carried out on
whole plasma and ultrafiltrate samples from patients treated
with PLD and NPLD dialyzers. Analyses were performed
under the same conditions described in Fig. 1, but with
lower protein loads (7.5 lg of total proteins per lane) to
avoid signal saturation and thus to tentatively increase res-
olution in the region between 50 and 80 KDa, i.e. the region
in which the most abundant nitrated proteins were observed.
Densitometry scanning of 1D WB images showed very
similar patterns of nitrated proteins in uremic and healthy
control plasma (Fig. 2b, panels 1, 2 and 4). Although
semiquantitative analysis of immunorecognized species by
this test has limited reliability, all the assessed samples of
uremic plasma showed a higher area under the curve than
in the healthy controls, thus confirming DB results shown
in the previous paragraph.
On the basis of apparent MW, qualitative results
obtained by 1D WB experiments were consistent with the
tentative identification of albumin as main target of nitra-
tion in uremic and healthy control plasma (Fig. 2b, peak at
68 KDa). The peaks with apparent MW between 50 and
60 KDa were tentatively assigned to the already reported
nitration targets fibrinogen chains, a1-antitrypsin and
a1-antichymotrypsin (Parastatidis et al. 2008; Heffron et al.
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Fig. 2 Qualitative analysis of 3NT-containing proteins in HD plasma
and ultrafiltrate samples. 1D-WB analyses were carried out in PLD
and NPLD plasma proteins under non-saturating conditions (7.5 lg of
proteins/lane, ECL exposure 0.5 min.). a The SDS-PAGE and WB
analysis carried out in NPLD plasma and ultrafiltrate samples,
representative of the entire set of samples investigated in this study.
Corresponding densitometric data are shown in b and c. Densitometry
profiles of WB analyses carried out on PLD plasma and ultrafiltrate
are shown in detail (c) to highlight the enrichment of the protein band
with apparent MW = 80 KDa. NPLD ultrafiltrate (b, Panel 3) shows
a marked increase of the band in the region between 25 and 30 KDa.
Abbreviations are as in Fig. 1
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2009; Gole et al. 2000; Pignatelli et al. 2001). Finally, the
nitrated peak with MW of 80 KDa could be compatible
with transferrin, while the peaks between 20 and 35 KDa
were consistent with the reported nitration of Apo-A1
(Zheng et al. 2004), but also with a series of other proteins
including the IgG light or k chain, one of the most abun-
dant protein fractions in plasma.
When examined by 1D WB, ultrafiltrate samples from
patients treated with NPLD (Fig. 2b, panel 3) and PLD
(Fig. 2c) showed the presence of a less complex pattern of
nitrated proteins with respect to whole plasma. In partic-
ular, NPLD ultrafiltrates essentially showed the presence of
peaks at 68 KDa and in the region 20–35 KDa, while PLD
ultrafiltrate contained peaks with MW of 68 and 80 KDa.
In both ultrafiltrate samples, the bands corresponding to
nitrated proteins occurring in the 50–60 KDa region were
markedly reduced with respect to whole plasma.
2D PAGE and LC-MS/MS identification of nitrated
proteins
Figure 3 shows typical 2D PAGE analyses and the corre-
sponding WB images obtained with anti-3NT antisera of
uremic proteins in plasma (Fig. 3a), and in PLD and NPLD
ultrafiltrate samples (Fig. 3b) that were previously exam-
ined by 1D WB (see above and Fig. 2). After matching WB
and coomassie stained 2D PAGE patterns (Fig. 3a), im-
munorecognized nitrated proteins were isolated by cutting
gel spots, and these candidate nitroproteins were submitted
to molecular identification by in situ digested with trypsin
and LC-MS/MS analysis of the resulting peptide digests.
Spectral data were used to search for a non-redundant
protein database using the Mascot software and identified
proteins are shown in Table 2. Most abundant plasma
proteins such as albumin, IgG light and heavy chains,
antithrombin and a1-antitrypsin were tentatively identified
with this procedure as nitration targets. However, also
some low abundant proteins like the complement factor D
could be identified. Other candidate targets of nitration
were assigned by direct matching of WB images with
existing 2D PAGE images of human plasma available for
consultation and analysis at: http://www.expasy.org/cgi-
bin/map2/def?PLASMA_HUMAN). These proteins inclu-
ded fibrinogen A, B and C chains that showed their char-
acteristics sequel of spots in the 2D MW/PI region,
serotransferrin, ceruloplasmin and haptoglobin (Fig. 3a;
Table 2). The same analyses carried out on selected spots
from 2D-PAGE gels of PLD and NPLD ultrafiltrate sam-
ples (Fig. 3b), produced essentially comparable results.
This LC-MS/MS identification of nitrated proteins
fractionated by 2D-PAGE was useful to further increase the
level of information obtained in the preliminary 1D WB
experiments performed on whole plasma and ultrafiltrate
samples shown in Fig. 2. Thus, the peak at 68 KDa
(Fig. 2b, c) very likely corresponds to albumin and the
peak region of 20–35 KDa should include IgG light chains
together with other minor components as complement
factor D. In the same way, the peak at 80 KDa essentially
consisted of transferrin, which is highly enriched in PLD
ultrafiltrate. The findings described for the 1D WB analysis
of ultrafiltrate samples were also confirmed by this analy-
sis. Main nitrated forms of the region 50–60 KDa are
absent in these samples (essentially fibrinogen A and B
chains, and IgG heavy chain) while a1-antitrypsin was
detected together with other minor components in the PI
region of albumin that was not identified.
Immunopurification and albumin depletion
In an attempt to selectively enrich the relative concentration
of plasma nitroproteins, immunoaffinity (IA) and immuno-
precipitation (IP) experiments (Fig. 4a, b, respectively) were
performed using the same antisera used in the WB and DB
experiments of above. The IA procedure produced similar
protein recoveries in uremic and healthy control subjects
suggesting that the experiment was performed under satu-
rating conditions with respect to the binding capability of
anti-3NT antisera. Accordingly, the fractions not retained
during the immunopurification process contained abundant
anti-3NT positive material (Fig. 4c). The IP experiment was
then carried out under non-saturating conditions providing a
higher purification yield than IA (Fig. 4b). Indeed, nitro-
proteins were not detectable in the washing buffer and in the
supernatants after IP (Fig. 4c), and the amount of 3NT-
containing proteins was lower in healthy controls than in HD
patients (mean difference = 22%; n = 4 each).
IA and IP samples prepared from both whole plasma and
ultrafiltrate samples were then analyzed by 1D PAGE and
WB showing that most abundant nitrated components have
an apparent MW between 50 and 60 KDa. This finding
confirms the elective nitration of proteins such as fibrino-
gen chains that were described in the 2D WB analysis of
Fig. 3 and in literature (see Parastatidis et al. 2008; other
references are reported in the ‘‘Discussion’’ section). In this
MW region, nitration of a1-antitrypsin and IgG heavy
chains had also been tentatively inferred by 2D WB
(Fig. 3). At the same time, albumin does not appear to be
recovered during IA and IP experiments. This was partic-
ularly obvious in the IA experiment of Fig. 4a. This finding
was confirmed by albumin depletion of plasma samples
carried out with blu-agarose affinity chromatography and
subsequent SDS-PAGE and DB analyses (shown in the
supplemental files as Fig. 2a). In both uremic or healthy
control plasma, the large majority of the immunodetectable
3NT (approx. 95% of the signal detected following
dithionite reduction) was observed in albumin-depleted
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samples. As calculated by densitometric analysis of SDS-
PAGE, these samples contained approximately 45% of the
total proteins (shown as supplemental Fig. 2b). These data
demonstrate that albumin is much less extensively nitrated
than fibrinogen and other less abundant species in plasma.
Bidimensional MS analysis of nitroproteins
after chemoselective labeling and identification
of 3NT residues
Direct identification of nitrated proteins and accurate
definition of nitration sites in uremic plasma proteins was
inferred by bidimensional tandem mass spectrometry (A-
moresano et al. 2007) after trypsinization and dansyl-
chloride labeling of nitropeptides. Selected spots of 2D
PAGE maps and immunoresponsive to anti-3NT antisera
during 2D WB experiments were assessed with this pro-
cedure. After selective labeling of 3NT residues by
reduction to 3-aminotyrosine and specific dansylation, the
exact location of original nitro-groups within the amino
acid sequence of nitropeptides was successfully identified
by bidimensional tandem MS analysis in some compo-
nents of the IgG chain region (Table 3). This MS analysis
was performed by PIS and MS3 scan mode combination.
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Fig. 3 2D-PAGE and WB analysis for the qualitative evaluation of
3NT-containing proteins in HD plasma and ultrafiltrate samples.
Qualitative identification of nitrated proteins in HD plasma and
ultrafiltrate samples was carried out by 2D-PAGE (a top panel, b left
panels) and WB (a bottom panel, b right panels) according to the
procedure previously described in (Galli 2007; Piroddi et al. 2007).
Protein identification by LC-MS/MS analysis was carried out in
selected protein spots (highlighted by squared straight line). Other
proteins were identified by gel matching (spots highlighted by
squared dashed line) using as template the human plasma 2D map
available for consultation at the Expasy website (http://www.expasy.
org/cgi-bin/map2/def?PLASMA_HUMAN). The list of proteins
identified with this procedure is reported in Table 2. White dots
shown in WB films indicate reference points used during image
matching with the corresponding 2D PAGE by PD Quest software
(Bio-Rad)
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In PIS mode, the MS detector can only detect peptide
precursor ions producing the m/z 170 fragment. The
selected precursor ions were then subjected to a combined
MS2 and MS3 experiment to specifically detect only
those ions originating the dansyl-specific m/z transition
234 ? 170 in MS3 mode. Figure 5 shows a typical pro-
file obtained from this analysis carried out in some of the
main spots corresponding to the IgG chain regions in the
2D map shown in Fig. 3a. As expected, the TIC chro-
matogram (Fig. 5, upper panel) exhibited a larger number
of signals most of which were very likely unrelated to
3NT-containing peptides. In fact, the corresponding pre-
cursor ion TIC profile shown in the lower panel, exhibited
a much simpler ion pattern in which the MS2 spectra
showed only the diagnostic fragment ion at m/z 170.
Further selection based on MS3 scan recording the m/z
transition 234 ? 170 (Amoresano et al. 2007) removed
the remaining false-positives leading to the identification
of truly nitrated peptides. Finally, MS/MS analysis of the
labeled peptides produced fragmentation spectra that were
used to determine peptide sequences for unbiased evalu-
ation of protein identity and unambiguous location of the
nitration site within its structure. The results of this PIS
and MS3 procedure are reported in Table 3 that shows
modified Tyr residues in chemoselective-labeled nitro-
peptide and the SwissProt accession code for protein
identification of seven different peptides all belonging to
immunoglobulin species.
Discussion
NO-mediated protein damage may contribute to sustain
events of uremic toxicity and the cardio-inflammatory
comorbidity of CKD patients. Actually, protein nitration is
increased in uremia as well as in other inflammatory con-
ditions and may produce functional consequences that are
compatible with an increased cardiovascular risk (Ischiro-
poulos 2009). Notwithstanding, protein nitration in uremic
plasma remains poorly characterized as levels, targets and
clinical importance are concerned. The main reason for this
lack of information is the complexity and poor reliability of
methods and techniques currently available to perform
these studies. Extensive characterization of 3NT-contain-
ing proteins in complex biological samples, such as
plasma, remains in fact an analytical challenge and even
most updated and sophisticated shotgun proteomics tech-
niques fail to provide suitable (high-throughput and
selective) analytical platforms (Abello et al. 2009). The
proteomic platform developed and applied in this study to
investigate qualitative and semi-quantitative aspects of
uremic plasma nitroproteome includes low-specificity
exploration tools such as 2D-PAGE, immuno-detection/
isolation techniques, and also specific tools for the unbi-
ased identification of 3NT-containing species by bidimen-
sional MS after chemoselective labeling.
The immuno-dot blot analysis method originally pro-
posed by Pignatelli et al. (2001) was improved and used to
obtain a semi-quantitative assessment of total nitroproteins
in plasma before to proceed with qualitative assessments.
Although this analysis method overestimates the actual
levels of 3NT in plasma proteins (Ryberg and Caidahl
2007), it has been useful to demonstrate an increased
burden of nitration in uremic plasma than in healthy con-
trol plasma. Indeed, CKD and HD plasma contained
0.212 ± 0.104 and 0.274 ± 0.132 pmol 3NT/lg total
plasma proteins, respectively, while healthy control plasma
contained 0.030 ± 0.017 pmol 3NT/lg total proteins
(p \ 0.01 vs. both the two groups of patients).
In the exploration of uremic nitroproteins (qualitative
analysis) carried out by 1D and 2D WB, albumin appeared
the most abundant plasma nitroprotein; however, immu-
nopurification experiments and selective removal of this
protein showed that the relative contribution of the nitrated
form of albumin to total protein 3NT levels is very low.
These findings are consistent with the results obtained in
earlier studies carried out by some of us on uremic proteins
obtained by in vivo ultrafiltration (Galli 2007; Piroddi et al.
2007) and also with the results obtained by other Authors
that studied whole plasma and also anti-3NT immunopre-
cipitated uremic proteins (Mitrogianni et al. 2004).
Albumin was not detected as nitration target by WB
even after immunoprecipitation of 3NT-containing plasma
Table 2 Tentative identification of nitroprotein targets in uremic
plasma as inferred from 2D maps and WB analyses
Spot Nr Protein SP code MW Nr
peptides
LC-MS/MS analysis
A1AT Alpha 1-antitrypsin P01009 46878 37
ANT3 Antithrombin-III P01008 53025 4
ALBU Serum Albumin P02768 71317 39
CFAD Complement Factor D P00746 27529 3
IGKC Ig K chain C region P01834 11773 9
– Ig K chain V–III region WOL P01623 11853 3
Gel-matching procedure
IGHG Ig gamma chain C region P01860
IGLC Ig lambda chain C region P01842
FIBA Fibrinogen alpha chain P02671
FIBB Fibrinogen beta chain P02675
FIBG Fibrinogen gamma chain P02679
CERU Ceruloplasmin P00450
HPT Haptoglobin P00738
TRFE Serotransferrin P02787
IGHA Ig alpha-1 chain C region P01876
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proteins in the other observational studies of Gole et al.
[2000] and Pignatelli et al. [2001]. Accordingly, no iden-
tification of intramolecular targets was reported for the in
vivo nitrated form of albumin that after in vitro exposure to
peroxynitrite was identified to contain modified Tyr resi-
dues in position 138 and 411 (Jiao et al. 2001). On the
contrary, nitration sites have been identified in the in vivo
nitrated form of fibrinogen b chain (Parastatidis et al.
2008), which is proved to be one of the most nitrated
species in human plasma in spite of a relative abundance on
total proteins of 3%. Thus, albumin appears to sustain the
unspecific immunorecognition of 3NT in plasma proteins,
and this may explain also why in the absence of nitropro-
tein separation, immunodetection methods largely overes-
timate total nitroprotein levels in plasma.
Immunodetectable nitroalbumin has been recently
reported and quantitated with a newly developed ELISA
test, in plasma of neonates with asphyxia-induced
encephalopathy by Wayenberg et al. (2009). These authors
observed in patients with neurological symptoms median
levels of nitroalbumin of 14.4 ng/ml that decreased to
7.3 ng/ml in asymptomatic neonates, which correspond to
approximately 3.7 and 1.8 9 10-5 mol nitroalbumin/mol
human serum albumin (HSA), respectively. These values
increased to approximately 5.7 9 10-5 mol nitroalbumin/
mol HSA (i.e. 22.6 ng/ml) in patients that in combination
with neurological symptoms developed severe renal injury,
but not hepatic or cardiac complications. These results
confirm the key role that the kidney plays to control plasma
protein damage and also the substoichiometric character of
albumin nitration that in turn reflects the low levels of
protein 3NT and the selectivity of nitration pathways in
human plasma (Abello et al. 2009; Souza et al. 2008;
Ischiropoulos 2009; Ryberg and Caidahl 2007).
Immunoaffinity (IA)
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Fig. 4 Partial purification of nitrated species in uremic plasma by
immunoaffinity and immunoprecipitation. Pooled samples of HD and
healthy control plasma were treated for IA or IP analysis as described
in the text and the resulting protein samples were assessed by 1D
PAGE (15 lg proteins/lane) and WB analysis (a and b, respectively).
WB analysis of the nitrated proteins recovered in the elution fractions
of IA experiments and the supernatant and washing buffer obtained
from IP experiments are shown in c. Further details are reported in the
text. Abbreviations are as in Fig. 1
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During preliminary immunorecognition tests (qualita-
tive analysis by 2D PAGE and WB, Fig. 3) other nitration
targets identified in uremic plasma corresponded to protein
targets previously described in small observational trials on
other inflamed patients, as ARDS and lung cancer patients
(Gole et al. 2000; Pignatelli et al. 2001). These included
transferrin, ceruloplasmin, fibrinogen, and a1-antitrypsin.
At the same time, other targets were tentatively identified
for the first time in this study by 2D PAGE/WB and LC-
MS/MS analysis and included IgG light and heavy chains,
complement factor D, and haptoglobin.
Fibrinogen b chain, the most characterized nitration
target in human plasma (Parastatidis et al. 2008; Nowak
et al. 2007), was confirmed as one of the main nitrated
species also in uremic patients. However, this nitrated form
of fibrinogen was present also in healthy control plasma
and the present study suggests also that a and c chains of
fibrinogen are nitrated in uremic and healthy control
Table 3 Bidimensional tandem
mass spectrometry identification
of nitration sites in protein spots
corresponding to main IgG
regions of 2D PAGE (Fig. 3)
Protein SP code Nitration site
Ig lambda chain V–I region BL2 P06316 VTISCSGSSSNIGNDY*V
Ig lambda chain V–I region EPS P06888 VSISCSGSSSNIGKNYVDWY*QQLPGTAPK
Ig heavy chain V–II region ARH-77 P06331 YYY*GMDVWG
Ig heavy chain V–III region BUR P01773 TYY*ADSVRGR
Ig heavy chain V–III region VH26 P01764 DNSKNTLY*LQMNSLR
STYY*ADSVKGRFTISRDNSK
GLEWVSAISGSGGSTYY*ADSVK
In
te
ns
ity
 (c
ps
)
Time (min.)
Fig. 5 Bidimensional LC-MS/
MS analysis of IgG
nitropeptides after
chemoselective labeling.
Tryptic peptide mixtures from
selected spots occurring in the
IgG regions of the 2D map and
immunoresponsive to anti-3NT
IgG were reduced and the
resulting aminotyrosine
epitopes of nitropeptides were
labeled by dansyl-chloride and
processed for 2D-LC-MS/MS
analysis according to
(Amoresano et al. 2007). The
upper and lower panels show
the total ion current (TIC)
chromatogram and the precursor
ion scan monitoring of the
dansyl-chloride fragment ion
with m/z 170, respectively.
These ion chromatograms are
representative of the entire set
of 2D-LC-MS/MS analyses
performed to identify
nitropeptides of IgG chains
reported in Table 3
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plasma. Thus, fibrinogen chains seem to represent consti-
tutive targets of nitration in human plasma and future
studies are required to quantify their extent of nitration in
patients and healthy controls, since this could reveal a
higher risk of thrombogenicity (Parastatidis et al. 2008;
Peluffo and Radi 2007; Heffron et al. 2009; Nowak et al.
2007). Fibrinogen nitration was recently proposed to rep-
resent a surrogate marker of inflammation of possible rel-
evance in clinical trials (Heffron et al. 2009) and thus could
be adopted in laboratory protocols to assess sub-clinical
inflammation in uremia and dialysis patients. Further
studies should be addressed to establish whether nitration
of coagulation proteins is part of the oxidative stress-
mediated events that are believed to sustain a defective
coagulation (increased fibrinolytic activity) of uremia and
dialysis patients (Pawlak et al. 2006). Thus, the study of
fibrinogen nitration and more in general of other nitration
targets among coagulation proteins (these include for
instance a1-antitrypsin, which is abundantly expressed in
the nitroproteome of uremic plasma and NPLD ultrafil-
trate), could be of relevance in uremia and dialysis patients
since chronic inflammation and impaired coagulation are
main uremic symptoms that cannot be corrected with
present dialysis therapies.
The study of the uremic nitroproteome performed on
plasma proteins separated by in vivo ultrafiltration revealed
first information as regards the potential of extracorporeal
treatments to correct the accumulation of large solutes
containing RNS-derived post-translational modifications
(PTMs). These particular plasma protein samples were
obtained from patients on treatment with PLD and NPLD
dialyzer membranes. These two types of high-flux dialyz-
ers produce different protein patterns in ultrafiltrate sam-
ples due to percentage of porosity and pore size
characteristics that result in nominal cut-off values of
C70 KDa and B30 KDa, respectively (Galli 2007). In this
study, we found that albumin is the most abundant com-
ponent recognized by 3NT immunoblotting in both the
PLD and NPLD ultrafiltrate samples, followed by IgG and
fibrinogen chains, transferrin, a1-antitrypsin, ceruloplasmin
and haptoglobin. Transferrin is one of the most abundant
nitrated forms selectively removed by PLD. This is the
most important pool of iron in the body with the highest
turnover rate for this transition metal, and noteworthy
dialysis patients show a characteristic tendency to develop
disturbances of transferrinemia and impaired transferrin
saturation (Canavese et al. 2004). Another target of nitra-
tion in uremic plasma associated with iron metabolism is
ceruloplasmin, which was observed in ultrafiltrate samples
from NPLD-treated patients, while only traces of this
protein were observed in PLD ultrafiltrates. The nitration of
this protein was already identified by immunoprecipitation
and WB analysis of HD plasma in the pioneering study of
Mitrogianni et al. (2004). These authors identified only this
target as more extensively nitrated in HD patients than in
healthy controls. Nitration of these two iron related pro-
teins in uremic plasma might have implications for an
abnormal metabolism of this transition metal, for uremic
anemia and for a higher susceptibility to oxidative stress
(Sezer et al. 2007). A defective iron metabolism increases
also the susceptibility to infections and is a well recognized
cause of impaired immune function in CKD and HD
patients. These clinical traits are often associated with iron
overload by massive iron therapy that is used to combat
severe anemia in HD patients (Canavese et al. 2004).
NPLD were found to selectively remove a1-antitrypsin
and IgG light chains, which are heavily represented in the
nitroproteome of uremic plasma. On the contrary, IgG
heavy chains, another main nitration target in uremic
plasma, are not present in ultrafiltrate samples. Key com-
ponents of complement pathways as the B and D factors
have been observed in traces in the nitroproteome of NPLD
ultrafiltrates. Complement factor B and D are part of the
alternate pathway of the complement system that, together
with complement factor 3b, generate the C3 or C5 con-
vertase. Complement activation during HD reflects the
scarce biocompatibility of the extracorporeal treatment and
may have severe clinical consequences for these patients
(Koller et al. 2004). Changes in IgG and complement
factors in uremic plasma induced by HD therapy have been
proposed to sustain leucopenia and neutrophil activation
with mechanisms that involve oxidative stress (Koller et al.
2004; Kormoczi et al. 2001). Nitration of both IgG and
complement factors has been investigated in vitro. IgG
nitration results in a defective binding of C1q subcompo-
nent of human complement (McCall and Easterbrook-
Smith 1989), while nitration of C5a results in a lowered
biological activity by reduced binding to granulocyte
receptor (Johnson and Chenoweth 1985).
Noteworthy, IgG light chains, that are the second most
represented nitroproteins in NPLD ultrafiltrates after
albumin, are markedly increased in CKD serum being
excreted and metabolized primarily by the kidney (Cohen
and Horl 2009). These interfere with respiratory burst and
apoptotic cell death mechanisms of neutrophils thus lead-
ing to defective cell-mediated immunity and impaired
resolution of inflammation. The contribution of IgG nitra-
tion to IgG light chain accumulation and uremic toxicity
remains unexplored.
As a key finding in this study, for the first time we have
been able confirm by an unbiased approach that IgG chains
are nitrated in vivo in uremic plasma. Using a chemose-
lective labeling procedure previously set up by some of us
(Amoresano et al. 2007), nitropeptides corresponding to the
lambda and heavy chains of uremic IgG were identified by
bidimensional tandem mass spectrometry analysis and
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nitration sites were specifically assigned. Further analyses
are in progress to identify by means of this unbiased
approach other nitrated proteins in plasma and a recent
evolution of this procedure (Chiappetta et al. 2009) is
expected to translate present qualitative data into quali-
quantitative experiments.
In conclusion, with this study we provide the first
extensive analysis of nitration targets in uremic plasma
proteins carried out by immunorecognition and LC-MS/MS
analysis. Since specificity of this qualitative investigation
needs to be assessed for each protein target, in this study
we developed a procedure of chemoselective labeling to
obtain the unbiased identification of nitroproteins during
bidimensional MS/MS of plasma proteins that are prelim-
inarily screened and isolated by 2D PAGE and WB. This
approach has been successfully applied for the first time to
the identification of nitration sites in the human IgG mol-
ecule exposed to RNS in vivo, and we expect that it could
be used in future large-scale proteomic studies to identify
other plasma nitroproteins.
Moreover, the nitroproteome analysis of this study has
revealed that uremic plasma shows an abnormal burden of
nitration and the tentatively identified nitration targets
suggest pathway and disease-specific events that deserve
further investigation to be confirmed and to ascertain their
clinical relevance with respect to immuno-inflammatory
and cardiovascular symptoms of ESRD. Disease-specific
differences in the relative abundance of nitrated forms
cannot be excluded at present and will be further investi-
gated using the chemoselective labeling and MS/MS
analysis approach proposed in this study.
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Dansyl labeling and bidimensional mass spectrometry to
investigate protein carbonylation
Angelo Palmese, Chiara De Rosa, Gennaro Marino and Angela Amoresano*
Department of Organic Chemistry and Biochemistry, School of Biotechnological Sciences, Federico II University of Naples,
Naples, Italy
Carbonylation is a non-enzymatic irreversible post-translational modiﬁcation. The adduction of carbonyl groups to
proteins is due to the presence of excess of ROS in cells. Carbonylation of speciﬁc amino acid side chains is one of the
most abundant consequences of oxidative stress; therefore, the determination of carbonyl groups content in proteins
is regarded as a reliable way to estimate the cellular damage caused by oxidative stress. This paper reports a novel
RIGhT (Reporter Ion Generating Tag) (A. Amoresano, G. Monti, C. Cirulli, G. Marino. Rapid Commun. Mass
Spectrom. 2006, 20, 1400) approach for selective labeling of carbonyl groups in proteins using dansylhydrazide,
coupled with selective analysis by bidimensional mass spectrometry. We ﬁrst applied this approach to ribonuclease
A and lysozyme as model proteins. According to the so-called ’gel-free procedures’, the analysis is carried out at the
level of peptides following tryptic digest of the whole protein mixture. Modiﬁed RNaseA was analyzed in combined
MS2 and MS3 scan mode, to speciﬁcally select the dansylated species taking advantage of the dansyl-speciﬁc
fragmentation pathways. This combination allowed us to obtain a signiﬁcant increase in signal/noise ratio and a
signiﬁcant increase in sensitivity of analysis, due to the reduction of duty cycle of the mass spectrometer. The unique
signal obtainedwas correlated to peptide 1-10 of RNaseA carbonylated and labeled by dansylhydrazide. This strategy
represents the ﬁrst method leading to the direct identiﬁcation of the carbonylation sites in proteins, thus indicating
the feasibility of this strategy to investigate protein carbonylation in a proteomic approach. Copyright  2010 John
Wiley & Sons, Ltd.
Carbonylation is a non-enzymatic irreversible post-
translational modiﬁcation of proteins. The adduction of
carbonyl groups to proteins is due to the presence of excess of
ROS (Reactive Oxygen Species) in cells. These can react both
with proteins and with other biological macromolecules
like carbohydrates and lipids, generating more reactive by-
products, namely RCS (Reactive Carbonyl Species). Proteins
can react directly with ROS leading to the formation of
derivatives possessing highly reactive carbonyl groups
(ketones, aldehydes), or with reactive carbonyl compounds
derived from oxidation of carbohydrates (glycoxidation
products), lipids (malondialdehyde, 4-hydroxynonenal)
and glycation and lipoxidation end products.[1,2]
Lysine, arginine, proline and threonine are particularly
susceptible to direct oxidation on amino acid side chains
leading to the formation of a-aminoadipic semialdehyde,
glutamic semialdehyde, 2-pyrrolidone and 2-amino-3-
ketobutyric acid, respectively.[3–5]
The increase in carbonylated proteins during cellular
ageing or in response to oxidative stress is not a casual event;
in fact some proteins are more susceptible to ROS than other.
Therefore, the deﬁnition of the entire set of target proteins of
oxidative stress is a hard challenge since these proteins are
specie speciﬁc.[6–11]
Carbonylation of speciﬁc amino acid side chains[3–5] is one
of the most abundant consequences of oxidative stress; so
determination of the content of carbonyl groups in proteins is
regarded as a reliable way to estimate the cellular damage
caused by oxidative stress. For this reason several methods
have been developed to determine the content of carbonyl
groups in proteins.[12–17] A simple and accurate method to
quantify protein oxidation uses 2,4-dinitrophenylhydrazine,
which speciﬁcally reacts with carbonyls to form 2,4-
dinitrophenylhydrazone;[18,19] the amount of hydrazone is
quantiﬁed by using a spectrophotometer technique. How-
ever, this method is not suitable for proteins containing
chromophores adsorbing at 360–380nm (i.e. heme-containing
proteins) and requires large amounts of proteins, not always
available. The DNPH assay has also been used in combi-
nation with Western blot analysis using anti-dinitrophenyl
antibodies, enhancing the sensitivity of the method.[20–22]
As an alternative, ﬂuorescent methods have been devel-
oped based on the use of ﬂuorescein hydrazyde[23] that
reacts speciﬁcally with carbonyl groups and can be detected
ﬂuorometrically at 489 nm.
A radioactive method has been developed that use sodium
borotritide for reduction of carbonyl groups and their Schiff
bases; this methodology has some drawbacks such as the use
of radioactive reagents with risks for safety and non-speciﬁc
incorporation of tritium into proteins.[24]
A proposed method for detection of carbonyl groups uses
biotinhydrazide for carbonyl labeling; labeled proteins can be
analyzed exploiting the speciﬁc interaction biotin-avidin; this
strategy has been used in combination with an afﬁnity
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chromatography step and mass spectrometric analysis to
identify speciﬁc sites of carbonylation in proteins.[25–31]
We have recently reported an innovative approach, named
RIGhT (Reporter Ion Generating Tag), which involves dansyl
labeling of nitration and phosphorylation sites and relies on
the enormous potential of MSn analysis.[32,33] Taking
advantage of the experience already made, this work reports
a novel RIGhTmethodology for selective labeling of carbonyl
groups in proteins using dansylhydrazide coupled with
selective analysis in precursor ion scanning mode.
EXPERIMENTAL
Chemicals
Dithiothreitol (DTT), trypsin, a-cyano-4-hydroxycinnamic
acid, ethylenediaminetetraacetic acid (EDTA), urea, sodium
hypochlorite solution and bovine ribonuclease A (RNaseA)
were from Sigma (St. Louis, MO, USA). 5-N,N-(Dimethyl-
amino)naphthalene-1-sulfonohydrazide (DNSH), ammonium
hydrogen carbonate (AMBIC) and iodoacetamide (IAM) were
purchased from Fluka. Acetonitrile (ACN) was from Romil.
Triﬂuoroacetic acid (TFA) (HPLC grade) was purchased from
Carlo Erba. All solvents were of the highest purity available
fromBaker. All other reagents and proteinswere of the highest
purity available from Sigma.
In vitro carbonylation of RNaseA
RNaseA was dissolved in a 5mM NaClO solution to a ﬁnal
concentration of 0.5mg/mL. The reaction was carried out at
378C for 15min. Carbonylated RNaseA was immediately
desalted by size exclusion chromatography (SEC) on a
Sephadex G-25M column (GE Healthcare). Protein elution
was monitored at 220 and 280nm. The fraction containing
proteins was collected, lyophilized and stored at 208C.
Disulﬁde bridge reduction, Cys alkylation and tryptic
digestion
Carbonylated RNaseA was dissolved in denaturant buffer
(urea 6M, Tris 300mM, EDTA 10mM pH 8.0) and disulﬁde
bridges were reduced with DTT (10-fold molar excess on
the Cys residues) at 378C for 2 h and then alkylated by
adding IAM (5-fold molar excess on thiol residues) at room
temperature for 30min in the dark. Protein samples were
desalted by SEC on a Sephadex G-25M column (GE
Healthcare). The fraction containing proteins was lyophilized
and then dissolved in 10mM AMBIC buffer pH 8.0. Trypsin
digestion was performed using an enzyme/substrate ratio of
1:50 (w/w) at 378C for 16 h.
Bacterial strains, growth conditions and protein extract
preparation
Escherichia coli K12 strain was grown in aerobic conditions at
378C in LB medium. After 16h, bacteria were harvested by
centrifugation and resuspended in Buffer Z (25mMHEPES pH
7.6, 50mMKCl, 12.5mMMgCl2, 1mMDTT, 20%glycerol, 0.1%
Triton) containing 1mM PMSF. Cells were disrupted by
sonication. The suspensionwas centrifuged at 9000 g for 30min
at 478C. After centrifugation the protein concentration of the
extract was determined by Bradford assay.
Labeling of carbonyl groups with DNSH
The sample was lyophilized and then dissolved in 10mL of
H2O. To this solution were added 100mL of a 6.5% TFA
solution in ACN and an equal volume of a 5mM DNSH
solution in ACN. Solutions were allowed to react at 378C for
8 h.
Mass spectrometry
Matrix-assisted laser desorption/ionization mass spectrom-
etry (MALDI-MS) experiments were performed on a
Voyager-DE STR MALDITOF mass spectrometer (Applied
Biosystems, Framingham, MA, USA) equipped with a
nitrogen laser (337nm). A 1mL volume of the total mixture
was mixed (1:1, v/v) with a 10mg/ml solution of
a-cyano-4-hydroxycinnamic acid in ACN/50mM citrate
buffer (70:30 v/v).
Nanospray liquid chromatography/tandem mass spec-
trometry (nanoLC-MS/MS) experiments were performed on
a 4000 Q-Trap mass spectrometer (Applied Biosystems)
coupled to a 1100 nanoHPLC system (Agilent Technologies).
Peptide mixtures were loaded onto an Agilent reversed-
phase pre-column cartridge (Zorbax 300 SB-C18, 5 75mm,
3.5mm) at 20mL/min with solvent A (0.1% formic acid, 2%
ACN in water, loading time 5min). Peptides were then
separated on an Agilent reversed-phase column (Zorbax 300
SB-C18, 150mm 75mm, 3.5mm), at a ﬂow rate of 300 nL/
min using 0.1% formic acid, 2% ACN in water as solvent A
and 0.1% formic acid, 2% water in ACN as solvent B. The
elution was accomplished by a 7–50% linear gradient of
solvent B in 50min. Amicro-ionspray sourcewas used at 2 kV
with liquid coupling, with a declustering potential of 50V,
using a uncoated silica tip (o.d. 150mm, i.d. 20mm, tip
diameter 10mm; New Objectives, Ringoes, NJ, USA). Spectra
acquisition was based on a survey precursor ion scan for
m/z 170. The Q1 was scanned from 400 to 1400 in 2 s with
resolution ’low’, and the precursor ions were fragmented in
q2 using a linear gradient of collisional energy from 30 to 80V.
Finally, Q3 was set to transmit only ions at m/z 170 with
resolution ’unit’. This scan mode was followed by an
enhanced resolution experiment for the ions of interest and
then by MS2 and MS3 experiments of the two most abundant
species. MS2 spectra were acquired using the best collision
energy calculated on the basis of m/z values and charge state
(rolling collision energy). MS3 experiments were performed on
the fragment ion at m/z 234, with a ﬁxed linear ion trap (LIT)
ﬁll time of 350ms and an activation time of 100ms, scanning
the mass range from 160 to 180m/z.
RESULTS AND DISCUSSION
The analytical strategy described in this paper fulﬁls the
proteomics needs of sensitivity and speciﬁcity in the analysis
of substoichiometric post-translational modiﬁcations, such as
protein carbonylation, associated with protein oxidation.[33]
Existing methodologies, essentially based on immunochemi-
cal techniques,[20–22] which although sensitive, lack the
capability to precisely localize modiﬁcation sites, information
that is often required to completely understand the
biological signiﬁcance of modiﬁcation. Here we suggest a
derivatization procedure based on dansylhydrazide having a
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chemical moiety that gives rise to characteristic product ions,
thus allowing the exploitation of tandem multi-stage mass
spectrometric (MSn) analysis. As exploited before, the dansyl
derivatization introduces: (a) a basic secondary nitrogen
into the molecule that enhances the efﬁciency of ionization
and (b) a dansyl moiety whose fragmentation is highly
reproducible.[31,32] We tested this approach using ribonuc-
lease A and lysozyme as model proteins. According to
’gel-free procedures’, the analysis is carried out at the level of
peptides following tryptic digest of the whole protein
mixture. RNaseA (0.5mg) was carbonylated with NaClO
under controlled conditions,[14] and then rapidly desalted by
SEC as described in the Experimental section. NaClO-
induced modiﬁcations were then analyzed by MALDI
mapping analysis. Aliquots of the sample containing RNaseA
and carbonylated RNaseA were reduced with DTT and
alkylated with IAM. The protein samples were digested with
trypsin, and the resulting peptides mixtures analyzed by
MALDI-MS. Mass spectral analyses led to the veriﬁcation of
some 95% sequence coverage and allowed us to locate the
carbonylated residue in the peptide 1-10. In fact, MALDI-MS
spectra show the occurrence of a signal at m/z 1149.6
(Figs. 1(A) and 1(B)) exhibiting a molecular mass not
corresponding to a theoretical one within the RNaseA
sequence. This signal was assigned to the peptide 1-10
showing a DM¼1 Da. This value corresponds to the mass
difference existing between lysine and a-aminoadipic
semialdehyde after a protein carbonylation event. In fact,
protein carbonyls generated by oxidation of lysine, arginine,
or proline residues, and frequently used as markers for
oxidative protein modiﬁcation, determine a difference in
the molecular mass of amino acid side chains.[4] Oxidation
of the proline or arginine side chain forms glutamic
semialdehyde, while lysine oxidation results in aminoadipic
semialdehyde, introducing carbonyl groups in the protein
structure. The hydroxyl group of the threonine side chain can
Figure 1. (A) Partial MALDI-MS spectrum shows the occurrence of a signal at m/z 1149.6 attributed to the peptide 1-10 of
RNaseAwith DM¼ –1 Da, corresponding to themass difference existing between lysine and a-aminoadipic semialdehyde after
a protein carbonylation event. (B) Zoomed region of the MALDI-MS spectrum of carbonylated RNaseA.
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also be oxidized to form the carbonyl group. The presence in
the MALDI spectrum of the signal at m/z 1150.6 attributed to
the theoretical peptide 1-10 indicated that the carbonylation
reaction was not quantitative. No signal occurring at m/z
1148.6, and corresponding to the peptide 1-10 doubly
modiﬁed by carbonylation at the second residue of lysine,
was detected. However, the mass spectrum showed the
occurrence of a signal at m/z 1131.6 (Figs. 1(A) and 1(B))
showing a DM¼18Da with respect to the carbonylated
peptide. This species was probably due to the formation of a
cyclic intermediate originating from the reaction of the
N-terminal amino group with the aldehyde of the oxidized
lysine residue in position 1. A similar procedure was applied
to lysozyme carbonylation. The tryptic mixture of carbonyl-
ated lysozyme was then submitted to MALDI-MS analyses.
Interpretation of MALDI-MS spectra showed the occurrence
of a signal whose molecular mass could not be explained on
the basis of the theoretical ones. It should be noted that, like
RNaseA, lysozyme showed the presence of a lysine residue at
the N-terminal position. As detected before, the signal at m/z
605.3 corresponding to carbonylated peptide 1-5 was not
detected. However, a signal at m/z 587.3 (18 Da lower than
carbonylated species) was detected. This peak was absent in
the spectrum of wild-type lysozyme (Fig. 2(A)), and was
tentatively assigned to the cyclic intermediate. To support our
hypothesis, we decided to modify the strategy, introducing
an acetylation step to block amino groups (namely
N-terminus and Lys e-amino groups).[34] Following the
Figure 2. Partial MALDI-MS spectra of carbonylated lysozyme (A) and acetylated carbonylated lysozyme (B). In (A) the signal
at m/z 606.4 is attributed to the peptide 1-5 of lysozyme, the signal at m/z 587.4 is tentatively assigned to a cyclic intermediate
formed after carbonylation of the protein. In (B) two related signals occurred at m/z 647.3 and 690.3. These signals were
attributed to the peptide 1-5 carbonylated and acetylated (3M¼þ 42 Da) and the same peptide doubly acetylated, respectively.
The absence of the signal at m/z 587.3 could be appreciated, thus conﬁrming the formation of the cyclic intermediate at the
N-terminal residue.
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Figure 3. (A) Formation of the a-aminoadipic semialdehyde hydrazone following dansylhydrazide reaction. (B) MALDI-MS
spectra of the carbonylated RNaseA peptide mixture after dansylhydrazide reaction. The signal at m/z 1396.7 was detected
showing a mass increment of þ247 Da attributed to the peptide 1-10 modiﬁed by hydrazone formation (DM¼þ247 Da).
(C) Zoomed region of the MALDI-MS spectrum.
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reaction, the acetylated N-terminal amino group cannot react
with the aldehyde moiety occurring at the oxidized residue.
The acetylation reaction was carried out by using acetic acid
N-hydroxysuccinimide ester (1000-fold molar excess on
proteins). The mixtures were then analyzed by MALDI-TOF
MS and the spectra revealed the disappearance of signals
attributed to the cyclic intermediate formation. As an
example the MALDI-MS spectrum recorded from the
acetylated and oxidized tryptic peptide mixture from
lysozyme showed the presence of two related signals at m/
z 647.3 and 690.3. These signals were attributed to the peptide
1-5 carbonylated and acetylated (DM¼þ42 Da) and the same
peptide doubly acetylated, respectively. The absence of the
signal at m/z 587.3 (Fig. 2(B)) could be seen, thus conﬁrming
the formation of the cyclic intermediate when a-aminoadipic
semialdehyde is at the N-terminal residue. The formation of
the cyclic intermediate blocks the reactivity of carbonylated
lysine, which is not suitable for reaction with the hydrazide
moiety of the DNS derivative.
Labeling with DNSH
Because of the non-reactivity of the cyclic intermediate we
decided to work on carbonylated RNaseA only. Moreover,
the acetylation of carbonylated lysozyme means the intro-
duction of a further step that complicates the analytical
strategy and is not useful for our purpose. Labeling of
carbonylated residues of RNaseA was carried out using
dansylhydrazide. The yield of the addition reaction was
monitored by MALDI-MS analysis. Mass spectral analysis
showed the decrease of intensity of the signal at m/z 1149.6
(Fig. 3(C)), indicating the labeling of this species. A new
signal at m/z 1396.7 was detected showing a mass increment
of þ247 Da (Fig. 3(B)). This signal was attributed to the
peptide 1-10 modiﬁed by a-aminoadipic semialdehyde
hydrazone formation following dansylhydrazide reaction
(Fig. 3(A)) on the RNaseA. Moreover, the absence of further
species with a DM¼þ247 Da probably indicates the
speciﬁcity of the reagent for carbonyls, i.e. carbonylated
lysine. The MALDI-MS spectrum still shows the occurrence
of the signal at m/z 1131.6 assigned to the cyclic intermediate
originating from the reaction of the N-terminal amino
Figure 4. Fragmentation pathways of dansyl derivatives
after collision-induced dissociation. The speciﬁc fragmenta-
tion can be used for selective precursor ion scan analysis for
the fragment atm/z 170 and the transitionm/z 234!170 can be
used as dansyl-speciﬁc MS3 transition.
Figure 5. LC/MS/MS chromatograms of dansylated
RNase A trypsin mixture: (A) TIC of the full scan MS/MS
analysis, in which a large number of signals most of which
are not related to dansyl-modiﬁed peptides are present. The
combination of PIS and MS3 (B, C) analysis allowed us to
obtain a signiﬁcant increase in signal/noise ratio and a
signiﬁcant increase in sensitivity of the mass spectrometric
analysis. The unique signal at 19.8min in the PIS TIC was
correlated to peptide 1-10 of RNase A carbonylated and
labeled by dansylhydrazide.
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group with the aldehyde of the oxidized lysine residue in
position 1. The formation of this intermediate determines
the disappearance of carbonyl groups of lysine in position 1,
thus this residue is not yet reactive towards the hydrazide
moiety.
LC/MS/MS analysis of dansylated peptides
Discrimination between modiﬁed and non-modiﬁed pep-
tides is achieved by taking advantage of the instrumental
features of a hybrid (triple quadrupole/linear ion trap)
mass spectrometer. Peptide analysis is carried out by
LC/MS/MS, and the peptide ions of interest are discrimi-
nated by two selectivity criteria based on two subsequent
tandem MS experiments, a precursor ion scan followed by
an MS3 scan mode in a bidimensional tandem mass
spectrometry selection.[33] Thus to locate the modiﬁcation
site on the peptide, we performed an LC/MS/MS analysis of
the entire peptide mixture using a linear ion trap 4000 Q-Trap
instrument, operating with Precursor Ion Scan as survey scan
mode. The precursor ion scan mode allowed us to analyze
the only precursor ions producing the fragment at m/z 170,
generated by typical fragmentation of dansyl and its
derivatives.[31] The selected precursor ions were then
analyzed in combinedMS2 andMS3 scanmode, to speciﬁcally
select the dansylated species by combining the Precursor
Ion Scan analysis for the fragment at m/z 170 and taking
advantage of the dansyl-speciﬁc MS3 transition m/z 234!170
(Fig. 4). Figure 5 shows LC/MS/MS chromatograms from the
dansylated RNaseA trypsin mixture. As clearly indicated in
the ﬁgure, by comparison of the TIC proﬁles from PIS
and MS3 (Figs. 5(B) and 5(C)) with the TIC chromatogram of
LC/MS/MS full scan analysis (Fig. 5(A)), the precursor ion
scan mode still showed the occurrence of a large number of
signals, most of which not related to dansyl-modiﬁed
peptides. In fact, the corresponding MS2 spectra do not
show the occurrence of a fragment ion at m/z 234. Further
selection based on the MS3 scan removed a large number of
false positives leading to a simple ion chromatogram
essentially dominated by a unique signal, indicating the
presence of a single dansyl-modiﬁed peptide. The combi-
nation of PIS and MS3 analysis allowed us to obtain a
signiﬁcant increase in signal/noise ratio and a signiﬁcant
increase in the sensitivity of the mass spectrometric analysis,
due to the reduction of the duty cycle of the mass
spectrometer. The unique signal at 19.8min in the PIS TIC
was correlated by its MS and MS/MS spectra to peptide 1-10
of RNaseA carbonylated and labeled by dansylhydrazide
(Fig. 5). Moreover, the modiﬁed lysine residue was easily
detected by interpretation of the MS spectrum and thus
conﬁrming the previous hypothesis of carbonylation at the
level of Lys 7 within RNaseA. Figure 6 shows the MS2
spectrum of the triply charged ion atm/z 466.2 of peptide 1-10
carrying a dansylhydrazone moiety. The MS2 spectrum
related to the peptide 1-10 showed the presence of
fragment ions belonging to both the y and the b series.
However, some features make interpretation of MS/MS
spectra problematical. In fact the modiﬁed peptide is not very
stable during collision-induced dissociation, so that the
peptide bond between alanine in position 6 and modiﬁed
a-aminoadipic semialdehyde in position 7 was not comple-
tely fragmented under the conditions used in the experiment.
Thus the occurrence of a signal corresponding to the y4 ion
can be detected even at very low intensity. This fragment ion
in fact corresponds to the peptide sequence KFER still
containing Lys modiﬁed by a dansyl moiety. Moreover, the
DNS neutral loss (m/z 234 Da) from the modiﬁed
a-aminoadipic semialdehyde residue can be appreciated.
In fact, y ions exhibiting a DM of 233 Da, corresponding to
y fragments that have lost the DNS moiety but still retaining
the hydrazone moiety, can be observed in the spectrum
(Fig. 6).
Figure 6. MS2 spectrum of triply charged ion at m/z 466.2 of the peptide 1-10 carrying a dansylhydrazone moiety. The
attributions are properly annotated.
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Figure 7. Chromatographic proﬁles of TIC (A) and PIS (B) experiments obtained by bidimensional LC/MS/MS analysis of
100mg of the carbonylated RNase A spiked to 10mg of entire cellular extract of Escherichia coli.
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Analysis of a complex protein mixture
The proposed strategy was then confronted with a more
complex sample, in order to demonstrate the ability of this
analytical method to speciﬁcally locate carbonylated residues
in a proteomics analysis. Carbonylated RNaseA (100mg) was
spiked to 10mg of entire cellular extract of Escherichia coli.
This sample was then analyzed using the procedure
described above. Proteins were reduced by DTT and thiols
were alkylated with IAM; then the protein mixture was
digested with trypsin and the resulting peptide mixture
was submitted to labeling with dansylhydrazide as described
in the Experimental section. An aliquot of the resulting
dansylated peptide mixture was submitted to bidimensional
LC/MS/MS analysis in PIS and MS3 modes as described
above. Results of LC/MS/MS analysis are summarized in
Fig. 7, showing the chromatographic proﬁles of TIC
(Fig. 7(A)) and PIS (Fig. 7(B)) experiments. In the TIC proﬁle
a large number of signals are present, that could be due both
to false positives or real dansylated peptides. However, the
selectivity of the bidimensional analysis allowed us to
eliminate all false positives since a unique signal referable
to carbonylated and dansylated peptide 1-10 of RNaseA was
detected. The manual interpretation of the MS2 spectrum
related to this signal allowed us to reconstruct the above
mentioned peptide and to locate the modiﬁcation site at the
level of the lysine in position 7 within the peptide 1-10. To
the best of our knowledge this strategy represents the ﬁrst
method leading to the direct identiﬁcation of carbonylation
sites in proteins, thus indicating the feasibility of this strategy
to investigate protein carbonylation in a proteomic approach
(manuscript in preparation).
CONCLUSIONS
In this study the use of dansylhydrazide in combination with
advanced mass spectrometric experiments allowed us to
speciﬁcally identify carbonylation sites of RNaseA also in a
complex mixture as the entire protein extract of E. coli. The
generation of carbonyls group in RNaseA was obtained by
the oxidation with NaClO, with a slight modiﬁcation of the
protocol proposed by Headlam and Davies,[14] and allowed
us to speciﬁcally convert just one lysine residue (namely Lys 7)
of RNaseA into a-aminoadipic semialdehyde. Dansylhydra-
zide was then used to speciﬁcally label the a-aminoadipic
semialdehyde residue and the peculiar fragmentation path-
way of dansyl derivatives was then exploited for mass
spectrometric analysis with a hybrid instrument, such as a
triple quadrupole/linear ion trap mass spectrometer, in
Precursor Ion Scan analysis combined with MS3 analysis, in a
bidimensional LC/MS/MS analysis. The combination of PIS
andMS3 analysis allowed us to obtain a signiﬁcant increase in
signal/noise ratio and a signiﬁcant increase in sensitivity of
mass spectrometric analysis, due to the reduction of the duty
cycle of the mass spectrometer. In this way we were able to
speciﬁcally identify the only modiﬁed peptide of RNaseA and
also to locate the modiﬁcation sites, namely the oxidized
residue. This work represents the ﬁrst method leading to the
direct identiﬁcation of the carbonylation sites in proteins, thus
indicating the feasibility of this strategy to investigate protein
carbonylation in a proteomic approach.
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Abstract Anα-L-arabinofuranosidase produced by Pleurotus
ostreatus (PoAbf) during solid state fermentation on tomato
pomace was identified and the corresponding gene and
cDNA were cloned and sequenced. Molecular analysis
showed that the poabf gene carries 26 exons interrupted by
25 introns and has an open reading frame encoding a protein
of 646 amino acid residues, including a signal peptide of 20
amino acid residues. The amino acid sequence similar to the
other α-L-arabinofuranosidases indicated that the enzyme
encoded by poabf can be classified as a family 51
glycoside hydrolase. Heterologous recombinant expression
of PoAbf was carried out in the yeasts Pichia pastoris and
Kluyveromyces lactis achieving the highest production level
of the secreted enzyme (180 mg L−1) in the former host.
rPoAbf produced in P. pastoris was purified and character-
ized. It is a glycosylated monomer with a molecular weight
of 81,500 Da in denaturing conditions. Mass spectral
analyses led to the localization of a single O-glycosylation
site at the level of Ser160. The enzyme is highly specific for
α-L-arabinofuranosyl linkages and when assayed with p-
nitrophenyl α-L-arabinofuranoside it follows Michaelis–
Menten kinetics with a KM of 0.64 mM and a kcat of
3,010 min−1. The optimum pH is 5 and the optimal
temperature 40°C. It is worth noting that the enzyme shows
a very high stability in a broad range of pH. The more
durable activity showed by rPoAbf in comparison to the
other α-L-arabinofuranosidases enhances its potential for
biotechnological applications and increases interest in
elucidating the molecular bases of its peculiar properties.
Keywords α-L-arabinofuranosidase . Fungus .
Recombinant expression .Pichia pastoris
Introduction
The α-L-arabinofuranosidases (EC 3.2.1.55) are enzymes
that degrade hemicelluloses, such as arabinoxylan, arabino-
galactan and L-arabinan, cleaving α-L-arabinofuranosidic
linkages and acting synergistically with other enzymes to
allow the complete hydrolysis of hemicelluloses and pectins.
The α-L-arabinofuranosidases can be found in plant,
bacteria and fungi.
There is a growing interest into α-L-arabinofuranosidases
due to their application in various industrial processes, such
as the production of L-arabinose to be used as food additive,
increase of wine aroma by hydrolysis of monoterpenols,
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clarification of fruit juices, improvement of the overall
quality of bread by delaying the bread staling, improvement
of animal feed digestibility, and enhancement of pulp
delignification (Numan and Bhosle 2006).
The α-L-arabinofuranosidases are glycoside hydrolases
that cleave terminal non-reducing α-L-1,2-, α-L-1,3- and/or
α-L-1,5-arabinofuranosyl residues from polymers that
contain L-arabinose. Some act on short oligosaccharides,
while others are capable of hydrolyzing side-chain
arabinose residues from polymeric substrates. α-L-arabi-
nofuranosidases are classified into families GH3, GH43,
GH51, GH54 and GH62 of the classification of glycoside
hydrolases based on amino acid sequence similarity
reported in the CAZy database (http://www.cazy.org/)
(Cantarel et al. 2009).
In many cases, microorganisms that utilize hemi-
celluloses possess α-L-arabinofuranosidases with various
substrate specificities and biochemical properties. Some
fungal species produce several α-L-arabinofuranosidase
isoenzymes.
The white-rot fungus Pleurotus ostreatus has been
widely studied for its ligninolytic activity due to the
expression of a laccase multigene family (Pezzella et al.
2009), while only recently its hemicellulolytic capability
has been reported with detection of xylanase activity during
solid state fermentation (SSF) on tomato pomace and the
observed correlation between production times of xylanase
and laccase activities suggested their synergistic action in
waste transformation (Iandolo et al. 2011).
In this manuscript an α-L-arabinofuranosidase was
identified by proteomic analyses of the enzymes responsible
for xylanase activity produced by P. ostreatus at the eighth
day of SSF on tomato pomace. The gene and cDNA
coding for this enzyme named PoAbf were cloned and
sequenced. A heterologous expression system was set
up for PoAbf in the yeasts Pichia pastoris and
Kluyveromyces lactis achieving the highest production
level of the secreted enzyme in the former host. rPoAbf
produced in P. pastoris was purified and characterized.
Materials and methods
Non-denaturing polyacrylamide gel electrophoresis
The zymogram analysis was performed by a modified
version of method reported by Ratanakhanokchai et al.
(1999). Samples from P. ostreatus (Jacq.:Fr.) Kummer
(type: Florida; ATCC MYA-2306) suspended in sodium
phosphate buffer (50 mM, pH 6.8) were subjected to
electrophoresis in an sodium dodecyl sulfate (SDS)-10%
polyacrylamide gel containing 0.1% birchwood xylan.
After electrophoresis, the gel was soaked in 25% (v/v)
isopropanol by gently shaking to remove the SDS and
renature the proteins in the gel. The gel was then washed
four times for 30 min at 4°C in 0.1 M acetate buffer
(pH 5.5). After further incubation for 60 min at 50°C, the
gel was soaked in 0.1% Congo red solution for 30 min at
room temperature and washed with 1 M NaCl until excess
dye was removed from the active band. After, the gel was
submerged in 0.5% acetic acid; the background turned dark
blue and the activity bands were observed.
In situ mass spectrometry analyses
Slices of interest from the non-denaturing polyacrylamide
gel electrophoresis (PAGE) on samples from P. ostreatus
(Jacq.:Fr.) Kummer (type: Florida; ATCC MYA-2306) were
destained by washes with 0.1 M NH4HCO3 pH 7.5 and
acetonitrile, reduced for 45 min with 100 μL of 10 mM
dithiothreitol in 0.1 M NH4HCO3 buffer pH 7.5 and
carboxyamidomethylated for 30 min in the dark with
100 μL of 55 mM iodoacetamide in the same buffer.
Tryptic digestion was performed by adding for each slice
100 ng of enzyme in 10 μL of 10 mMNH4HCO3 pH 7.5 for
2 h at 4°C. The buffer solution was then removed and 50 μL
of 10 mM NH4HCO3 pH 7.5 were added and incubated for
18 h at 37°C. Peptides were extracted by washing the gel
slices with 10 mM NH4HCO3 and 1% formic acid in 50%
acetonitrile at room temperature.
The peptide mixtures were filtered by using 0.22 μm
PVDF membrane (Millipore) and analysed using a 6520
Accurate-Mass Q-TOF LC/MS System (Agilent
Technologies, Palo Alto, CA, USA) equipped with a 1200
HPLC system and a chip cube (Agilent Technologies). After
loading, the peptide mixture was first concentrated and
washed on 40 nl enrichment column (Agilent Technologies
chip), with 0.1% formic acid in 2% acetonitrile as the eluent.
The sample was then fractionated on a C18 reverse-phase
capillary column (Agilent Technologies chip) at flow rate of
400 nL/min, with a linear gradient of eluent B (0.1% formic
acid in 95% acetonitrile) in A (0.1% formic acid in 2%
acetonitrile) from 7% to 80% in 50 min. Peptide analysis was
performed using data-dependent acquisition of one MS
scan (mass range from 300 to 1,800 m/z) followed by
MS/MS scans of the five most abundant ions in each MS
scan. MS/MS spectra were measured automatically when
the MS signal surpassed the threshold of 50,000 counts.
Double and triple charged ions were preferably isolated
and fragmented over single charged ions. The acquired
MS/MS spectra were transformed in mz.data format and
used for protein identification with a licensed version of
MASCOT 2.1 (Matrix Science, Boston, MA, USA). Raw
data from nanoLC–MS/MS analyses were used to query
the P. ostreatus database (http://genome.jgi-psf.org/
PleosPC15_2/PleosPC15_2.home.html; http://genome.jgi-
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psf.org/PleosPC9_1/PleosPC9_1.home.html) and the
Mascot search parameters were: trypsin as enzyme;
allowed number of missed cleavage, 3; carbamidomethyl
as fixed modification; oxidation of methionine; pyro-Glu
N-term Q as variable modifications; 10 ppm MS tolerance
and 0.6 Da MS/MS tolerance; peptide charge from +2 to
+3. Spectra with a MASCOT score of <25 having low
quality were rejected. The score used to evaluate quality
of matches for MS/MS data was higher than 30. Trypsin,
dithiothreitol, iodoacetamide, and NH4HCO3 were purchased
from Sigma. Trifluoroacetic acid-HPLC grade was from
Carlo Erba (Milan, Italy). All other reagents and
solvents were of the highest purity available from J. T.
Baker (Phillipsburg, NJ, USA).
Isolation and sequencing of gene and cDNA
Chromosomal high-molecular weight DNA from P. ostreatus
was prepared as described by Raeder and Broda (1988).
Total RNAs were extracted from lyophilized mycelia by
using QIAGEN RNeasy Plant (QIAGEN, Italy) and
following manufacturer's instructions. Reverse transcrip-
tion reaction was performed using MultiScribe™ Reverse
Transcriptase (Applied Biosystems, Branchburg, NJ,
USA) and the oligonucleotide dT-NotI as primer.
Products of the PCR experiments, performed using the
gene-specific oligonucleotides (Table 1), were cloned into
the p-GEM-T Easy Vector (Promega, Italy). Sequencing
by dideoxy chain termination method was performed by
PRIMM Sequencing Service (Naples, Italy) using universal
and specific oligonucleotide primers.
Analysis of gene and protein sequences
Sequence of gene and cDNA were deposited with the
EMBL Data Library under accession numbers HE565355
and HE565356, respectively. Alignments of DNA and of
deduced amino acid sequences were generated using
ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2/index.
html). Signal peptide prediction was achieved using
SignalP V2.0 (http://www.cbs.dtu.dk/services/). Potential
N-glycosylation sites (Asn-XXX-Ser/Thr) were computed
on the NetNGlyc 1.0 server (http://www.cbs.dtu.dk/services/
NetNGlyc/), and O-GalNAc (mucin type) glycosylation
sites were predicted on the OGPET 1.0 server (http://
ogpet.utep.edu/OGPET/).
Heterologous expression
Strains, media and plasmids
The Escherichia coli strain Top 10 (F-mcrA D
(mrrhsdRMS-mcrBC) f80lacZDM15 DlacX74 deoR recA1
araD139 D (ara-leu) 7697 galU galK rpsL (StrR) endA1
nupG) was used in all DNAmanipulations. E. coli was grown
in Luria–Bertani (LB) medium (in grams per liter: 10 bacto
tryptone, 10 NaCl, and 5 yeast extract) supplemented, when
required, with 100 μg ml−1 of ampicillin.
The K. lactis strain used for heterologous expression was
CMK5 (a thr lys pgi1 adh3 adh1URA3 adh2URA3) (Saliola
et al. 1999). Plasmid pYG132 (Saliola et al. 1999) was
engineered from pKD1, a plasmid originally isolated from
Kluyveromyces drosophilarum (Falcone et al. 1986) that
can replicate stably in K. lactis. Both K. lactis strain and
plasmid were kindly given by Prof. C. Falcone (University
“La Sapienza”, Rome, Italy). Insert expression is controlled
by the ethanol-inducible KlADH4 promoter (Mazzoni et al.
1992) and the Saccharomyces cerevisiae phosphoglycerate
kinase (PGK) terminator. K. lactis was grown in different
media, supplemented, when required, with 100 μg ml−1 of
geneticin G418: YPPG (in grams per liter: 10 yeast extract, 40
bactotryptone and 20 galactose), YPPD (in grams per liter: 10
yeast extract, 40 bactotryptone and 20 Glucose), YPPA
(in grams per liter: 10 yeast extract, 40 bactotryptone,
Table 1 List of primers used in
the amplification experiments Primer Nucleotide sequences Annealing temperature (°C)
5′ arabin-FW1 ATGTATCGACTCGCTGCACT 60°C
5′ arabin-FW2 ATGTAGGCCTTGGCCCTTG 60°C
5′ arabin-FW3 ATGTTTGAGGTAATGACAATGC 60°C
5′ arabin-FW4 ATGCACGACTCTCCTAGTATCAC 62°C
5′ arabin-FW5 ATGTTCATTCTGAATGATATGCA 60°C
5′ arabin-REV GCAGCCCCATCGATCGTCAC 66°C
Intarabin-FW GACGATCGATGGGGCTGC 62°C
Intarabin-REV GGCGACCGTTTGCAGGCG 62°C
3′ arabin-FW GCCACGCAATGGAATCACC 60°C
3′ arabin-REV CTACGACGCCTTGATAGTGA 60°C
contr pYG132 FW GGGAGAGCTCCAGCAGGGC 66°C
contr pYG132 REV GGTTCTACCAGCAGGGACGG 66°C
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and 20 L-arabinose), YPPX (in grams per liter: 10 yeast
extract, 40 bactotryptone and 20 xylose) and YPPWS
(in grams per liter: 10 yeast extract, 40 bactotryptone
and 20 wheat straw).
The “Easy Select Pichia Expression kit” (Invitrogen,
Carlsbad, CA, USA) was used for expression in P. pastoris
strain X33 following the manufacturer's instructions. pPICZB
was chosen as expression vector. Its expression cassette
includes the AOX1 promoter that allows methanol-inducible
high level expression and the AOX1 transcriptional terminator.
P. pastoris transformants were grown in BMGY (1% yeast
extract, 2% peptone, 1%(v/v) glycerol, 0.00004% biotin, 1.34%
yeast nitrogen base with ammonium sulphate and 0.1 M
potassium phosphate, pH 6.0) and BMMY, the same as BMGY
except that it contains 0.5% (v/v) methanol instead of glycerol.
Vector construction
The vectors pYG-abf and pPICZ-abf used for recombinant
expression of PoAbf in K. lactis and P. pastoris, respectively
were prepared cloning poabf cDNA in pYG132 (in HindIII)
under control of the ethanol-inducible KlADH4 promoter
(Piscitelli et al. 2005) and in pPICZB (in EcoRI/XbaI) under
control of methanol-inducible AOX1 promoter.
Yeasts transformation, cultivation and enzyme production
K. lactis transformation was performed by electroporation
with a Bio-Rad MicroPulser apparatus, as specified by the
manufacturer. The cells were spread on a YPPG medium
containing 100 μg ml−1 of geneticin G418, after an
overnight incubation at 28°C in YPPG. Agar plate assays
on YPPG supplemented with 100 μg ml−1 of geneticin
G418, 0.5% ethanol and 20 μg ml−1 of the chromogenic
substrate 4-methylumbelliferyl-a-L-arabinofuranoside
(MUA) (Carbosynth, Compton, Berkshire, UK) were used
to select transformants. The Abf-expressing clones were
identified under UV light by the presence of fluorescence
around the colonies after incubation at 28°C for 3 days.
100 uL of ethanol were added each day to the lid of the
plate to compensate for its evaporation. The transformed
clones were screened for PoAbf production by growing
them in 10 mL of selective medium (YPPG containing
geneticin) supplemented with 0.5% ethanol, at 28°C on a
rotary shaker (150 rpm). Ethanol (0.5%) was added daily
and samples were taken at intervals to measure optical
density and ABF activity. The best producing clone was
chosen to study PoAbf production. Inocula grown on
selective YPPG medium were used to seed flasks
(250 ml) containing 50 ml of selective medium (YPPG,
YPPD, YPPA, YPPX or YPPWS) starting from 0.6 OD600.
Cultures were grown at 28°C or 20°C on a rotary shaker for
7 days.
The recombinant plasmid pPICZB–abf was linearized by
PmeI hydrolysis and introduced into P. pastoris strain X33
by electroporation. The electroporationmixture was plated onto
YPD–zeocin agar medium. After 72 h at 28°C, the trans-
formant colonies were screened for activity production
on plates containing the chromogenic substrate MUA. P.
pastoris transformants were grown at 30°C in 20 mL of
BMGY in an incubator shaker until cell density (OD600)
reached the value of 20. The cells were inoculated in 50
mL BMMY in a 250-mL flask to an OD600=1 to start the
induction. The culture was kept in an incubator–shaker at
28°C for 15 days (200 rpm) with the addition of 0.25 mL
of methanol once a day to maintain induction. For
optimizing production, the best producing clone, after
growth at 28°C in 20 mL BMGY to an OD600=20, was
inoculated in 50 mL of two modified versions of BMMY
containing 1% or 1.5% (v/v) methanol and incubated at
28°C or in BMMY at 20°C.
Enzyme activity assays
Xylanase activity assay
Xylanase activity assay was performed according to Bailey
et al. (1992). The reaction mixture consisting of 1.8 mL of a
1.0% (w/v) suspension of birchwood xylan in 50 mM Na
citrate at pH 5.3 and 0.2 mL of enzyme dilution (in 50 mM
sodium citrate at pH 5.3) was incubated at 50°C for 5 min.
Released reducing sugars were determined by DNS
method, by adding 3 ml of DNS solution and then
incubating the mixture at 95°C for 5 min. Absorbance
was measured at 540 nm. One unit of enzyme is defined as
the amount of enzyme catalyzing the release of 1 μmol of
xylose equivalent per minute.
α-L-arabinofuranosidase activity assay
α-L-Arabinofuranosidase activity was determined
according to Yanay and Sato (2000). The activity was
measured by spectrophotometric method with p-nitro-
pheny l α - L - a r ab ino fu r anos ide (pNPA) (Go ld
Biotechnology, St Louis, MO, USA) as substrate. The
assay mixture contained 200 μL of the substrate solution
(2 mM pNPA in 50 mM sodium phosphate buffer pH 6.5)
and 200 μL of appropriately diluted enzyme solution.
After incubation at 30°C for 10 min, the reaction was
stopped by the addition of 1.6 mL of 1 M Na2CO3. The
liberated p-nitrophenol in the mixture was measured by
spectrophotometry at 405 nm (ε=17,000 M−1 cm−1). One
unit of α-L-arabinofuranosidase activity was defined as
the amount of enzyme releasing 1 μmol of p-nitrophenol
per minute in the reaction mixture under these assay
conditions.
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PoAbf purification
Proteins secreted by rPoAbf expressing P. pastoris were
precipitated from the medium (after cell removal by
centrifugation at 5,000×g for 10 min) by the addition of
(NH4)2SO4 up to 80% saturation at 4°C and centrifugation
at 10,000×g for 30 min. The precipitate was resuspended in
0.02 M Tris–HCl pH 7.5 and loaded on HiTrap Phenyl FF
high sub (GE Healthcare, Uppsala, Sweden) equilibrated in
buffer A (0.02 M Tris–HCl, 1.2 M (NH4)2SO4, pH 7.5),
and the proteins were eluted isocratically with buffer B
(0.02 M Tris–HCl pH 7.5). Fractions containing activity
were combined and concentrated on an Amicon PM-10
membrane and analyzed by SDS-PAGE.
Protein concentration determination
Protein concentration was determined by the method of
Lowry et al. (1951), using the BioRad Protein Assay
(BioRad Laboratories S.r.l., Segrate, MI, Italy), with bovine
serum albumin as standard.
Determination of molecular mass
The molecular mass of rPoAbf produced by P. pastoris was
determined by using a Superdex 200 HR 10/30 column (GE
Healthcare, Uppsala, Sweden). The column was eluted with
50 mM Tris–HCl buffer, pH 7.0, containing 150 mM NaCl.
The calibration was performed with thyroglobulin
(669 kDa), apoferritin (440 kDa) alcohol dehydrogenase
(150 kDa), bovine serum albumin (67 kDa), and ovalbumin
(45 kDa) as standards.
Optimum temperature and temperature stability
To determine the optimum temperature of the purified enzyme,
the substrate of the activity assay (2 mM pNPA) was dissolved
in 50 mM sodium phosphate buffer pH 6.5 and the incubation
(10 min) was performed at 30°C, 40°C, 50°C, 55 C and 60°C.
The temperature stability of rPoAbf was studied by incubating
the purified enzyme preparation in 50 mM citrate phosphate
buffer pH 5.0, at 30°C, 40°C, 50°C and 60°C. The samples
withdrawn were assayed for residual α-arabinosidase
activity performing incubation (10 min) at 40°C. The
experiments were performed in duplicate and reported
values are representative of three experiments.
Optimum pH and pH stability
To determine the optimum pH of the purified enzyme, the
substrate of the activity assay (2 mM pNPA) was dissolved
in citrate phosphate buffers (McIlvaine 1921) with pH
values between 3.0 and 7.0 and in 50 mM Tris–HCl with pH
values 7.0 and 8.0 and the incubation (10 min) was performed
at 40°C. The pH stability of the purified enzyme preparation
was studied by diluting it in citrate phosphate buffers,
pH 3–8 and incubating at 25°C. From time to time,
samples were withdrawn and immediately assayed for
residual α-arabinosidase activity performing incubation
(10min) at 40°C. The experiments were performed in duplicate
and reported values are representative of three experiments.
Assays of enzyme specificity
Activity of PoAbf was assayed against the substrates pNP-
α-L-arabinofuranoside (Carbosynth, Compton, Berkshire,
UK), pNP-β-D-xylopyranoside (Carbosynth, Compton,
Berkshire, UK), pNP-α-D-glucopyranoside (Carbosynth,
Compton, Berkshire, UK) pNP-β-D-glucopyranoside
(Carbosynth, Compton, Berkshire, UK) and oNP-β-D-galac-
topyranoside (Carbosynth, Compton, Berkshire, UK) at
concentrations in the range 0.1–6 mM in citrate phosphate
buffer (McIlvaine, 1921) at pH 5.
Activity against the natural substrates CM-linear arabinan
and larch arabinogalactan, and the arabinooligosaccharides
1,5-α-arabinotriose and 1,5-α-arabinohexaose (Megazyme
International Ireland, Co. Wicklow, Ireland) was assayed
measuring the liberation of arabinose as equivalent of
galactose, by means of the D-galactose/lactose kit
(Megazyme International Ireland, Co. Wicklow, Ireland),
following the manufacturer's instructions. 600 mU (measured
on pNPA) of PoAbf were incubated with 0.2% arabinans in
100 mM sodium acetate buffer pH 4.6, at 37°C for 72 h
(final volume, 300 μL). Arabinooligosaccharides were dis-
solved in 100 mM sodium acetate buffer pH 4.6 and incubated
with 7 mU (measured on pNPA) of PoAbf at 37°C for 1 h
(final volume 300 μL). The activity of PoAbf against
AZO-wheat arabinoxylan (Megazyme International Ireland,
Co. Wicklow, Ireland) was assayed following supplier's
instructions. The experiments were performed in duplicate
and reported values are representative of three experiments.
Determination of kcat and KM
For determination of the Michaelis–Menten constants KM
and kcat, the activity assay was performed at pNPA
concentrations from 0.1 mM to 2.0 mM at pH 5.0
performing incubation of 10 min at 40°C. The experiments
were performed in duplicate and reported values are
representative of three experiments.
Mass spectrometry analyses of rPoAbf
α-L-arabinofuranosidase was dissolved in denaturant buffer
(Tris 300 mM pH 8.0, urea 6 M, EDTA 10 mM), and
disulfide bridges were reduced with DTT (tenfold molar
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excess on the Cys residues) at 37°C for 2 h and then alkylated
by adding IAM (fivefold molar excess on thiol residues) at
room temperature for 30 min in the dark. Protein sample was
desalted by size exclusion chromatography on a Sephadex G-
25M column (GE Healthcare). Fractions containing protein
were lyophilized. Lyophilized fractions were dissolved in
10 mM AMBIC buffer pH 8.0. Enzymatic digestion was
performed using both trypsin and V8 protease using an
enzyme/substrate ratio of 1/50 (w/w) at 37°C for 16 h.
MALDI–MS experiments were performed on a Voyager-DE
STR MALDITOF mass spectrometer (Applied Biosystems,
Framingham, MA, USA) equipped with a nitrogen laser
(337 nm). Of the total mixture, 1 μL was mixed (1/1, v/v)
with a 10-mg mL−1 solution of α-cyano-4-hydroxycinnamic
acid in ACN/50 mM citrate buffer, 70/30 (v/v). Spectra were
acquired using a mass (m/z) range of 400–5,000 amu.
Results
Enzyme identification
The native PAGE showed that two different xylanase bands
can be detected analyzing the second and the eighth days of P.
ostreatus (Jacq.:Fr.) Kummer (type: Florida; ATCC MYA-
2306)-SSF on tomato processing residues, when maximum
level of xylanase activity—related to any enzyme acting on
any part of xylan—was reached (Iandolo et al. 2011). The
activity positive protein band with lower electrophoretic
mobility produced at the eighth day was excised from a
preparative, non-denaturing gel and analyzed by proteomics.
By comparison with genome sequences of the monokaryon
strains P. ostreatus PC15 (http://genome.jgi-psf.org/
PleosPC15_2/PleosPC15_2.home.html) and PC9 (http://
genome.jgi-psf.org/PleosPC9_1/PleosPC9_1.home.html), the
protein was identified as an α-L-arabinofuranosidase—
having the ID 29657 in P. ostreatus PC15 and 94793 in P.
ostreatus PC9 strains—that was named PoAbf. The fact
that, even if xylanase activity had been found, an
arabinofuranosidase was identified can be explained
considering that arabinoxylan is used as a substrate and
that this substrate contains arabinose side branches on which
the enzyme seems to act. The time course of α-L-arabinofur-
anosidase activity was then analyzed during P. ostreatus SSF
on tomato processing waste by using the pNPA as substrate,
thus demonstrating the presence of a peak of around
0.18 Ug−1 dry matter at the sixth day of fermentation.
Sequences of the poabf gene and cDNA and its derived
protein
Analysis of genome sequence of the monokaryon P.
ostreatus strain PC15 showed that the gene with ID
29657 is interrupted at the 5′ region and does not contain
any start codon. On the other hand, a complete coding
sequence was identified in the monokaryon P. ostreatus
strain PC9 for the gene with ID 94793. However, analysis
of the deduced amino acid sequence corresponding to the
latter gene according to the annotated version showed that it
lacks the signal peptide, in spite of the demonstrated
extracellular nature of the analyzed α-L-arabinofuranosi-
dase. The analysis of genome sequence of PC9 strain
upstream of the annotated start codon allowed design of
different oligonucleotides to be used in PCR experiments to
amplify cDNA coding for the investigated protein in the
dikaryon strain P. ostreatus ATCC MYA-2306. This cDNA
was synthesized by PCR on RNA extracted from P.
ostreatus grown on tomato processing residues at the eighth
day of SSF using as primers oligonucleotides (Table 1)
whose sequences were designed on the basis of genome
sequence to amplify three overlapped fragments. By
carrying out PCR experiments of the 5′ region with different
primer oligonucleotides at the 5′ end (5′ arabin-FW1-5) in
combination with the same oligonucleotide at the 3′ end (5′
arabin-REV), it was possible to ascertain the start codon of
poabf, considering which oligonucleotide gave the most 5′
extended region. poabf gene was also synthesized by PCR
on P. ostreatus ATCC MYA-2306 genome.
The cDNA coding for PoAbf has an open reading frame
of 1,941 bp and it codes for a protein of 646 amino acids. A
unique signal peptide sequence of 20 amino acids could be
singled out, which satisfied criteria for a “minimal” signal
sequence (von Heijne 1985).
The mature protein is 626 amino acids in length and has
a calculated molecular mass of 68,912.51 Da. The coding
sequence is interrupted by 25 introns as detected when the
cDNA and gene sequences were compared. The intron size
ranges from 46 to 112 bp. All introns are flanked by the
consensus sequences GT.AG (Kupfer et al. 2004). No
potential N-glycosylation site (Asn-X-Ser) was found in
PoAbf deduced amino acid sequence, while Ser160 and
Thr187 were identified as potential O-GalNAc (mucin type)
glycosylation sites within the patterns T-n-GST-n-VS and
T-n-RTT-n-PS, respectively.
Similarity searches were performed with Basic Local
Alignment Search Tool (BLAST) using the deduced
amino acid sequence of PoAbf as the query and a library made
with the sequences of experimentally characterized family
GH51 enzymes (http://www.cazy.org/GH51_characterized.
html) extracted from the Carbohydrate-active enzymes
database (http://www.cazy.org/, Cantarel et al. 2009). The
best hit (62% identities) was with an α-L-arabinofuranosidase
from Meripilus giganteus (EMBL accession CAL81200.1;
Sørensen et al. 2006), followed by several enzymes from
Aspergillus spp. (EMBL accessions BAB96815.1,
BAB21568.2, AAC41644.1, etc.) displaying ~35% identities
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with PoAbf. Plant and bacterial GH51 ABFs gave lower
scores, typically less than 30% identities. The distribution of
genes encoding enzymes similar to PoAbf was examined by
performing a BLAST search (conducted on Sept 22, 2011)
on the non-redundant protein sequence databank of the
NCBI. The results revealed that only a limited number of
fungi have GH51 enzymes with over 50% identity to PoAbf,
namely Leucoagaricus gongylophorus, Serpula lacrymans,
Schizophyllum commune, Postia placenta and Coprinopsis
cinerea. All other fungal hits showed less than 40%
sequence identity with PoAbf, hinting at possible differences
in substrate or product specificities.
The family GH51 glycoside hydrolases have a catalytic
mechanism with retention of configuration with two
glutamates involved in catalysis (one acting as an acid/base
and the other as a nucleophile) (Henrissat et al. 1995).
Three-dimensional structures of family GH51 ABFs have
been obtained for two bacterial enzymes, namely from
Geobacillus stearothermophilus (Hövel et al. 2003) and
Clostridium thermocellum (Taylor et al. 2006). The
catalytic domain is a (β/α)8 barrel, and the active site
glutamates are found at the C-termini of strands β-4 (acid/
base) and β-7 (nucleophile) (Taylor et al. 2006). Based on
this information and the sequence alignment, the proposed
catalytic glutamates of PoAbf are located at positions 364
(acid/base) and 471 (nucleophile).
Recombinant expression system
The enzyme α-L-arabinofuranosidase secreted by P. ostrea-
tus, PoAbf, was expressed in K. lactis and P. pastoris. The
poabf cDNA sequence was optimized for yeast recombi-
nant expression by adapting it to the yeast codon usage and
avoiding its hydrolysis by the endonucleases adopted for
the cloning. Synthesis of this cDNA was performed by
MrGene (http://mrgene.com).
K. lactis transformants
When the production of recombinant α-L-arabinofuranosi-
dase in K. lactis was assayed on plates containing MUA as
substrate, around 20% of transformants caused a fluores-
cence emission after 3 days. Eighteen recombinant clones
were grown in liquid cultures and evaluated for Abf
production by assay with pNPA. The amount of extracel-
lular α-L-arabinofuranosidase activity produced after 7 days
ranged from (0 to 3.50)×10−3U mL−1. The best producing
clone was used to optimize production of rPoAbf and study
the time course of recombinant α-L-arabinofuranosidase.
Cultures were carried out to improve α-L-arabinofuranosi-
dase production, varying the growth conditions. Decreasing
the growth temperature from 28°C to 20°C led to a 10-fold
increase of activity production. Comparison of growth time
courses at the two temperatures showed only a slight delay of
yeast growth due to the temperature decrease. Glucose,
galactose, L-arabinose, xylose and wheat straw were tested
as carbon sources. The maximum activity level was obtained
at the seventh day with all the tested substrates. The highest
production of secreted activity was achieved at 20°C in the
medium containing glucose (62.0×10−3U mL−1), fol-
lowed by those containing xylose (49.72×10−3U mL−1),
galactose and wheat straw (35.55×10−3U ml−1) and
arabinose (20.36×10−3U mL−1).
P. pastoris transformants
All the P. pastoris transformant clones were proven to
secrete recombinant α-L-arabinofuranosidase activity as
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Fig. 1 Effect of growth temperature on α-arabinofuranosidase activity levels produced by P. pastoris recombinant clone
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shown by assay on plates containing MUA as substrate,
giving fluorescence emission after 3 days. Seventeen
recombinant clones were grown in liquid cultures and
evaluated for Abf production. The maximum amount of α-
L-arabinofuranosidase activity produced after 15 days was of
30×10−2U mL−1, corresponding to 8.3mU O.D.−1, in culture
supernatant and of 1.2 mU O.D.−1 in the cellular extracts.
The best producing clone was used to optimize rPoAbf
production, study the time course of α-L-arabinofuranosi-
dase production and characterize the recombinant enzyme.
It was shown that rPoAbf production increases linearly for
at least 1 month. Cultures were carried out to improve α-L-
arabinofuranosidase production, varying the growth condi-
tions. Increasing methanol concentration from 0.5 to 1 and
Table 2 MALDI–MS analysis of the reduced and carboxamidomethylated rPoAbf digested with trypsin
Peptide m/z Sequence
1-3 469.28 MYR
352-357 643.40 RAALGR
104-110 747.43 FTVPAGR
255-261 758.46 GQTVPTR
543-551 1033.60 YIPSTLPSR
481-489 1041.53 AAYMIGMER
383-391 1073.65 WPAFVNALR
552-561 1095.60 TGTAFWGVTR
244-254 1297.68 FFRFPGGNNLE
91-103 1369.79 SVPVSNSLPNSLR
226-239 1447.74 ANGMRDDIATALAE
156-170 1546.90 TTSGSTIVSQTVPIR
111-125 1547.76 TGQVGFANSGFFGMK
247-261 1586.81 FPGGNNLEGQTVPTR
171-186 1717.95 GASTSWQQISVSLTPR
358-372 1723.92 AQPFKLTYVEIGNED
628-644 1786.95 TFTFAAAGFSVNVITIK
240-254 1782.00 MKPKFFRFPGGNNLE
226-243 1931.99 ANGMRDDIATALAEMKPK
44-61 1945.01 DISHSGDGGLYAELLQNR
450-468 1965.03 YAAISTNPNDIFGSPANGR
534-551 2027.07 LFSTNMGNEYIPSTLPSR
244-261 2037.06 FFRFPGGNNLEGQTVPTR
552-571 2136.10 TGTAFWGVTRNTATGEIIIK
448-468 2151.11 GEYAAISTNPNDIFGSPANGR
441-468 2961.42 NGVTFYEGEYAAISTNPNDIFGSPANGR
469-489 2281.07 LTFSTMQSASGEAAYMIGMER
104-125 + Oxidized Met 2292.19 FTVPAGRTGQVGFANSGFFGMK
134-155 2345.26 GSFFVKFPTASSFTGNLIVGLR
363-382 2404.19 LTYVEIGNEDFFASDTYTYR
372-398 3167.65 DFFASDTYTYRWPAFVNALRGAFPNLK
140-170 + GalNacHex 3572.62 FPTASSFTGNLIVGLRTTSGSTIVSQTVPIR
140-170 + GalNacHex2 3734.80 FPTASSFTGNLIVGLRTTSGSTIVSQTVPIR
490-525 3865.11 NSDIVFAASYAPLLGHVAGSQWTPNLIAFD TGNVYR
187-223 3967.06 TTPPSTDNQFFVTIDGAAASGQTINFAMFS LFPPTFK
51-90 4111.13 GGLYAELLQNRALQQVTPNTAASLNAWSAI NGGQISVVAD
62-103 4247.44 ALQQVTPNTAASLNAWSAINGGQISVVADS VPVSNSLPNSLR
126-170 4722.30 IVASSTYKGSFFVKFPTASSFTGNLIVGLR TTSGSTIVSQTVPIR
441-489 5224.16 NGVTFYEGEYAAISTNPNDIFGSPANGRLT FSTMQSASGEAAYMIGMER
Ser160 in bold is glycosylated
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1.5% causes a decrease of rPoAbf production by 2.5- and 4-
fold, respectively, while decreasing the growth temperature
from 28°C to 20°C lead to an increase of activity production
(up to 1.1 UmL−1 after 15 days) (Fig. 1). Enzyme activity was
also found in intracellular protein fraction at both analyzed
temperatures (Fig. 1).
rPoAbf characterization
The enzyme purified to apparent homogeneity was
subjected to structural and functional characterization
as described below. The estimated molecular weight
deduced from SDS-PAGE is 81,500 Da, considerably
larger than that deduced from cDNA sequence (data not
shown), probably due to an anomalous hydrodynamic
behavior during electrophoretic separation on SDS-
PAGE as expected from a glycosylated protein (see
below). Using chromatography in a calibrated Superdex
200 HR 10/30 column (GE Healthcare, Uppsala,
Sweden), a molecular weight of 39,000 Da was obtained for
the native enzyme (data not shown). These results
indicate that PoAbf is a monomer. The reason for the
smaller apparent molecular weight in gel filtration could
be retarded migration of the α-arabinosidase in the gel
matrix, as was also reported for the α-arabinosidases
and xylanases of Trichoderma reesei (Lappalainen 1986;
Poutanen 1988). The presence of a galactose-binding
domain like in the enzyme could be the reason for its
binding to the column material.
Mass spectrometry analyses of rPoAbf allowed us to
map 77.9% of the total amino acid sequence and the results
are summarized in Table 2. Mass spectral analyses led to
the localization of a single O-glycosylation site at level of
Ser160, while Thr187 was found unmodified. Figure 2
shows the partial MALDI–MS spectrum obtained from the
analysis of the tryptic peptide mixture of rPoAbf. The
spectrum shows the occurrence of a signal at m/z 3572.62
assigned to peptide 140-170 modified with an oligosaccha-
ride chain containing a GalNac and an Hexose moiety;
moreover it is evident that the presence of a signal at m/z
3743.80 was attributed to the same peptide carrying a
GalNacHex2 oligosaccharide moiety thus indicating the
heterogeneity of O-glycosylation at Ser160.
The enzyme follows Michaelis–Menten kinetics towards
pNPAra: the KM for this substrate is 0.64±0.11 mM and the
kcat 3,010±145 min
−1. The pH optimum for the enzyme
(assayed in a range from 3–8) is 5 (Fig. 3a) and the optimal
temperature is 40°C (Fig. 3b). PoAbf shows a half life of 17 h
at 50°C and few minutes at 60°C, while it retains 100% of its
activity for at least 1 week at 30°C and 40°C. PoAbf shows
very high stability in a broad range of pH (T1/2 pH 3=24 days;
T1/2 pH 5=51 days; T1/2 pH 7citrate–phosphate buffer=38 days; T1/2
pH 7Tris–HCl buffer=42 days; T1/2 pH 8=38 days).
The hydrolyzing ability of rPoAbf was tested versus a
series of other nitrophenyl glycosides: pNP-β-D-xylopyrano-
side, pNP-α-D-glucopyranoside, pNP-β-D-glucopyranoside,
and oNP-β-D-galactopyranoside. Among these compounds,
only pNP-β-D-glucopyranoside was recognized by the
Fig. 2 Partial MALDI–MS spectrum obtained from the analysis of the tryptic peptide mixture of rPoAbf
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enzyme and a KM of 3.79±0.12 mM and a kcat of 9.3±
0.5 min−1 were measured for this substrate.
The enzyme was shown able to hydrolyze both the tested
arabinooligosaccharides 1,5-α-arabinotriose and 1,5-α-arabi-
nohexaose (Table 3). PoAbf is active on CM-linear arabinan
(Table 3), while it does not hydrolyze larch arabinoga-
lactan. Moreover, when the enzyme was incubated with
the AZO-wheat arabinoxylan, it was shown to possess an
endo-1,4-β-xylanase activity of around 0.55±0.08 UmL−1.
Discussion
To the best of our knowledge, this is the first report on
the cloning, recombinant expression, purification and
characterization of α-L-arabinofuranosidase from the
genus of Pleurotus. This α-L-arabinofuranosidase was
identified analyzing the enzymes responsible for xylanase
activity produced by P. ostreatus SSF on tomato pomace.
The gene and cDNA coding for this enzyme named PoAbf
were cloned and sequenced. Analysis of the amino acid
sequence of PoAbf places the enzyme in family 51 of the
glycoside hydrolases.
A heterologous expression system was set up in the
yeasts P. pastoris and K. lactis using the leader sequence of
PoAbf in both the expression systems and the highest
production level of the secreted enzyme (180 mg L−1) was
achieved in the former host. Decreasing growth temperature
from 28°C to 20°C caused an increase of recombinant
expression level of extracellular enzyme of around three-
fold. Comparison of production levels of intracellular
recombinant enzyme at the analyzed temperatures allowed
us to demonstrate that the low temperature favors the
production but it does not improve protein secretion. Many
studies have demonstrated that temperature is a critical
parameter in P. pastoris growth and recombinant protein
production, in both batch and fed-batch systems and it has
been reported that reducing induction temperature to 20°C
or even lower values is beneficial for the efficient
expression of heterologous proteins in P. pastoris. A
common opinion accounting for this effect lies in the fact
that lowering temperature could at least help to reduce cell
Table 3 Arabinose liberation from natural substrates and
arabinooligosaccharides
Substrate Amount of released sugar (μg/mL)
Larch arabinogalactan 0
CM-linear arabinan 327±24
Arabinotriose 112±18
Arabinohexaose 102±26
Equivalents of galactose were measured as described in section
“Material and methods”
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skeleton lysis and protease secretion when cultivated on
methanol, besides reducing cell death. Jin et al. (2010)
reported that lowering induction temperature from 30°C to
20°C causes a 100-fold increase of recombinant production
of Porcine interferon-α in P. pastoris. A reduction of
temperature from 30°C to 25°C or 20°C resulted in a 2- and
3-fold increase of the specific productivity of the 3H6 Fab
fragment, respectively (Dragosits et al. 2009). Li et al.
(2001) showed that the increase of the recombinant
production of herring antifreeze protein at lower temperature
might benefit from the better protein folding. In fact,
cultivating the cells at lower growth temperatures induces
the rate of protein synthesis and thus may allow the nascent
peptide chains to fold properly. By lowering the induction
temperature to 22°C, also recombinant polygalacturonate
lyase activity exhibited a 2.9-fold increase compared to
cultivation at 30°C (Wang et al. 2009).
In all the other expression systems so far set up in P.
pastoris, α-L-arabinofuranosidase was expressed under the
control of yeast signal peptide. When compared with the
other α-L-arabinofuranosidase recombinant expression
systems, the system hereby reported showed similar or
better yields, in terms of both units per milliliter and
milligrams per liter. Particularly, our system was proven
to be more efficient than the other recombinant
expression systems so far reported in P. pastoris, where
an expression yield of 20 mg L−1 for the α-L-arabinofur-
anosidase B from Aspergillus kawachii (Miyanaga et al.
2004) and of 0.2 UmL−1 for the α-L-arabinofuranosidase
from Trichoderma koningii (Wan et al. 2007) was
achieved. Yields obtained in S. cerevisiae expression
systems ranged from 0.013 UmL−1 for the α-L-arabinofur-
anosidase from Aureobasidium pullulans (Wan et al. 2007)
to 1.40 UmL−1 for Aspergillus niger α-L-arabinofuranosi-
dase (Crous et al. 1996). Similar activity levels were achieved
with E. coli expression systems, giving 0.94 UmL−1 (Lee et
al. 2011) for the α-L-arabinofuranosidases from Penicillium
sp. LYG 0704, 1.48 Umg−1 for the α-L-arabinofuranosidase
from Fusarium oxysporum f. sp. dianthi (Chacòn-Martìnez
et al. 2004) and 1.2 UmL−1 (Shi et al. 2010) for the α-L-
arabinofuranosidase from Streptomyces sp. S9.
rPoAbf produced in P. pastoris was purified and
characterized, and it was shown to have some properties
similar to the other members of family 51 ABFs (Numan
and Bhosle 2006). Their subunit molecular weight
generally ranges from 56–81 kDa. All enzymes show an
acidic pH optimum and a value of KM for pNPAra ranging
from 0.5–0.8 mM.
PoAbf revealed to be a versatile enzyme able to work on
arabinooligosaccharides, with a higher affinity for the
shorter ones, and on the natural polysaccharides linear
arabinan and arabinoxylan, displaying both exo- and
endoxylanase activities. It is worth noting that PoAbf
shows very high stability in a broad range of pH,
mostly at acidic pH, while most of other α-L-arabino-
furanosidases were proven to be less stable, such as
recombinant arabinofuranosidase from Streptomyces sp.
9 that totally lost its activity after incubation for 1 h at
pH 4 (Shi et al. 2010), or A. pullulans α-L-arabinofur-
anosidase that shows a half life of 29 min at pH 3 (Wan et
al. 2007). PoAbf stability at pH 3 is also higher than
stability of α-L-arabinofuranosidase from T. reesei
(Poutanen 1988). The highly durable activity of rPoAbf
enhances its potential for biotechnological applications
and increases interest in this enzyme as a candidate for
mutagenesis experiments aimed at elucidating the molec-
ular bases of its peculiar properties.
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